>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bLsbRsRsmbRsbLibLsLgbLcbRgbRsRsmbRsRgbRsRsmbRsbRgbRsbRgbRgbRsbRsRsmbRs
RsmbRsRsmbRsRsmbsbRebLiLsbRibRjLsRsbLgbRebsbLgbLcLjLobLobRsRsmbRgbRsbR
sbRsbRsRsmbRsbRsRsmbRsbRsRsmbRsRsmbsbRsbRsbLsRsbRcbLobRobLiLsbLgbLsbLs
LsmbLsbsbLsRsbLsbLsbLsbLsLsmbLsbLsbsbRsRsmbRsbRsbRsbLsRsbLsbLsLsmbLsbL
sbRsbLsbLsbLsbLsbLsbLsbLsbLsbLsbRsLsbLsLsmbLsbLsbLsbsbLsLsLsmmbLsbLsbL
gRsbRgLsRsbLsLsmbLsRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bLcbLcRsbRgbRsLsRsbRsRsLsmbLebLsLsmbLcbLebLsLsmbLjbLobLsLibLebRsRsmbRc
bRgRsmbRjRjRsmbLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLibRgLsbLibLgLsbLsLsmbLsbLebLebLsbLsLsmbLgbLgbLgLiLgbLgbRsbLibLibLsLs
mbLsLsmbLsLsmbLsLsmbLsbLgbLsLsmbLsbLgbLsbLsbLgLobLsLsmbRgbLsLsRsmbLsbL
ibRobsbLjLsmbLsbLsbLobLhbRiLsbLsbLgbLsbLjRsbLcLsmbRsbRsbLgbLibLibRsbRo
bRibRsbsbsbLsbRibRsLsbRsRsmbRsbRsbRsRsmbRobLsbLoLsmbRcRsmbLgbLoRsLibLs
LgbLsbRcbLibLhLsbLsLsmbLibLcLibLcbLiLsLsRsLsmbLgbLgLsLsmbLgbLgbLgRsbLg
bLibLgLsbLgbLgbLgLsbLgLsbLsbLgLsbLiLhbRsbRgLsbRgLsbRsbRsbRsbRsbRsbLsbL
hLsbLsbLiRsbLsLsmbLcLibLcLsLsmmbLsLsLsmmbLsbLibRsbLcbLibLcLgLcLiRsbLgL
sbLsbsbLsbLsbsbLgLsbLgbLsbLsbLsLsmbLgLsbLgbLgbLgbLgbLgLsbLgbLsLsmbLgLs
LsmbLgbLgbLgbLgbLsbLgRsbLsbLgLsbLgRsbLgRsbLgRsbLsbLgbLgRsLsbLgbLiLsbLi
bLcLhbLcLsmbLsLsmbLcLgbLcbLsRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRsbRibRsRsmbRsbRsbRgbRgbRsbRsbLsRsRsmbRsbRsbRsbRsbsbRsbRgRsmbRg
bRsbRgbLgbRgbRgbRgbRsbRgbRsRsmbRsRsmbRsbLsRsRsmbLsRsbLsRsbLsRsbLsRsbRg
bLsRsLsbLsRsbLsbRgbRgbLsRsRsmbRsRsmbRsbRsbRgbRsRsRsmmbRsbRsRsmbRsLsLsR
sLsmbLsLsRsmbLsRsbLsRsRsmbLsLsRsRsmmbRsRsmbRsbLibRsRsmbLsbLsRsRsmbLsLs
mbLsRsbRsRsmbRsbRsRsRsmmbRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRgRhbLgbRsbRobLsRjRsmbLsRoLsLiLsbLgLgLsbLibLgLobLgbRebRsRsmbRgbRgbRgb
RgLobLeLsbRgbRsRsmbLsbRsLgRsbLgbLgLsbRsLsbRsLsbLsbLsLsmbLsbLgLsLgRgbRh
bLeLcbLibRjbRsLsbRsbRibRobRibLsbLgbLsLsmbLgLsbLgbLgbRoRgbLibLjbRobRebL
ibRibRobLjbRgRsmbRgbLjbLgbLiLsbRsbRcRhbRibLsbLibLgbsbsbsbRsbRiRsmbLsbs
bLsbRsLsbRsLsRsbLsbRoLsbRibsbLgbsbLsbLgbLsbLsLsmbRsLsbLsLsmbLsLsmbRsLs
LsmbLsbLsbLsLsmbLgbLsbLsLsLsmmbLsLsmbLsbLsLsLsmmbLsRsbLsLsLsLsmmmbLgRs
bLsLsLsmmbLsbLsbLsLsmbRjbRoLsbLsLsmbRhLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRibRsRsmbRsbLcbLsbRsbLibLgbLgRsbLgbLgbLibLgbLsLsLsmmbLsLsmbLsbLoRsbRg
bRsbLsbRibRibRjbLsRsbRsbRsRsmbRsbRsRsmbRsbRsbRgLsbRsRsmbRsLsbRsbRsbLob
RsLsbRcbRjRsmbRjRsmbLsLsmbLsRsRsmbRgRsRsRsRsRsmmmmmbLsbRsRsmbRsRgbRsRs
RsRsRsmmmmbRsRsmbRsbsbRsbLsRsLsbRsbRsRsmbRsbRsRsmbRsLsRsRsmbRsRsmbsbsb
RsRsRsmmbRsbRsbRsRsRsRsLsmmmbRsRgbRsbRgbRgbRsbLsbRsbRsRsmbRsLsbRsbRebL
sbRgbRsbRsbRsbRsbRsRsRsRsRsmmmmbRsRsRsmmbRgRibLcbRhRebRsbRsbRsbRsbRsbR
gRsmbRgbRjbRgRsmbRsbRsbRsbsbRsbRsbRsbRsbRsbRsbRsbRsbRgRsmbRsRsRsRsmmmb
RgRsmbRgbRgRsRsmmbRgRsmbRgRsmbRcLsLsmbRsbRgRsmbRiLsbRoRgbLsbLsbLiLgbLg
bRsbLsbLsbLsLsLsmmbLsLgbLsLsmbLsLsLsmmbsbLsbLsLsmbLsLsLsmmbLsLsmbRsbLs
LsmbsbLsbLsbLsbLsbLsbLsbLsbLsbRsLsbLgbLsbRsbLsbLgbLsLsLgLsmbLgbRsbLsbL
gbLgLsbLgLsbLsLsLsLsmmmbLgbLgbLgLcLsmbRebRibRgbRsbLgRsbRsbRsbRsbRsbRsb
RsbRsbRsbRsbRsbRsbRsbRgbLsbRsbRsbRsbRsRsmbRsbRsbsbRsbLsbRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bsbLgbLsbLibLibLib

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bLobLcbLibRoRsmbLcbRgbRsRsmbRgbRgRsmbRsRsRsLsmmbRsbRgRsmbRsbRsbRsRsmbL
sLgRsRsmbRgRgbRgRsRsRsRsmmmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bLsbLiRsLsbLgbLsLsRsmbLsbLsLsmbLsLsmbLgbRcbRebRibRgLsbRsLsbRgbRsbReRsL
smbRibLsbLsRsbLibRsbLsbLebLibLgRsbRgbRsbLsbLsbRsbRibRcRsmbLgbLsLsLsmmb
LgRsbLgbLsRsbRsbRjRebRgRsmbLsLsmbRsbLsbRsbRsbRsbRsbLsRsbRsbRsRsmbRsRsm
bRsRsRsRsmmmbRsRsmbRsRsmbRsRsmbRgbRsRsRsRsmmmbRgbLsLsLsmmbRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLsbLsLsmbLgbLgLsbLgbLsLgLsRsbLcLsmbRsbRsbRibRjbLsRhbRgbRsRsmbRjLsbRgR
smbRibLcbLcbLibLsbLibLgLsbLgLgbLsLsmbLsbLgLsbLgbLsLsRsmbLibLsLsLsmmbLs
bLgbLsLsmbLibLcbRibRsRsmbRsbRcRsmbRhbRcbLhbLcbLhbLsbRgbLjLsmbLjLsmbLgb
LiRsbLhLsbLhLsbLibLhLgbLsLsmbLgLsbLsLsmbLiRsbRsLsbLsLsmbLgbRsbLsLsmbLg
bLibLcbLsLcLsmbLjRsbLhbRgRsRsmmbRjRgRsmbRibRibRibRcbRsRhbRcRsmbLcbLhbL
cbLibLhbLcbRjbRibLsbLsRsbLsbLsLsRsLsmbLsbLsLsmbLsLsLsLsLsmmmmbLsLsmbLs
bLsbLsbLsLsmbLsLsmbLsLsmbLsLsmbLsLsLsLsmmmbLsLsRsmbLsLsLsmmbLsLsLsmmbL
sLsmbLsRsbRsRsLsmbRsLsLsLsLsLgLsmmmbLgbRsbLsLsmbLsLsLsmmbLsLsLsRsmmbRs
LsbRsRsLsLsmmbLsLsmbLsLsLsmmbLsbLsbRsRsRsmmbLsLsmbLsLsLsRsmmbLsLsLsLsL
smmmmbLsLsRsmbLsLsRsmbLsLsLsRsmmbLsRsbLgLsbLsLsmbRsLsLsLsmmbLsLsLsLgLg
LsmmbLsLsmbLsbRsLsLsmbLsLsLsLsmmmbLsLsmbRsbLsLsLsmmbLgLsLsLsLsLsmmmmbL
sLsLsmmbLsLsmbLgLsbLsbLsLsmbLsLsLsmmbLsLsmbLgbLgbLsLsmbLsLsmbLsLsLsmmb
LgbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRsbRsbRgRsmbRsbRgbRsRsmbRsLsbLgbRgbRsRsmbRsbRgbRgbRsbRsbRsbRsbRsRsmbR
sbRsbRsRsmbRsRsmbRsbRsbRsLsbLsRsRsmbRgbRsbRsbRsbRsRsmbRsbRgbRsbRsbRsbR
sRsmbRsbRsbRsRsRsmmbRgbRsbRsbLsbRsbRgbRsRsmbRsbRsRsmbRsbLsbRsbsbRsbLsb
RsbRsbRsbRgbRsRsmbRsbRsbRsbRebReLsLsmbLgbRsbLgbLsbLsLsRsmbLsbLsbLsbLsL
smbLsbLsbLsLsmbLsbLgbLsbLsbLsbLgbLsbLsbLsLsmbLgbLsbLsLsmbLsbLhLsbLibRs
bRoLsLsLsmmbRsbRgRsmbRhRhLsRsbLsLsmbRsbRcbRsbRiRsmbRgbRsRsmbRsbRsRsmbR
oRsmbRibRoRsmbLsbRjRcbRibRsbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRsbRgbRsb
RebLsbLibLhLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bRgbLobLcbLcRsbRsbRsbRiRsmbRebRcbRcbLoRsbRhbRcRsmbRsRsRsRsRsRsRsRsmmmm
mmmbRsRsmbRsbsbsbRsRsmbRsLsRsRsmbRsRsmbRsRsRsmmbRsRsmbRsRsmbRsRsRsmmbR
sbRsRsRsmmbRsRsmbRgLsbsbRsRsRsmmbRsLsRsbLsbsbRsbLsLsmbRsbRsRsLsRsRsRsm
mmbRsRsmbRsRgRsRsRsmmmbRsRsmbRsbRsRsmbLsRgRsRsmmbRsRgRsmbRgRsmbRsRsmbR
sRsRsRsmmmbRgLsbLsbRsRsmbRsRsRsmmbRsRsRsmmbRsbRsbRsbRsbRsRsRsRsRsmmmmb
RsRsRsRsmmmbLsRsbRsbRsRsRsRsmmmbRsRsRsRsmmmbRsbRsbRsRsRsRsRsRsmmmmmbRs
RgbRsRsRsRsRsmmmmbRsbRsRsmbRsRsLsmbRsbRsbRsRsmbRsbRsRsRsRsmmmbRgRibRsR
sRsmmbRsRgbRsRsRgmbRgRsmbRsRsmbRgbRsbRgRsmbsbRsbRsbRsRsRsRsmmmbRgbRsbR
gRsmbRsRsRiRsRsRgRsmmmmbRsbRgbRsRsmbsbRgbRsbRgRgRcbLibLcLibLsbLiLsbsbR
sRsmbRsbLgLgbLcLsLsmmbLiRsbRibRsLsbLsbRsbRsRsmbRsbRsRsLsmbRsbRsRsRsmmb
RgRsRsmmbRsRsRsmmbRsbRsLsbRsRsLsmbRsRsRsmmbRsRsmbRsbRsbRgbRsbsbsbRsRsR
sRsRsmmmmbRsRsmbRgRsmbRgbRsRsRsmmbsbLsRsRsmbRsRsmbRsbRsRiRgbRsbRsbRgbL
sbRsRsmbLsLsmbLsbRgRsmbRgbRgbRsbLsRsbRsRsmbsbRsbRsRsmbRsbRsbRsbsbRsRsm
bRsbRsRsmbRsRgbRsRsRsRsRsmmmmbRgRsmbRsbRsbLsbRsbRsbRsbRsbRsbRsbRsbRsbR
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bLibLgLsbLsbLsLsRsmbLgbLgbLgbLsbLgRsbLoLibLsbLcbLhRsbLebLcbLcbLiLsbLob
LcbLcbLhLsbLcbLhLsbLobRobRebRcbRcbRhbRcRsmbRebRibsbRiRsmbRhRsRhmbRgbRi
RiRibRhbRsRsRsmmbRgLsbRsLsbLsRjRsLsmbRsRsRsmmbRsbRiRsRsmmbRgRsmbRsbRgR
sLsmbRiRsmbRsRsRsmmbRsLsbRsRsmbRsbsbRiLsLsmbLsLsmbLsbRsbRgRsmbRsbRsbRg
bRibRsRsmbRsbRsbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLibLiLsbLgbLsbRsbLgbLsbLsbLsbLgbRsbRobsbLsbRgbRsbRsbRgbRgbRsbsbRsbRsb
RsbLsRjbRibLsbRoLsbLjbRjbLiLsbLjLgLsbRsbRsbRsbLgbLgbRoLsbRiRsmbLsbRgbR
ibLebLibLsbLjbLibLeLsbLgbLjbLcbLsbLsLsRsmbLgRsbLibLibLjLsmbRjbRcbLjLsm
bLjbLibLsbRcRsmbLgLsbLjbLjbLibLjbLgbRsbRsRsmbRsbRsbRsRsRsmmbRgbRsbRgRs
mbRsbRgbRsbRsbRsbRgbRsbRgRibLsLsmbLsbLsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRoRsmbRcbLcbRcbRobRobLjbLcbRebLjbRjRsmbLjbRibRcbLgbRibLibRjbLgbLgLsLg
LsLsLsRsmmbLgLsbLsLsmbLiLsbLgbLsbLsLsRsLsLsmmbsbLgbLgRsRsmbRjbLjbLiLsb
LgLsLsLsLsLsLsLsmmmmmmbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bLgbLgLsbLgbLgbLgLgRsbLcLsmbLsbRsbRsbRibRiLsbRgbRgbRibRiRsmbRsbRsbRsRs
mbLsbRsbRsRsmbRgRsmbRobLgbRjbRjbRhRsmbRcbRjLsbRibRibLjbLoLsRsmbLobLjbL
cbLcbRhbRhbRiRsmbRibRjRsmbRgbRsbRsbRgbRsRsmbRsRsLsmbRhbLsbLsbLsbLsRsbL
sbRsLsbLsRsbRsRsRsmmbRgbLeLobRiRsRsRsmmmbRsbLsbRsbLsLsmbRsbRsbRgRsmbRs
bsbRsbRebLsbLsbsbRsbRsbLsbLcLibLsbLibRsbLsbLgbLsLsmbLibRsbLgbRsbRsbLgR
sbLsbLsbRsbLibRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bRsRsmbRiRsLsmbRibRsRsmbRgbRsbRsRsmbRgRsmbRsbRjbLsbLiRsbLgbsbLsLsmbLgb
RsbLsbLjLsLcmbLgRsbRsbRgbLjbLcbLjbLibLibLgbLsbLhRsbLibLiRsbLibRsbLcRsb
LhbLjbRjbRjbRjbLhbRsRsmbLjbRsbRsbLjLsmbRsbLsLsLsmmbLsLsmbLgRsbRsLsbLgb
LsbLsbLsbLsbRsLsbLsbLsLsRsmbLsLsLsLsmmmbLsbLsbLsLsLsLsmmmbLsbRsbRsRsmb
LsLsmbLsbLsLsmbLsRsbRsLsbLsLsmbLsLsmbRsRsLsmbRsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bRsbRgbRcbLibLgLsbLgbLgLgbLgLsbLgbLgLsbLgbLgLsbLgbLsbLoRsRsmbLibRibRgb
LcbLcbLjbLjbLcbsbRsRgbRgbRsbRiRsmbRgbRgRsmbRsbRsRsRsmmbRgRsRgmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bRgbRgRsmbRiRsmbRgbLobLsbLibLgbRsbLobRebLobLibRoLsLsmbRhLsbRibRoLsbLjb
RgbRobLobLobRobRobRoLgLsbRobRoLsLsmbRobRcLsbRcLsbLjbRcLsbRhbRcbRjbRjRs
RsmmbRhRsmbRcbRcRsmbRjRsmbRhbRsbRgbRgbsbsbLjbLsbRsbsbLsLsmbLsLsmbLsLsL
smmbLsLsLsmmbLgbLsLsmbLgRsLsbRcbRcRsmbRsbLjbRhbRgRsmbRgbRgLsLsmbRgRsmb
RibLsLsLsmmbRsRsmbRgbRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bLobLoRsbLjbLcbLoRsbLobLobLsLobLobLcbLjLsmbLjRsbLcbLobLibLjbLibLcbLgLs
LsmbLgbLsbLsbLsLsmbLsLsLsLsRsmmmbLibRsLsbLsLsmbLgLsbLsbLgLsbLgLsbLgbLs
bLsbLsLsLsmmbLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bsbRebRhbRobRcbRobRobRebRobLobLoRsbLobLobLcbLobLobRobRhbRobLobLobRibLc
bLibLibLjbLibLjRsbLibLjLsmbLjRsbLjRsbLjLsRsmbLiLsbLsLgRsbLgLsLsLsmmbRs
b

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bLcbRobLjbLcRsbLcbRcbRsRsmbReRsmbLsbRsbLgbLgLsLsLsmmbLgLsbLgbLsbLebRcR
smbRibRsRsmbsbLgbsbsbRsbsbRgbLsRsbRgbRgbRsbRsbLsbLsbRsRsmbRgbRsbRsRobL
sbRcRsmbRcbLcLsLiLsmbRjbLibLgbLibRgbLiRsbLibRsbLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bLobLiRsbRsbLsbLobLcbLcbLobLcbLcbLjbRjbLhbLjbLjbRibLjbLjbLhbLibLjLsmbR
sRsmbLgbLgLsbRsbLsLsmbLgLsbLgLsLsmbLsLsLsLsLsmmmmbLsLgLsLsmbLgLsbLjRsR
smbRjbLjbLibRsRsmbLsbLsLsmbRsLsLsLsLsLsLgmmmmbLcRsLsbLhLibLsLsmbRsbLsL
sLsLsmmmbLsbLgLsLsmbLsLsRsmbLsLsLsLgmmbRsLsLsLsLsLsLsmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bLobLcbLjbLibLjbRoRsmbLoRsbRobsbRjLsLsmbRhbRcbRjLsbRhbRhbRhbRebRjRsRsm
mbRjbRsRsRsmmbRhbRiRsmbRgRsmbsbRjbsbRgRsmbLsLsmbLsRsLsbRsbRjRsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLgbLgbLgLsbLsLsmbLibLsLebLibLgbLiLsbLgLsLiRgLiLsbLiLsbLibLgbLib
LgbLgLsbLgbLgbLgbLsbLsbLgbLgbLgLsLsmbRsLsbRsLsbLcbLhbRsbsbRgbRgRsmbRsb
LebLsLsmbLsLsLsmmbRgRsmbRsRsLsmbRgbRsRsmbRsRsRsmmbRsbLsbRgRsRsmmbRsbRg
bRibRgbRsRsRsmmbRgbRgbRgRsmbRsRsRsLsmmbRgRsLsmbRsRsmbRgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bRobLsbLobRibRgbRgRsmbRsbRebLoRoRsmbLcLsmbLibLiLsbLgbLgbLgLebRgbRsbLib
LgbLgbLsbRsbRsbLgbRsbLobLsbRsbRgbRsbRsbRsRsmbRsbRsbRibLsbLsbLsbLsbRsbR
sbRgRsmbRcbRsbRsbRsRsmbLsbRsbRsbRsbRsbRcbLsbRhbRiRsmbRsbLsRsbRsbRgLsbR
gbLjbLhbLcbRibRibRhbRhLsbLsRsbRgbRsRsmbRgbRgbRibRcbRgbRsbsbRibRgbRsbRi
LjRsbRoLsbLsbRsbRjbRibRsbRsRsmbRgbRsbRsRsmbsbLsbRsRsRsmmbRsbRsRsmbRsLs
bLsRsbRsbRsRsmbLsLsmbLsbLsLsmbsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bLgbLgbLeRsbLgbLibRsbLsbLgbLgbRibLsbLsLsmbRhRsmbRsbLsbLgbLibRsRjRgbRgb
RgbRsbRsbsbRsbRsbLsRsRsmbRsbRgbRsRsRsmmbRsRsmbRsRsRsmmbRsRgbRsRsmbRsRs
RsRsmmmbRsRsRsRsmmmbRsRgbRsRsmbRsbRsRibRgbRsbRgbRgbRsbRsbRsbRgbRsbRibL
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bLsRsbLsbRgbLsbLgbLgbLsbLsLsmbLsLsmbLgbLsbLoRsbLgbRsbRsbRibRsRoRsmbLcb
LobLibLobLobRsbRsbLsLsmbLsLsLsmmbLsbLsbLsLsLsmmbLsLsmbLsLsLsRsmmbLsbLs
bLgbLgLsLsmbLsLsmbLsbLsLsLsmmbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bRsbRhRgbRsLsbLsbRsRsmbRsLsbRsbRsbRgbsbRsRsmbRsbRsbRsbRsRsmbsbRsbRsbsb
LsRsbRgbsbRsRgbRsRsRgmbRjLsbRcbRsbLsbLsbLgLsbLsLgbLsLsmbsbLsLsmbLsLsmb
LiLsbLibRsbLsLgbLhLsbLsbLgLsbLsLsmbLgbLhbRsbRsbLsLsmbLjbLiLsbRsLsbLsbL
sbLgbLgbLsbLsLsLsmmbLgbLsbLgLibLhbRsbRsbLibLibLsbLsbLsLsLsmmbLsbLsLsLs
mmbLgLsLsmbLiLsLibRsbRsbRsbsbsbsbsbsbsbsbRsbsbsbLhbLjbLcbRsRsLsRsmbLiL
sbLsbLsbLsbLgbLgbLsLsmbLibLgbLsLsmbLsbLsbLsbLsLgbLobLsbLsbLgbLgbLsLsmb
LsbLsLsmbLsbLsLsmbLsbLsLsmbLsLsmbLsbLsLsLsmmbLsbLsbRsbLjLgbLsbLsbLgbLs
bLsLsLsmmbLsbLsLsmbRsLsbLgLsbLsLsmbLsbLsbLsLsmbLsLsLsmmbLsbLgLsbLibLgb
LsbsbLsbsbsbsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bRebLsbLobLibLsbRsLsbRibLibLebLobLoLsmbRgbsbRsbRsRsLcmbRjbRsbRsbRgbLgb
RibRibRgRoLsbRcbRibRgbRsbLsbRsbRgbRibRgRsLsmbRgbLsLsmbLsbsbLsbsbLsbsbs
bsbsbRiLgbLsLsmbLsbLsbLsbLsbsbRsRsRsRsLsRsmmmbLibsbsbRsLsbLgbRgbLcbLib
LebLibLcbRebLiLsLsRsLsmbLsbLsLsLgLsLsLsmmmbLsLgLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bLgbRgbLsbRgbRsbLobLgLsbLgbLobRcbRcbRsRsRgmbsbRjRsmbRsRsmbRgbRsbRsbLsR
sRsRsmmbRsbRgbRgRsmbRgbRgbRsbRsbRsbRgRsRsmmbRsRsmbRgbLsRsbRsbLsRsLsbRs
RsmbRsbLsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bLsbRebLgLsbLsbLibLsbLsbLsbLsbLobRibRcbRcbRibRhRsmbRcRsmbRibRibRgRsmbR
gbRgbRjbRgbRgRsmbRgRsmbRgbRgbRsbRsbRsRsRsRgRsmmmbRgRsRsmmbRsRsmbRsRsRs
RsLsmmmbRgbRsRsRsRiRsmmmbRgRsmbRsRsRsRgRsRgmmmbRsRgbRibRibLsbLgbRsRsmb
RsRsRsRgRsmmmbRgbLsRgbRibsbRsRsRsmmbRgbRsRsRsRsRgRsmmmmbRgbRsRsRsRsmmm
b

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLobRsbLobRsLsbLobRsbLobRjbRiRsmbRjbRcbLiLsbRcbRebLsbLsLsmbLobRibLobRg
bLobRobRcbRebLibLjbLobRsRgbRoRsmbRgbLjbRibRsbLsbRgbLsLsmbRsbLsbLgbRsbR
cbRibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLhbLcbLibRgbLcRsbLcbLsbRhbRsbRgbLobLgbLoRsbRgbRebRsbRobRcbRibLsbRoLsb
RibRobLsbRjbRcbRcbRcLsbRobRcLsbRobRobReRsmbRcbRcbLcbLoRsbLjbLibRjbRcbR
cbRcbLjbRhbLcbRjbLjbRibLjbRhRsmbRcLsRsbLjbLibRjbLibRjbLjbRhbLjbLhbLjbR
jbLiLsbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsLsmbLobRobRcbLobRibRsRsmbRoLsbLsbLeLsbLcbLgRsbLsLsLsLsmmmbLsLsLsmmb
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bLsbRsbsbLsbRgbRgLebRjRgbRebRsbRsbRsRsmbRhbRebLsbLsLsmbLsbsbLsbLebRobL
sbLebLsbRsbLiRgbRibRibRgRjbLobRsRobLsRsbLgLsbRjbLgbLhbLiRsbLsbRjbRsbRs
bRgRsRsmmbRgRsmbRgbRsbRgRsLsRsmbRsRsRsmmbRsbRsRsmbRgbRsRsRgmbRsbRsbRgb
RsbRgbRsRgbRsbRsbRsbsbRsbRsbRsLsbRsbRsbRsbRsbsbRsbRsbsbRsbRsRsmbRsRsRs
mmbRgbRsbRgbRsbRgbLsLibRsbRsbRsRsmbRgbRgbRgbRsRsmbRsbRsbLjLjbLhbLsLgLs
bLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRgbRsLobLobRobLcLsmbRcbLcbRcbLcbRcbLjLsLsmmbLhbLhbLcbRcbLcLsLsmmbLcbR
obLcbLjLsmbRcbLjbRsbLsLsmbLsLsLsmmbRsbLcbRobRjbRhbRoRsRsmmbLiLsLsLsLsL
smmmmbRjRjRiRibRcRsRsmmbRgRsmbLjLsmbLsbLsbLsLgbLgbLgbLsbLibLsbLsLgLhLc
bRiRsmbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRibRsRgbRsbRgbRsRsLsmbRgbLsbRsbRgbLsbRibsbsbLsbLgbRjRcbRibRsRsmbRsRsm
bRebRcbRjbRobRsbRsbRsbRiLsbLsLsmbRcLsbRcRsLsmbRhbLgbLgbLgbRsbLjbRiLsbR
cRsmbRcLsbRebRibRgLsbRgLsbLsbRsRsmbRsbLgbRebLoLsmbLcbLhbRibRobRcbRcbRc
bRcbRiRsmbRibRgbRibsbLsbsbsbRsRsmbRiRsmbLsLsmbRgbRsbRgbLobRsRsmbRsbRgR
smbRgbRjRsmbRcbRhbRcbRibRibReRsmbRhbRhRsRgmbRgbRgRsLsRsmbRgbRibRgRsmbR
ibRjRcbRibLibLgbLibLcbLsLsmbLcbLhbLoLsmbLsbRsRsmbRobRibRgRsmbRhbRibRsb
RibRcbRsbLhbLibRcbRibRcbRjbRhbRjbRcbRcbRsbLsbLsbRgbRiLsbRgRsmbRsRsLsmb
LsbRiLsbRhbRsRhbRhRibRgRsmbRgRsmbRhbRgRsRsmmbRebRibRjbRhbRibRibRebRgbR
ibRsRsmbLcbLhbLibLiRsLsbLibRsbRebRhbRhbRibRibRcbRibRcRsmbRgbRibRsRsRsm
mbRgbRsbRsRgbRgbRcbRhbLibLibLgbLgbLiRsbLibLiLiLsLsmbLiLgLsLsLgLsLgmbLe
LsLhbLsbLgbLhbLibLcbLcbLhbLibLcbLhLsbRhbRjbRjRibLhbRhbLjbLhbRjRsmbRjbL
jbRjRgbRgbRsbRibLiRsLsbLgbRjRjbRcLgbLsbLsbRgRsmbRgRsmbRgRsmbRibRgRsmbR
sbRjRsmbRjLsLsmbRgbRgRsRsRsmmmbRgbRgbRsbRgLsbRgbRibRjbRgbRjbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bsbRsbLgbRsRsRsRsRsmmmmbRsRgbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bReRsLjLsLsmmmbRcbRibRgbRibRcbLsbRsbLcLsmbsbRsRsRsmmbRsRsLsmbLsLsLsLsm
mmbLsLsmbLsLsLsmmbLgbLsLsLsmmbLsLsLsLsLsLsLsmmmmmmbLsLsmbLgbLsLgbLgbLg
LsbsbLgbLsbRibRibRiRgbRgbRsbRgbLsbRsRsmbRibRgbLsLsmbRsbRjRgbRibLsbLsLs
mbLsLsLsmmbLsbLsbRhbRibRibRsbLsbLsLsLsmmbLgbLgbLsLsLsmmbLgLsLsLgmbLsbL
sbLgLsLgbLsLsmbLsbLgbRgbRibLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bRsbRhbRjLsbRcbLsLsLsmmbLcbLsRsLsbLcRsbLsLsmbLiLsbLsLsmbRsbRsbsbLsbLiL
sbLsbLhbLsbLsLsLsLsmmmbLsRsbLibLibLcLsmbRiLsbRoLsbLsLsLsLsmmmbRebRsLsR
sRsRsRsRsmmmmbRsRsRsRsmmmbLsRsRsRsRsmmmbRsRgbRsRgRsRsRsRsmmmmbRsRsRsRs
mmmbRsRsmbRsRsRsRsRsmmmmbLsRsRsmbRsRsRsmmbLsRsRsRsRsRsRsmmmmmbRsRgRsRs
mmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bRobRgRgbRsbRsbLsRsbRcbRibLsbLjbRgbRcbRhbRcbRebRsRiRsmbLgbRoLsRsbRgbRo
bRgbLsbLgbRsbLgbLsLsmbRsbRcbsbRcLsbRgRsmbRcRcLsLsmbLjbsbRgbsbLsLsmbLcb
LibLgLsbsbsbsbsbsbsbRoRsmbLgbLhLsbLiLsLsmbRsbLjbRsbLsbLsbLsLgbLgbLsbLg
bLsbLgLsbLgLsbLiRsRsmbLsbsbLgbLsbRgbLiLsbLgbRgRsmbRsbLsbLgbRsbLgbLiRsL
gbRsbRsbLobLsbRibLibRhbRibRcbRsbRsbLoRsRsRcRsmmbRsbsbsbLsbsbsbsbsbsbsb
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bRebLibLgbLcRsbLibLhbLjbLiRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bLcbLobLsbLobRobLobLcbLcbRcRsmbLobLcbLobLobLibRobRobRoLsbRcbRsRcbLcLsm
bLcbLcbLsbRsbRhbRsRsRsmmbRsRsmbRgRsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bRgbRsbLobLsbLsbRobLebLebRjbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bRobRjbLjbLobRsbLjbLcRsbLsLiRsbLhbLcbLobLcbLjbLcbLcRsbLjbLjbRcbRjbRobR
jbRibRjbLsbRjbRsbRsbRsbLsbLgbLgLsLsLsLsmmmbLgLsLsmbRsLsbLgbRsbLsLgbLsL
sLsmmbLsLsLsLsmmmbRsLsbLsLgbLsLsLsmmbRsbLsLgbLsLsLsmmbLsLsLsLsmmmbRsLs
LsmbLgLsbLsLsLsmmbLsbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbRsbLsLsLsLsmmmbL
gLsLgbLgLsLsLsmmbLgbLsLsmbLsRsbRsLsbLsbLgLsLsLsLsmmmbLsLsmbLiLsbLgbLib
LgbLgRsbLgbLgbLsLsLsLsLsLsLgmmmmmbLsLsLsmmbLgLgbLgLsLsLiLsmbLgLsbLebLg
LsbLiLsbLsbLgbLgLsbLgbLsbLsbLgbLsbLgbLsbLgbLsbLgbLsLsRsmbLgbLgbLgbLsLs
mbLgbRsLsLsLsmmbLsbLgbLiLsbLsLsmbLibLibLgLgbLgbLibLgbLibLgLsbLgbLgLgbL
gbLgLsbLgLsbLiLsbLsLsLsmmbLgbLgbLgLsLsmbLgbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bLgbLgbLsbLgbLgbLgbLsRobRcbLsRsbRjbRiLsRoRsLsmbLsbLgbLsbLsbLoLsmbLsLib
LcbLobRgbRsRsmbRhbLsbRobRobRobRobLhbLoLsmbLcbLobLobLobLobRhbLoRsbLobLc
LsmbLobLobLcbLobLcbLsbLiLsbLgLsbLsLiLoRgbRsbRsRsRsmmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 131821; End: 132321;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bRobLjbRcbLcbRjbLjbLjbLhbRcLsbLgLsLsmbLibLcLsmbLibLibLgLsbLgbLiLsLsLsm
mbLibLibLgbLgbLgbLgbLgbLgbLgbLsLgLsbLsLgbLgbLgLsLsLsRsmmbLsbLgbLgbLsLg
LsbLiLsbLibLgbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLsbLsbsbRsLsbsbRsbRsRsmbsbLsbRsRsmbLsRsLsbLsbLsbLsbRsbRsbLsbLsL
smbsbLsbLsbsbLsLsmbLsLsmbLsLsmbLgbLsLsmbLsLsmbLsLsLsmmbLsbLhbRcbRsbRgb
LcbRsRsRsmmbRsRsRsRsmmmbRsRsRsmmbRsRsRsmmbLsRsbRsbRsRsmbsbRsRsRsmmbsbR
sRsRsmmbLsRsbRsRsRsRsRsmmmmbLsLsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRsRsRsRsmmmbRsbRgRsmbRsRsmbRsRsRsRsmmmbRsRsRsmmbRgRsmbRsRsRsmmbRgbRib
RgbRiRsmbLsLsmbRibLjbLibRgbRsRsRsRsmmmbRgRiRsRsmmbRsRgRiRsLsmbRsRgbRsb
RsRsmbRsRsRsRsRsRsmmmmmbRsRsRsmmbRgRsmbRsRsRsLsRsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLgRsbLgbLsRsbLsbLsLsmbLgRsbLsbLsbLsRsbLgbLsbLgbLsLsmbLsRsbLsbLgRsbLsb
LsRsbLsbLgbLsbLsLsmbLsLsmbLgbLgbLsLsLsRsmmbLgbLibLhbRsbRsbsbLjbLgLsbsb
RsbsbsbLhbLiLsbLsLsLsmmbLsLsmbLsLsmbsbLsbLsbLgbLsbLgbLibLgbLsbLsbLgLsL
smbLgbLgbLiLsbLsLsmbLgbLgbLsLsmbLsLsmbLsLsmbLgbLgRsbLgRsbLsbLsbLsLsmbL
sLsmbLsbLsLsLsmmbLsLsLsmmbLsLsmbLgbLsLsmbLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRgbLsRsbLsLsmbRsbRsRsmbRsRsmbLsRsbLsRsRsmbRsRsRsRsRsmmmmbLsbRsb
RsbRsbLsRsbRsbRsbRsRsRsRsmmmbRebLsbLgbLsLsmbLsbRsLsLsmbRsbRsLsLsmbLsLs
mbLsLsmbRgbRsRsmbLgLsLsmbRsbRsbRsRsLsLsmmbRsLsbRsbLsbLgbLgbLgbLgbLsLsL
smmbRsbLsbRsLsLsmbRsbRsbRsRsLsmbLsLsLsmmbRsLsbLsbRsbLsLsmbLsLsLsmmbRsL
sbRsLsLsmbLsbLsLsmbLgLsbLiLsbRsbRsbRsbLiLsbLgbRsbRsLsLsLsmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRobRcRcRiLsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbLsbsbRsbRsbRsbLsbLsbRgRsmbR
cRsmbRgbRsbRgbRgRsRsmmbRgbRsbRsbRsRsmbRgRsmbRgbRsLsbRsLsbLsLjbRibRsbLc
bLcRgbLibRsbLsbRjbLsbRsbsbRibRsbRsRsmbRsRsRsmmbsbRsbLobLsLsmbLsRsbLibL
cLsmbRgRsRsmmbRsbRibRsLsRsbLsbLsbReRsmbRhRiLsbLjbRsbLsbsbRsbRsbRsRsLsR
smbRsbRsRsmbLsbLsbLsbLsbLsbLsbLsLsLsmmbsbRobLcbLsbLsLsmbLsbRobRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRgbRgbLsRsbRgbLsbRsbRsRsmbRgbRsRgRsmbRgbRsRsmbRgbRgRsmbRsRsmbRsbRsRsm
bRsbRsbRsRsmbRgRsmbRgRsmbRiRgRgbRgbsbLsLsLsmmbRsLsbsbLsLsmbLsLsmbLsbLg
bLsbLsLsmbLsLgbLsbLsbLsbLsbsbRsbLsbLsbsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsb
RsLgbLgbLsbLgbLsbLsbLsbLsLgLsbLsLsLsmmbLsLsmbLsbLsbLebRcbRibRibsbRsbRs
bRsbRsRsmbRgRsmbRsRsmbRsbRsbLsbRgbRgRsRsmmbRgbRgbRgRsmbRgRsmbRgbRgRsmb
RgbRsbRsbRsbRsRsmbRsbRsRsmbRgRsmbRgbRgbRgRsmbRsRsmbRgbRsbRsRsmbsbRsbsb
RgbRgbRgRsmbRsRgbRgbRgbRsbsbRsRsmbRsbRsbRsbRsbRsbRgRsmbRsbsbRgRsmbRgbR
gbRgRsRsmmbRgbRgRgbRsLsbLsLsRsmbRgbRsbRsbRsbRsbRsbRsbsbRsbRsbRsbRsRsmb
RsRsmbRgbRgbRgbRgRsmbRgbRsbLsbRsLsbLsbLsbRsbsbRgbRibRgRsLsmbRgbRgbRsbR
gbRgbRsRsmbRgRsmbRsbRgLsbRgbRgbRsRsRsRsmmmbRcLsbRgbRsRsmbRgbRgbRgbRgRs
mbRgRsmbRgbRibLoLsLsmmbLsbRsbRsbLsbLsbLsLsmbsbsbsbLsbRsLsbLsbLsbLsRsbR
sbLsbLsbsbRsLsbLsbsbLsLsmbLsbRsbLsbLsLsmbLsLsmbLsLsmbsbLsLsmbLsbLsbsbL
sbLsbLsbLsbLgbLsbLsbLsbLsbsbsbLsLsmbLsLsLsmmbLsbLsLsmbLgbLsRsbLsbLsbLs
LsmbsbLsbLgbLsbLsbLsLsmbLsbsbLsbLsbLsbLsbLsLsmbLsbLgbLsbLsbLsLsmbLsbLs
RsbLsbLsbLgbLsLsLsmmbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbR
sbLsbRsbLsbLsbLsbLsbLsbLsbLgbRsbLsbLgbLsLsmbsbLgbLsLsmbLsLsmbLsbLsRsbL
gLsbRsbLsbLsbLgbRsbLsbsbLsLsmbLsbLsbLsbLsbLsbLsbLsLsmbLsbLgbRsbLsbsbLg
bLsbLsbLsbsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bRobRebLcbRobRsbRebLcbLebLjbRjbLebRebRobLsbRobLebRebRebRebRobLcbLobLob
RebRcbLobLebRcbLgbLibLobLobLebRobRebRobLebLobLobRjbLobRobRebRobRebRcbL
obLcbRobLebRibRebLsbLobRobRobLobRebLobLobLebLhbRcbLobRobLebLgbRebLcbRs
bLcbLibRebLsbRcbLobLcbRobLebRgbRgbLobRobRsbLcbRobRobRobLobLobRebLobRcb
RgbLgbLobRebLebRobRobRcbRebRobRsbRcbRobLobLebRebLebLobLobLobLgbLjbLobR
gbLobLibLcbLobRobLjbRobLebLebLebLebLebRebLobLibRobLcbLcbRobLobRebLobRo
bRcbRjbLcbLcbRobRobLebLobLobRhbRobLhbLobRibRobLgbRebLibRebLobLobRgbRcb
LsbRsbRobLobRibLobRobLhbRsbLobRsbRobLebRobLobRobRebLobRebLobLgbRibLebR
ebRebRobRcbRobLebLgbRebLebLebRcbRcbRobRebLobLobLcbRcbRobLobRgbLebLobRo
bLobLebLebRobRobLobRcbLobRobRibLcbRgbLobLebLgbLobRobLobRgbRebLgbLcbRib
RibLcbLobLcbRobLobLgbRobLebLcbLibLcbLcbRgbRobLobRebLobLobLhbLcbRobLobL
ebLobLebRobRcbLebRibLobRobLebLobLobLebLcbRgbRcbLobLebLgbRebLebLebLcbRo
bRobRcbLebLgbLebLobLsbLebRibLcbLebLobLobLgbRobRobLgbLobRcbRhbLobLobLcb
LcbLhbRcbRobRcbLebLibRsbLebLgbRsbRebRobRcbRcbRgbLcbLgbLhbRebLobRhbLgbL
cbRcbLibRgbRgbLibRibLebLobLobRsbLebLobLjbRobRcbRsbRcbRobRobRobLcbLgbLc
bRobRobRobRobLebRcbLobLibLebRobRgbLobLebLibLebRhbRobLebLebRobLcbLsbLob
LebRobLcbLobRgbRobLcbLobRebLebLobRobRgbRobLcbLibRebLhbLibLobRhbRobLobL
obLobRsbRebRobRobRobRobRobLcbLebLebRibLgbRebLibRgbLobLobRobRibRebLebRe
bLobRobRebRobRobLebRobLobLobLobLibRobLebLobLobLebRebRcbRebLobRcbLcbRob
LobRhbRibRcbLobLgbLobLcbLgbLhbLcbLobRobLobLobRcbRobRebLobLebRcbLgbLobL
ebLobLobRobRcbRebLobLebRibRebRobLebLobLibLebLibLobLebLobLhbRibRebRebRo
bLcbLobLobLcbRcbRcbLcbRobLcbLsbRhbLobRobLebRcbLobLebLcbRobRobLcbLibRsb
LcbRcbLebLobRcbRobRhbRibRebRgbRgbRebLebLsbRobLebRobRobRebRgbRobRsbRcbL
obRobRebRobLobRebRcbLcbRcbRebRebLibLcbLobLcbLsbLebRhbRgbRcbLobRebRibLg
bRebRobRcbRgbLgbLobLobLebLobLebRibRobRobLobRobLcbRobLibRhbLobRebLobRgb
RebLibRebLobLobRebLobRobLobRsbRobRobRsbLcbLobLcbRobLebLobRcbLcbRobRcbR
ibRobLibLobRobRebRebRobLobLhbLebRobLebRobRobLcbLobLcbRobLcbLgbLcbLcbRg
bLsbLhbLebRgbRobLhbLhbLcbRibLgbRcbLobRobLgbRebLobRebLobRhbRobLobLcbRhb
RcbRobRcbLebRobLobRobLgbRebLobRsbLcbLibRobRobLobRcbLibLsbLgbRobRcbLcbL
cbLgbLsbLcbRebRobRebLebLibRobLebLobRcbRcbLobRcbLcbRgbRebRobRobLobRsbLc
bLobRobLcbLcbLibRgbLebRobRcbLobRcbLobRobRcbRobRhbLebRebLcbLebLobRgbLjb
RobLobRcbRobRcbRsbLebLebLcbRobRebRobRcbRgbLcbRobLebLobRebLgbLebRcbLgbR
obRcbRgbRibLcbLobRcbRobLibRebLcbRobLobRebLobLibRibRebLobLobRibLobRebLo
bRobLibLobLcbRsbRibRebLibRobLobLobRhbRobRibRcbLobLobRebLobRgbLobLcbRgb
LebLobLebRobLhbRobLgbRcbLibLebLobRcbLobRobLobRcbRcbRibLobRgbRjbRobLobL
ebRobRobLebLobLcbRgbRcbRcbRebLobRobLgbLebRebLebRobRobLsbLobRobRobLebLe
bRcbLcbLobRobRebLobRobRobLebRobRcbRebLibLibLsbLebRebRebLebLsbRcbRobRob
RobRobRebRobLobRgbRobLobRobLobRebLcbRibRibLebRcbRcbRobLobRobRcbLobRobL
obLobLobLcbLobRgbRsbLebRobRhbRebRobRebRobRcbLhbRobLobRobRebLgbLobRebRi
bLcbRobRgbRsbLobRibLobRgbRebRhbRobLgbRgbLebRebLcbRobRcbRebRobLibLcbRob
LobLobRebRhbRobRobRcbRgbLobLobLcbLebRgbRcbRobRobLcbRcbLibRebRobLobLobR
obRcbRgbLobRobRsbLobLebLcbLcbLobLobRobRobLobRobRobRobRgbRcbRobRebRobLi
bRsbRgbLobRebLebLcbRobLhbRibRcbLcbLobRobRcbRobRobRibRcbLsbRgbLobLobRob
LobRebRebRcbLebLebLebLcbRibRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRsRsmbRgRsRsmmbRsbRgRsmbRsRsRsmmbRgRsmbRgbRsRsmbRsRgbRsRgRsmbRgRsmbRs
RsmbRcbRobRcbLobLobRibLobLsLsmbRsLsbLsLsmbLgbLebLjbLobLibLibLcLgLsRsbL
ebLcbLgLsbLcLsmbLjbLcbLhbLobLsbLgbLcLsmbLibLibLcbLiLgRsbLcbLhbLsLsmbLg
bLiLsbLcbLcbLgbLcbLibLebRsLsbLsbLobLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLsbLgbLsLsLsLsLsmmmmbLsLsLsmmbLsLsmbLsLsLsLsmmmbLsbLsLsLsLsLsmmmmbLgL
sLsmbLgLsbLsLsmbLsLsmbLsLsRsLsmbLgbLgbLsLsLsLsmmmbLgRsbLgbLsbLsLsLsLsL
smmmmbLgbLsLsLsRsmmbLgbLsLsLsLsmmmbLsLgbLsLsLsmmbLgbLsLsLsLsmmmbLgLsbL
sLsmbLsbLgbLsLsmbLgbLgLsbLsbLsbLgLsLsmbLsLsLsRsmmbLgLsbLsLsLsLsmmmbLsL
sLsmmbLsLsmbLsLsmbLgbLsLsRsmbLgbLsLsmbLsLsLsmmbLsLsmbLgRsLsbLsLsRsLsmb
LgLsLsmbLgLsbLgbLsLsLsLsmmmbLgbLsbLsLsLsLsLsmmmmbLgLsLsmbLgRsbLgbLgLsb
LgLsbLsbLgRsbLsLsmbLsLsLsLsmmmbLsLsmbLsLsLsLsmmmbLgLsLsmbLgbLsLsLsmmbL
sLsmbLsLsLsLsLsLsRsmmmmmbLgLsbLgLsLsmbLgLsbLsLsLsLsmmmbLgLsbLsbLgbLsLs
mbLgLsbLgbLgbLsbLgbLgLsLsmbLsLsmbLsLsmbLgLsbLgbLsLsmbLsLsmbLgLsbLgbLgL
sbLgLsbLsbLgLsbLsLsLsLsmmmbLgbLgbLgLsRsbLgbLgbLgbLgLsbLgLsbLsLsmbLgRsL
sbLgLsRsbLgbLsLgbLgLsLsmbLsLsmbLgbLgLsRsbLgbLgLsbLgLsRsbLgLsbLgbLgLsbL
gbLgbLgRsRsmbLgbLhLsbRjRgRiRgRsRimbRsbRiRsmbLsbLsRsbRsRsmbRsbRsRsmbRsb
RsbRsbRsRsRsmmbRsRsmbRsRsmbRsbRsbRsbLsRsbRsbLcbLibLhRsbRsbLsRsbLjLsmbL
sRsLhbLsbLsbLsbLsLsmbRsbLsbLsLsmbLsRsbLsbLibLsLsmbLsLsmbLibLsbLibLsbLs
bLsbLsbLsbLsbLgbLsbLsbLsbLgRsbLsLsmbLsLsmbLsbLibLgLsbLsRsbLsLsRsmbLgbL
gbLsLsmbLsLsmbLsbLgRsbLsbLsLsLsmmbLgbLsLsmbLgLsbLsLsmbLgbLsbLsbLsbLgbL
sLsLsLgmmbLsLsmbLgRsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bReRibsbLibRsbLsbLibRjbRcbRhbRsbsbRjbLcLcbLibLgbLsbLsbLsbLsRsRsmbLsLsm
bLsbLhLsbLsbLsbLcbRibLcLsmbLsbLibLsbLibLobRsRsmbLsbRibRgbRsbRsRsmbRsbR
sbRsbRsbRsLsbRgbRsbRsbRsbRsLsbRsRsRsmmbRsRsmbRsRsLsRsmbRsbRsRsmbRgbRgb
RsRhLsbRsbRsRsmbRsbRsbRsbLcLsmbLgbLgLsbRsLsbLiRsbLgbLiLsbLebLiLsLsLgmb
LibLgLgLsbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bRsRsmbRgRsmbRsRsRsmmbRgbRgLsbRgbRsbRgbRsbRsRsmbRsbRgRsmbRsRsRsmmbRsbR
gbRsRsmbRsbRsbRsRsRgmbRgRsmbRgRsmbRsRsmbRsRsmbRsbRibRgLsbLsbsbsbsbsbLs
bsbRsLiLsRsbLiLsbRsbLiRsRsmbRsbRsbLibLibLsbLgbLcbRsRsmbRsbLsbLsbRsRsmb
RsRsmbRsbLsbsbRsRsmbLsbRsbsbLsbLgbLiLcLiLsbRsbLsbRjbRgRsmbRsbRsbRsRsmb
RsbRsbRsbRgbLsbRsbRgbRsbRsbRsbRgbRgRgRsRsRgmmbRiRsRhmbLsLibsbsbLsLsmbL
sbsbRsbLsbRsbLsbLsbLsbLsLsmbLsbLsLsmbLgbLgRsLsbRsRsmbLsbLgbLgbRsbLsLsm
bLsbLsbLsbLsbLgbsbsbLsbLgbLsLsmbLsLsmbLsbLgbLgLsbRsbLsbLsbLiLsbRcbLcbL
hRsLsbLsLsmbLgbLsbRsRsmbLsbLsLsmbLsbLsbLsbLsbLsLsmbLsbLsbLsLsmbLgbLiLs
bRsbLsLsmbLgLsbLsbLsbLgLgLcRsbLgbLsbLsbRjbsbRsbsbRsRsmbRsbRsRsmbRsbsbs
bsbLsRsbRsbRsbRsRsmbRsbRsbsbLsbLsLsLsmmbRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bRgbRsLsbRiLsbLsLsmbRgbRibRoRsRsmmbRsbReRibRgRsRsmmbRsbRsbRgRiRsRiRsRi
mmbRibRiRsmbRsbRgbRgRgbRsbRsbRsbRsbRsbRgbRgRsmbRsbRsRsmbRgbRibLsbLsbRs
RsRsmmbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLsbLsbLsbLsbLsLsmbLsbLsbLsbLgbLsbLsLsmbLsLsmbLgbLsLsmbLgbLgLsbLsbsbLs
LsmbLsLsmbLsLsLsmmbLsbLsLsmbLgLsbLsbLgbLsbLgLsLsLsmmbLsbLgbLgbLsLsmbLg
bLsLsLsmmbLsLsLsLsmmmbLgbLgbLsbLgbLsLsmbLsbLsLsmbLsbLsLsmbLsbLsbLsLsRs
mbLsbLsbLsbLsbLsLsmbLsbLsbLgbLsLsmbLsLsmbLgbLgbLgLsbLgbLsbLgLsbLgbLgbL
gbLgLsLsmbLsbLsbLgLsLsmbLsbLgbLsLsmbLgbLgbLsLsLsmmbLgbLgbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRsbLgLsLgLsLsLsmmbLiLsbRsRsRsRsRsLsmmmmbRgLsbRiRsmbLsRsbRgRsRsRsRsRsm
mmmmbLsLjbRibRgbLcbLebLiRsRsmbLcbRibRcbRsbRcRsmbRsRsmbRiLsbRgRsmbRgRsR
smmbRcRsmbLhbLibLeLsbLiLeLsbLgLsbLibLibLgbLcbRiRsRsmmbRsRsmbRibRgbsbRj
Rsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bLsbLgLsbLsbLsbLgbRsbLsbLsbLsLsmbRsbLibLsLsmbLsbLsbLsbLgbLgbLsbLsLsmbL
sbRsLsbLsbLgbRsbLgbLsbLsLsmbLsbLsbRsLsbLsbLsbLsbLsbLgbLsbLsbLgbLsLsmbL
ibLgbLhbLgLsbRgbRsRjRsmbRiRsmbLsLsmbRsRsmbRsbRsRgbRsbRsbRsRsmbLsbRgRgb
RibRibRibRiRsmbRgbLsRibRsbRhbRobLib

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsmmbLgLgbsbLgLsbLsbLsLsmbsbsbLsbLsbLsRsbRsLsbRsLsLsLsmmbLsbRsLsL
smbLsbLsLsLsmmbLsbLsbLsLsmbRsbLsLsmbLsRsbLsLsLsmmbLsLsmbLgLsLsLsLgLsmm
bLsLsmbLsbLsLsLsLsLimmmbLsbLsLsmbLsLsmbLsbLsLsLsmmbLsbLsRsbsbLgbLgbLsL
smbLsLgLsLsLsLsmmmbLsbLsLsmbLsbLsbLsbLgLsbLgbLsLsmbLgbLsLsmbLsLsmbLsLs
mbLgbLsLsLsmmbLsbLsLsmbLgbLgbLsLsLsLsLsmmmmbLgLsLsmbLsLsLsLsmmmbLgbLgb
LgLsLsmbLsbLsLsLsmmbLgbLgbsbLsLsLsLsLsmmmmbLsLsmbLsbLsLsLsRsmmbLsLsmbL
ibLgLsLsmbLgbRsLsbLsbLsbLsLsmbLsLsmbLsLsLsmmbLsLsLsmmbLsLsmbLgbLsLsLsL
smmmbLsLsmbLgbLsLsmbLsLsLsLsmmmbLsLsmbLsLsmbLgLsLsLsmmbLsLsmbLgbRsLsLg
LsbLsLsLsLsmmmbLsLsLsmmbLgLsbLsLsLsmmbLgbLsLsmbLsLsmbLsLsmbLsLsmbLsbLs
LsmbLsbLsLsLsmmbLgLsbLgbLgbLsLsLsmmbLgLsbLgbLgbLgbLgbLgbLsbLsbLsbLgbLg
LsbLgLsbLgbLsbRsLsbLsLsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bRsRsRsmmbsbRsRsmbRcbRgbRsbLsLsmbLsbRibLoLsmbRcRsmbRgbRgbLobRsLsLsLsmm
bLsLsLsmmbLebLibLobLsbLgbLebLibLiLsbLhbLebLhbLiLsbLsLsmbLsbLibLibLibLg
LgRsbLgLsbLibLiLgbLsLsmbLibLsbLjbLibLiLsbLiLsbLgbLhLsbLgLsbLsLsmbLebLe
bLsbLgbLiRsbLgbLcbLibLiLsbLhbLoLsmbLcLsmbLgbLgbLgLgbLibLibLobLgbLjLgbL
ibRhbRibRgbRibLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bRiRsmbRsbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsRsmbRsRsRsmmbRsbRgRsmbRsRsRsmmb
RgbRsRsmbRgLsbLsLsRsRsmmbRsbRgRsRsmmbRsRsRsmmbRgRsmbRsRsRsRgmmbRgbRgRs
mbRgbRibRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
bLsbLsbLgLcLsmbRgbLgbLhbLiLsbLiLsbLjbLgLsLsLsmmbLibLgLsbLebLibLeLsLsmb
LibLgbLgLsLsmbLgbLsbLibLgLsbLiLsLsmbLgbLebLsbLsLsLsLsmmmbRsRsRsmmbRhbL
ebLgbLgLsLsmbLgRsbLgLsbLgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bLgLsLsmbLjLcbLjLsLsmmbLhLsbLcbLiLsbRsRsmbRcbLcbLibRcbRcRsmbLhbLcbLcbR
ibRebRhLsbRcbLsLsLsmmbLcbLcbRcbRebRobRhbRgbRgRsmbRhbRiRsmbRibRsbRsRsmb
Lsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
bLsbLgbLgbRsbLebRgRsmbLgbLgLsbLibLgbLibRsbRhbRhbRhbRgRsmbRgbRgbRebRsbR
iLsbRgbRgbRcbLsbRgbRhbRcbRgbRgbRibRgbRsbLgbLjbLibLiLsbLibLebLgbLsbLgbL
sbLgRsbLgbLgbLibLgbLgbLiLsbLgbLgbLgbRsRsmbLgbLsbLibLgbLgbLgbLcbLhRsbLg
bLibLibLibLibLsbLcLsmbLgbLibLcbLibLgbLebLibLeLsbLgbLgbLgbLgbLibLhLsbLi
bLgbLgbLhbLgbLibRgbRebRiRsmbRgRgbRgbRibRibRsbRgbRibRibRgbRgbRgbRsbRibR
sbRgbRibRgbRsbRgbRgbRgbRibRibLsbRibRibRgbRgbRibRibRibRibRibRgbRibRgbRg
bRibRibRgbRgbRgbLsbRjbRgbRiRsmbRgbRgbRgbRibRibRgbRgbRibRgbRibRgbRgRsmb
RgbRibRgbRibRibLhbLibLibRjbRcbRiRsmbRgRsmbRgbRgbRgbRibRibRibRiRsmbRgbR
ibRibRgRsmbRibRibRgbRibRgbLibLebLibLebLibLibLibLiLsbRgbLibLibLhbLibLgb
LgbLiRsbLibLgbLebLibLibRibRjbRgRsmbRgbRibRhbRibReRsmbRsRsmbRiRsLsmbRiR
smb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bLsLsLsLsmmmbLsLsLsmmbLgLgbLgLsbLgRsRsmbRsbLgRsbRsbRsbLsbLsbLeLsbLcbLj
bLeLsbLsLsmbLjbLjLsmbLhbRsRsmbLjbLebLeLgbLcbRgRsmbRoRsmbRjbLcbLeLhLsbL
ebLibRjbLiLsbLiLsRsbLsLsmbLgLgbLeLsbLebLiLgLsbLgbLcbLibLcbLcbLcbLiRsbL
iLsLgLsbLeLiLebLebLibRsbRibRebRoRsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bLsbLsLsmbLsbLsLsLsmmbLsLsLsLsRsmmmbRcbRibRgbRiRsmbRhRsmbRhbRebRebRcLs
bRgbRcbRgbRibReLsbRsbRsbRoLsRsbRgbRebLsbRgbRgbRgRsmbRibRgRsLsmbRhRsmbL
sbRsbRcbReRsmbRhbRobLcbRiRsmbRhbRsRsRsRsmmmbRsbLsRsRsRsRsmmmbRebRobRcb
RibRhbRcRsRsmmbRebRibRgRsmbReLsRsbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRebRiRsRsmmbRibRgbRgbRsRsRsRsRsmmmmbRgRsmbRgbRgRgbLcbLsLsmbLsbLsbRsbR
jbRgbRsRsRsmmbRibLsbRibRsbRsRsRsmmbRgbRgRsmbRiRsmbLcbLcbLgLsbLsbRcbRgb
ReRsmbRiRgRsmbRibRsbRebRgRsmbRgbRsRgbRsRsmbRgRsmbRgbLsRsRsmbRibRgbRgRs
mbRgbRgbRgRsRsmmbRgbRsbRebLobLcbLgbRoRsmbRibRebRgRsReLsmbRebReb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLsbLsbLsLsmbLsbLsLsLsmmbLsLsLsmmbLsbLsLsmbLibLsLgLsbRsRsRsRsmmmbRgbLg
LsbLsLsmbLsbLsLsLsmmbLsLsLsLsmmmbLsLsLsmmbLsLsmbLsbLgbLsbLsLsmbLsbLgLs
LsmbRsLsbLibRsRsmbRsRsmbRsRsRsRsmmmbLsbLgbLsLsLsLsLsmmmmbLgbLjLsmbRsRs
mbLsLsmbLebLhbLibRsRsLsmbLsbLhRsbLoLsmbLhRsbLcbsbLsbRobLsbRsbRsbsbsbRc
LsbRsbsbLsbLsLsmbLsbsbLgLsbLgbLgLsbLsLsmbLsLgLsbLsLsLsRsLsmmbLsLsmbLsb
LsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbLobLgbLoRsbRsbRsbRsRsRsmmbRsRsRgRsmmbLsRsbRsRsmbLsRsbRgRsmbRsbR
gRsmbRsbRsRsmbRgRsmbRsbRcbRoLsRsbLgbRsbRsRsmbRsbRsRsRgRsmmbRsRsLsmbRsR
gRsRsmmbRcRsmbLsbLobLibLibLsbLebLebLebLibLibRsbRsbLsbsbLsRsbsbLsRsbRsb
sbLsbRsLsbLsLsLsLsmmmbRsbRsbLsbRsbsbLsbRsLsbLsRsbRsbRsbRsbRsbRsLsbLsbs
bRsbLsLsmbRsbLsbLsbLsbsbLsbRsbsbsbRsLsbRsbsbLsLsLsmmbRsRsmbRsLsbRsLsbR
sLsbsbsbsbRsRsmbRsbRsbLsLsmbLsRsbLsbRsbLsLsmbsbsbRsLsbRsLsbLsRsbLsLsmb
sbRsRsmbLsRsLsbLsRsbsbsbRsbRsLsRsbsbRsLsbRsbRsLsbsbRsLsRsbRsRsmbLsbRsL
sbRsbsbRsbLsbLsbRsLsLsRsmbsbsbRsbRsLsRsRsmbsbLsLsmbLsbLsbLsbsbLsbRsLsR
sbRsRsmbLsRsbRsLsLsmbLsbLsLsRsmbRsRsmbRsLsRsbLsbRsRsmbsbLsRsRsmbRsbLsb
LsRsRsmbRsLsbRsbsbsbRsLsLsmbRsbsbRsbLsRsbRsRsLsmbsbLsbLsbRsbLsbRsRsmbs
bRsbRsRsRsLsmmbRsbLsRsbRsbRsbLsbLsbsbRsbRsbLsLsmbsbLsbsbRsLsbsbRsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bLsLsLsLsmmmbLsbLsLgLsbLsLsmbLsLsLsLsLsLsmmmmmbLsLsmbLsLgbLgbLgLsLsmbL
sLsmbLgbLsLgbLsLsmbLgLsbLgLsLsLsLsmmmbLgbLgbLgLsLsmbLgLsLsmbLsLsmbLgbL
gLsbLcLsmbLobLcRsbLsbLsbLsRsbRsbLsbLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLgLsbLsLsmbLsbLgLgbLebRgRhbRibsbsbRsbRsRsmbLsLsmbRsbLsbLsbLsbLsLsmbRs
bRsbsbLsRsbsbsbRsRsmbLsbRsbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsRsRsRsRsmmmmmm
mbRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsmmbRsbRsRsRsmmbRsRsmbRsRsmbRsbRsRgRsRs
mmbRsRsRsRsmmmbRsRsmbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bLsbLsLsLsmmbLsbLsbLsLsmbsbLsbLsLsmbLsLsmbLgLsLgbRcbLgbLsbLsLsLsLommbL
sbLsLsmbLsLsmbLsLsmbLsLsLsLsmmmbsbLsLsmbLsLsmbsbLsbLsRsLsbLsLgbLobRgRs
mbRsRsmbRsbRsbRsbRsbRsRsmbRgLsbLsbRsRsmbRsbLsRsbRsRsRsmmbRsbRsbRgbRsRs
RsmmbRsRsmbRsRsmbRsRsRsRsmmmbRgRsmbRgbRgbRsbRsRsmbRsRsRsmmbRsRsRsRsRsR
smmmmmbRsRgbRibRibRibRgbRebRebRgbLsbRsbRsbLsbLsbRsbsbsbLsbLsbsbRsbsbRs
LsbsbsbLsLsmbLsbsbsbsbLsbsbsbsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bRsbRsbRsbLsbLgbLiLsLsmbLcbRoRsmbLjbLgbLsbLsbLobLsbLibLgbLsbLgRsbLsbLe
bsbLhRsbRgRsRsmmbRgRsmbRsRsRsmmbRcRsmbRgbLhLsbRsbLjLgbLsbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRgRsRsRgRsmmmbRgbRsRsRsmmbRgbRsRsmbLsRgbRgRsmbRgbRgRsRsRsRsmmmmbRgbRs
RiRsmbRgRsmbRgbRsRsmbRsRgbRgbRsRsmbRgbRgRsmbRgbRgRsmbRsRgRsmbRgRsRsmmb
RsRgbRgbRgRsmbRsRsRgRsmmbLsRsRgbRibRgRsmbRgbRgRsRsmmbRibRgbRsRgbRsRgbR
sRibRgRsmbRgbRgRsmbRsRsRsRsRsRsRsRsmmmmmmmbRgbRiRsRsmmbRibRsRsRsmmbRiR
sRsmmbRgRsmbRgRsmbRcbRcbRcbRhbLsbRebRebReRsmbRebRebReRsRcmbRebReRsmbRe
RsmbRebRibRibRiRgRsRgRsmmbRgRsmbRgRsmbRgbRgbRgbLsbRsbRsRsmbRsbRgbRgbRg
bRsbRsLsLsLsmmbRsRsmbRgbRsbRgbRgbRsRsmbLsRsRgbRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bRcbReLsbRibRgRsmbRibRcbRgbRiRsmbRjbRcbLobRiLsbRcbRibRiRgbRsbRiLsbRibR
hbRgbRhbRiRsmbRgRsRsRgRsmmmbRgRsRsmmbRibRiRsmbRiRsmbRsRsmbLsbRibRsRsmb
RgRgRgbRibRgRsmbRgbRgbRsbRgRcbRsRsmbRgbRhbRibRgbRgRsmbRgRsmbRibRiRsmbR
gRhbRgbRhRgRsRsmmbRibRgbRgbRsRsRembRgbRiRsmbRsbRgbRgbRsbRgbRgRsmbRsRgb
RgbRsRsmbsbLsLsReLhLsmbRsLhbLgbLeLsRsbLsbLiLsbLiLsbLgbLgLsbLeLebRibReL
sbRgbRsRgbRgLsbRgbRsRsRsmmbRgbRgbRsbRgRsmbRgbRsRsmbRgRsmbRsRsmbRsbRgbR
sbRgbRgbRibLiLsbLebLhbLsbLgbLsbLsbLsbRsbLsbLiLiLsbLhLgbLsLsmbLgbLsLsLs
mmbLsbLgRsbLsbLgLcbRgbLcLhbLgbLgbLsbLgbLsbLsbLsbLsbLiLhLsLeLeRsbsbLibL
hbsbsbRsbLsRsbLsLsRsmbLsLsmbLiLeLiLsbLsbLgLsbLgLibLiLibLebLiLiLsbLgLjL
gbLebLeLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bsbLjbRibLibLjbRjbLjbLcLsmbRgRsmbRgbReLsbLcbLcbLcbLcbLcbLebLhbLcbRsRcb
RcRgRsmbRibRcbReRgbRhbLsbRgLsbRjbLjbRcbRcbRcbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsLsLsmmbLsbLsLsLsLsLsLsmmmmmbLsbRsbLibRobRcLsbLsLobLhLsLsLsmmbRoRsmb
LgbRcRsmbRsRsmbRsbRcbLobLcbLibLsLsmbLhLsbLobLcLsmbLiLsbLob

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bLsLsmbLsLsmbLgbLsLsmbLsbLgbsbRsLgLsbLsbLgbRsbLgLgLsbLiLsLhbRsbLsbRsbR
gbRgRsRsRsmmmbRsRsRgRgRsRgRsRsRgRsRgmmmmmbRgLsbRsLsbRsLsbRsbRsRsmbRsbR
sRsmbRsRsmbRgRsmbRsbRgbRgbRsbRsRsmbRgbRsRgRgRsmbRgRsRsRsRsRsmmmmmbLsRs
bRsRsRgmbRsRgRsmbRsRgbRibRgRsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsRsRsmmmmmmmb
RsRsRsRsRsRsmmmmmbLsbLsbRsbRsRsmbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRibRsRsmbRibLsbRibRiRsLsmbRibRhbRibRebRiRsmbRcbLsRcbRibRibRcbRgRsmbRe
bRcRsmbRibRebRcbRhbRibRiLsbRobRcbRhRsmbRibRcbRgRsmbRcRsmbRgRiRsRsmmbRs
RsmbRobRebRcbRsbRiRsmbRcRsmbReRsmbRebRgRsmbRibRobRjRsmbRcbRebRhbRhbReb
RebRhRsmbRsbRjbRsbRibLsbLsRsbRsbRibRsbRsRsmbRiRsmbRsbRibLibLsbsbRhbRhb
LoRhbLsRhLsbLgbRcbRhbRiRsmbRobRsbLhbLiLsbLgLgbRcbRcbRibRiRsmbRibRibRiR
ebRebRiRsmbRibRsbRibLjbRcbRsRsmbRsRsRsLsmmbRsbRibLgbLjLsmbRebRsRsmbRiR
smbRgbRsbsbsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRjbRibLsbRcbRibRgRsmbRgRsmbRgbRgRsmbsbRgbRgbRibRsbRiLsbRcbRsbRibRiRjL
sbRcbLgbLebLhbLgbLhbLcbLcRsbReRsmbRhbLhLsbRcRsmbLhbRhbRhbLoRsbRcbRibRj
bRjbRibRhRsmbRibRjbRgbRgRsmbLgLsbLsLsLsmmbRgLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bLgbRsLsbLebRiRsmbLsbLsLsLsmmbLgLsbRibLeLsbLgbLcbRibRjRsmbRhbRibRebRcb
RcbLebLibLcbLibRjRgRsmbRhbLgbLeLsbLhLsLsmbLjbLibLcbRhRsmbRebReRgbRebLc
bLgbLgbLibLhbRibRhbRibLgbLgLsbLiLebRgbRsbRhbLebLgLsbRcbRebRibRsbRhLsbR
hbRgbRibLebLibLgLsLgbLgLsRsbLgLcbRgbRhbRhbRcbLgbLjbLibLcbLgbLiLgbLebLg
bLcbRcbRcbRcbRcbRibLcbLibLibLibRhbRiRsmbReRsmbRsbRsbRebRebRgbLsLsmbRib
RhRsmbRhbLhbRsbLgLsbLibLgbRsbLjLhbLibLibLsbRgbLjLibLcbLhbLibLgbLgbLibL
cbRibLibLgbLibLhbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsLgmmbLsLsmbLsLsmbLsLsLgLsmbLsLsmbLsbLgbLsbLibRsbLsbLgLsLsmbRsLs
LsmbRsbRsbLgbRsLsbLsbRsbRsbLsLsmbLgRsbLcbRcbRobRebReb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bRgbRsRsmbRsRsRsmmbRgRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsRsmb
RsRsRsRsRsmmmmbRsRsRsmmbRsRsRsRsLsRsmmmbRsRsRgRsmmbRgRsmbRsRsmbRgRsmbR
gRsRsmmbRsRsRsmmbRsRsmbRgRsRsmmbRgRsRsmmbRsRgRsRsmmbRgRsRsRsRsmmmmbRgR
smbRiRsmbRibLsLgRsbRgRsRsRsmmmbLsLsRsLsRsmbRsRgRgbLeLsbReRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bRibRcbLibLsbLjLsmbLibLibLcLsmbRcRgbRcbRgbsbRebLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bLsbRsRsRsmmbRsRsRsRsmmmbRgRsmbRibRcRsRsmmbLsbRgbLeLsbLcbLiRsbLcLsLsmm
bLsbLsbLsbLsLsmbLcbLcbRebRgbLjLjLsmbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bRibRobLhRsbLcbRcbRhbLcbLhbLcbLhbLgLibLsbLcbLgLhbLibLsbLiLibRsbLobRhRs
mbRhbRcbLcbLcLsmbRgbRebRgbRiRibRebRgbRibRsRgbRcbRgbLcbLibRsLsbRhbLcbLc
bLsbLjLibLibLsbRcbRjRsmbRhbRobLgbLibLcLsmbRgbRsRgbRgbRgbRcbRibRcbRcRsm
bLjbLcbLibLsLsLsmmbLcRsbRsbRcbRibRiRsmbRibRibRcbRcbRjRhbRgRgbRibRebLsb
Rcb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bLsbLibLgbLgbRsbLiLsRsbLgbLgbLgLsbLgbLgbLgbLibLgbLgbLgbLibLiRsbRgbRibL
ibRibLjbLcbRebRebRibLcbRoRsmbRgbRsbLibRsRebLsbRibLobRcbRiLsbRsbRgbRibR
ibRcLsbLebLibLgLsbLibLgbLibLibLiLsbLgbLgLsbLgLsbLgbLgbLsbLgLsbLiLsLsmb
LibLsbLgLsbLgLsbLsbLgLsbLibLiLsbLibLibLgbLgLsbLibLeLsbLsbLsbLsbRsbLsbL
sbLhbLgbLgLsbLiLsLsmbLgLsbLgLsbLiLsbLibLiLsbLgbLgLgbLibLobLibRibRgRsmb
RibRibRibRibRiRgbRsbLcbLhLsbLgbLibLibLebLiLsbLcbLcbLgbLhbLiRsbLgbLiLsb
LgLsbLibLiLsbLibLibLibLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bRsbLsLsRsLsmbRsRsRsRsmmmbRsbLsRsRsmbRsRsRsRsmmmbRsRsRsRsmmmbRgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132322; End: 132822;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bRsbLsbLgLcbRgbLsbLebLsLsmbLibRcbRibRsbLhbRjbLibLiLgbRibRhbRcRsmbRgbRo
bRhRsmbRgbRibRcbRiLsbLebLebLeLsbLeLsbLebLebLibLgbLeLsbLibLibLhbLcbLibL
gbLibLcbRibRiRsRsmmbRiRibReRsmbRgbRsbLgbRgRsRgmbRsbRgbRsbLsRsRgRsmbRgb
LsRsRsmbRgRsmbRsbLsbRsbRgbRsbRsRsReLcmbRgbRgbRibLhLsbLibLgbLibLsLsmbLe
bLgbLebLhbLebLiLsbLibLhLsbLgbLibLibLcbLcbLebLhbLhbLebLgbLeLsbLiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bLsbLobLobRgRgbRsRsRsRgmmbRoLsbRoRsmbRgbRibRsRsmbRsbRsRsmbRsRsRsmmbLsL
smbLsRsbRsRsRsmmbLsbRsRsmbRsRsmbLsRsRsmbLoRsbLibLgbLsLsmbLsbLgbsbLsLsL
smmbLsbRsbLsbLsLsmbLsLsLsmmbLsbRsbRobRhRsRsmmbRgbRibLibLibLibLibLcbLgb
RgbRiLsRsbRiRsmbRsRsmbRgRsmbLsRsbRsbRsbLsRsRsmbRsbRgLsbRcbRibRgbRsRsmb
RibRsRsmbRsRsmbLsRsbRsbRsbLsbRsbRsbRsbLsbLsbLsRsRsmbRsbRsbRsbsbRsRsRsm
mbRsRsRsmmbRsRsmbRsRsmbRsRsmbRsRsmbRsRsRsmmbRgbRsbRsbRsRsLsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bsbsbRsRsRgmbRgbRsRgRsmbRgRgRgRsRsRsRsRsRsRsRgmmmmmmmbRsRiRsRsmmbRgRsm
bRiRsmbRsRsRsmmbRgRgbRgbRgRsRsRsRsRsRsmmmmmmbRgRsRsmmbRgRsmbRibLcbLibL
obRsbLcbLiLsbLsLsLsmmbLobRgbRcbRiRibRcbRibLhbLsbLiRsbLhLhLeLsbLiLsbLib
sbLgLhbLibLgRsLsbRhRsmbRsbRsRsmbRsbRgLsbLsRsRsRsmmbRsRsmbRsRsRsRsmmmbR
sRsLsmbRgRsRsRsmmmbRgRsRsRsmmmbRiRsRsmmbRgRsRsRsRsmmmmbRgRsRsmmbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLsLsLsLsmmmbLsLsmbLsLsmbLsbLgLsbLsbLsbLsbLsLsmbLsbLsLsmbLsLsmbLsbLsLs
mbLsbLhbRgbRsLsbRsRsLsmbRsbLsbLgbLgbLgbLgLsbLgbLsLsLsmmbLsLsLsmmbLsbLs
bLsLsmbLsLsmbLsLsmbLsLsmbLsLsLsLsmmmbLsLsLsmmbLsLsLsmmbLibLcbRiRsmbRsb
sbRsbRsbLsbRsbRgbRsRsmbLsbRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bRsbRsLsbLsbLgbLsbRsLsLsmbRsbRsRsLsmbRsRsLsmbLsbRsRsLsmbRsbRsLsbRsLsLs
mbLsLsmbLsbLsbRsLsbRsLsLsmbRsLsbRsLsLsmbLsbLsbRsLsbLgbLsLgbLsbLsLsLsmm
bRsLsLsLsmmbLsLsLsmmbLsLgbLsLsmbsbRsLsLsmbLsbRsLsbLsLsmbRsLsbRsLsLsmbL
sLsLsmmbRsbLsLsmbRsLsbLsLsmbRsLsbRsLsbLgbLgbLsLsmbLgbLgRsbLsLsmbLsbLsL
smbLsbLsLsmbLsLsmbLsbLsbLsbLsLsmbLsbLsRsbLsLsmbLsLsmbLsbLsLsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bLsbRsLsbRgbRibRiRgbLebLcRsLsRsbRibRgRsmbRsbRsRsRsmmbRsRsmbRsRsmbRsRsm
bRgRsmbRgRsmbRgbRsRsRsmmbRsbLsLsmbLsLsmbLsRsbLsbLsbRsbRcRsmbRjLsbRibRh
bRcbRiLsLsmbRobRiRgbRgbRsRsLsmbRsbRiRsmbRcbRgbRsbLcbLcRsbRgRsmbRgbRhbR
sRsmbRgbRgRsRsmmbRgbLsRsRsmbRsbRiRibLhbLcRsbLsbLibLgbLgLsLsmbRsbLhbLgb
RsbLibLgbLsLsmbLibLgbLgbLsLgbLgLsLsmbLsbLcbLhbLhLiLsLebLgLebLsLsmbLibL
ibLgLeLsbLgbLgbLiLsbLiLsRsLibLeLsbLgLsbLeLebLebLcbLcbLsLsmbRsbLsLsmbLs
bLsLsLsmmbRsLsbRsbLgLsbLgbRjbRiRsmbsbLsbRsRsmbsbsbLsbLsbRibRsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bLsbLsLsmbLgLsRsbsbLsbRsbLsbLsbLgbLsbLsLsmbLgbLsbLsbLsbLsLsmbLsbLgbLsb
RsbLsbLsbsbLsLsRsmbLoLsmbLgbLsbLeLiLsbRjbRsbRjbRgbRsLsbRsbRsLsbRsRsRsm
mbRsRsmbRsbRsRsmbRgRsRsmmbRgRgRsmbRgRsRsmmbRsRsmbRgbRsbRsRsmbRgbRgbRgR
smbRsRsRsmmbRsRsRsmmbRgRsmbRgRsmbRgbLsbRsRsmbRsbRsRsmbRsbRsbRsRsmbRgLs
bRsbRgbRsRsRsmmbRgRsmbRsbRsbRgRsmbRgRsmbRsRsRsRgRsmmmbRgRsmbRgbRsRsmbR
sRsRsRsmmmbRgRsmbRsRsRsRsmmmbRsRsRsRsmmmbRgRsmbRsRgbRgbRgRsmbRsRsRsRsm
mmbRsRgbRgRgbRgbRsRsmbRsRsRgmbRgRsRsmmbRsRsRsmmbRsRgRsRsmmbRsRsRsRsmmm
bRgRsRsmmbRgRsmbRsRsRsmmbRgRsRsmmbRgbRgbsbsbsbRsbRgLsbRsRgbRsRsRsmmbRs
RsRsmmbRsRgbRsRgRsmbRsRsRsLsmmbRgRsRsmmbRgbRgRgbRsbRsbRgbRgRsmbRgRsmbR
sRsRsRsRsmmmmbRgRsmbRgbRgbRsRsRgmbRgbRgbRibRgbRibRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bRobRcbLebLobLebLobLobRgbLebRebLobRebRjbLsbLcbLjbRobRjbLobRjbLcbLobRob
RebLcbRobRcbRjbLebRjbLsbLjbRobLsbRsbLjbLhbLobRobLebRobLebLsbRobRebLobL
jbRsbLebLsbRebRjbLobRcbLsbRobRobLebLcbLgbRobRhbLebLjbRebRebLibRjbLobLo
bRcbRobRgbRsbLobLobLjbRobLibLobLcbRebLobRobLobLobLsbLobLobRobRebRcbLeb
LebRsbLcbLobRebRjbLebRebRebRobLobRobLobRebRobLgbRobLcbLjbRjbLobRebRebL
jbRebRobRjbLobLobLobLjbRebRobLobLobLcbRsbLobLibRcbRibLobLibRebLcbLobRc
bRebLcbRobRebRcbRobLebLibRobLibRobRobLcbRobLgbLcbRebLobLsbLobRgbRcbRob
LgbLcbRebRebRjbRobRobRibLobRebLebRcbLobLibRcbLobRcbRobLgbRebRhbLsbLcbR
cbLebRhbLobLgbLobRcbLgbRcbRobLobLebRobRibLibRibRobRobLobRebLcbLobRcbRo
bRcbRgbLobRebLebRebLebLebRobLebRsbRgbLcbRcbLobRobLobLebRsbRobRobRebRib
LobLcbLobLcbLcbRobLjbLebLcbLebRcbLobLobRsbLebLjbLgbLcbRebLobRebLebRebL
jbRcbRebRebRjbLobRibLcbRobRebRcbRobRcbRibLobRobRcbLcbLcbRcbLcbLcbLobLe
bLobLjbRobRobLhbLcbLcbRcbLsbLobRjbLebRcbLcbRcbRebRebLcbLobRobLebRobRob
LobLcbLcbLsbLebRobRobLobLobRobLobLsbLcbLibLhbRcbRebRobRobLcbLjbLibLebR
sbRebLjbLobLcbLobRobLobLobLebLobRobRobLebRcbLcbLobRcbLobLsbLibLebLobLo
bRcbRsbRobRibRobRebRobLebLebLobLcbLcbRobRobLobLobRobLobRgbRibLcbLebRib
LcbLibLobLobRcbLobLobRobRobLobLobRobLobLibRcbLibLgbLcbRobRcbRobLcbRcbL
ebRebRcbRgbRobLebRcbRobLebRcbRobLobLobRobLobRebRobRcbRebRsbRebRobRobLc
bLcbLobLebRebLobRsbLebLebRobLobRsbRibRobLsbRgbRobRebLobRebLhbRebRobLeb
LobLebLobRobLgbRebRebLcbLebRsbRibRcbLobLobRcbLobRobRobRobLebLobRibLobL
obRibLobLebRebLebRcbRcbLgbRebLobRcbLebLcbLibLcbRhbRebRjbLobRsbLobRobRc
bRobLobLobRobRebLobRgbLgbRobRsbRobRsbLgbRcbLebRebRobRcbLibRcbRobRobRsb
RibLjbLobLebLhbRebRcbRgbLobLcbRebLobRcbLjbLebLobLsbLobRobRcbLcbRobLebR
ibLgbRobRobLebLcbLobLobLobLobLobRibLibLcbRobLobRcbLebLebRcbRebLgbLibLi
bLobRobRobRsbRebLobLobLobLobRebRcbRebRobRjbLebRebLgbRebLcbRcbRcbLsbLob
RibLibRobRobLgbLgbLobLobRebLjbLobLobLjbLobRibLgbLebRcbLobLcbLobRobRcbL
obLsbLebLcbLebRobRibLobRobRebRebLobLobLebRibLobLibRcbLobLcbLgbRcbRebLo
bRebLobRcbRebLobLobLebRcbLcbRjbRcbRebLjbLebRebRebLhbRibRebLcbLsbLobRhb
LcbRobRcbRobRobRebLjbRobLobLebRcbLebRcbRobRebRobLobRobLsbRebRobRsbLobR
obLjbLebRobLcbRebRobLibLobRobRsbRcbRgbRobLsbRobRcbLcbRobLebRobLobRgbRh
bLhbLibLobRebLcbRcbRcbLobRobLcbLsbRibLsbRobLobRhbRsbRobRgbLcbLebLobRjb
LcbRebRcbLobLobRebLcbLsbLcbRobLobRobLobRcbRsbLobRcbRobLobLobRebLebLibL
ebRsbRhbLobRebRobRcbRcbRobLcbRobLebRobRebLobRebLgbLcbLebRebRobLebLhbLi
bRhbLcbLebRgbLobLebLsbRcbRcbLobRobRcbLcbRebRjbRebRobRcbLcbLobRcbLsbLob
RobLobLjbRobRebRgbLobRobRobRebLobLcbRobLobRcbRobLjbLibLcbLebRobLcbRobR
obLebRebLibRhbRebRobLobLobRhbRebRgbLobRobLebLebLcbRebLebLgbRebRobRhbRc
bRobRsbRebRobRebLobRibLebRebRebRebRobRebLebRobLobRjbLobLebLebLibRobRcb
LebRebRobLebLobRibRebRcbRebLobLobRobLobLsbLjbLcbLebLgbRebRcbLjbLebRobL
ebLobRibRibLibLebRcbLobLcbRsbRebRobRobLebRobLobRsbRcbLebLobLobRcbRobRo
bLsbLcbLobLobLcbLibRebRjbLcbLobRobLobRobLobLobRobLebRgbLebRgbRobLsbLob
RebLobRsbLebLebRcbRebRobLibRebLgbLebLebLobLobRsbLobRobRebLobRcbRsbRhbR
ebLebLobRobLjbRobRobRobRebLsbRobLjbRebRsbRebRobRsbLobLcbRobLcbLcbLobLj
bRebLobRobRcbLobLobLobLobLcbLobRobRobRebLobLcbRsbRibRsbRcbRebLobLebRcb
LobLobRobLobRobRgbLgbLobLobRjbLobRibRobRsbRobRobLcbLobRsbRobRebRhbLobL
gbLobLobRcbLobLebRsbRobRobLobRjbRsbLobLjbRsbLobLsbLobRebLebLobLebRsbRe
bLobLjbRcbRibRsbLebRobLebLjbRebLsbLobLobLibRebLebRobLobRcbRsbRobLobLcb
LobRebRobRebLebLebLobRsbRobLjbLobLcbLebRobLobLibRebLobLebRobLcbRibLebL
obLgbRebRobRebRobLgbRobLobRjbLebLob

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bRob

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bLhbRjReRsmbRcbLibRcRsmbRsRsRsmmbLjLsmbLcbLibLiLeRsbLcbRcbLibsbLsLsmbL
gbLsRsbLsbLsLsLsLsmmmbLsbLgbRsbLcbLgLgRsbRsbRsRsmbRgbRsbRsbRiRsRsmmbLs
LgLgbRibLibRsRiRsmbRibRcRebRebLgbLsbLgbRsbRsbRgbRsbRsbRsbRsbRgbRcRgbLs
bRsRsmbRgRsmbRgbReRsmbLibLibLibLgLsbLebRsbRebLibLibLibLsbLcbLibLibLiLs
bLsbLsLsmbLgLsbLiRsbLibLibLibLibLhbLibLgbLgLsbLebLiLsbLgbLibLgbLcbLibL
jbLibLiLgLsLgbLeRgbRgbRgRsmbRsRgbRibRgRsmbRgbRcbRibRgRsmbRibRsRsmbRgRs
mbLsRgbRiRsRsmmbRgbRibRgbRiRiRsRimbLsbRsRgbRgbLsRsbRsRsmbRgRsRsmmbLsRs
RsmbLibLibLiLsLsmbLibLgbLibLcLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLgbLgbLsbsbLsbLsbLiRsLsLsmbLgbLgbLsLsmbLsLsmbLibLsLsmbsbLgRsbLsbLsLsm
bLsLsmbLgRsbLsLsmbLsLsmbLibLsLsmbLsbLsLsLsmmbLibLgbLsbLgLsbLibLgbLsLsm
bLsbLgbLsRsbLgbLsbLgbRsLsbLsbLgbLgbLsbLsbLsbLsLsmbLsLsmbLsbLsbLgbRsbLs
RsbLsLsLsmmbLibRsbLsLgbLgbRsLsbLsLsmbLgRsbLsRsbLiLsbRsbLgbLgLsRsbLsbLs
bLcbLcbLgbLibLsbRsbLhbLsbLgbLsRsbLsLsLsmmbLsbLgbLsLsmbLsbLsLsmbLsLsLsm
mbLsbLsLsmbLsLsLsmmbLsRsbLgbLsbLsLsmbLgLsbLsbLsbLsLsmbLgbLsRsbLgLsbLsb
LgbLgbLgbLsbLsLsRsmbLgbLgbLgbLsLsmbLsbLsbLsLsmbLsLsmbLgbLsbLsLsmbLsLsm
bLsLsmbLsbLgbLsLsmbLgbLsbLgbLgbLsbLsbLsLsmbLgbLsbLsRsbLgbLsLsLsmmbLgbL
sbLsbLsbLgbLgbLsbLgRsbLsbRsLsbLsbLgbLjRsbRsLsbLgbLsLsmbLsLsmbLsLsmbLsb
LgbLsLsmbLgLsbLgLsbLgLsbLsbLsLsmbLsLsmbLgbLsLsLsmmbLgbLsbLsLsLsmmbLgbL
sLsLsmmbLgbLsbLsbLsbLgLgbLgbLgLsbLgbLgbLsLsmbLsLsmbLsbLsLsmbLgbLgLsbLg
bLgRsbLsLsLsmmbLgLsLsmbLgbLsbLsLsmbLgbLgbLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bLgbLgbLgbRobLiLsLgLsbLebLsLgLsLsmbLgbLsLgLgbLgLsbLhbLgbLsLgbLgLsbLgLs
bLgLsLsmbLsLsLgmbLgLsbLgbLgbLsLsmbLsbLgRsbLsbLgRsbLgbLgLsLsLgLsLgmbLsb
LsLsmbLgLsbLhbLgLsbLsLsLsmmbLsLsLsmmbRsLsbLsbLgbLgLsbLsbLsbLsLsLsmmbLs
LsmbRibLjbLibLhLsbLcbLibLebLsbLebLebLibLeLsRsbLeLsLsLhmbLgbRobRhRgRsRi
RgmbLsRebRsRgLsbLsbLsbRsbRsRsRsRsRsRsmmmmmbRgRsRsRsRsReRsRsmmmmmmbRgRs
mbRsRibRgRsmbRgbRgbRgLsbRgbRgRsmbRsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsRsmbR
sRsRgRembRsbLsbRsRsmbRsRsmbRsbRsbRsbRsRsRsRsLsRsmmmbRsRsLsmbRgbRsRsRsm
mbRgbRsRsRsmmbRsRsRsmmbRgbRsRsmbReReRsmbRebRgRsmbRsbRsbRsbLsbRgRsLsmbR
gbRsRsmbRsbRgbsbRjRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bsbRsRsmbRgRsRsmmbRsbRgbRgbRsRsmbRgbRsRsmbRgbRsbRsbRgRsmbRiRsRsmmbRgRg
RsmbRgRsRgmbRsbRgRsmbRgbRgbRgbRgbRsbRgRsmbRsRsmbRibRgbRsbRgbRsRsmbRsRs
RsmmbRsRsmbRgbRsRsmbRgbRsRsRsmmbRgbRsbRsbRsLsbRsbRsRsRsmmbRsRsRsmmbRgL
sbRsbRsRsmbRgbsbRsRsmbRsRsRsmmbRsRsRsmmbRgbRgbRgbRsbRgbRgRsRsRsmmmbRsb
RsRsmbRsbRsbRsbLsRsRsRsmmbRsbLsRsLsbRsRsRsRsmmmbRgRsRsRsmmmbRgRsmbRgbR
gbRgRsRsRsmmmbRgRsmbRgbRsRsmbRgbRgRsmbRsRsRsmmbRsbRgbRgRsRsRsmmmbRgRgb
RsRsRsRsmmmbRgRsRsmmbRgRsRimbRgLsbRgRsRsmmbRgRsLsmbRgRsmbRgbRgRsmbRgRs
mbRsRsmbRgbRgbRgRsmbLsRsRgRsmbRgbRsbLsRsRsmbRgbRgbLsbRgRsmbRsbRgLsbRsR
smbRgbRgRsmbRgRsmbRsRsmbRgbRsRsmbRgbRgbRsRsmbLsRsRsmbRsbRsbRsbRsbsbRsR
sRsmmbRsbsbRsRsmbRgbRgRsmbRgbRgbRgRsmbRgRsRsmmbRsRsmbRgbRgRsmbRsbRsbRs
RsRsmmbRgbRsbRsRsRsmmbRgRsmbRgbRgbRgbRgRsmbRgbRsbRsbRgbRgRsmbRgbRgRsmb
RgRsRsRsmmmbRgbRgbRgbRgbRgRsLsmbRgbRsbRsbRsbRgbLsbRgbRsbRgbRgRsmbRgRsR
smmbRgRsmbRgRsRsRsmmmbRgRsmbRsbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsbRsbRsbRgb
RgLsbRgRsRsmmbRgbRibRgRsmbRgbRsbRsbRsbRgbRgbRsbRgbRgbRgbRgbRgbRgRsmbRg
bRgbRsbRsbRgbRgLsbRgRsmbRgRsmbRgbRgbRgbRgbRsRsmbRsbRsbRgRsmbRsbRsbRgbR
sbRgRsmbRgbRgbRgLsbRgbRgbRgbsbRsbsbRsbRsbRgbRgRgbRgbRgbRgRsmbRgbRsLsLs
mbRgbRsbRsbRsbRsbRsRsmbRgRsmbRgLsbRgbRgbRgbRgbRsbRsbReRgRsmbRsbRiRsmbR
gbRgbRgbRgbRgbRsbRgbRsbRsbRgbRgbRgRsmbRgbRgbsbsbLsLsmbsbRsRsRsmmbRsRsm
bRsbRsbRgbRgRsRsRsRsmmmmbRgRsmbRsRsmbRgRsmbRgbRgRsLsmbRgbRsbRsRsmbRsbR
sbRsbRsbRsbsbLsRsbRgbRsbRsRsmbsbRsRsmbRgbRgbRgbRgbRgbRgbRsRgbLsbRsbRsb
RsbRsbRsbRgLsbRgbRsRsmbRsbRgbRgbRgbRgRsLsmbRsbRgRsmbRgRsmbRgbRsbRsbRgb
RsbRsbRsbRsbRgbRgRsRsmmbRgbRgbRgbRgbRgbRgbRgLsbLsRgbRgbRgbRsbRsLsbRsRs
mbRsbRsbRsbRgbRgbRgLsbRgRsmbRgRsmbRgbLsRsLsbRsbsbRgbRsbRsbsbRsRsmbRgbR
gRgbRgRsmbRgbRgbRgbRgbRsbRsbRgbRsRsmbRgRsmbRsbsbRgbRsRsmbRgbRgRsmbRsRs
RsmmbRsRgbRgRsmbRgbRgbRgbRsbRcbLgRsRgbRebRibRsbRhRsmbRebRcbRebRebReRsm
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bsbRgbsbReRsmbRsbRibRhbRsbRiRiRsRimbReRsRgmbRsbRsbRsbRgbRgbRgbReRsmbRs
RsLsmbRgRsmbRgbRsbRsRsLsmbRgbRgbRsbRsbRsLsbRsRsmbRsRsmbRsbRgLsbRgRibRs
bRgbRsbRsRsmbRsbRgbsbRgbRsLsbRsbRgbRsbRsbRsRsmbRiRsRgmbLsbRsbRgbRibRsR
smbRsbRsRsmbRgRsmbRibRiRsRgLsRsLsmbRjRsmbRgRsmbRsbRsbRjRsmbRsbRsbRgbRi
RgRibRgRsmbRgbRgbRibRhRsmbRcLsbRgbRsRcbRsbRcLsbRiRhbRsbRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLsLsmbLgbLgbLgLsbLsbLgbLgLsbLsbLgbLgLsbLgbLgbLgbLgbRobRiLsbRsbRobRgRs
mbRcbRsbRcbRhbRibRobLcbLiLsbLiRsbRcbRgbRcRsRsmmbRhLsbRsbRoRgbLibLibLcL
smbLjbRsLjLsmbLsLsLsmmbLibLiLsbLibLibLgRsbLgbLgLsLsmbLsbLgbLsbLgbLsbLs
bLsLsmbLsLsmbLgbLsbLsbLsbLsbLsbLsbLsbsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsbL
sbLgbLsbLsLsmbLsbLsLsmbLgbLsLsmbLgLsbLgbLsbLgbLsbLsLsLsmmbLgLsLsmbLsbL
gLsbLsLsmbLgbLsLsmbLgLsLsmbLsLsmbLgbLgLsLsLsmmbLgbLgLsbLsLsmbLsbLgbLgb
LsLsmbLgbLgbLgLsbLgbLsLsmbLgLsbLsLsmbLsLsmbLsbLsbLgbLgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bLobLcLsmbLiLsbLebLgLgbLiLgLsLeLgbLgbLeLsLsLsLsmmmbLcLsLsmmbLiRsbLcbRi
bLiLeLebLibRebRgbRibReLsbRcbRgbReRsmbRiRiRsmbRgbRiRsmbRiRsRsmmbRgbsbsb
RgRsmbRgbLgbLcbRibRjRsRsmmbRibRjRgbLcLsmbLhRsbReLsbRgRgRibRgbRsRsmbRsb
RsbRsRgbRgbReRsmbRhbRibRibLiLsbRsRsRsmmbRgbLebLcbLibLibRiRgbRibRgbRsbL
sLjbRcbRsLsbRgRsRsRsmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRsbLsbLsbLsbLsbLsbLsbLsbLsbRsbLsbLsLsLsLgmmbLgLsLsmbRsLibRobRiRsmbRib
RgRsmbRgbRgbRsRsmbRgRgRsmbRoRsmbRgbRcbRiRsmbRgbRiLsbRcbRibRibRcbRsRibR
hRsmbRgRsmbRgRsmbRgbRgbRsRsmbRsRsLsmbRsbRsbLsbRsbRsbLsbRsbRsbRsbRsbRsR
smbRgbRibRcbRiRsmbRhbRibRiRsmbRgbsbRsRsmbRsRsmbRgRsmbRibRcbRgbRcRsmbRi
bRiRiRsmbRiRsmbRgbRgbRgbRgRsmbRgbRgbRhRsmbRhbRsRhbRibRibRiLsLsLsmmbRsR
smbRsbsbsbsbsbRsbRsbRsbRsbLsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLgLsLsLsmmbLsLsmbLsLsLsmmbLsbLsLsmbLsLsLsmmbRsLsLsLsmmbLsbLsLsmbLsbLs
LgbLgbLsLsLsLsmmmbLsLsLsmmbLsLsLsmmbLsLsmbLgbLsLsLsLsLsmmmmbLsbLsLsmbL
sLsLsLsmmmbLgbLsbLsLsLsmmbLsLsmbLgbRsLsLsmbLsLsmbLsbLsLsLsmmbLgbLsLsmb
LsLsmbLsLsmbLgLsLsmbRsbLsRsbLsbLsLsmbLgLsbRsLsbLsLsLsmmbLsLsmbLsLsLsmm
bLsLsmbLsLsLsLsLsLsLsmmmmmmbLgbRsLsLsmbLsLsLsRsmmbLsLsLsLsmmmbLsLsmbLs
LsLsLsLsmmmmbLsRsbLgbLsbLsbLsbLsLsLsmmbLgbLsLsLsmmbLsLsmbLsbLsLsmbLgLs
LsmbLsLsLsmmbLsLsLsLsmmmbLsbLgLsRsbLsLsmbRsLsbLsbLsLsmbLsLsmbLsLsmbLsb
LsbLsbLsbRsLsLsLsmmbLgbLsbLsLsmbLsLsLsmmbLsLsmbLsLsLsmmbRsLsLsLsLsmmmb
RsLsLsmbLsLsLsmmbLgLsbLsLsmbLsLsmbLsbLsbLsbLsbLsLsmbLsLsLsmmbLsLsLsmmb
LsLsLsLsLsmmmmbLsbLsLsLsmmbLgbLsLsLsmmbLsbRsLsLsLsmmbRsLsbLsLsLsLsLsmm
mmbLgLsbLsLsLsmmbLsLsLsLsmmmbLsbLgbRsLsLsmbLsbLsLsmbLgLsLsmbLsLsmbLsLs
LsLsmmmbLsLsmbLsLsLsmmbLsLsLsLsmmmbRsLsLsLsmmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bRcRsmbLjLsmbLcbLibLcLsLsLsRsmmmbLeLebLhbRebLobLcbLibLgLsbLgbLcbLebLiL
ebLiLsbLgLgLgbLhbLgbLsbLsbLibLgbLibLsbLibLibLcbLcbLgbLibLjbLgbLgLebRoR
smbLibRiRsmbRibRsRsmbRjbRcbRibRebRhRsmbRobLgLsbLcbLgRsbLgLsbLiLjbLoRsb
LgbRcbLsbRoRhRgRsmbRgbRcbLsbRiRgbLsbLibRebRhbReRsmbLobRebRhRsmbLebRebL
jbRhRsmbLibLjbLgbLcbLcbRsbLcbLgbRebLsLsmbLiLgbLjbLsbLiLhLgbLcbRobRibRg
bRibLjbLebLibLiLsbLsbLsbLibLgbLibRsbLibLsbLgbRjbLgbRsbRebRcbLsbRibRiRs
mbRiRsRimbRiRibRibRgbRsbReRgbRebRebRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bRibRcbLgbLobLcbLebRebLebLjbLgbLobRebRebRcbLobRobRobRobRcbRebLobRobLeb
RcbRibLcbLsbRcbLebRobRebRobRhbLjbRobLobLcbLobRobLgbRobRobRsbRhbLebRcbL
obRebLobRcbLjbRobRobLebRcbLibRebRebLebRobRebRobRcbRsbRebRcbRobLobLcbRo
bLebRebLsbRobRcbLobLebLibRobLibLebRhbRcbLsbLebLobRsbRcbLebRobLhbLjbLob
RcbRcbLjbLhbLobLobLobLobLcbRibLcbRgbLcbRobRebRcbLebRobLcbLebLobLcbLobR
cbLjbRobRhbRebRibRebLebRobLebLibLebLobLobRebLibRhbLsbLcbRjbLebRobRebRo
bRcbRcbLobLgbLebRgbLibRobRjbRcbLgbLebRobLobRebLobLibRobLebRcbLgbLobLob
LgbLobLgbRcbLobRcbRcbLsbLsbLcbLsbLcbLgbRcbLcbLcbRebRgbRobRgbRobLcbLobL
cbRgbRobRobRobLcbRobLcbRebLcbRcbLsbLebLebRebLcbRobLcbRcbRobLobLobRibRs
bRebLobRebLobRibLgbRebRobRcbLobRjbLebLhbLobRobRobLobLebLibRobRcbLebLcb
RobRcbRgbLgbLibLebLcbRebRibLobRhbRobLibLobLobRobLebRcbLebRibLobLobLobR
obRgbLhbLebRobLebLebLobLobRebLcbRobLobLobLibRobRcbLebRobLobLcbLebLibRg
bLobRebLebLcbRcbLobRobLebRobLhbRobLobRebLibLobRibLobLobLsbRjbRcbLobLib
RcbLebRhbLgbRobRgbRobRebRobRcbLcbLobRcbRgbLibLobLobLobRobLobLcbLcbRebL
obLsbRcbLobLhbRcbLcbLobRsbLebLebLebRebLibLobLgbRobLebLgbRebRebRsbRobLo
bLobRobRgbLibRebLobLobLobRgbLobLobLgbLcbLcbRobRebRobLebLgbRebRebRibRgb
RcbRebRobRebLobLobLebLobRgbLebLjbRcbLobLobRobLobRcbRobRebLobLebLebLobR
cbLobLcbLobRobRibRebLobRobRcbLcbLobRcbRebRobLebRcbLebRebRobLsbLsbLgbLc
bLsbLcbRsbLebLobRobRobRgbRobLcbLobRobRebLhbLobRebRcbLobRcbLobRibRcbLob
LobRobRcbRebLobLgbLcbRobLhbRibRobLebRobLobLgbLibLebRobRobRobRcbLsbRhbL
cbLobLobRsbRebLebRobLebRibRcbRobLobLcbRobRebRobLobLcbLcbLobRebLobLobLc
bRebRibLobLobLcbRobRcbRhbLobLjbRobRobRobRobRsbLcbRobLhbLebLobLcbLebLjb
LcbRobRjbRcbLcbRobLobRsbRcbRobRebLobLobRobLgbLgbLobRobLobRgbLobLibRjbL
gbRebRcbLobRobLobRebRebLjbRsbLgbLsbRobRcbLibRcbRobRibLgbRibRobLebLobLo
bRobRobLobLebRcbRcbLcbRgbRibRibRebRebLcbRobRibLebRebLebLcbRcbRsbLebLob
RobLobLobRcbRcbLebLsbRebLobLcbLjbLobLebLjbRcbRobRobRobLebRcbRobLobLebR
cbRsbLhbRibRebRobLcbRobLobLcbRcbRobRibLobLgbLebRobRebRobLibLcbLobRebRi
bLobLgbRobLobRebLobLobLcbLobLobLcbLibLjbLobRjbLobRobRobLebLgbLibLobRob
LgbLobLobLobRobLobLgbRcbLcbLgbLgbLobLcbLcbRebRebLobRebLcbRobLobLobLobR
obLobLobLobRgbLebRjbLobLobLobRsbRobLebLjbRibRibLobLsbRcbRobRobLobRsbLi
bRebLobRobLobRebLgbRgbRebRebLobLebRobRcbLcbLgbRibLobLgbLsbRobRjbRobLeb
LibLobRobRobRobLcbLjbLebRcbRebLebLebRobRsbRobLobLibLgbLobRobRibRjbRibL
obRgbLcbRibRcbRobRgbRebLobRobRcbRobLcbRcbLcbRcbRebLjbLobLobRobLobLcbLo
bLibLjbLobRgbLobRcbRjbLebLobLobRebRhbRsbLobRgbRobRebLebLcbRobRjbRebLob
RibLobRobLebLebRcbRjbLobRobLgbRobLobLebLobLsbLibRcbRobLibRjbRobRjbLobL
jbRgbLebLobLobRcbLibLobLebRibRjbRobLjbRobRobRobRobLobLebRobRgbRjbLobRi
bRjbLobRobLgbRobRobLebRobRjbRcbLcbLobRibLobRobRebRcbRebLibLebLcbRjbLeb
RobRcbLgbRobRgbRobLibRjbRsbRcbRjbRcbRjbRibLibRobLibRcbLjbRjbLebLobLobL
ebRobLobRobLobLobRobRobLobRebRcbRibLobLcbLobLobRcbLebLibLgbRcbLcbLobLe
bRobRgbRcbLobLcbLobRebRgbLibRobRebLebRebRcbLobRsbRjbRebRobRobLjbLobReb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bLsLsmbLgbLibRebRobLebLibLibLgLsbLhbLhbLiLsRsbLibLiLsbLebLgLsbLebLiLsb
LiLsLsRsmbLeLsbLebLsbLcbLibLibLobLsbLiLsbLsLeLsbLebLjbLiLsLsmbLeLsbLeR
sbRsbRiRhbRobLhLgLgLgLsLsmbRoLsbRiRsmbRhRgbRgbRebRhRsRsmmbReRsmbRgRebR
ebRebRcbRhRsmbRgbRcbRcbLgbLgRsbLjLgLcbLcbLjLsmbLebLgbLcLsmbLsLiLgLsbLo
bRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
bLhbRhbReLsRsbLsbLgbLcLsmbLgRsbLhbRhRsmbLgLeLsbLgLsLsLimbLiLsRsbLgRsbL
hbLibLsbLgRsbLjLgLhbLibLgLsbLhLsbLhbLgbRsbLiLsbLgLsbLgRsRsmbLhLsLsmbLg
bLgLsbLibLiLsLibLiRsbLiRsbLibLgLsbLiLgLsLhbLibLgLsbLiLgbLgbLgbLgbLjLsm
bLeLsbLhbLiLibLgLsRsbLiLgLsbLgLiLibLhLgbLiLiLsLibLcbLjLgLsLsmbLibLiLsb
LibLibLcbLcLsLsmmbLiLsbLibLebLgbLcbLhLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bLibLcbLibLgbLgbLgbLgbLibLibRibRebRhRsmbRgbRibRiRsmbRgbRgbRibRgbRibLgL
sbRjRsmbLjRsbLgbLibLgLsbLsRsbRcbRgbRiRsmbRcbRhbRiRsmbRibRgRsmbRibRibRi
bRhbRgbRiRsmbRcRsmbRibLgbRibRibRsbRebRgbRibRibRhbRgbRibRibRcbRgbLibRsR
cLsbRibRgbLsbLebLibLibLgbRsRsmbLsbRjbRjbRiRsmbRgbRgbLgRsbRgbRgLsbRgbRg
bRibRgLsbRiRsmbRibRgbLebLhbLgbLgbRebRiRsmbRgbRgbLgbRibLsbLhbLebRgRsmbL
iLsbRsbLibLcbRcbRebRibLgbRibRsRsRgmbRgRgRgbRgbLsbRiRsmbRgbRibLibReRsmb
LsbLibRibRcbRibRgbRgbRgbLjbLhbLiRsbLgbLibLsbRgbRebRibRibRgLsRsbRgLsbRh
bRibRibRgbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bLibRgbLcbRcRsmbRebRiRgRhbRiRsmbRiRsRsmmbRebRgRiRsmbRcRsmbRcbReRsmbRhb
ReRsmbRebRhbRobReRsRsRgmmbRiRsRgRsRsmmmbRebLjbRibRhbLibRibRibLibLhbLsb
LhbLcbLibLibLiLsbLibLcbRgbLhbLibLiLsbLgbLiLsbLgRsbLsLsmbLgLsbLibLiRsbL
gbLhbLiLsLsmbRsbsbLgbLibLebLeLcbReRsmbRebRcbRgRsmbRiRsmbLebRsbLeLsLsmb
LgLsbLibLiLsLiLsLsmbLiRsLsbLgbLibLibLebLhLgbLibLibLiRsbLiLsbLebLgbLibR
sbLgbLsbLgbLgbLiLsLsmbLibLhbLgbLebLebLibLiLsbLebLiLsbLgLsbLiLsRsbLibLi
LgbLcbLcbLibLibLgLgLsbLibLibLgbLiLiLsbLiLgLsbLiLhLibLeLsLsLiLsmbLibLeL
ebLibLibLeLsbLgbRsbRjbLjLsmbRsbLebLhbLiLebLiLsLsmbLibLsbLgbLiLiLgbLibL
eLgLebLhbLjbLebLhbLcbLeLsbsbLeLsbLcLgbLcLhbLeLhLebRgbLibRebRebRebRsRib
RcbRsbRibReb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bLebRjbLgLsbRhbRgRgbRsbRgbRsbRgRsmbRgbsbRebLgbRjbRgRsmbRsRsRsmmbRgRsRs
RsmmmbRsbRiRgbRgbRsRsmbRibRgRgbRsbRgbRibRgbLsbRiRsRgmbsbRibRgRsmbRsbRs
bRsbRgbRgRsRsmmbRsbRgRsmbRsbRsRsRsmmbRsbRgRsmbRgbRsRsmbRsbRsLsbRgbRsRs
RsmmbRsbRsbRsbRgbRgbRsbRsbRsRsRsmmbRsRsRgmbRgbRibRgbRibRiRsmbRebRibRib
LgbLsbsbsbLsbRiRsLsmbRiRsmbRcbLebRhLsbRhRsRsmmbsbRhRsRsmmbRibRsbRcbRib
RibRebRgbRhLsbLibLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRibRsbRsbRsbRsLsbRsbRgLsbLgbRsRsmbRsbRsRsmbRebRgbRgRsmbRsbRgbLs
RgbRebRebRhbLiRibRcRsmbRiRsmbRibRiRsmbRgRsRsmmbRgbRibRebRsbRgbRhbsbRsb
RibRibRgbRgbRgbRsRsmbRsRsmbRgbRsRsmbRgbRsbRsRgbRgbRgRsRsRsmmmbRsbRsRsm
bRsLsbRsRsmbRsbRsRsRsRsmmmbRsbRsRsRsRsmmmbRsRgbRgbRgRsmbRgRsmbRgbRibRg
RsmbRsRsRsmmbRsRgbRgRsmbRgbRgbRgRgRsmbsbRsbRsbRsRsmbRgbRsRsRsmmbRsbRsb
RsRgbRgbRgRsRsmmbRgbRibRsRsRsRsmmmbRgbRsRsmbRsRgRsmbRsRsRsRsRsmmmmbRgR
smbRgRsmbRgbRgbRebRgbRgbRgRsmbRgbRgbRiRsmbRgbRgLsbRgbRsbsbRsbRgRsRsmmb
RgRsmbRgbRgbRgbRgbRgRsmbRsbRgbRgRsLsmbRibRibRsbRebRiRsReRsRiLsmmbRsbRc
RsmbRsbRobReRsmbRgRsRgmbRibRibRsbRgbRibRgbRebReLsbRibRibRibRgbRibRgbRs
bRgbRsbRebRiRsmbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLibLobLsLsmbLcLsmbRsbRsbLsLsmbLgbLsbLibLgbLsLsLsLsmmmbLsbLibLsbLsbLsb
LsLsmbLhbLibLgbRsRsLsmbLsbLgbLsbRsbLsLsmbLgRsbLsLsLsmmbLsLgbLsLsmbLgbR
sbLgbLgbLsbLsbLsLsmbLhbLgbRsRsmbRgbRgbLhbLsLsmbLgLsbRsRsmbLsLsLsmmbLsL
smbLgbLcbLsbLcbLibLgbLgbLhLsbLjbRsbLiLsbLgLsbLhbRgLsbRgbLhbLgbLgbRsbLs
LsmbLibLgRsbLsbLgbLgbLsLsLsLsmmmbLgbLgbLgLsbLgbLsbLsbLsRsbLsbLibLgbLgb
LgLsbLgbLibLibRsbLjbLibLgbRobLibRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bsbsbLsLsmbRcbRebRgbRsRgbRcRsmbLgbRsbRjbLobLcbLsLsmbLsbRjbRhbRiRsLsmbR
obRoLsRsbRgbLsRsRsmbRibRsRsLsRsmbRibRsbReRsmbRobRhRsmbRiLsbRibRgRsmbRg
RsRsmmbRgbRgRsmbRibRcRsmbsbRebRhbRgRsmbRibRgLsbRiRsmbRibRgbRgRsmbRiRsm
bRcbRibLsbRibRiRsmbRibRibRibRiRsmbRgbRiLsbRgbRiRgRsRiRsmmbRiRiRsmbRgRg
Rsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bRsRsRsmmbRsbRsRsRsRsRsLsRsRsRsRsmmmmmmmbRsRsRsRsmmmbRsRsLsmbRgRsRsmmb
RsRsmbRsRsRsmmbRsRsRsRsmmmbRsbRsbRsRsmbLsRsbRsRsRsRsRsRsmmmmmbRsRsRsRs
RsmmmmbLsRsRsRsRsRsRsmmmmmbRsRgRsLsRsmbRsbRsbRsbRsbRsRsRsRsRsmmmmbLsRs
bRsRsRsmmbRsRsmbLsRsRsRsRsRsRsmmmmmbLsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRs
RsRsRsRsRsmmmmmbRsRsRsRsRsRsmmmmmbRsRsRsmmbRsRsmbRsRsmbRsRsRsRsRsmmmmb
RsbRgbRsbRsRgRsRsmmbRsRsRsRsmmmbRsbsbLsRsbRsRsmbRsRsRsRsRsmmmmbRsRsRsL
smmbRsbRsRsRsRsRsRsmmmmmbRsRsmbRsbRsRsRsRsmmmbRsRsRsmmbRsRsRsmmbRsbRsb
sbRsRsmbRsRsmbRsRsRsRsmmmbRsRsmbRsRsmbRgRsRsmmbRsbRsRsRsRsRsmmmmbRsRgb
LsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsbRsRsmbRsRsRsRsRsmmmmbRsbRiRsRsmmbRg
bRsRgbRgRsmbRsRsRsRsmmmbLsRgbRsRsmbRsRsRgRsmmbRgbRsRgRsRgmbRsRsmbRsbRs
RsRsmmbRgRsRsmmbRgbRsRsRsRsmmmbRgbLsRsRsRsRsRsRsmmmmmbRsRsRsmmbRsRsRsR
sRsmmmmbRgRgbRsRsmbRsRsRsRsRsmmmmbRgRsRsRsRsmmmmbRibReLsbLebLiLsbLgLsL
sLsLsLsLsmmmmmbLgLsbLgLsRsbLgbLsbLgRsbLsLsLsmmbsbLgbLgbLsLsLgmbLsLsLsm
mbLsLgbLsLsLsLsLsmmmmbLgLsbLgLsLsmbLjLeLsbLgbLsbLgbLgLsLsmbLgLsLsLsLsL
smmmmbLebLgLgbLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bLebLibRsRsRgmbLibLebLibLeLsbRsbLjLgLsbRobRcRgRsmbRhbRsbRiRsmbRgbRcbRh
bRgbRsRsmbRgbRsbRsRsRsmmbRsRsRsRsmmmbRgbLcLsmbRgRgRsmbLsbRcbRcRsmbRgRs
mbLobLsbRsbRsbLgRsbLhbLobRgRsmbRibLgbLcbLibLibLsRsLsbRgLsbLgLsRsbLcbLi
bRgbRsbRibRgRsRsmmbRsbRsRiRiRsmbLgLsbLgbLibLhbLeLsbLsbLobLgbLobRgRsmbR
gbRibLobRib

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRsbRgbRgbRgRsmbRgbRgRsmbRgbRgRsmbRsbRsbRsbRsbRsRsRsmmbRsbRsbRgRsmbRgb
RsbRsbsbRsRsmbLsbLcLsmbLiLsbRebLoRsbRcbRebLsbRhbRgRsmbRhbLsbRoRsmbRibR
gbRsbLjbsbRsbRsRsmbRsRsmbRsbsbRsbLsRsbRgbRsRsmbRsbLsbRsbRsbRsbRsbRsbRs
bRsbRsbRsbRsRsmbRebLjbRebLgbRhbRebLsbRobRsbLjbLiLgLeRsbLgbLgLsbLgbLsLs
mbLsbLgLsbLsbLsbRsbLsbLsbLgRsbLsbRsbRjbReRsmbRibLgbLcbLgbLiLsbLibLhbLi
bLsLsmbLgbLgLsbLgbLgbLibReRsmbRsbRgbRsbRsRsmbRgbRgbLsbRsRsmbLsbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLgRcbRibLgbLsRsbLgbRsbRcbRibRiRsmbRibRgbRibRiRsmbRiLsRibLobRiRsmbRebR
eRsRiRgmbRgbRgbRiRgRebReRgbLebRcRsmbLjbRgbRsRgbRhbRsbRibLebRibRibRgRgb
RgbRsbRsbRgbRiLsbRgbLsbRcbRibRgRsmbRiRebRebRebRebRebRebRgRsmbRsRsmbRgb
RgbRgbRiRsmbRgbRgbRiLsbLgbRjbRibRcbRgbLjLsmbRsbRjbLsbRibRgRsmbRgbRgLsR
sbRsbRhbRibLsbRgbRibRobLhRsbLcbLgbLsbLsRsbRsbLsbLsbLsbLibLsRsbLsbLgLsb
LhbRibLobLibRsbLibLgbLebRebRebRibRibRsbRjbRobRibRibRcbRibRjbRsbRebRebR
ebRsbLsbRibRgbRibLsbRiRsmbRgbRgbRsbRgbRgbRsbRgbRgRsRsmmbRgbLjbRcbRebRj
bRiRebLibLsbRebRebRebRebRibRgbRgbRsbRiRsmbRgRibRgRsmbRgbRsbRgbRibRhbRe
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLcLsmbRcbRhLsbRebRcbRgRsmbRibRibRiRsmbRcReRgbRibRcbRhRsmbLsbRiRsmbRhb
RsbRgbRebLjLsmbLibLiLsbLibLcLsLsmmbLcLcLsLsmmbLsLobLjbLibsbLeLsLsmbLib
LcbLiLcLsmbLsbLibLsRsbLsbLsbLhbLhbRhbRibRcLsbRgbRhRsRsmmbRcRiRebRibRcR
smbRibRiRsmbRiLsbRibRhbRhRcbRibRoRsmbRcbsbsbsbsbLcbLjbLibLjbLibLibLcLs
mbLgLcLgbLgbLgbLgLsbLgbsbLgLeLsbLsbLgbLibLibLsRsLebLgbRsRsmbLjbLobRebR
iLsbRhbRhbRhRsmbRiRiRjbRhRsmbRcRsmbRibLsbRibRgRsmbRibRgRsLsmbRibRiRsmb
RcbLgbLeLebLebLgRsLiRsbLsbLebLebLsbLibRcbRjbRiLsbsbRiLsbRcRsmbLibLibRc
LsbRhbRsbRebRhbRcbRiLsbRhbRebRib

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bRgbRoLsbLsLsLsLsLsmmmmbLgLsLsmbLcLsmbRcbLsbLjbLsbLsbLsbLiLsLsmbLgLsbL
jLsmbLcbLoLsmbLgLsLgbsbLsbLsLsmbLsLsmbLsbLgLsbLgLsbLcLsmbLgbLcLsLsmmbL
ibLibLhLsbLsbLoLsmbLgbLsLsmbLgLsbLgRsbLgbLgLsLsmbLgbLgbLgbLiLsbLsbLibL
iLsbLgbLgbLcbLibLsLhLsbLibLibLibLibLsbLibLcbLgbLgbRsbRcbRibRgbReRsmbRg
bRiRsmbRgbRsbLsbRsbRgbRibRgbLebLiLsbLgbsbLgbLgbLiLsLsLsLsmmmbLgbLcbLib
LcbLiLsbLgbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bLgbRsRsmbRsbRsRibLgbLsbRgbLsbLjbLcbLibLgbLibLgLsLsLsLsLsLsLsLgmmmmmmb
LsLsLsLsmmmbLgLsLsmbRsLsLsmbLsbLgbRjbRjbRebRgbRgRsmbRsRsRsRsRsRsmmmmmb
RiRsRsmmbRgbRibRgRsmbRsbRiRsRsmmbRgbRebRgbRebRsRgRcRibRoRsmbLcbRsLsRsb
RsbRsbLgbRsLsbRsbRibReRsRsRsmmmbLsLsmbRsbLsbRibRgRsRsRsmmmbsbRgRsRsmmb
RiRsmbRcbRgbRgbRgRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRsbRibRsRsLsmbLsbLhbLibLeLgLsbRcbRsRcRhbRcRsmbRiRsmbRcRsmbRibRibReRsR
smmbRibRhRsmbRjRsmbRebRcRsmbRibRsbRgbsbsbRsbRsRgRsmbLsRsbRgbRsbRsbRgRs
mbRgbRsbRsRsmbLsbRgRsmbReRsRsmmbRsbLjLgbRhRsmbLjbRcRsmbLjbRcRsmbRhRgRs
RsmmbLsbLjbLgbRcbRcbReRsmbLsbRibRcbRiRsmbRhRsmbRhLsbRebRiRsmbRebRebReb
RjbRiRsRimbRsbRiRsmbRgRsmbRibRiRsmbRgRsmbRhRsReRsmmbRebRiRsmbRgRsmbReb
RhbRibRibRgbRiLsbRhRsmbReRsRembRiRebRibRebRobLoRsbLiRsbLsbLgRsbRcRsmbR
gRsmbRsbRgRsRsmmbLsLsmbLsRsbLsRsbRsRsRsmmbRsbLsRsbLsbRsRsmbRsbRibRsbRs
bRgRsmbRgbRsbLsbRgbRsbRsbRsbRsbLsbRgbLjbRjRsmbRgbRgLsbsbRgRsmbRsbRgRsm
bRsRsmbLsbRgbRgbRsbRsRsmbRsbReRsRiRsRsmmmbRsbRsRsmbRibRcbRibRcbRcRsRhm
bRibRcLsbLjbRsbReRsmbRgbRgbRibLjbRibRibRibRiRsmbRebRebRebRiLsbRobRibRo
bRsbRjbLjbLhbLibLibLibLiRsbLsLibLgbRsbLibLgLsbLibLgbLgbRjbRjbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bLjbRjbRjbRcbRcbRobRcbRibRibRobRcbRcRsmbRgRsmbRcbRcRsmbRibRgbRgbRebRcR
smbRibRibRjbRgbRibRibRiRsmbRjLsbRibRhbRsbRcLsbRebRcLsbRjbRjbRhbRgbRgRs
mbRgbRgRsmbRgbRgbRsbRjRsmbRjRsRsmmbRsRsRsmmbRibLsLsmbLgbRsbLsRsbLsLsLs
RsmmbLsLsLsmmbLsLsmbLsLsmbLsbLjbRcbRcRsmbRibRcbRjRgRsmbRibRcbRcbRcRsmb
RibRgRsLsmbRibRgbRhRsRsmmbRibRibRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bLebLsbLgbLibLgbLsbLebLsbRgbLhbLibLgLsbLibRgbRebRgbRibRibRibRgLsbLgbLi
bLgbRcbRhRsLsmbRcLsbLgbRhbLsLsmbLibLjbLhbRgbLiLsbLsbLiLsbLgLgbLhLsbLeb
LgbRibRgbLjbLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bLcbLhbLcbLgbRcRsmbRcbLibLebLcbLsbRhbRibRgbRsbRsbRgRsmbRgLsbRsbRcbRiRs
mbRgbRgbRgbRgbRgbRsbLsRsbRibLcbLcLsmbLcbRcRsmbRibLiLhbRcbReRsmbLobLgLs
bLgbLgbLsbLibRcbRgbRobsbLibLgbLgLsbLibRsbLcRsbLgLsbLsbRebRgRsmbRiRsRsm
mbRsbLebLcbLsbRibRibLebLsbLgLsbRsRsRsmmbLgbRsLcbLsbLobLgLsbLhbLibRobRi
RgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bRhbLjbLgbRjbRsRebRobLiLsbLebLgbLcbRibReRsmbRibRibLsRsbRibRgbRibRcbRib
RibRobLcbRsbLebLeLsbRsRsRsmmbRsRgbLeLsbLsLgLsLsmbLgbLsLsLsmmbLgLsLsLsL
sLsmmmmbLgbLiLgbLsLsLsLsmmmbRsRsmbLgLsLsmbsbsbsbsbsbsbsbsbsbRjbLiLsbLs
LsmbLsLgLgLsbRsbLsbLgbLgLsbRsRsRsmmbLsLibReLsbRjRgRsRsmmbRibReRgRiRebR
gRsmbRsbRgbRibRibRibRsbLcbLgbLgbLibLibLgLsbLgbLiLgLsLsLgmbLgLsLebRibRi
bRhRhbRibRiRsRembRgbRibRibRgLcLsLsmmbRgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bLgbLsbLsbRjbRcbReLsbRgbRcLsbRoLsRsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bLebRgbRiRsLsmbReRsmbRsbRgbRgRsLsmbRgbRsbLsRsbRgbRsbRsLjbRobLcbLhRsbRi
bRgbRgLsbLjbLgbLiLsLsLiLsLsmmbLibLgbLgbLgLsbLibLeLsbLibLiLsLsRsRsmmbLg
bLgbLgbLgbLgbLgbLiRsbRgbLcbLibLibLsLsLsLsLiLsmmmbLgLsbLgRsbLsbLsbLsLsm
bLsbLgRsbLsRsbLcbLiLsbLsLibLsbRsbRsbLgbLgbLsbLhLsbRsbLsRsbLiLsbLibLeRs
LsbRsbRjRjbRsRsRsmmbRiRsRiRgmbRibLjLsmbLiLsLiLhRsbRsbLgRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bLsbLsLsLgmbLibLibLsbRgbRsbRgbRgbRgRsmbRgRgbRgbRibRgbRgRsmbRibRgbRcbRh
bReRsRsmmbRsRsmbRgbRgRgbRgbRgbRgbRhbLcbLcbLcbLsbLibLibLcbRjbRibRebRobR
cbRhbRgbRgRsmbRgLsbRsbRgRsmbRsbRgbRgbLsbRgLsbRibRibRgbRhbRhbRibRgbRibR
ibRebRcbRiRsmbRibRebRhRibRgbRgRgbRcRsmbRibRibRebRgbRibLsbRgRibRsbRgbRg
RsRgmbRgLsbRgRsmbRgbRsbRsbRjRsmbRhbRsbRebRibRgRsmbRsLsbRgbRsRsLsmbLsbR
sbLsbLeLsbLgbLhLsLebLcbLgLsbLibLibLeLsbLibLjLibLhbRsbLobLebLibLibLgbLs
bLsbLsLibRsLgbLsbRjRsmbsbRsbRibRgbLgLibRebLhbRgbRcbLiLibLgLsLsmbLcbLcb
LobLiLibLcbLsbRcbRibRiRsmbRgbRebRebRhbRcbRibLoLsmbLibLhbLeLsbLibLibLeb
LeLiLeLebRibRebLebLcbLibLebLsbLebLibLibLgbLsbLhbLibLgbLcbLebLsLsmbLcbL
eLsbLhLsbLgbLgbRsbLsbRcRsmbReRsRsmmbRcbRebRhbLebLobLsbLibLgLhbRgbLcbLh
bLsRsbLebLebLiLsbLeLsbLibLiLsbLiLgbLebLeLsLebLebLgbLibReRsmbLibLibLibL
ibLgbLiLsbLebLgLsLhbLiLsbLgbLiLsbLgbLcLebLsbLhbLibLibLibLcbRsbRcbRibRc
RsmbLgbLhbLoLsmbLibLcbLcbLhbLcbLoRsbLcbLhbLibReRsmbRhLsRiRibRgbRgbReRg
bLebRhRsRsmmbRibRgRsRgRsmmbRsbRibRibRgbRcbRobRebRibRibRgbRgRsRembRhRsm
bRibRibRcbRobLjbRebLibLcbLjbLobLcbLgLsbLgbLgbLibLibLiLgbLgbLgRsbLibLgb
RhbReRiRsmbRebReRgbRgbRibRhbLcbLibLibLgbLgbLsbLgbLibLibLibRebRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
bRibRsbRibRcbRhbRsbRibRibRsRsmbRibRibRibRibRibRhLsbRgbRibRgbRibRibRibR
hRsRsRemmbRgbLobLibLibLiLsbLebLiLeLsbRcbLobRibRiLsbRgbRgRsmbLgbRsbRgbL
sbRgRsmbRsRgLsbRsbRsbRsRsmbRgbRsbRgRsmbRibLsbLiLsbLhbLhbLcbRsbRoLsbLsb
RcbRiRsmbRhbRsbRsbRibRibRsRcbRobRgbLcbLiLsbLhbLibLsbLsbLgbLsLsLsmmbRjb
LibLibLibLebLebLcbLgbsbsbLgRsbLibLibLibLgbLiLsbLibLsbLhbLibLgLsbLgLsbL
gLsbLgLsbLsLgbLsLsLgmbLibLebLgLsbLgbLgbLcbLhRsbLsLsmbLibLibLgbLsbLgLsb
LibLsLsmbLiLgbLebLhbLhLsbRhbRhbRibRibLcLhbLiLsbLibLsbLsLsmbLibLibLibLi
RsbRcbRsbLhbLcLsmbLcLsmbLgbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
bRsbLsRsbRgRsRsRsmmmbLebLobLobLcbLgbLibLobLobLcRsbRgRsmbLobLiRsbLiRsbL
gbLgbLsLsLsmmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 132824; End: 133324;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bsbLsbLgRsbLgbLsbLsLobLebLsbLhbRcbRgbRiRsmbRgbRgbRibsbRhbLibLibLibLcbL
ibLsbLgbLibLhbLhbLcbLibLgLsbLgbLgbLsLsmbLibLgbLsLgbLiLsbLhbLiLsbLgLsbL
iLsbLibLibLibLibLeLhLsbLiLsbLibLebRsLgbLgLsbLgbLgbLgbLgLsbLibLgLsbLgLs
bLsbLgbRgbLsbRibLsbRibRgRsmbRgbLhbLjbRjbRhbRibRgRsmbRgLsbRgbRsbRsbRcbL
hbLgbLgbLgbLgbLibLiLsbLgbLiLsbLhbLebLcLeLgbLhbLebLebLgLsbLgbLebLiLsbLh
bRobRsLsbRobRcbRibRibRcbRcRsmbRgbRcRsmbRgRibRgbLsRgbRgRsmbRgbRibRgRsmb
RgRsmbRgbRgRebRebReRsmbRgRsRsmmbRhbRgbRgbRsRsmbRsRsmbRsbRgbLsRsbRgbRib
RibRhbRibRibRgbRibRebRgbRibRgbRiRsmbRgbRgbRiRgRsmbLebLhbLeLsbLibLhbLhb
LibLcbRoRsmbReRebRebRcbRibRibRgbRibRhbRibRebRebRiRsmbRcbRebRgRsRimbRsR
smbLsRgRsmbRgRsRgRsmmbRsbRsbRsbRhRsRsmmbRsbRgbRgbRsbRsbRsRsmbsbRsRgRsR
smmbRgRsmbRgbRsbRsbRgRgbRebRhbRebRgbRhbRsRsmbRibRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bsbRsbRsbRsRsmbsbsbRsbsbRsRsmbRsRsRsmmbRsbRsbRsbLsRsbRsbRsbRsbLsbsbRsR
smbsbLsbsbRsbRsbRsbLsRsbRsRsmbsbsbLsbsbRsbsbLsRsbLsbLsRsbRsbRsRsmbLcLs
mbRebRgRsRiRsmmbRiRsRsmmbRiRsmbRobRcbRgbRsRgRsRsmmbLsbLcbRjbRcRsmbRsbR
sbRibRgbRibRgRsmbRgbRgRsmbRgbRgRsmbRgbRsRsmbRgReRebRebReRsmbRsRsLsmbRi
RsRsRgRsmmmbRiRsmbRebRiRsRsmmbRgRsLsmbRebRgbRibRgbLsbsbRsbRebsbRiRsmbR
gbRgbRgRibRebRgbRgbReRebRebRgRsmbRibRsRsmbRiRsmbRgRsRgmbRibRibRgReRibR
ebRiRebRgbRibRsbRsbRiRsRsmmbRsRsmbRsRiRsmbsbRgRgbRobRoRsmbRebRibRgRsRg
mbRsbRsRsmbRsRsmbRgRgRsRsRsmmmbRiRsRgmbRgbRgbRgbsbRibRgRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRgRsmbsbRsRsRsmmbRsbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsRgRsRsRsRsRsRsRsm
mmmmmmbRsRsRgmbRgRsRgRsRgRsRsmmmmbRsRsmbLsRsRsRgmbRgRsmbRgbRgRsRgmbRgR
gbRibRoRsRsRimmbRgbRsRsmbLcbLgbLebRsbRsbLsbLgLsbRsbLsRsbLsbLjLsLsmmbLi
LsbLhbRsLsbLgLsLsLsLsmmmbLibLhbLgLgLsbLsbsbLsLibLgLsLsLsmmbLgbLeLsbLsb
LgLeLsbLebLcLsLgmbLsbLgbLiLsLsmbLiLsbLibLgLsLsmbLibLiLsbLebLgLsbLgbLiL
sbLsbLhbLiLsbLibLgLebLgbLgLsbLgbRsLiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLcbLcbLgLsLsmbLgLsbLibLgLsbLiLgbLgbLhbLcbLcbLibLgLsbLgLsLiLcRsbLgbLgb
LgLsbLgbLgbLgbLgbLsLsRsmbLsbLgbLsbLibLsLiLsbLgLsbLgbLsLgbLgbLsLsmbLsLs
LsmmbLsLsLsmmbLsbLsbLgLsbLibLcLsmbLgbLibLgbLibLgLsbLgLsLsLsmmbsbsbLgbL
gbLsbLsbLsLsLsmmbLsLsLsLsmmmbLsLgLsbRsbLgbRsLsbLibLibLibRgbsbRgRsmbsbL
sbLsbRsRsRsmmbRsbLobLebLibLgLsLgRsbLibLgbLiLsbLgbLsLgLsLsLimbLcLsmbLiL
sLeLsLeLiLgLgbLgbLeLeLebLhLsLsmbLeLeLeLebLsLgbLiLsbLsbLeLibLgbLeLeLeLs
bRcbsbsbsbsbRsbLsLsRsmbLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bLgbLgbLsLsmbLsLsmbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsRsbLsbLsLsmbLsRsLsbLgb
LsbLsbLgbRsLsbRsLsbLsLsmbLsLsLsmmbRsbLsbLsbLsbLsbLsbLsbLsbLsbRsLsbLsLs
mbLsbLsbLsLsmbLsbLgbLsbLsbLgbsbsbLsRsbLgbLsbLsbLsbLsbRsLsbLsbLsbLsbRsL
sbLsbLsLsmbRsLsbLsLsmbLsbLsLsmbLsbLsbLsbsbLsbLsLsmbLsbRsLsbLsbRsLsbLsb
LsLsmbLsLsmbLsbLsbLsLsmbLsbLsbLsbLsLsmbLsbLsbRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRsbRibLiLsbLobLibLgbLgbLsLsmbRcbRibRibRsbRsbRsbRsbLhbLibLgbLgbR
sbLsbLsbLsbRsbsbRsbLsRsbLsRsRsmbRsbLgbLibRsLsbRsbLsbLsLsLsmmbRsbLsbLsb
LsbLsLsLsmmbLsLsLsLsLsLsmmmmmbRjbRcbRiRsmbRsLsbLsbsbLibLgLsbRoRsmbRhRi
RsmbRsbRsbLsRsbRsbsbRsbRsbsbLsbLsbRsRsmbRgRsRsmmbRgLsbRsbRsbLsbLhbRjbR
hbRgbRgRsmbRgbLsbRgRsmbRgRsmbRgbRgRsmbLsbLiLsLsLsmmbLsbRcbLsbLibsbLiLs
bRjbLcbLibLiRsLsbLibRjRsmbRgRgbRgbRsRsmbRsbRsRsLsRsRsRsLsmmmbLsbLibLiL
sbLhbLsbRjbRiLsbRsRsmbsbsbLsbLsbLsbLsLsmbLsbRsbsbLgbRsbLsLsLsmmbLgbLgb
LgbLsRibLgbLjbLiLsLsLsmmbLgLsbLsbRebReRibLsbLsRsbRsbsbRsLsbsbRsbRsLsLs
mbsbRgRsRsmmbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRgRsmbRgbRgRsRsRsmmmbRgbLsbRgbRgbRsRgRsRsmmbRgRsmbRgbRgbRgbRcbRcbRhbR
ibRiRsRsmmbRebRiRgRgbRiRibRibRsbsbRgbLsRgRsRsmmbRibRgRsmbRgbRgRsmbRgbR
sRgbRgbRgbRgRgbRibRgbRsbRgRsmbRsLsbRsbRsRsmbRgbRgbRsbLsbRgbRgRsmbRsbRs
RsmbRgRsmbRcbRsRsmbRcRsRsmmbRsbRgbRebRgRibRsbRsbRsRsRgRsmmbRibRibRsRiL
sRsbLjLcLsRsmbRiLsbRsRsRsRgmmbRgbRgRsmbRgbRgbRibRsRsmbRgbRsRsmbRsbRsbs
bsbRsbRsbRgbRsbRsbRgbRsRsRsmmbRgRsmbRsRebRibLsbLsbRibRgbRsRsmbRsbRsbRg
bRsRsmbRsRgbRgbRsbRsbRgbsbRgbLsbRsbRgRsmbRgbRsRsRsmmbRgbRgRibLsRgRsmbL
sbRsbLsbRsbRsRsmbRsbRsLsbRsRgbRgbRgRsmbRsRsmbRgbRgRsmbRsRgbRgbRgbRgbRg
bRgbRgbRibRgLsbLsRgRsmbRsRgRsRsmmbRsRgRsmbRgbRgRsmbRibRgbRibRibRgbRgbR
gRsmbRgRsmbRsRsRsRsmmmbRsRsmbRibRibRibRgRsRsRsmmmbRgRgbRgbRgbRsbRsbLsb
RgRsmbRgbRgbRgbRcbLobLsbRcbLcLsmbsbLsbLibLgLsRsbLsbLsLsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bLgbRobLgbLobRebRebLobLebLobLobRebRcbLobLebLebRsbRebLcbLobRebLobRgbReb
LcbRebRibLcbLibLcbLobLobLebRsbLgbRebRsbLcbRgbLjbLobLobRobLobLobRsbLibR
obLobRibLsbRobRobLcbLebRobRebLebRibLobRebLibLibRebLebLobLobLobRsbLcbRo
bRebRobRobRebRebRobRobLobRobRebLibRebRebLobRobLobLebRebLobLobRobRebLib
LgbRobRibLebLibRcbLcbLebLebRgbLobRobLobRhbLcbLobRebRobRobRebLobRcbRobL
sbLebLgbRobRobLibLcbRcbRobRebRebLobRebLobLibLgbLgbLgbRcbLibRobRobRobRo
bRibLcbLebLobRobLebLebRcbLibLcbLibLebRibRobLcbRebLibRobRcbLgbRobLebLeb
LobRgbRobLobRgbRebRsbRobLebLobLgbLebLobLobLibRibRgbLgbRcbLobRebRobRebR
obRebRibRcbLebRebLsbLgbLcbRgbLcbRebLcbRhbRgbLebRgbRobRobLobLgbRobLcbRe
bRobRobLobRobRcbRobLcbRgbLobRebRobLibRebRobRobLjbLibLobRebLgbRibRibLeb
RobLobLibRibLobLgbLobLibRibRobLobRobLobRjbRobRsbLcbLobLibRebLobRebLobR
cbLebLobLobRobLobLsbLebLgbLobRcbRibLgbRobRebLibLebLcbRobLebRibRobLobRc
bRebLebLobLobRobRobRebRobRobRobLebRebRobRobLobLibLobLobLcbLobRobLebRob
RobLebLcbRobRgbLhbRibRebRobRobLobLsbRobRhbRebLhbRcbRgbRebLebRobLhbLobL
cbRobRgbLebRibLebLobLsbRhbRobRgbLhbLobRobRobRcbRebRebRebRhbRebRcbLcbLc
bRgbRebLobRobLsbRobRcbRebLobLjbLobLebLebRibRcbRcbLobLebLobRobLobRcbLeb
RibRobLobRgbLobLobLcbRobLobRcbRobRgbLobLjbRobLobLgbRobRobLcbLcbLibLgbR
ebRebLebLibLhbLibRsbRcbLsbLhbRcbRobLebLibRebLebLcbRcbRgbLebLgbLobRebRc
bRibLobLgbLcbRebRebRobRsbLobRcbLobLhbLobLhbLibRobLibRgbLibLobRobRebRob
RibLibRobRebRebLgbRibRobLobLobLsbRibRebLebLcbRebLebLebLobLibLobLebLobL
ebRebLebRobRibLobRgbLobRobRobRgbLebRobRobRcbLgbRobRhbRebLebLobLobRhbRh
bLobLobLobLcbLebLobLgbRjbRobLcbLobLobRobLebLcbRcbLcbRebLcbLcbLobRebLib
LcbRibRobLebRobLobLobLobRobLebLobLcbLebRebLgbLobRobLebRebLsbRcbLibRobR
obLebLcbRobLobRebRcbLobRebRebLobLcbRobRcbRobLcbLgbRobRcbLobRobRobLobLi
bRebRobLsbLcbRobRobLsbRebRcbLcbLebLibLsbRobLebRobLobLibLebRgbLobLgbRob
RobLebLobLebRgbRobLobRobLcbRebLcbLibRobLcbRobLcbRobLobLebLobRobRsbRsbR
ebLebLibLebRsbLebRibRobRobLebLebRobRobLobLcbRcbLobRobRgbLobRobRobRjbLo
bLebLcbRobRcbRibLsbLhbLobRobRebLibRobRobRibLobLhbLobRsbRebLgbLsbLebReb
LebLhbLcbRebLhbLobLgbLobLobRcbRobRgbLobLcbLcbLebRgbLobRebLgbRebRobRcbL
hbRhbLobLhbRhbRobLobLcbLebRobLobRgbRibLobLobRebRcbLhbRgbLebLobLobRcbLo
bRobLcbRobRibLobLobLobRebRebRebLcbRebLobLobRobRcbRobLsbRobLibLobLobLeb
RobLebRsbRebRibRebLgbRcbLcbLcbRebLobLobRebLcbRebLsbRebRgbRebRebLobLebR
obLobRobRsbRobLebRibRobLebRcbLobRhbLobLcbLobLebRcbLcbLobLebRebLsbRobLo
bRobRobRebLsbLobLcbRebLebLibRobLsbRobLobLebLsbRobRobLcbRobLebLcbRobLob
RobLobLobRjbLcbLobRcbRgbLobLebLebRobLsbLcbLgbLcbLibLebRobRobLebLobLobL
ebLebRcbLcbRobRcbRebLebRebLjbRobRcbLcbRobRgbRobLobRobLobLcbRebRhbLobRo
bRibRebRjbRibLobLobRobLobLobLcbLebLobLcbRebLibLobRibRsbRcbRobRcbLibLob
LebLebLsbLebLcbLcbLobLjbLebRebRibRgbRobRobRibRobRobLobLobLobLhbLgbRcbR
obRobLobLcbLcbRibLobLibLobRsbRobLobLobLobLobRobRebRobLebLobLebRibRobRc
bLebRsbLobLhbRebRebLcbRjbRgbLgbLobRobRibLcbRhbLcbLibRibLgbLobLcbLjbLob
LibRgbRibLobLobLobLcbLobRcbLobRobLobLebLsbLibRcbRjbLsbRjbLcbLobRgbLebL
ebRobLobRobRcbRobRobRebLobRobLcbLjbLobLgbLobRgbRobLobRcbRebLebRcbLobRj
bRcbLobRcbRcbRgbLcbLsbRob

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bRcbRcbRsbLeLsbLoRsbLcbLgLsbLiLsRsbRjbRjbRjRsmbRcbRiRsmbRibRcbLobLcLsm
bRsLsbLiLsLsmbRgbLsRjbRjbLebLhLiRsbLsLgLsbLebLgLsbLsbRsbRgbLebRgLcbLcL
smbLeLsLibRsbLsbLeLsbRgLsbRibRibLebRcbRcRsmbRgbRibRgLsbRgRgbRibLgLsbLg
bLebRgbRgbRgbRiRgbRsRhbLcbLebLsbLhbLiLsbLgLsRsbRsbRsLsbRjbLoLsmbRibRcb
RcbRoRsRsRsmmmbRiLsRiLsbRcbRibRgbRebLsbsbLgbRgbLgbRiRsRimbRcbLcLgLsbLg
Lsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bsbLgLsbLgbLibLgbLgRsLibLiLsbLibLibLgbLeLsbLgbLsbLgLhbLibLibLiLsbLgLsb
RebRgbRibRsRebLjbLhbLibLgbLibLebLeRsbLebLibLhLsLsmbLebLsbLgbLgbLgbLiLs
bLgbLsbLeRibRgLsbLebLiLsbLgbLebLeLsbLebLgbLgbLebLgLeLebLgLsbLhRsbRjRsm
bLhbRcbRgbRiLsbRebRgbRgRsmbRgLsRgbRgRsmbRgbRcbLsbLgbRiRsmbLjbRebRebRcR
smbRcRsmbRgRsRgRsRiRgRsmmmbLgbRhRsRsmmbRsRsmbRiLsbLiLibLgbLebLcRsbLcbL
hbRsbLgbLibLeLsLgRsbLcbLibLiLsLsmbLgbLgbLiLsbLiLsbLgbLgbRgbRjbRjbsbsbR
gbLebRjbLsbLgbLgbLibRsbRcRgbRcbRcbRhbRsRsmbRgbsbsbsbLsLsmbsbLsRsbRhbRs
RsmbRgbReRsRsRimmbRhbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLgLsbLsLsmbLgbLsbLsLsLsmmbLgbLgLsLsmbLgbLgLsbLsLgbLgbLgbLgRsLsbLgbLgb
LsLsLsmmbLsLsmbLsLsLsmmbLsLsmbLgbLgLsbLgLsbLiLsbLsLgbLgLsbLgLsbLgbLsLs
mbLiLsLsmbLibLhbRobRibRiRsmbLcbLibLgbLgbLgLgLiLgRsbLiLebLibLsbLgRsbLsL
smbLsbLsLsmbLgLsbLsLsmbLgLsbLgbLsLsmbLsbLsLsmbLsbLsLsLsmmbLsLsLsmmbLsb
RgbLgRsbLsbLsbLsLsmbLsbLgbLgbLgbLsbLsbLsLsmbLsLsRsLsmbLgbLsbLsbLgbLgLs
bLgbLsLsmbLsRsbLgbLsRsbLsbLgbLsbLgLsbLsLsLsmmbLgbLgRsbLsLsLsmmbLsbLsbL
sbLsRsbLgbLsLiLsbLsLsmbLsbLsLsmbLgbLgbLsLsRsLsRsmbLgbLsbLsbLgbLgbLgbLs
LsLsRsmmbLsbLgbLsbLsbLsbLsRsbLgbLgLsbLgLsLsmbLsbLsLsmbLgRsbLsLsmbLsLsm
bLsbLgbLgRsbLgRsbLsbLgbLgbLeLsbLsbLiLsbLsLgLsLsmbLgLsRsbRsbLsLsmbLgLsb
LhLsbLsLsLsmmbLcRsbLgbLcLsmbRhbRsRibsbLcbLibLibLgLsbLgLsbLgbLcbLhRsbLh
RsbLcLsmbLcbLeRsLsbLsbLiLsbLgbLsbLibLcbLcLsmbLgbLgbLgLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bLhbLcbLsbLsbRibRibRhRsmbLhbLcbLcRsbLebLibLiLsLeLgbLebLibLeLsbLsbLibLc
bLcLgbLgbLgbRsbLiLsbRsbLebLhRsbLobLcbLgbLgLgbLsLgLsLsmbLibLgbLgLsbLgRs
bLgbLgLsLsmbLsbLsbLsbRsbLsbLsbLgbLibLcbLgLsbLiLgLebLgLsLeLsbLsLsLsmmbL
gbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsbLibLebLcbLgLgbLgbLgbLcbLgLsbLgLi
bLibLhbLcbLebLeLebLibLebLebLeLsbLebLebLgbLibLgbLebLibLsbLgbLcRsbLsbRjb
LiRsbRgbRhbRgRsRgLsmbRgbRgbRsRsmbRgRhRsmbReRsmbRsbRsbRgRsmbRgbRgRgbRiR
smbRgbRgbRsbRgbRgRsmbsbRibLiRsbsbRibRgbRsbRgbRgbReRgbRgbRgbRgbRgLsRsbR
gRsmbRgbRhbLoLibLgLsbLjLgLsbLibLobLibLgbLibLibLgbLebLgbLgbLibLiLsbLibL
ibLibLgbLibLebLgbLibLjLsLsRsmmbLsbLsbRjbRgbRhbRgbRgbRhbLsLsmbsbRsbRgbR
gRsmbRgbRgbRgRgRsLsmbRsbRibRibRibRibRgbsbRgRsmbRgbRsbRsbRsRsmbRgRsRsmm
bRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bRsRgbRsbRgbRsRsmbRsbRsRsmbRsRgRsmbRsbRsRsRimbRebReRsmbRibRsRsmbRgbRgb
RhbRebRgRgLsbRgbRebLjbLgbRiRsmbRgRsRgmbLsRsbRsbRgbRibRgbRibRgRsmbRgRsR
smmbRsRsmbRgbRgRsmbRgRsmbRibRgRsRsmmbRgRsmbRgbLsRgRsRgRsmmbRibRgRsRsmm
bRiRgbRgbRgbRgRsmbRgRsmbRgbRgbRgbRsbRsbRgRsmbRgRsmbRgbRgRsmbRgRsmbRgbs
bRgbRgbRgbRgbRgRsmbRgbRiRsRimbRgbRgRsRsmmbRgRsmbRgRsmbRgbRsbRsbRgRsmbR
gbRgbRgRsRsRsmmmbRgRsmbRgbRgRsmbRibRgbRsRsRgmbRgbRgbRgRsmbRgRsmbRgRsmb
RgbRgRsmbRsRsmbRgbRgLsbRgbRgbRgRsLsmbRgbRgbRgbRsbRgRsRsmmbRgbRgRsmbRgb
RgbRsRsRsmmbRgbRgRsmbRgbRgRsmbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbRgRsmbRgRs
mbRibRgRsmbRgbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRsLsRsRsmbRgRsmbRgRs
mbRgRsmbRgRsLsmbRgbRgRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRibRgbRgbRgbRsRgbRg
LsbRgbRgbRgRgRsmbRgbRsRsmbRgRsmbRiRsmbRgbRgbRgbRgRsmbRgRsmbRgRsRsLsmmb
RgbRgbRsbRgbRgRsmbRgRsRgRsmmbRgRsmbRgRsmbRgbRgbsbRgbRsRsmbRgbRgRsRsmmb
RgbRgRsmbRgbRgbRsRsRsmmbRcRsRgRsmmbRibRibRibRgRiRsmbRgRsRgRsRsRgmmmbRh
bRsRsmbRsbRgbRibLjbLcbLcbLiLibLgbRjbLibRobReRsmbRcbLsbRgRsRgmbRiRgbRgb
RiRsmbRgRgbRiRibRibRgRsmbRgRiRsmbRgRiRsmbRibRebRiRiRgRgbLjbLibLcbLibLi
LsRsbLibLiLiLsbsbLjbRjbLibLsbRebRgRsmbRibLjbLcbLiLsbLiLsbLgRsbLgbLgLgR
sbLibLiLsbLibLibLibLebRibRgRsmbRgbRsRsRiReRgmbReRsmbRgbRgLsbLjbLibLiRs
bLoRsRebRiRgRgbReReRiRsRiRsRgmmbLcbLibLibRjRgbRebsbRsbRsbRgRiRsRsRsmmm
bRiRsmbRibRiRsmbRgbLsbLjbRsbReRsRsmmbRebReLsbReRsRsRsmmmbReLsbRobRibRc
RsmbRgRiRsmbRgReRebRgbReRsRembLsLsmbLjbRsbLcbRcbRgRsmbLsbRgbRgbRgRgbRi
RsRgmbRgbRsbLjbRjLsbRjRsmbRjLsbLhbLibLgbLgLebLgLsLsmbLgbLgLebRibLjbLjb
RgbRgbRiRsRsmmbRgbRibRgRsmbRgbRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bRibRhRsmbRhRsmbRcbRgbRcbReRsmbRgRsmbRhbRiRsmbRebReRgbRiRsLsmbRsRsmbRg
RsRsRgmmbRgbRgRsmbRgbRsRsmbRiRsRsmmbRsRsmbRgRgRsmbRsRsRgRgLsmbLsbRsRsR
smmbRgbRgRgRsmbRsRsmbRibRgRiRsRiReRsRsRsmmmmbRiRsmbRgbRgRsRgRsRsRsmmmm
bLsbRgbRgbRgRgRsRsmmbRiRsmbRgRsRsmmbRsRsRsRsmmmbRiLsLsLsmmbRgRsRsmmbRi
RsmbRhRsmbRhbRiRiRgRsmbRiRsmbRcRsmbRsbRcRsmbRcbRsbRcLsbReReRsmbRibRgbR
ibRebRgbRiRsmbRiRsRsmmbRcRsmbRibRcRsmbsbRebReRsRgRsRsRgmmmbRiRsmbRebLg
bLgLgLsRsbLsbRsbsbRsbRsbsbLsLgbRjbRibRiRsmbRgbRjLsbRsRsRsRsRsRiRsmmmmm
bRebRhLsbRibRcbRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLsbRjbRobRobLgbRobRibRgbRibRgRgbRgRebReRsRgmbLsbRgRsRsmmbRgLsbRebRiLs
bRibLhbLoLsmbLgbRsbLhbLebRobLhbLibLhbRsbLibRgbRjbRibRibLjbRiRsmbRibLsL
jbLjbLcLsmbLsLsmbLibLiLsbLhbLiLsLgbLibLibLiLsbsbLobRgbLgRsbLsbLsbLsbLg
bRsbRgbLsLsLgmbLsbLsbLsbLsbLgbLsLsmbLibLgLsbLgLsLgbLgbLgLsbLebLiLsbLib
LiLsbLiLcbLebRsbLcbsbLibLhLsbRobRgbLgbsbRjbLhbLcLsmbLsbLibLibLcRsbLcLi
LsbLgbLibLgbLiLsLiLiLeLsbLgLsbLebLibLgbLobLcLeLeLsbRsbLjbLibLibLgbLibL
obLebLgLsbLibRobLibRoLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bLjLsmbLcbLcbLgbLgbLhLsbLgbRjbRgbRiRsmbRjRsmbRibRibLgLsbLcLsmbLiLgbLgL
gLsbLgbLiLgbLibLibLcbLibLibLgbLhLsLsmbLibsbRjbRjRsmbLhLsbRcbRgbLjbLebL
iLgLsbLeLsbRhRsmbRgbRibRiRsmbRibRibRebRhbRibRibRgRsLsRsmbRgbLebLebLcbL
ibRebRiLsbRcRsmbRibRibRgRsmbRibRebRobRgLsbRibRebRebRibRcbRcbRhRsmbRiRs
mbRibRiRsmbRebRibRobRcRsRiRembRibRcbRhLsbRibRibRsbRcbRsLsbRcbLobRsbLiL
sRsbLsbLgLsbLgbLjRsbLgLsbLcbLibLibLgRsbLobLibLibLeLsLsmbLgbLgLsLgLgbLs
RsLsbLiRsLsbLgbsbsbLjbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRsRsmbLsRsbLsbRibRgRsRsmmbRibRibRiRsmbRhbRgbRiRsmbReRibRibRgbRiRsmbRg
bRsbRsbRsbLsbRgbLsbRibRgRsRsmmbRgRgbRibRsLsbRsRsmbRgLsbRgRsLsmbRgRsmbL
obLebLjbLobRsbRsbLsbLsbLjbLhbLibLgbLgLsbLgbLgLsbLibLibLgbLibLsLgbLibsb
RsRsmbRsbLsbLsLsRsLsmbRsbsbLgbLsbLgbLsbLsbLgbLsbLsbLsbLgbLiLsbLsbLgbLs
LsmbLsbsbLsbLsbRsLsbLsbLibLiRsbRsbLibLgLsbLiLsbRsRsRsmmbsbLgLsbLsbLsbL
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsLsLsmmmmbLsbLsbLsLsLsLsmmmbLsLsmbLsLsmbLsbLsbLsLsLsLsmmmbLsLsLs
mmbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsLsmbLgLsLsLsmmbLsLsLsmmbLsLsLsmmbLgLsb
LcbReRsmbRibRibRcRgLsbRibsbLsRsbRsbRjRjbLcbLoLsLsmmbLgbLgLsbLibLibLiLs
LsLsRsmmbRsbLgbLcRsLsbLcLsmbLeLsbLgbLibLsbLsbLsLsmbLsbLsbRsLsRsbLsbRsb
RsbsbLsLsmbLiLsLgLsLgbLsbLgbLgLsbLibLsLsmbLgbLgbLgbLgLsLsLsmmbLsLsmbLg
LsbLibLgLsbLgLsLsmbLgbLsLsLsmmbLhbLgbLsbLsLsmbLgbLgLsbLgbLgRsbLsLsLsmm
bsbLsLsLgRsLsLsmmbLgLsLgbLgLsLsLsmmbLgLsLsmbLsLsmbLsLsmbLiLeLsbLgLsbLg
bLgLsbLgbLgLsbLsbLsbLsLsmbLgLsbLgbLiLsbLibLhLsLsLsLsmmmbLeLsLibLgbLsbL
sbLsbLsRsbLsbLibsbLgLsLsmbLibLiLsbLhbLeLsbLibLgbRsLgbLiLsLsmbLsbRsLgRs
LsbRsbLsbLsbLgRsbLsRsbLsLsmbLibLgbLgbLgLsLsLsLsmmmbLgbsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bLgbLobRgbLibLsbLiLsbLiLsbLibLibLibLjLsLgmbRcbRhRsRsRsmmmbRgRsRsmmbRcb
RhRsmbRibRcbRgbLebLibLibLcbLgbLhLibLcbLebLcbLiRsbLibLcbLibLiLiLsRebRhb
LhLsbLgbRebsbRsLsbLsbRsRsmbRsbLsRsbRsRsmbsbsbsbsbsbLsbsbLsRsLsbRsbRsLs
bRsbLiLsbRebRibRsRcbLsLsmbRobRhbRobLeLebLebLebRobRibReRsmbLgRsRsmbRsRi
RsRsmmbRsLsLsmbRgbRgbRgbLibRebRibRebRgbLsbRibRoLsbLsbRcbRgRsRsmmbRoLsb
RobLibLiLsbRibRibRgbLibLebLcbLibLcbLibLgbRsbLebLibLgbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bLsbRibRhRsmbRgRgLsbRobRibRobRebRibRobRcbRoLsbRhRiRsmbRebLjbRjbRjbLsbL
obRobRgRsmbRcRgbRibRibLhbRsLgRsbLsbRcbRobRibRibRibRgRsmbRgbRsRsRsmmbRs
bRsbsbRhRsmbRiLsbLobLhLsbLgLsbLiLsbRsRsmbsbRcbRcbRibRcbRcbReLsbRcbRcLs
bRcbRjRiRsmbRebRobRibRgbRgbRobLebLhLsbRcbRcRsmbLobLcbRcbRebRsbRsbRsbRi
RsmbRjbRebRcRsmbRgbRcbLcbLibLsLcbLcbLibLsLsmbRjbRiRsRsmmbRcbRibLcbLobL
sbLobLiLsbLibLgbLsbRgbLsRsbLsbLsbRsbLgLsbLiLebLcbLibLebLsRsbRiRsmbRcRg
bRobRsbRgLsbsbsbLsbLsLsmbLibLsbLibLsbLibRsbRgbLjbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bLsbLhbLeLsbLibLhbLibLsLsmbLcbLgLebRobRebRsbReReLsbRhbRebRiRsmbRibLgbL
ibLcbLcbRibLebLcbLjbLhbLcbLhbLibLebLobRgbRgRebRibRgbRebRsRsmbRibRibReR
gbRiLsRgbRebRgRsRhmbRibRcbRcbRibLobLhbLeLsLsmbLobReRgRsmbRoLsbLeLebLib
LebLibLgbLgLebLiLsbLiLibLiLeLibLgbLiLsLgLsbLhbRibRcbRibRgbRobRibLcbLib
LibLcbLibLgbLibLcbRiRsmbRjRsmbLibLsRcbLjbRiRsmbLjbLjbLibLgbRsbRhRsmbLe
bLibLhbLcbLebLhbLibLibLebLeLsbLeLgbLeLebsbRsbLsbLgbLsLsmbRsLsbLgbLgbLc
bLcLsmbLcbLjLsmbLibRibRcbRiRsmbRibRebRiRsRembLsbLoRsbRgbRjbRibRibRibRc
bRgbRhRsmbRibRiRsmbRibRibLjbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
bLcbLsbLibLhbLeRsbLeLgbLeLsbLgbLgLgbLobLgbLiLsbLibLsbRsbLgbLeLsLsmbLeb
LiLiLiLsbLiRsLsbRgRsmbRgbLcLsmbLcLsmbLiLiLgRsbLeLgLibLeLsbLibLebLeLsbL
hbLgbLhRsbLiLebLibLebLibLibLcbLibLebReRsRsmmbRibRibRibRobRgbRibRibRoLs
bLgbLibLgbLibLgbLgbLgbRjbLibLiLcLsmbLgbLebRsLibLebRsbLgLsbLgLeLsbLiLsb
LibLibRcbRebRiRgbRgRsmbRebRibRobRiRsmbRiLsbRgbRiRsmbRibReRiRsmbRiLsbRi
bRiRsmbLcRsbLcbLoRsbRibLcbLibLcRsRsmbRsbLcbLebLgbLgbLhRsbLgLsbLgRsbLib
LgbLcbLibLhLsLsmbLsbLsLgLsLsmbLgbLhbLcbLibLcbLibLgbLgbLgbLcLsmbRsbRebR
oLsbRsbLibLibLgbLgLsbLgbRsbLibLebLiLsLsmbLibLsbRoLsbRibRgbRibRobRgbsbL
hbLiLsRsbLgLiLsLsLsLimmbLcbLcbLibLgbLibLsLsmbLgLebRcbRiRsmbRgRhbRgbRiR
sLsmbRibRibRhLsbRibRgbRgRibRsRhRsmbRgbRgbRcbRcRsmbRiRebRibRjLsbRhbRibR
cbRibRgbRiRsmbRgbRgbRsbLsbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bRsbRgbRebLgbLibLibLsLsLsLsLsmmmmbRsLsRsbLsbLibLibLsbLebLibRibRibRibRi
LsbRgbRhbRgbLibRiLsbRgbRibRiLsbLsRgRsmbRgbRibRibRibRgbRibRgbRgbRiRsmbR
iLsbRcbRibRibRebRibLsbRhbLhLsbLhbRjbRibRcRsmbRgbLhbRibLgbRjbRhbRebRibR
gbRebRgbRibRibRsbLibLgbRcbRhbLsRibRgbRibLgbRibRibRiLsbReRsmbRsbLgbLgLs
bLibLsbLibLsbLiLsbLsbRsLiRsbRjbRsbLgbLjbRcbRiRsmbRibRgLsbRsRsmbLibRhbL
sRsbRgbRiRsmbRgbRebLgRsbRgLsbRibRebLgRsRsmbRibRibRibLibReRsmbRsRsRsRsm
mmbLibLiRsbLibLibLhbLibLiLsbRsbLibLibLsRsbRibRibRiRsmbRgLsRsbRcbRiLsbR
jbRiRsRimbRibLgbRhRsmbRibLibRibRgbRgbRibRibRhbRibRibRcbRgbRiRsRiRsRsmm
mbLiRsbRgbRiRsmbRgbRgbLgbRibRgbRsbRgbLsRsbsbRgRsmbRibRibRibRgbRgRgbLsb
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bRgbLiLsbRjbRsLsbRgbRgbRibRjbRsRsmbRgbRgRsmbRgbReRsmbRgbRibRcbRgbRhRsm
bRiRsmbRgbRcbRcbRebRibRgbRgLsbRibRibReRsmbRibRibRgbRgbsbsbsbsbRsbRsbRe
bRiRsmbRsbReRsRsmmbRobRcbRibReRsRsmmbRgRsmbRiLsbReRgbRgbRsbRgbRsbRibRi
RsmbRgbRiRsmbReRsmbLhbRcRsmbRibRibRebRiRsmbRgbRgbLsbLsbLsbRgRsmbRsbRsb
RhRsmbRiRsRsmmbLgbRcRsmbRhRsmbRebLebRsbLgbLiLsbLcbLcbLgLsbLibLiLsbLibL
hbLibLibLiLsbLsbLiLgLsbLcbLcbLeLsbLiLibLibLiLsbLiRsbLibLgLibRibRibRiLs
bRcbRiRsRgmbRobRhbRebRgbRsRsmbRsRjbsbLsbRebRgbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bRgbRgLsbRgbRsbRhbRhbLsLsmbRiRsmbRebRiRsmbRgbRibRiRsmbRhbRiRsRsmmbRiRe
bRibLebRebRibRebRsRsRsRsmmmbRgbRebRsbLsbLsbRebRebRsRsmbRebRibRibLsbLeb
LgbLcbLgbLgbLiLsbLgbRiRsmbRgbRsbRhbRjbRjbRiLsbLibLsLsmbLjbLgbRsbRsbLgb
LgbLsLsmbRcbLeLsbRjbRjbRibLhbLibLhbLibLiLcLsmbLgbRgbRcbRhbsbRcbLsbRgbL
iLeLibRgbLgbLsbsbsbRiLsLsmbRgLsbRibRhLsbRibLebLcbRgbLcbLibLsbLibLibLhb
LebRibRgbRebLsbLgbRgbLobLiLobRgbRibsbLsbLobRjbRibRsRsmbRgbLgLsbLgbsbLs
RsbRibLsbRiRsLsmbLhbsbsbLsbLcbLiRsbLibLibLibRsbLibRhbRgbsbsbsbsbRcbRib
LsbLsbRhbRiRsmbLjbReLsRsbRibRibRhbRibRcRsmbRiRsLsmbRsbRiLsbRhRsRiRsmmb
RgbLgbRibRsbRsbLgbRibRcbLgbLsbRcbRibRibRgbRcRebLjbLibLebRsbLsbLgbRebLe
LeLebLiLsLgbLgRsbRjbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRjbRsbRsbRsbRsbRsbRsbRgbRgbRsbRsRibRsRgRsRsmmbRgbRiLsbRiRgbRgbRsbRibR
ebRgbRsbRsRgbRsbRsbRgRsmbRgbRgbRgbRjRgRsmbRgRsmbRibRibRgbRgbRebRgLsbRg
LsbRgbLsbRsRsmbRgRsmbRgbRgbRgRsmbRsbRsbsbRsRsmbRsbRsbRsRsRsmmbRsbRgbRg
RsRsmmbRgRsmbRsRsmbRsRsmbRgbLsRgbRgRsmbRsRsRsmmbRsRsRsmmbsbRjbRsbRgbRs
bRsRsRiRsRsmmmbRiRebRgbRsbRebRgbLcLebsbRsRgRsmbRgbRsbRgbRgbRsRsmbRsRsm
bRsbLsbRsbRsRsmbRgRsmbRsbRgbRgbRgbLsRsbRsLsbRgbRebRebRcbLobRebRibsbRsb
RebRhbRebRibRsbRsbRsbRsRsRimbRebRhbsbRsbRebRgbRibRgbRiRebRgbRebRiRgRsm
bRsRsRsRsRimmmbRgbsbRgbRhLsRsbRgRsRsmmbRgRsmbRsRhbRsbRgLsbLsbRsbLsbReb
RiRsmbRgLsbRibRibRiRsmbRgRsmbRibRgbRobRgbRsbRsRsmbRgbRebRebRebReRsmbRg
bRibRsbRsbReRsRiRhmbRebRebRebRebReLsbReRgRsRgRsmmbRgRsmbRhRsRsmmbRgbRs
RsmbRgbRgRsmbRebRgRsRimbRgbRibRiRsmbRibRibRsbRsRsRiRsmmbRgbRibRibLjbLg
bRibLjbLjLsLsmmbLsLsmbLjLsLsmmbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLcbRsLsbLsbLgbLibLibLgLsLsmbLiRsbLsbLibLgbLsbLibRsbLsLsmbLsbLgbLsbLeb
LibRgbLhbLibLgbLibRsbLgbLgLsbLsbLhLsLibLgbLsLgbLibLsbLsbLsbRsLsbLsLsmb
LgbLsbLgLsbLgLsbLibLiLsbLhbLgbLgbLgbLsbLgLsbLgbLgLsLibRsbLsbLsbLiLsLsm
bLhbLsbRsbLeLsbLgbLgbLgbLsLsmbLgbLiLsbLibLgbLgbLgbLibLebLsbsbLibLgbLgb
LgbLgbLsbLsbLsbLsbLhLiRsbsbLoLsLsmmbRgbLjLsmbLsLgLsLsmbLibRsbLibRobRib
RhRsmbRibRgRgRgRsmbRsbRibRiLsbRsbRsLsbRebRebReRcbLgbRgbRebRhbRiRsmbRob
LobLgbRsbLsbLsbLibLgLsbRibRgRsmbsbLhbLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bRsbLsbLsLsmbLoLsRsRsmmbLsbRsLsRsLsRsLsLsLsRsLsRsLsRsLsRoLsLsRsRsLsRsL
sRsLsLsLsRsRsmmmmmmmbRsLsLsRsRsLsRsmmbLobRsbsbsbsbsbsbLsbsbRsbLcbLoLsm
bRsLoRsLsLsLsmmbRoRsmbLsLsRsmbRsLsLsLsLoLsRsmmmbRsLsLsLsRsmmbRsLsLsRsR
sRjmmbRsLsLsRsLsRsRsRsmmmbLsRsLsbLsRsLsbLsLoRsLsRsLsRsLsbLsRsLsLoRsLsL
sLsLsRsRsLsRsLsmmmmbLsLsRsLsRsmbLsbLsRoRsmbLsRsLsRsLsLsRsLsRsRsmmbLsLs
RsLsRsRsLsLsmmmbLsRsRsLsRsmbLsRsRsLsRsLsRsmbRsbRsLsRsbRsRsmbRsbLsbRsRs
LsRsLsLsmmbLsRsbLsbRsbRsLsbRsbLsbRsLsbLsbLsbRsRsLsmbLsbLsLsRsmbLsbRsbL
sLsRsmbsbLsLsmbRsbLsbRsbLsLsmbRsbsbLsRsLsRsbRsbLsbLsRsRsmbRsRsmbLsbRsb
RsbRsbsbLsbRsLsLsRsmbLsLsmbRsbLsRsRsmbLsLsmbRsbLsbRsLsbRsLsbLsRsbLsbLs
RsRsmbRsRsmbRsbLsbLsbLsbRsRsLsmbLsbRsbLsbRsbRsRsmbsbRsLsbLsbRsLsbRsLsb
RsbLsbRsLsRsbRsbLsbLsLsmbRsbRsbLsbsbLsbLsRsbLsLsRsmbLsLsmbLsLsmbRsbLsb
RsRsLsmbRsbLsbLsRsbRsbLsLsRsmbLsRsbRsbsbsbRsbLsbRsLsRsbRsbRsbRsbRsbLsL
sLsLsRsmmmbLsRsbLsbLsbRsbRsLsbLsRsRsmbRsLsLsmbLsRsLsRsLsLsmbLsbRsLsbRs
bLsLsmbRsLsRsRsLsRoRsRsLsRsmmmbRsLsRsLsbRsLsRsLsRsRsRsRsLoRsLsRsLsRsmm
mbRsRoRsRsLsRsRsmmmbRsLsbRsbRsbRsRsLsRsLsRsLsmbLoRsbLsRsRsmbLsRsLsLsLs
mmbRsbLsLoLsLsRsLsRsLsLsLsRsRsmmmmmbRsLoRsLsRsRsLsRsLsLsRsLsRsmmbRsbLs
bLsLsmbRsLsRsbLsbLsbLsRsLsLsRombLsRsRsmbLsbLsLsmbLsRsbLsRsRsLsmbLsbLsR
sbRsbRsLsbRsLsRsRsLsRsmbLsLsRsmbRsLsbRsRsmbRsLsRsbRsbRsLsRsbLsbLsbLsRs
LsbRsRsmbRsbRsbLsbRsLsRsRsmbRsRsRsRsmmmbRsRsmbLsLsmbRsbRsRsLsLsRsRsmmm
bRsLsbLsbLsbLsLsmbRsLsRsRsmbLsbsbRsbLsbRsbRsbsbRsLsbsbLsLsmbLsbLsbRsbR
sRsRsmmbRsbLsRsLsbLsbLsbRsbRsbLsLsmbRsLsbsbRsbRsbLsRsRsmbLsRsRsmbRsbLs
RsbRsRsLsmbRsRsmbRsbLsbRsbRsLsbLsbRjbLsRsbLsbRsbRsbRsbLsbRsbLsbLsLsmbR
sRsmbRsLsbRsbRsbLsbLsbsbRsbRsRsRsmmbRsbRsRsmbRsbsbLsRsRsmbRsbRsLsbRsbR
sbLsRsbLsbRsRsmbLsbLsbRsbRsRsmbLsbRsLsbLsLsmbRsRsmbRsRsmbLsbLsbRsbRsbR
sbLsbLsbLsbLsRsbLsLsmbRsbLsLsmbRsbRsLsbRsbRsbLsbLsbRsbLsbRsRsmbRsbRsbR
sLsRsRsRsRsLsRsRemmmbRsLsbLsbLsbRsLobLsRsLsbRsRsLsmbRsLsRsLsbRsLsLobLs
bLsLsRsmbLsRsRsLsmbLsbRsLsbLsRsLsbLsbRsbLsRsRsmbRsbRsRsmbLsbLoRsbRsbRs
bRsbsbRsLsbLsbRsLsRsRsmbRsLsbRsRsmbRsRsmbRsbRsLsbRsbRsLsbRsbLsbLsbLsLs
mbLsbRsbLsRsbsbLsRsRsmbRsbLsLsRsmbLsLsmbLsRsbsbLsbLsRsbLsRsLsbRsbLsbLs
RsbRsbLsbRsRsmbLsbLsRsLsbRsRsLsmbLsRsRsmbLsRsbRsbRsbsbRsbRsRsmbRsbLsbR
sLsbRsbsbLsbRsRsmbRsbLsbLsbRsLsbRsbLsbRsLsbLsRsbLsbLsRsbRsLsbLsbLsbRsL
sbLsLsmbLsbRsbRsbLsLsLsRsmmbRsbRsLsbLsbLsbLsLsmbRsbLsLsRsLsmbRsbLsLsmb
LsbLsbRsbRsbRsbRsRsmbLsRsRsmbLsbRsbRsLsRsbRsRsLsRsmbRsbLsRsbRsLsbRsLsR
sbLsbLsbRsbLsbLsbRsLsRsLsbRsRsmbLsbRsbLsRsbLsRsLsbRsbRsLsbsbLsLsRsmbRs
LsLsmbRsbRsLsbLsLsmbRsbLsbLsbRsRsmbRsbLsRsbLsbRsbRsbRsRsmbRsbLsbRsLsbL
sbRsbLsRsbRsbRsLsRsbRsLsbLsbRsbLsRsbLsbLsbRsbLsLsmbRsbRsbRsbLsLsmbLsLs
mbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bRsLsbRsbRsbRsRsRiRsRsRsmmmmbRgRsRsRgRsRsmmmmbRsRgbRgRsmbRgbRsRsmbRsRg
bRsRsRsRsRsmmmmbRgRsmbRiRsRsmmbRgbRhbReRsmbRhRsmbRibRsbLcLsmbRsbRgbRgb
RibRiRsmbRgbRibRgbRsRsmbRsbsbRsRsmbRsbRsRsmbRsbLsbsbsbRgbsbRsbRibRcbRe
bLhbLsbLiLibLsLsmbLgbLgLsbLsLsmbLgbLsLgLsbLsbRcRsmbRcRsmbLsbRcbRsbRoRs
RsRgRsmmmbReRsRsmmbRiRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLgLsbLsLsLsLsmmmbLgLsbLsLsLgLsmbLsLsLeLsmbLhbRgLsbLebLgLebLsLsL
sLsmmmbLgbLsbLgLsbLsLsmbLgbLsLsLsLgmmbLgLsbLiLsLsmbLgbLsbLoLsmbLhbLgLi
bLeLsbLhLcbLgbLebLhLsbLeLsbLibLeLsLsLsmmbLeLsLsmbLebLeLsbLibLcbLgLsLsL
gLsmbLgLgbLebLiLsLsLsLhLiLsmmbRjbLsLsLsmmbRibRobLgLgbLgbLiLsbLhLsbLiLs
bLsLsLsmmbLgLsLsLsLsLsLsmmmmmbLgbRebReRsmbRebRiRsmbRebRgbRebRibRhRsRsm
mbRebRgbRgRsRimbRgbRgRsRsmmbReRgRgRibReRsmbReLsLibLeLsLebLgbLebLgbLeLs
bLgLsbLsLsmbLsLgLsLsLsLsmmmbLiLsLsmbLibLibLsLsLsmmbLsLsLsLsmmmbLsLsLsL
sLsLsmmmmmbLsLsLsmmbLsLsLsmmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLs
LgLgLsbLibLhLsbLebLcbLsbLgbLgbLgbLebsbsbLsLsmbLsLsmbReRsmbRgRsRsRgmmbR
oLsbLgLsbLibLcLgLsLsmbLgLsbLcLsRsLeLimbLebLgbLebLibLebRsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bRsRgRsmbRebRhbRebRibRgbRiRsmbRgRsRsmmbRibRgbRcRsmbRgRsmbRiRsmbRgbRsRg
bRiRsRsmmbRibLibLeLsbLiLsbLgLsbLgbLsbLsbRgbRjbRiRsmbLjbLebLsLsmbLibLgb
RsRsmbRgRsmbRgRsmbRsbLebLcLsmbRsLsbRsbLsbLibLhbLibLeLsbLiLsbLiLsbLiLsb
LcbLgRsbLibLgRsLsbLibLgbLgbLgLsbLsbRibLcbLibLgRsbLsbLgbLsRsbLgbRsbsbsb
LsRsbsbsbLsbRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRiRsmbLgbRhbRebRibRgbLcbLhLhbLiLhLsbLgLsbLebLsLsmbLsbRsbLsbLsbLsRsRsm
bLsbLsbLsbLsbLsbLsLsmbLsbLsLsLsmmbLsRsbLsRsLsbRsbLsLsmbLgbLsbLsRsbLsRs
bRsbRjRsmbLcRsbLhbLcbRgbLcLsmbLiLsbLgbLibLhLgbLiLebRsbLgbLhbRcbRebRibR
ibRgRsmbRgbLsbRsbRsbRsbRsbRgbRgbRsRsmbRgbRsbRsbRsbLsRsRsmbRsRsmbLhbRcR
smbRibLsbRibLcbLibLgLgbLgLgLsLgbLeLsLsmbLgLsbLsbLgLsRsLsbLsLebLcbRoLsb
LibLibLgbRgbLgLsbLgLsbLsbLsLsmbLsLsmbLsbLsbLebLhbRiLsbLgbLibLgLsbLsbLg
bLgLsbLjLsmbRgbLibLibLsbRjbLhbLcbLgbLgRsbLgLgbLeLsbLgLibLibLgbLgbRsbLg
bLsbLibLeLsbLgbLsbLgbLsLsmbLsbLgLgLsbLsbLcLsmbLgbLsbLsRsbLsLsLsmmbLgLs
bLgbLgbLgbLgbLibLgLsbLgbLgbLgRsbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLsbsbL
sbRsbLsbLgbLgLsbLgbLgbLgbLibLebLhbLiLsbLeRsbLibLgbLiLsbLgbLgbLgbLgbLgL
sbLgbLibLsbLobRsbRobRibLsbLgbRobRgbRgbRgbRjRsmbRsbRibRhbLgbLjbLgbLgbLg
bLgLsLgbLgbRsLgbLebLgbLebLgLsLsmbLibLsbLgLgbLgbRsbRjbRjbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bRcbRibRgbRgbsbsbRgbRgbRgbRjbLibRhbRibRhbRjbLjbLeLsbLgbLibLibLoRsbRjbR
ibRibRebRobRibLsbLcbLhbLibLgbRibRjbRhbRcbRgbRibLebLcRsbRibLcbLgbLcbLib
LcbLgbLhbLgbLhbLgLgbLibLcbLobRibRibRobRibLcbLjLsmbRibRgbLhbLsbRsbLibLi
bLibLcbRibLgbLgRsbRibLgbLibLhbLgbRsbRibRobRgbLcbRsbLjbLhbRibLhbLcLsmbL
gbRgbLjbRjbLibLibLibLsRsRsmbRjbLibLhbLgbRibRjbLibLhbRibLhbRgbRibLgbLjb
RjbsbLibLiLsbLibRgbLgbLibRsLsbLgbRsRjbRsbRgRsmbRjbLibRsRsmbLibLibRsRsm
bLibLgbLgbLgbRgbLgbLibLgbLgbLgbRgbLibLgRsbRjbLgbLibRjbLibLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bRcRsmbReRsmbRiRsmbRibRiRsmbRiRsmbRcbRibRiLsbLgbRhRsmbLjLsmbLjbLibLcbL
ibLhbLibLiLsLsmbLcbLiRsbLcLsLsmmbLcLsmbRjbLibRjbRibLhbLiLsbLgbLgbRjLsb
RebRiRsmbRibRiRibRibRobRcbLjbLiLsbLiLsRsbLgLebLibLibLibRsbsbLibsbLibLg
bLiLsbLibLgbRcbRiLsbRhbRhbRibRibRhRsmbRiRsRsmmbRobRiRsmbRsRhLsbRiRsmbR
hbRgbRibLcbRsLiRsLiRsbsbsbsbLibRjbRjbRhbRibRiRhbRibRebRibLsbRibRibRibR
ibReRsRimbRgbRobRgbRhbLsbRibRiRsmbRcLsRsbRsbRhbRiRsRsmmbRhbRcRsmbRhLsb
sbRibRibRgbRgRsmbRcbRiRsmbRibLjbLjbLibLgbLibsbLgbLgbLjbRiLsbRgbLgbRjbs
bRjRsmbRiRsRembRhRsmbRiRiRsLsmbRgRgRebRebRebRebLsbLsbLsLsmbRsRsmbLsbRj
bRgRsmbLjbLjbLgbRibLjbLcbRiLjbLhbRcRsmbLibLgbLcRsbLibLibLibLcbLoLsRsmb
LgbLgbLibLibLgLsLibLhLsbLobRsLibLibLibsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsbRcRsmbRgbRsbRibRgbLsRsRibRebRhbRebRebsbRgbRebReRebRibRgbRgLsLsmbRg
bRsbsbRgbRsbRebRcbRjRgbsbsbRebRsLsbRgbRgbRsRgbRibRibRibRebRgbRobLebLeL
sbLgbLibLibLgLsbLgbLgbLibLcbLiLsbLgbLiLsLsmbLgLsbLgbLsbLibLgbLibLgbLgL
sbLsbLibLgbLgbLibLgbLibLgbLsLsmbLgbRcbRibLgbLcbRcbRgbRebRhbRcbRsLsbRgb
RgbRibRgbRcRsmbsbLcbLgbLibLibRibRobRcbRiRsmbRibRgbRibRgbsbsbsbLgbLcbLi
bLibLiLsbRcbRhLsbRgbRcbRibRcbLsbLhbLgRsbLgbLebLeLsbLibLibRcbLibRjbLcLs
mbLhbLibLcRsbLibLgbLgbLibLgLsbLibRibLcLibLgbRcbRhbRhbRhbRibRgbRjRsmbRi
bRibRgbRibRcbRcbRibRibLgbRcbRgLgbLjbRibsbRsbRibRgbLsbRsbRsbRsLsbsbLsbs
bLsbLsLsRembRebRebRibRhbRgbRcLsbRhbLgbLjLsmbRjbRcbRcbRhbRgbLobLcbLcbLi
LsbLoRsbRgbRibRibLiLsbLgLsbLibLgbRgbRjbRibLjbLcLsmbLgbLgLibLebLgLsbLgb
LgbLhbLhbLgbLgbLibLibLhbLgbLibLcbRsbLibLcbLgbLsRsbRhbLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bRhbsbRhRsmbsbRsRsmbRgbRgRsRsmmbRgbRgRgReRsmbRibRibRebRiRgbRiRsRsRsRgR
hRimmmbRebRgbRgbRgbLobRsbRibRgbRibRgbRiRgRebRibRiLsbRebRhbRiRsmbRebRgb
RebRgbRebReRebLsbRsbRgRsmbRgbRgbRsRsmbRsbRibRsbRgRsRsmmbRgRsmbRgbRgRsm
bRsRsmbRgRsmbRgRsmbRiRsmbRebRibRibRhbRiRsRsRgmmbRgbRibRgbRsbRgbRgRgbRg
RsRsRsmmmbRgbRsRgRsmbRibRebRgbRibRgRsRgmbRibRgRsmbRebRhbRiRhRebRgRsmbR
gbRgbRibRibRebRgbRibRsRsmbRsbRsRsRsmmbRgbRiRsmbRibRiRsmbRiRsRsRimmbRgR
sRsmmbRgRsmbRiRsmbRgbRgRgbRiRiRgRsmbRibRebRhbRebRgRsmbRgRgbRgbRgbRjbRs
bLjbLibLiRsbLgLibLiLsLgbLsLsmbLsbRsbRgRsmbRgbRibRgRsRgRsmmbsbRiRgbRebR
ibReRsmbsbRgbRibRgRsmbRsbRsbRibRgRsmbRiRsRimbRgbRiRsmbRiRgbRgRsmbRgRsR
smmbRiRsRsRsmmmbRgRsmbRgbLcbLobRiRgRgRgRibRibReReRsmbRgbRibRhLsbLgbLgb
LgbLgbLgbLgRsbLibRsbLiLgbLiLsLsmbRsLsbRiRsmbRgRsRsRsRsRgRgRsLsmmmmmbRg
bRgbRgRsRsmmbRibRibRibRiRsRsRgmmbRgbRibRiRsRsmmbRibRsbLsbRgbRgbsbLsLsm
b

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRibLibRibRibLsbRsbLjbRhbRgbLjbRcbLsbRibRsbLsbLsRsbRsLsbsbRiLsbRsRsmbL
sbReRiLsbLebLibRsbLibLsbLcbLibLiLsbLiLsbLgbLibLibLebLibLeLsbLgLsbLibRh
bLhRsbsbRhbRgLsbLsbRsbRsbLsbLsbRgbRsLsbRgRsmbRsbRsbRsbRsbRsbReRgbRsbLg
bRsbRgbRgbRgRsLsmbRgbRgRsRsmmbRsbRsbRebLsbLcbRcRsRsmmbRgbRsbRibRibRibR
cbRiRsmbRhRsmbRebRcbRhbRibRobRibLcbLhbLiRsbRcbRgbRgbRgbRgbReRsmbRgbRiR
smbRgbRcRsmbRibReRsmbRgbRiLsbRibRibRcbRhRsmbRibRhbLsbRgbRhbRobRibRgbRg
bLsLsmbRgbRgbRgbLebLibsbRobRibRgbRsbLsbRsbRgbRgRsmbRgbRgbRsbRgbRsbRgbR
sbRgbRgbRgbRsbRgbRsbRgbRgbRsbRsbRgbRgRsmbRebRsbLsbLcbLgRsbRcRsReRsRsLi
mmmbRibRiLsbLsbRsbRgbRgRsRsRsmmmbRebRibLjbRcRibRebLobRibRgbRibRsRebRgR
smbRsRsRsRsmmmbRgRsmbRgbRgbRebRgbRiLsbRcbRcbRsbRcbRibRibRhbRiLsbRibRiR
smbRibRibRibsbLgbRibRibRibRiLsbRgbLcLsmbLibLgbLgbLgbRjbRhbRjLsbRgbRibR
ibRgbRibLibLjLiLsbLibRgbRgbRibRiRsmbRibRgLsbRjRsmbRibRibLjbRibLibRjbLi
LsbLgbRiRsRsmmbLjbRsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRhbRhbRhRsmbRhRsmbRibRebRhbRibRgbRgbRibRcRsmbRhRsmbRcbRibRgbRgbRibRgb
RgbRgbRgRgRsmbLsbRsbRsRsRsLsmmbLsLsmbRsbRsbRsRsRsRsmmmbRgRsmbRgbRgRsmb
RiRsRsRsmmmbRcbRcbRibRiRsmbRsRibRgRsmbRiRsRgRimbRiRsmbRgRsmbRgbRibRibR
ibRebRcbRiRsmbRiRgRsmbRgbRgbRgbRgbRgbRjLsbRiLsbRhbRebRebRebRhbRgbRsbRs
LsbRgbLsLgbsbRsRsmbsbRsbRgRsmbRibRsRsRsRsmmmbRebRjRgRgbRibRiRsRsmmbRib
RebRibRibRiRsmbRgRgRsLsmbRgRhbRsbRibRgbRcbRcbRcRcbRiRiRsmbRgRsmbRgLsbR
ibRcLsbRobRibRgbRgbRgRsmbRgLsbsbRgLsbRiRsmbRcbRcbRhRsmbRibRgbRibRgbRgb
RgbRiRsmbRgbRgRsmbRgLsbRgbsbLgbRgbLsbRjbRcbRibLcbLcLgLobLiLiLibLgLsbLe
bLiLiLsRsbRiLsbRgbLjbRsbRibRgbRcbRsbRcbRibRsbReLgbLgbLsLsmbLibLhbLgbLc
LsmbLiLibLibLgLgLeLgbLebLcRsbRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bRsRsmbRibLcbRcbRobLgbLcbLcbLebLeLsRsbLibLcbLhbLebLgbLcbLebLeLsLsmbLsb
LcbRgbRibRgLsRsbRcbRibRjRsmbRebRebReLsbRhbLcbRobRibRgRsmbRibReRsmbRgbR
iReRsRembRebRiRebRibRgbReLgbLgLiLibLibLebLebLibLibLobLsbRjReRsRimbLibR
cbRiRibRgRsmbRibRebRibRibRebRibRgbRibRibRsbLeLsbLiLsbLgbLebRsbRiRsmbLs
LsmbRibRhbRibRgbRgbRcbRhbRcbLjbRjRsRsmmbRiRsmbRibRhbLibLgLibLgbLeLibLg
bRgbLebLebRcbLeLsbRsbRibRibLgbRibRebRcbRgbRibRiRsmbRcbLibLcbLiLsbLibLi
LibLhbLgbLebLgbLgbsbRsbRjbLgLsbLibLebRiRsmbRhbRgbRhbRibRcbRibLhLibLsbR
ibRgbLjbLebLgbRsbRcbRibRibRsbLgbLsbRsbLsLsmbLibLsbRjbRhbRgbRgbRibLjLhb
LibLgbLibLsRsbLjLsLsmmbLgLsLebRibLibRibRibRcbRgbLibLebLgLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRibRiRsmbRcRsmbLgbRcbRiRsmbRgbRiRsmbRgRsRsmmbRgbRebRebLcLsmbLcLsmbLgL
eLsbLgbLgbLcLsmbLebLgbLibRobRjbRiRsmbRgbRibRibRgbRgbRgRsLsmbRgRsmbRsbR
sbRsbLsbRgbRsRsmbRsbRsbRibRsRebRgbRhRgbRgbRhbRgRsmbRebLgbLgbLibLsbLebL
sLsmbLcbLhLsbLebRsbLiLsbLhbLebLgbLcRsbLsbLcbLeLsbLibLgbLgLebLgbLsbLsbL
sLsmbLsbLgbLsLsmbLibLcLsmbLgbLcbLeLgbLibLgLsbLhbLebLebLgbLgbsbRsLsbLsb
LsbRsbLgbLgbLsLsmbLibLhbLgbLcbLcbLhbLebLgbLsbRsbLsLsLsmmbRsbLiLsLsmbLh
bRibRobRebRibRsbRibRgbRebRibRibRhLsbRiRibRiRsLsmbRgbRhbRgbRiRsmbRibRgb
RsbRgbRgbRgbRibRsbLsRsbRsbRsbRsbRgbRgbRgbRebRibRcbRibRiRsmbRebRgbRgbsb
RgbLsbRsbRgbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLsLgbLsLeLsbLeLsbLgLsLiLsLhLsLsmbLibLebLebRcbRhbRobLebLgbLgLsLsLsmmbL
sbLgbLibLibLsbRgbLibLhLsbLibLibLgbLgLsbLgLsbLgLiLsbRsbRjbRiLsbLjbLsbLs
bsbRebRibRsbLsRsRsmbLsLsLsmmbsbLsbRiLsbRgRsmbRgbRgRsmbLsbLgLsLsmbLhbLg
bLgbLgbLsLsLsmmbLgLsLgLsLsmbLgRsbLgbLgRsbLgLsLsmbLgbRsbRsbLgbLgLsLsmbL
gLsbLsLsmbLsLgbLgbLsLsLsLsmmmbLgLsbLibLhbLsbRibLcLsmbLibLhbLibLiLsbLib
LebLsLsmbLhbRsbLibLibLgLsLgLsbLgLsLebLhbLsbLsLgbLgbLsLsLgmbLiRsbLibLgb
LebLeLiLgbLgbLeLibLiLgLgbLeLgbLibLibLebLibLgbLsRsbLgbLiLsbLeLgLsLgLsLs
mbLebLibRsbLibRsbRjbRhbRibRibRibRgbRibRgRsmbRgRsRsmmbRsRsmbRgbRsbsbRsb
RsbRgbRgbRiLsLsmbLsLsmbLgLgbsbLsbLgLsLsmbLgbLgLsLsmbLgLsbLsLsmbRsLsbRs
bLibLsLsmbLsbLsbLsLeLhbLgbLgLibLhbLsbLsbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bLsLsRsmbLsLsLsLsmmmbLibRebRcbRcRsmbRhbLobRgbsbLibRobRhRibRjbLsbRebReb
RebRhbLsbRcRsmbRjbLgbRgbRebReRsmbRsbRgLebReRsmbRgbRsRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bLsbLsbRsbRsbLsbLsLsmbLsbLsbLsLsmbLsRsbsbLsRsbRsbRsLsRsLsbLsRsbRsLsLjb
LsbLsbRsbRsbLsLsmbLsRsbRsLsbLsbRsbLsRsbLsbRsbRsbRsbLsbsbLsbRsRsmbLsbRs
LsbLsLsmbRsbLsbRsLsbRsbLsLsmbRsbLsRsbLsRsLsbLsbLsbLsbsbRsbLsbsbRsbLsbR
sbLsbRsbLsbLsRsbsbRsbRsbRsbsbLsbLsRsbsbRsbLsbsbsbsbLsbRsbRsbsbLsbsbRsb
RsbsbRsLsbRsLsbLsLsmbRsbLsbsbsbRsLsbLsbsbRsbRsbRsRsLsmbLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
bRgbRibRibRebRhRsmbRibRibRiRsmbRibRibRhbRibRibRiRsmbRgRsmbRgbRsbRgbRsb
RibLgbLsLjbLgbLcbLsbLiRsbLgLsLsRsmbLsbLsRsbLgbLebRsbRcbRiRobLsbRcRsmbR
ibRiRsRembRhbRgbRibRibRgRsLsmbRgbRsRsmbRgRebRgbLjbLcbLibLgbLsLsLsmmbLg
LsLsmbLjLgbLgbLiLhbLgLsbLibLgLsLsmbLgLsbLiLeLsbLgRsbRjRsmbRobReRhRsmbR
ibLsRsbRibRsbRjbRsbRsbRsbRsbLsLiLsbLjbLjbLcLsmbRcRiRhRsmbRcbRibRgbRgRs
mbRgbRibRibRiRsmbRibRhLsbRgRsmbRgbRsbRcbLgLsbLibLebLibLiLgbLhbLiLsLiLi
LgbLhLhLsbLiLgLiLcbRebRcbRibLibLgbLebLgbRobRhbRobRobLgLibLhbLiLsLiLsLi
LsLgLgLsLebLgLsbLgbLgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bRibRibRiRsRsmmbRgbLsbRgbRsRgbRsbRibLibLeLsbRhbRjRjbRgbRgbRgbRgbRibLgb
RjbRibRibRgbRgbRiRsmbLibLhbLibLibLcLsmbRgbRibRsbLibRgbLsbRibRibReRsmbR
hbLjbLgbLjLsmbLibLibLcbLibLcbLhbRibRhbRgbRgLsbRgbLsRsbLjbLcbLibLeRsbLg
bLibLjbLgbLhbLibLcbLibLgbRcbRibRgbRgbLibRibLgbLsbLebLibLibLibRsbRgbLhb
LjbLgbLgbRibLebLibLgbLiLsbLhbLgbLhbLgLsbLgbRsbLibLsbLgbLebLgLsbLibLibL
ibLibLgbLgLsbRcbRibRiRsmbRgbRibRgbRibLgbLibLibLibRgbRebRgbLhbLibRebRib
RibRgbRgbRjRibRgbRebLebReRsmbRgbRibRgbLibLeLsbRibLjbRhbRibRibRebRibLhL
sbLibRcbRiRsmbRgRsmbRibRgbRhbRgbLibLhbLcbLiLsbLibLibLebRcbRibRgbRjbRib
RgbRsbLiLsLsmbLjRsbLcbRgbRibRibRgbLgbLcbLibLiLsbLgbRgbLibLibLgbLibLibL
gLeLsLgLebLibLibLibLoRsLsbRibLiLsbLsRsbLhbLhbLibLcbRgbRibRibRgbRibRgbR
ibRibLjLsmbLibRjRibRibRsLsbRgbRgbRsbRgbLjbRcRsmbRiRsmbRibRgbRiRsmbLjbL
hLsbLsbLsbLsbLsbRsbLgbLgbLgbLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
bRgLsbLibLhbLgLsbLhbLhbLibLibLiLsbLebLiLeLsLhLebLsbRsbLgbLsLibRoLsRsRi
RsmbRgbRobRhbRgbRhbRgbRibRgLsbLiLsbLibLgbLcbRsbRgbRibRsbRibRibRgbRibRi
bRgbRgbRiRsmbRgbRgbLsLeLebLgbLiRsbLgbLsLsLsmmbLsbLgLsbLgbLsbLsLsmbLibL
iLsbLibLhLeLsbLebLcLsmbLhbLhbLgbLhbLibLibLeRsbLebLhbLiRsLgbLhbLibLiLsb
LibLsLsmbLgbLibLgLgbLgbLibLhLsLsmbRibLebLibLibRhLsbRhbRibRibRgbRiLsbRi
bRgbLhbRibRibLibLjRsbRhbRibRjRsmbRgbRgbLjbRibLgbRibLgbRsbLjRsbRhbRibRi
LsbRgbRgbRiLsRsbLsbRsbRibRibLjbRibRibRibRgLsbRcbLhLsbLibRcbLcbRibRgbRi
bLibLjbLsLibRebLcbRcbLjbRcRsmbLcLibRsbLgLsbRjbLibRgbLcbRjbLhbRjbLebLib
LgbLeLsLsmbLiRsbLsbLibLgLsbRsLsbLsbLsLsmbLgbLiLsbLibLgLsbLgLsbLibLsbLg
bLsLsmbLibLebLibLcbRobsbRgbRgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bLsbRsbLsbRsbLiRsbLcRsbLcLibLcbLibLcbLiLiLgRsbLcLcLsmbLiLebLiRsRsmbRcb
RoLsLsRimbRiRcRgbRibRgbRgbRiRsmbRhLsbRibLsLcbLjbLcbLsbRcbLgbLgbsbsbLsb
sbsbRsRsRsRsmmmbsbsbsbsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133326; End: 133826;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bRhbRgbRibRebRiRsmbRibRiReRgbRebRibRebRibRibRebRibRibRcbRiRsmbRcRsmbRe
bRebRgbRiRsRimbLgbLcbLebLgbLhbLhbLibLibLibLcLsmbLgbLibLibLsbLibRgbLibL
gbLeLhbLgbLibLsbLgbLgbRobRgbRibRsbRgRgbRgRsmbRiRsmbRgbRibRiLsbLsbRiLsb
RibLgRsbLjbLgbLgbLibLgbLsbLgLsbLgbLgbLgbLsbLgbLgbLgbLgbLiLsbLibLhLsbLi
bLgbLibLgbLgbLsRsbLibLgLsbLgbLgbLgbLgbLsLhbLsbLgbLgbLsbLgbLsbLgbLgLsLs
mbLibLgbLgLsLgLsbLgbLgbLgbLgLibLgLgbLgbLibLsbLsLsLsmmbRsbLsLibLsbLgbLi
LsbLgbLgbLgLsbLsbLgLsbRsLsLsLsLgmmbLgbLebLibLiLsbLsLsmbLsbLibLgLsbLgLs
LgbLsLsmbLsbRsbRibRgbRsbLhLsbLibLgLsbLgbLsLhbLgbLgbLgLsbLibLgLgLsbLgLs
LsLsmmbLgLsLsLimbLgLsLsLgmbLibLibLgLsbLsbLgbLgbLgbLgbLjLsmbRsbLibLgbsb
sbLgLsLsmbLibLgbLibLgLsbLgRsbLgbLibLgLsbLgbLgLsLsmbLgLsbLgLsbLibLgLgbL
gLsLsLsLsLsLsmmmmmbLgbLgbLgbLgbLiLibLsLgbLgbLgLsLsLsmmbsbLsbLibLgLsbLg
bLgbLsbLgLsRsbLgbLgbLgLsbLsLsmbLgLsbLgbLgbRsbLgLiLsbLgbLgbLgbLsLsLsmmb
LsbLibLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bLsRsbRsRgbRgbRsRsmbRgbRgbRgbRgbLsRsbRsRsmbRsbRgbRsRsRsLsmmbRsRsmbRsbR
sRsmbRsbRsbsbsbRsRsRsmmbRsbRsbRsbLsLsmbsbsbsbsbsbsbLsbLsRsbsbLsbsbsbLs
LsmbLsbLsbLsbLgRsbLsbLsLsmbRsbLsLsmbLsLsmbLgbRsLsbLsLsmbLgLsbLsLsmbLsL
smbLcLsmbLhbLcbLgbRsbLibLsbLsbLsbsbLsbLsbsbLsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLgbLgLsbLgbLgLsbLibLgLgbLiLsLsmbsbLgLsbLgLsbLiLsbLiLsLiLsbLsbLg
bLsbLgLsbLsLsmbLgLsLsmbLibLgLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLgLsbLgLgLsL
smbLgLsLsLsmmbLsbLgLsRsbLsLsLsmmbLgLgbLiLsbLsLibLsLsLgmbLsbLsLsmbLsLsm
bLsLsLgmbLsbLgLsLsRsmbsbLibLgLsLsLsLsLsmmmmbLgLsLsLsmmbLgLsLsLsLsRsmmm
bLsLsmbRsLsbLgbLiLsbLsLgbRsbLgLsLsmbLiLsbLcLsmbLsbLibLgLsbLiLsbLgLsbLs
LsLsmmbLgLsbLsbLsbLgLsLsLsmmbLgLsLsLsLsmmmbLgbsbLsLsmbRsLsLsmbLsLsLsmm
bLsLsLsLsmmmbLgLsLsmbLiRsbsbLiLsLsLsLsmmmbLiLsbLsLsLgmbLibLibLcLsmbsbL
ebLgbLiLgLsbLgLsbLgbLiLsLsmbLibLibLgRsbsbsbLgLsbLgbsbRsbsbLgLgLsbLibLg
LgbLiLgLgLgLsRsbLsLgLsLsmbLgLsbLcbLeLsbLgLsbLgbLgbLsLgbLcbLibLgbLgLsbL
obRsbRhbRcbRibRiRsmbRiRsmbRiRebRebRebRebRsLsbRsbLsRsRsmbRsRsmbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLsbLsbLsbLsbLsbsbsbsbRsLsbRsRsmbLsbLsbsbLgLsbLsbLsLsLsmmbLgbLsbLgbLgL
sbLsbLsLsmbLsLsLsmmbLgbLsLsLsRsmmbLcLsmbRsbRgRsmbRgbRibLcbRsbRsbLsbLsR
sRsmbLsbLgbLsLsLsmmbRsbLgLsbLiLsLsmbLiLsbLcbRgRsmbLobLcLgLsbLgLsbLgLsb
LgbLsLsmbLsLsmbLgRsbLgbLsbLsLsmbLgRsbLsLsmbLgbLiLsLhbLgbLobLebLiLiLgLi
LebLgbRsLsLsmbLsLsLsmmbLsLsmbLebLeLsLhLsRsbLsLsLsmmbLgLebLeLsLsLgLsmbL
eLibLgbLgbLhbLiLebRibLebLgbLgLsbLgLsLsmbLgbLsLsLsmmbsbLsLsmbLsbLgLsbLg
bLsLsmbLsbLsLsLsmmbLsbLsLsLsmmbLsbLsLsmbLsbLgbLsbRsLsbLsLsLsmmbLsbRsLs
bRsbsbsbLgbsbRjbRcbsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bRsbLsbLsbLsbLsbRsLsbLsbLsbLsLsmbLsLsmbLsLsLsmmbsbsbLsLsmbLsLsLsmmbLsL
smbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbRsbLsRsbLsbRsLsbRsLsbLsbLsbLgbLgbR
sRsmbLsbLsbLsbLsbLsLsmbLsLsmbLsbLsbLsbLsbLsbLsRsLsbLsbRsLsbLsLsmbRsLsb
RsbLsbLsLsmbLsbLsbLsbRsbRsbLsLsmbLsRsbLsbLsLsmbLsbLgbLgbLsbLsRsbLsbsbL
sbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsRsbLsbLsLsmbLsLsmbLsLsmbLsLsLsmmbRsbRsL
sRsbLsLsmbRsLsbRsbLsbRsbLsbRsRsmbLsRsbLsRsbLsbLsbRsbLsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRsbRsRsmbRsbRsRsmbRsRsRsmmbLsRsbLsRsbRsbRsbLibLhbLibLibLiLsbRsbLgRsLs
bLgbLoRsbLibLcLhbLebLebLsRsbLsbLsbLsLsmbLgbLgLsbRsbLsLsLsmmbLgLsLsLsmm
bLsbLgbsbRsLsLsmbRsbsbLsLsRsmbLsbLgLsbRcbRhbLsbsbLgbLsbsbLgLsLsLsmmbsb
RsRsRsmmbRsRsmbRsRsmbsbRsLsbLsLsLsLsmmmbLsLsmbLsbLsLsmbLsbLsbLsbLiRsbs
bLoLsmbLcLibLebLibLsLebLgbLgbLobReLsbRgbRgbRgbRgbRsbRhbRibRhbRobRhbRib
RibRgbRibRibRobRgRibRibRjbLsbRhbRgbLsbRoRsmbRebRebRobRibRgRsLsmbLsRgRs
mbRjbRsRsmbRgbRsbRsbRsbRgbRsRsmbRgbRgRibRgLsbRgbLgbLiLsbLgRsbLgLsbLjbL
ebLjbRgLsbRhbRcbRjbLsLsLsmmbRgbLgbLsbRgbRsRibRibRgbRgbRsbRgRsmbRgbRjbL
ibLgbRsbLgRsbLgLsbLgLgbLgbRsbLobRgRsmbRgbLgbLgbLgLsbLgbRjbsbsbRsbsbsbs
bRsbsbsbsbsbLsbRsbLsbLgRsbLsLsmbsbLgbLsLsLsLsmmmbLgLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bLsbLsLsmbLsbLsbRsLsbLsRsbRsbRsLsLsmbLsLsmbLsLsmbLsbRsbRjbRibRgbRgbRsR
sRsmmbRgbRgbLsbRsbRsbRsbRgbRgRsmbRgRsmbRiRsmbsbRsbRsRsRsRsRsmmmmbRsRsR
smmbRsRsmbRsbRgbLsLcbLcbLeLsbLobLsbLsLsLsmmbLsLsLsRsmmbLgLsLsLgmbLsbLg
bsbLsLsmbLsbLsRsbLsbRjRsRsmmbLsLsmbLsLsmbLgLsbLgLsLsmbLsbLsbRsbLgbLsbL
gLsbRjbLoLsmbRsbRibLcRsbRobRcbRgbRibRibRgbReReRsmbRibRsbRsbRsRgbLsbRsb
RibRiRsmbRsRsmbRsRsLsmbRgRsRsmmbRgbRibRgbRsRsLsmbRsRsRsmmbRgRsmbRgbRgL
sbRgRsmbLsbReLsbLcLsmbRgbLsbRgbReRsRsmmbRsbRiRiRsmbRgRsRsmmbRiLsLsmbRg
bRsbRgbsbRgRsmbRiRsmbRgRsmbRgbRsbRgbRgbRgbRsbLsbsbRsbRsbsbLsbLsbRibRcb
RibRebRcbRgbRibRebRebRibRgRsmbLcbRgbRiRgbReRgRsmbRsbRsbsbRsRsmbRsbRsbs
bsbRgLsLsmbRsbRsbRsLsRsbRsbRsLsRsRsmbLsbRsbLsbRsbsbRgRsmbRgbRsbRgRsRsm
mbRibRsRsmbRgbsbRsbRsLsLsmbRsbRsRsmbRsbRgLsbsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bsbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bRobRsbLeLsbLsbLsbLsLsmbLiLsbRgbLsbRibLcbLgbLgLsbLsbLgbLhLgbLsbRoRsmbR
ebLjbRoRsmbRgRsRimbRgRsmbRgRsmbRibRibRebLibRgRsmbRhRiRebRgLsbRcbReRsmb
RebRcbRibLobLcbLhLsbLebLibLjLsmbLcbRsbLobLcbLeLgbRjbRibRgbRgRgbRgRsRsR
immbRibLgbLjbLcbRsbLeLibLeLsbLsbRsbLsbLibRgLsLsmbLebRsLsLsmbRjbRibLsbL
cLiLgbLebLibRibLoLsmbLeLsbLhbLsbLhbLcbLgLiRsbLiRsbLgbLsLsmbRgRibRhbRib
LobLiLsbLsLsmbLgLgLgbLgbLsbsbLsLsmbLhbRgbLeLsbLcbLcLsLiLembLgbLsbRcRsm
bReRsmbRcbRcbRiRsmbRebLcbLibLgbRsbLsbLsLhbRibLebRsbRcLsbRibRibReRsmbRi
bRcbRebRibRebLebLcbLgbLiLsbLebLibLgbLhbLibLiLgbLibLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRjbRsbRsRsmbRgRsmbRiRsRsmmbRgbRcbRcRsRsmmbLgbRcbRobRcbRibRhLsbReRsRsm
mbRebRgbRibRgLsbRiRsRembRebRgbRgLsbRgbRcRsmbLebLcLsmbRsLibLiLsbLibLhLi
bLibLiLsbLgbRsbLibLgbLgbLhbLibLcbRiRsmbRcbRcRsmbReRsmbRiRsmbRibRiRiReb
RsbRibRcbRcbRgbLibLjbRiLsbLiLebLebLiLebLgbLgbLsbLsRsbLgLsbLgbLsbLibLeb
LibLhLsbRcbRhbRibRcbLcbLhbLiRsbLgbLibLibLibLibLibLiLsbLgbLiRsLsbLgbLgb
LhbLiLgbLcbLiRsbLibLibLcLsLsmmbLhLiLiLsbLgbLsLsmbsbLsbRgbReRgbLcbRebsb
LhbRiRsmbReRsmbLiRsbRhRsmbRibRebRibRiRsRsmmbRgLsbRsRgbLgbLcbLhbLibLibL
ibLsLsmbLgbLibLibLhLsbLebLgLsbLibLibRebLjbLsbLibLjbLibRebRgRsmbsbLgbsb
RgbLebRcbLcbRcbRiLsbRgRsmbRcRsmbLgbRibRobRibLgbLiLsbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLsbLsLsmbLsLsmbLsbsbLgbLsLsmbsbLgRsbLsRsbLsbLgLsbRsbLsbLsLsmbLgbLsLsm
bLsLsmbLsLsmbLsLsmbLgbLsLsmbLsLsmbLsbLgbLsbRsbLsLsmbLgRsbLgLsbLsbsbLsb
LsLsLsmmbLgbLgbLsbLsbRsRsmbRsLsLsRsmbsbsbLgLsbLsLsLsmmbLsbLsLsmbLgLsLs
mbLsbLsLsLsmmbLsbLgbLsLsmbLgbLsbLsLsmbLsLsmbLgLsbLgbLsLsmbLsbLgbsbLsLs
mbLsLsmbLsLsLsRsmmbLsLsmbLgbLsLsmbLsbLsLsRsmbLsbLgbLgbLsbsbLsbLsLgLsbs
bLgbLsbLsLsLsmmbLsLsLsmmbLsLsmbLsbLgbLgbLsLsmbRsbLgLsLsmbLsbLsbLsLsmbL
gLsbLsLsmbLsLsmbLsLsLsmmbLgbLgbLgbLgbLgbLgbLsbLsLsmbLgRsbLgLsbLsLsmbLi
bLebLgLsLsmbLgbLgbLgbLhLsbLibLgbLibLgbLgbLgbLsLsmbLgbLiLsLsmbLibLgbLib
LibLibLibLibLgRsLsbLgbLgLsbLgLgLebLgbLcRsLsbsbRibLcbLibLsLsmbLibLibLiL
sbLiLsbLibLjRsRsmbLsbLibLcbLcbLibLiLsbLebLgLsRsbLgbLsLsmbLgRsRsRsmmbLg
bLhLsLgLsbLgbLibLibLhbLsbLibLibLibLibLiRsbLibLiLsLsmbLgLsbLgbLgLeLsLsm
bLgbLgbLgLgLsbLgbLsLsmbsbLibLcbLcbRsLhLsbLiLsLsmbLibLiLeLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bLjbRgRsmbRebRebRiRsRsmmbRiRsmbRgbRibRgbRsRsmbRgbRgLsbRebsbRgbRiRsmbRh
bRgbRiRibRgbRgbRgRsmbRgbRgRsmbRgRsRsmmbRibRibRgRgbRgRsRsmmbRgRsmbRgbRi
bRibRgbRibRgbRgbsbRhbReRsmbRibRhRsRsmmbRebRibRcbRibRebRiRgbRiRsmbRgbRe
RsmbRgRsRgmbRebRhbRgbRgbRgRsmbReRsLsmbRobLhbLibLgbLibRibRibRibLibLgbLg
bLibLibLgbLibLibLjRsbLgbLebLgbLhbLibLebLibLhLsLsmbLebLgRgbLgRsbRebRiRs
mbRgbRgbRiRibRsbRgRgbRgbRgbRgbRsbRgRsRsmmbRgbRgRsmbRsbRhRgbRgbRibRiRib
RiRgbRibRibRiRgbRgbRiRsmbRiRsmbRibRebRgbRgbRiRibRiLsbRibRiRsmbRgRsmbRi
RsmbRgbRibRsbRgbRgRsmbLgbRiRsmbRibRgReRsmbRsbRsbRibRgbRgbRsRsmbRgRsRsR
smmmbRgRsmbRibRgbRiRsmbRgbRgbRiRsRgmbRgbRgLsbLsLsmbLjbLcbLibLiLsbLibLh
bLiLsbLibLiLsbLibLiRsbLgRsbRsbLcbLgbLibLibLibLhbLgbLibLgbLibLibRsLsbLi
bLgbRgbRibRgbRgbRsLsbLhbLibRgbLjLsmbLgLibLgbLgbLiRsbLhbLibRgbRsbRgRsmb
RgbLgbLsbLiLsbLgbLibLsbLgLsbRjbsbRgbLjbLibRhRsmbRgbRsRgbRiRsRsmmbRgRgb
RibRgRgbRgbRsRsmbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bRgRsRsRsmmmbRgRsmbRgRsmbRgRsRsmmbRgbRgbRgbRsRsmbsbRibRgbRgbRgbRgRsmbR
gLsRsbRgRsRgRsmmbRgLsbRgbRsbRsRsmbRsbRiRsRsmmbLcbLgbLibLhLsbLibsbLiLib
LgbLiLsbLgLgLsLiLsbLgbLcbLcLsmbLsbLiLsLsmbLgbLibLcbLeLibLgLsLsLsLsLgmm
mbLcbLeLsRsLsbLgRsbLgLgLgbLgbLgLsbLjbLcbLhLibLibLgbReRsmbLsRgRgbRgRsmb
RgRsmbRgRsmbRhbRgbLebRcbRhbRgRsReRiRhmbRgbLhbLobLibLibLsLgbLibRobRebRe
bRiRiRsmbRebRhRebLsbRsbReReRsmbRebRgReRsmbRhbLjbRiRgRsmbRebRibReRgRibR
gbRhbLsbRjRsmbRibRibRgbRgbRiRsmbRibRjRhbRibRjbRibRcbRibRcbRsbRibRjRibR
gbRcRsmbLsbRjbRiRsmbRgRsmbRsbLjbRjbRibLjLgbLibLjbRsRebRgbRiRsmbRgbRibR
ebRebRebRebRgbLgRsRsmbRsbRgRsmbLeLhbRsRsmbRibRgRsRsmmbRgRsmbRsbRsLsbRs
RsmbRsRsRsmmbRsbRgbRgbRgbLsbRgRgRsmbRgbRgbRsbRsbRgRgbRgbRsRsmbRgbRsbRs
RsRsmmbLsRsbLsLsRsmbLibLibLsbLibRjRsmbLgbLsbLcbLcbLcbLcbLhbLibLibLgbLo
bRsbsbReRiRebReReReRsmbLjbLjbRiRsRsmmbRgbRsRsmbRsbRsRsRsmmbRgLsbRgRsmb
LsRsbRgRsLsmbRgRgRsRsmmbRgbLsbLsRsbsbLsbLsLsmbsbRsRsLsmbLcbRsbRjbLibsb
LcbRobRebRiRsmbRgRsRsRiRsmmmbRgRsRiRgRsmmbRgbLjbsbRcbReLsRsbRcbRcbRiRh
bRibRgRsRsmmbRgRsRsmmbRgbRgRsRsmmbRgbLjbLcbRcRgbLjbRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bRgRebRgRhbRibRgRsRimbRiRsmbRsbReLsbRcRgbRsRibRsRsReRgmbLsRsRsmbRgbRsb
RsbRsRsmbRgbRsRsmbRibRgbRgbRcbRgRsRsmmbRiRgRgRsmbRgRsmbRgbRgRsmbRgbLsb
RiRsmbRgbLcbLeLsbLsLsLsLsLsLsLsLgmmmmmmbLgbRcRsmbRhRsmbReRibRibReRsmbR
eRebRiRiRsmbRiRsReRsRemmbRgbRgRebRibRobReRsRgRsRsmmmbRibRsRibRcbRcRsRe
mbRebReRgbRiLsbsbLsbRgbRgbLsbLsbsbLsbRgRgbRibRcbReRsmbRsRsRsmmbRgbRsbR
gbRibRcRsmbRsRsmbsbRibRibRgRsRsmmbRibRhbRiRgbRhbRgbRibRsbLcbLeLsLsmbLi
bLibLiRsbLgLgLsLibLibLgLhbLiLhLsLeLeRsbLsbRsbsbLsbRjbLsRsbLsLsLsmmbLsL
sRsmbLgbsbRjbRhbRibRiRsmbLcbLcLsLsLsmmmbLiLsLsmbLibLiLeLsbLgbLgLsbLsbR
cRsmbRiRsmbReRsRsmmbRcbLsLcLsmbLgLsbLibLeLsLgLsLsmbLiLgLsbLeLsLsLsLemm
bRsbLgbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bRiLsbLsbRibRgbRsbLsbRsbRsbLcLsmbLibLgbLibRsbLiLsbLsbLhbLibLsLoRsbLcbL
iLsLeLebLgbLibLhbLgbLjbRjbRobLibLibRcbRiRgRsmbRiLsbRgbLibRjbLibLgbRsbL
sbsbLhbsbRgbRibRsbLjbLsbLsbRsbRsbRsRsmbLsbLsbRgbRoLsLsmbRcLsbLsbLhbLgb
LibLgbLsbRjbRcbRibRcbRgbRibRibRgRsRsmmbRiRhbReRibReLsbRiRebLcRsbRobsbR
sLsbsbLcbLsRsbRsRsmbLsLibLiRsLsbLiRsbLibRsbLhbsbLibRjbLibsbLsbRsbLibRc
bLsbRcRsmbRibRibRobRiRsRiRsRsmmmbRibRibRiRebRsbRgbRhbRcbRcbRiRgbRgbRiL
sbRebRhbRsbLibRcbLhbLcbLibRcbRcbRcbRsbRhbRibRhbRhbRibRebRsReRcbRobLgLs
bLiLsbLobLgbLoLiLsLgLiLsLibLibLibLcbLgRsRsmbLsbLgLsRsbLcLgbLibLiLgLgLs
bLgbRgbRibRgRsmbRgbsbRsbRgbsbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRgbRibLibRibLhbLcLsmbLhbLibLhLsbLeLsbLibLgbsbLjbLhbRcbLibLsLgLebRcbLg
bLcLsmbLibLiLsbLibLobLgbLobLcLsLsmmbLiLsbLebLebLgbLgRsbLibRobRibRebRhb
RobRcRsmbRiRebRgbRcRsmbRgbLcbLobLibLibLibLobLsRsbLobLcLeLhLsbLoRsbRsRs
mbLjbRsbLibLibRgLsbLebLgLsbRsRsmbLgbLeLsbRebRhbRgRsRsmmbReRsmbRsbRhRsm
bsbLhbLcbLgbRcbRiRsmbRebRebRibRcbRhbLgbRibRebRebLjbRjbLcbRcbRjRsmbRjbR
sRsRsRsmmmbRgRsmbRiRsRimbRebRgbRobLibLsbLibLgLsbLobLobLcbLhLsbLibLgLsb
LoLsmbRgbRiRgbRsRcbLgLsbRcRsmbRsRsRsRsRsRsRsRsmmmmmmmbRgbLcbLcbLiLsbLg
LgLsbLiLsbLibLcbRgRsmbRcbRobRhbRhbReRsmbRiLsbRibRgRsRsmmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bLgbLgbsbLgRsbLgLsLsmbLibLgRsLsLsmbLgbLgbLgbLgbLhbLsbLjLsmbLgbLsbLsbLs
LsmbLsLsmbLgbRsLsbLsbLgLsLsmbLgbLiLsbLgbLgLsbLgbLgLsRsbLsLsmbLsbLsbLgb
LsbLgbLsbLsLsmbLsLsmbLgbLsbLgbLgLsbLjLsRsmbLibLgbLgbLsLsmbLgLsbLsbLsRs
bLgbLsbLcbLsbRcbRiRsmbRsbLsbLsbLsRsLsRsbRsLsbLsbRgbRsLsbRgLsbRsRsLsmbR
sbRgRgbRiRsLsmbRebRiRsRsmmbRiRsmbRebRgRibRibRhRebReRsmbRgRsmbRhbRibRsR
smbRgRsmbRgRsmbRsbLsRebRsbRiLsbRiRibReRhRsRsReRemmbLsRsbRibRgRsRsmmbRg
bLibRgbRgbRibRibRibRiLsRgbRibRsbRsbRsbLibRsLsbRgbLsbRgbRgbRibRiRsRsLsm
mbRibRiRsmbRhbRcbRiLsbLsRjbRebLobRcbsbRsbLibRgbLibRibRibRibRcbRcRsmbRi
bRhRgbRsbRgbRebRebRsRsRsmmbRebsbRsbRibRibRebRiRsmbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLsLsmbLcbLeLsbLgLsLsLsRsmmbLgLsbLgLsLibLsbRsbRsLsbRsLsbLsbLsbLsbLsbLg
RsbLgbRsbLsRsbsbLgRsbLsRsLsbsbLgRsRsmbLiRsbLhbLibLiLsLsmbLcbLgLsbLsbLg
LiLsLgbLsbLsRsbLsbLgbLiLsbLhbLibLgLsbLgLsbLgLsbLsLsLsmmbLiLsLgLsLgLsLs
mbLsLsRsmbLsbLgRsRsmbLgLsbLiLsbLibLgLsLsLsmmbLeLsbLcbLibLgbLibLibLhbLi
bLiLsbLgLsbLiLsLsmbLgLsbLgbLgLsbLiLgbLgbLgLsbLiLgbLiLsbLcLsmbLgbLgLsbL
sbLsbLsLsmbLsLsmbLsbLsbLgLsbLsLsmbLhbLgLiLsbLiLiLsbLgLsbLcLhbLebLebRsb
LsRsbsbLhbRebLcbLhbLibLibLiLsbLiLsLsmbLibLgbLiLsbLiLsbLeLeLebLiLiLebsb
sbLgLsbLgbLgbLsbRsbLsbLgbsbRsbLgbRsbLcRsbLobLobLsbLcbLibLgbLebLsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bLibLcbLibLgRsbLiLsbRcbRgbLibLcRsbRiRsmbRiRsmbLibLibLibLhbLibLibLgLgbL
ebRhbLibLhbLgbLibLsbLcbLibLsLjbLcbLibLibLibLibLhbLgbLibLhbLgbLobLgbLhb
LhbLibLsLsmbLibLgbRjbRebLebsbRjbRhbLibRjRsRsmmbRibLiLsbLibLebLcbLibRcb
RgbRjbRhbLibLgbRibLhbRobRgbRibRebRgbLibLiLsbLjbsbRcbRiRgbRibRgbRibLgLs
bRjbLibRjbLjLsLsmmbLebLibLsbLcbLcbLiLsbRjbReRsmbLjbRjRgRsmbLcbLcbLcbLc
LsLsmmbLebRcRsmbRebLgbLibRibLiRsbRsbRcbLebLgLsbReRsmbLjbRjbLsbLeLsbRoL
sbRibRebRiLsbLibsbRcbLcbLcbLgbLcbLgLsbLcbLgbLiRsLsLsmbRcbLjLsmbRsRhRsR
smmbRjRsmbLjbRhRsRsmmbRgRsRsmmbRebLhbRobRhbRjRhbLebLibLibLibLibLiLsbLc
bLibLhRsbLgbLibRoRsmbRsbRcbsbLcbLjbLebLibLhLsbLibLgbLiLsbLgbLibLhbLibR
ibLibLhbLgbsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bLiLsbRgbRibRsbRgbRgRsmbRsRsmbRsbRsbRiRsmbLsbRsbRgbRgbRsbRibRgbRsbRsRs
RgmbRsbRgbRgbRgbRsRsmbRgbRgRsmbRgLsRsbRgbRibReLsbRcbRsbRcLsbLiLsbLobLc
LgbLsbLsLebLebLibReRgLsbRebLgbLsbRgbRsbsbsbRsbRebRjbLibRjbLjbRiRsmbReb
RebRgbRoLsLsmbRgbRcbRgRsRsmmbRgbRgbLibRoReRgbRebLgbRgbRsbRsRsmbRgbRsbR
ibRibLgbRgRsmbRgbLjbRobRibRebLibLcbLibLjbRjbLjbRcbRsRsLsmbRsRsRsmmbRgb
RsbRcbLgRsbRebLsRsbRhbRibRjbRsbRobRhbLcLsmbLobLgLsRsbLibLgbLibLcbLibLi
LsbLgbLsbLobLsLsmbRhLsLsRombRibLjLsLsmmbRebLibLibLgbLcbLhbLibLibLgbLsb
LjbLibLgbLibLgbRsRsmbLgbRobLjbLibRhbLjbRibRcRsmbsbLjbRobRibRobLgbLsbLg
bLiLsbLcLhbRsbLgbLgbLgLgbLiRsLsbRiRebRebRgRsmbRcbRobRiRibRsbRibRgbRhbR
ibRgbRcbRibRibRgbRgbRiRsmbRgbRgbRibRgbLibRibRgbRgbRibRgbLcbRcbRibLibRc
bRgbRgbRgbRibRgbRgbRgbRibRibRgbLsbRhLsbLibRgbRgbRgbRsbRsbRcbRibRgbRhbR
ibRsbRgbRgLsbLsbRjLsbLjLjLjRsbRibRgRsmbRgRsmbRibRgRsLsmbRoLibRebRgbRgb
LgbRgLsbLsRgbRsbRsRebLsbLgbRsbRsRsmbRgbRgbRsbRsRsRsRgmmbRgbRgbRsbLebLe
LgbLsLsLgLgRsmbLgbLebRcbRebRgbRsRsmbsbRgbRsbLob

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bLsbLcbLibLhbLsbLsLsmbLhbLhbLiLsbLibLjRsbRgRsmbRhbRgRibReRsmbRiRibRgRg
bRiRibRobRgbRibLibLebLiLiLsLibLibLgLeLsbLiLsbLebRsbLcbLibLibLibLgbLebR
ibRiRhbRibRiRsmbRgbRibRgbRcbRsbRgbRcbLsbLjbLjbLjLgLsbRjbLhbLebLebLebLh
LsbLeLgLsbLgbLibLiRsbLgbLhbLibRcbRcbReRhbLsLjbRibLsbLsRsbLibRcbRebRibR
iRsRembRgRsRsLsmmbRsRhbRhbRhbRgbLjLibLjbLibLgbLcbLeLebLsRsLsbLhbLsRgbR
cbRibRobLibLjbLjRsbLibLgbLibLhLibLgbLgbLibLebLebLibLgbLcLsmbLibLhLsbLe
bLgbLiLsLebLgbsbLgLsbLiLsbLhbLjLjbLjbLjbLibLibLhLsbLiLgbLibLcbLcbLebLh
bLibLibLjbRsbLjbRjbRsLsbLsRsbsbsbLsLjbLebLjbLcbLebLjLjRsbLeLsbLhRsLsbL
jLsmbLgLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
bRgbLjbLcbLibLibLsbLgbLebLgbLsLsmbLsLsLembsbLgRsbRgRsmbRcbRcbLcbLhbLib
LcLsmbLibLiLsbLibLgbLibLiLsbLebLeLebLebLebLebLibLiLsbLsLiLsbLibLobLcbL
cLsmbLgbLiLsLgLsbLibLsbLsbLsbRsLsbRsRsmbRjbRgbRebRcbsbRjRsmbRibLjbLcbL
cbLiLsbLhbLhLsbLibLibLibLhLsbLgbLibLibLibLebLiLsbLebLibLhbLebLebLebLhb
RiRgbRsRgbRiLsbLjbLibLebLjLgbLibLibLgbRjbRsbRcbRiRsmbRgLsbRgbRiRsmbRib
RcRsmbRcbRgbRibRibRcbRhbRgbRibRibReRsmbRgbRgRsmbRgbLgbRiLsbRgbRgbRibRi
bLhbRcbRibRibsbLgbRgRsRembRebReReLsbRgbLgbLcLsmbLgLsbLsbLjbRsRsmbLhbLg
bRjRsmbRgbRgbRebRgbRibRsbRibRsRgbRibRsRcbLcbLhbLhbLobRibRiRsLsmbRgbRgb
ReRsmbRgbRibRibRibRgbRibRgbRgbRgbLibRibRgbRgbRgRgRgRebLsbRibRibRgRsmbL
ibLgbRebRgRsRsRemmbRibRsbRibRiRebLjbLsbRiRsmbRiRgRebRgbRiRsmbsbRgRsmbR
iLsLsLsRcmmbRebRibRiRsmbsbLcbLgbLsbLgbLgbLibRjbLibRjbLibRibLgbLibLjbRi
bLibLjbLgbLjbRhbRjbLcbLjbRjRsmbRiLsbRjbLibRjRsmbLjbLibLibLibsbLgbLibLg
bLibRcRsmbRjRsmbLjbLsbLsbRjbLjLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bRibRsRsRsmmbRiRsmbRibRsbLsbLcbLibLiLsbLibLgbLgbLgbLgRsbRsbLsbLibLiLgR
sbRibLsbLobLibLibLiLsbLsRsLsbsbLgRsbRebLibLibLsbRjbRebRibRgbRgbRgbRgRs
mbRibsbLsbRgbRsbLgbLibLiLsbRsRsmbLsLsLsmmbLsbLgLgLsbLgbsbRsbLobRsbRebR
ibRibRgbRgbRsRsRsmmbRgRsmbRgbRgRsRsRsmmmbRgbLgLsbRibLibRibRibRsbRgbRgb
RgbRgbRsRsmbRibRsbsbRjRgRsmbLgbRibRebLgRsbLsbLjbLibLibLgbLibLsLiLsbLhb
LgbRgbRhbRgLsbRgRsmbRgbLiRsbRgRsmbRiRsmbRibRgbRgRsmbLgbRibLsLsmbRsbRsR
smbRgbLsbRgRsLsmbRgbRgbRsbRgbLgbRcbRibLsbRebLgbRibRibRgbLgbRibRhbRsbRg
bRsLjbRibRsRsRsmmbRsRgRgRsRsRsmmmbRgbRsRsmbRiRsmbRibLcbLhbLibLgbLgbLcb
LibRiRsmbRebRgRsmbRgbRiRsLsmbRsRsmbRibRibRibRcbLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bRgRsmbLsbRgbRgRsmbsbRsRsmbRgbRgRsmbRgbRsRsmbLcbLebLgLgLsbLiLhLsbLebLh
bRsbLibLhbLsbLibLcRsbLgLsbLebLhbLhbLgbRsbLhbLsbRjbRcRsmbRoRsmbRsbRcRsR
smmbRibRgbsbRibLcbLhbLhLibLgLsLsRsmbLgLsLsmbsbRsbRcbRcRsmbRsRsRsRsmmmb
RgbRcRgbReRebRgbLsbRgbReRsmbRgbRsbRgbRsbRsRgbRebRgbLsLsmbsbLobRiRsLsLs
mmbRgRsmbRiRsmbsbsbRgRsRsmmbRsRsmbRgRsRsmmbsbRcRsmbRibReRcbRhbRibRhbRg
RsmbRebRgbRiRgRsmbRibRebRgRgbRhRsmbRebRsRsmbRsRsmbRsRsmbRsbRgbRgRsRsmm
bLcbLcbLibLhLsbLebLibLibLcbLebLgbLgbLibLsbLsbLgLgLsbRibLhbRibRoRsmbReR
smbRgbRgbRiRebRebRebRebRibRiRsmbRcbLcbLiLsbLhbLebLhLsbLgLsLsmbLeLsbLeb
LebLiLgbLhLsbLgbLcLibLebLgLsRsbRsbLsRsLsbRsLsRsbLsRsbLcbsbLobLjbLcbLsb
LgbLgLsbRsLsLsmbLsLsmbRsRsmbRjbReRsmbLjbLebLhRsbLebLjbLcbLgRsbLgbLgbLi
bLsbLcLibRjbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bsbsbLgbLsbLgbRhLsbLsLsLsmmbRcbRgbRsbRhLsbLsbRgbRibRibLsbRsbRjLsLsmbsb
RsbRsRsmbRibLsbLsRsbLibsbRibRiRgbRgbRibRsbRjbRibRibRibRiRsmbRibLcLsmbL
cLsmbLgbLgbLsbRibsbRibRjbRiLsbRgbRgbLsRgbRgbRebRsRsmbRibRibRgRsRiRhLgm
bRiRsmbRgbRcbRcbRgRgbRgbRgRsmbRibRgbRsbRsbRgbsbRgRgbLsbRgbRgLsbLsLsmbR
cbsbRsbRhbRibRgRsmbRsbRobRsbRgbRobRiRsmbRibRiRsmbRibLsbRcbRiLsbRgbLobR
sLobRibRsbRjbRgbsbRsbLsLsmbsbRgbRgRsmbRsbRsbRhLsbRgRsmbRiLsbRiRcbRgbRj
bRhRiRsmbRgbRgbRgLsbsbRgbRgLsbLjbLhbLiLsLgbLgbLcbLsbLgbLibLibLcbLeLsbL
ibLjbRsbLgLgLsbLsbRjbLcbRsbRgbRiLsbRgbRjbLsbRjbRjbRibRgbLcbLjbLebLgbLi
LibRjRsRsRimmbRebRgbRhbRiRibRgbRgbRebLgLsbLeLsLjbLobLgbRgbLgbLibLgbLgb
LibRcbLeLsbLebLebLibLiLsbLgbLiLibLibLgbLgLsLsmbLibLgLibRiRsmbLobLcbLgb
LsLsmbLebLhbLibLibLgbLsbLgLsbLibRgbRebLobRgLsbRibRgRsLsmbRgRsmbRgbRsbL
sbRsLsbLgbsbRgbRibRsRsmbsbRgbRebRgbRgbRibRgbRgbRgbRsbRsbRgbRsbRgbRgbRg
bRgbLgbLcbLibLibLgbLgbLgLsLsmbLibLgbLeLsbLibLibLgbLgLsbRjbRsbLhbRibRgb
RibRibRibRgbLsbRgbRgbRgbRgLsbLgbLjbRsRsmbRhbRgbsbRsbRgbLsbLsbLsLsmbLsb
RgRsmbRsRgbRibRibRgbRgRsmbRsbRgbRsbRjRgbLsbRibLibLjbLiLsbLgbLgLsbLibRs
bLobLgbLcbLiLibLeLsbLiLsbLibLibLhLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRgRsmbLsLsmbLsLgbLgLibLsbLsLsmbLebLiLgbsbRsLsbRsLsLsmbRsbRsLsbLhbLsbL
ebLgbLsbLsRsbLiLsbLibLgRsLiLsbLiLsbLgbRsbRsbLsLsmbRsbLsbLibLsbRsbLiLsb
LebLsbLeLjbRsbLsLsLsLsmmmbLgLgLsLsLsLsLsmmmmbLibLgbLgLgbRsbLgbLibLsLsm
bLibLibLgbRhbRhbRgLsbReRsmbRgbRsbRiRsmbRgbRebRgbLsbRsbRebRgbRgbLsbRgRg
bRsbRsRgbRsbRgbRebRibRibRgbRgbRiRsmbRgRsmbRibRibRgbRcLgbRgbRibRebRibRg
RebRgRsmbReRsmbRgRsRgmbRgRsmbRiLsLsmbLsbRiRsmbRiRsmbRibRsbRsbRsRgbRibR
ibRgbLjbLiLsbLibLgbLgRsbLibRsLsbRsbLsLsLsLgmmbLgLibRsbLsbLgLgLsbLsLsLs
mmbRsbLsbLsbLsLsmbLsLsmbLsLgLsLsLembLiLsbLgRsbLsbLgbRsbRsRsRsmmbRjbRsb
RsbRobLibRiRsmbLibRibLhbLhbLgbLsLsLsmmbLsbLsLsmbLsLsLsmmbLsbLgLsbLsbLg
LgbLgLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLibLibLhbLgbLgbLgbLgLsbLgbLobRsbLiLsbLibRiLsbRgbRsRsmbRgRebRgLsbRgbRs
bRibRiLsbRiLsbLgbRibRibRgbLsRsLsbsbLsbLhbLhLsbLgLsLsLsmmbLiLsbLibLhbLg
bLibLsbLgbLgLsbRgbLjbLgbLsLsmbLgbLgLsbLibLgbLibLhbLibLsbLobRgbsbLsbLgb
LgRsbLgbLsbLsbLgbLgbLgLsbLiLsbLgbLibLsbLsLsmbLsbLgLsbLgLsbLiLsLsmbLsLs
mbLgbLibLibLibLgRsbLgbLibLibLgbLobRsbLgbLsbLgbRsbLsbsbLgLsbLiRebRsLsbR
sLsbRsbsbRsRsmbLsbRsbsbLsbRiLsbRibRibRobRhbRcbRobRcbRgbRiRsmbRgbRsbRgR
sRgRsmmbRsbLsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bsbsbsbsbsbsbLsbLsbsbsbsbsbsbsbLsLsmbsbLsRsbsbLsbLsbRsbsbLsbLsbsbRsbLs
RsbsbRsbsbLsRsbsbLsbLsbRsbsbLsbsbsbsbsbRsbsbLsbLsbsbRsbLsbsbRsbsbsbsbs
bLsbsbsbLsbLsbLsbsbsbRsbsbLsbRsRsRsmmbsbRsRsmbLsbsbsbRsbsbLsbsbsbsbRsb
LsbsbLsRsbRsLsLsmbRsbRsbLsLsmbLsRsbLsbLsbLsbLsbLsbLsbsbRsbsbsbsbsbRsLs
bRsbsbRsRsmbsbRsbLsbRsLsbsbRsbRsRsmbLsRsbLsbsbRsbLsbRsbRsRsLsmbRsbRsbL
sbRsbRsLsbsbRsRsLsLsmmbRsbRsbsbRsbLsLsmbLsRsLsbRsbLsbsbLsLsmbLsbRsbRsb
sbRsLsbLsbsbsbLsRsLsLsmbRsbRsLsbLsLsLsmmbLsRsbsbLsLsmbLsbLsbRsbRsbLsbs
bRsbsbLsRsbsbRsbLsbRsbsbRsbsbLsRsRsmbsbLsbsbRsLsbRsbsbLsRsLsRsLsbsbsbR
sbLsRsbLsLsRsmbRsLsbLsbsbRsRsmbRsbsbLsLsRsmbsbRsbsbsbRsRsRsmmbsbsbsbRs
bLsLsmbRsbRsLsbLsRsbRsbsbLsbLsRsbLsbRsLsLsmbsbLsbsbsbsbLsRsLsbLsbsbLsL
smbsbsbsbsbsbsbsbsbLsRsLsbLsbsbsbRsbLsbRsLsLsmbsbLsbLsRsbsbLsbRsLsbLsb
LsRsbsbsbLsbLsbsbsbLsRsbRsbRsbRsLsbRsbsbsbsbLsbLsbRsLsbLsbRsbsbsbRsbRs
LsbsbRsRsmbRsbLsbRsbLsbLsbsbsbLsRsbRsbLsLsmbLsbLsbRsRsmbsbsbRsLsbsbRsR
smbLsLsmbsbRsbRsbRsRsmbRsbRsbRsLsbRsLsbsbLsLsmbsbRsLsbsbRsbsbLsbsbRsLs
bsbsbsbRsRsmbRsLsbsbsbRsbRsbLsbsbLsbRsbsbRsbRsbsbLsbsbsbLsRsbRsbLsbsbR
sbLsbsbLsLsmbLsbRsbRsbLsRsbRsLsRsbRsRsmbLsRsbLsbRsLsbsbsbLsRsbRsbRsbRs
bsbsbLsLsmbsbsbsbsbLsRsbsbLsRsLsLsRsmbsbRsbsbsbRsbRsLsbLsbLsLsmbsbRsLs
bRsbLsbLsbRsLsLsmbRsRsmbLsbRsbLsbLsbsbRsLsLsmbRsRsRsLsRsmmbsbsbsbsbsbs
bsbLsRsbRsRsmbLsbsbsbLsbLsLsRsmbLgbLobRcRsmbRsbRgRsmbRsbRsbRsRsRsmmbRs
bRsbsbRsRebRebLsbRsLsbRsbRsbRsbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRgbRsRgRsRsmmbRiRsReRgRimbRgRsmbRsbRibRsbRiRsRgRsmmbRgbRsRgRsRg
RgmbRgRsmbRibRgbRgRsmbLsRsRsmbRsbRsRsmbRsbRiRsmbRgbsbLsbsbRsRsmbRgRsmb
RsRsmbRsbRsbRsLsbRsRsRsmmbRsRsRsRsRsmmmmbRgbRsbRsRsRsmmbLsbRsRsRsmmbRi
bRiRsLsmbRcbRobLgbLibRoRsmbRgRobLiLiLsbLibLsLsmbLgLsLsmbLgLsbLsRsLsbLg
bLgbLgbLibRsRsmbLgbLhbLgLsRsbLiLsbLgbLgbLibLgbLsbLgbLcbLibLgbLiLsbLgbL
gRsLsbLibLgLsLsmbLgLsLiLgbLgbLgLsbLgbLibLsbLgbLgLsbLgRsbLsLsmbLgbLgbLg
bLsLgbLsbsbLsLsLgLsmbLsbLsbRsLsbRsLsRsbRsbLsbsbsbsbsbRhRgbRoRsmbLeLsbR
jbRibRcRsmbRoRsmbRhbRibRgbRiRsRsmmbRgbRgRsRiRhRimbRgbRgRsmbRibRibRhRsm
bRhbRgbRcRsRgmbRoLsbRcbRebRebRgLsbRgbRibRgbRibRebRgbRibRiRsRembRiRgbRs
bRebRebsbRsbsbRsbRsbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLibLsLsLsLsLsmmmmbLgLsbLsLsLsLsLsLsLsmmmmmmbLsLcbLsbsbLcbRcbRiRiRsLsm
bRiRsmbRobLgbLeLsRsbLiLgLsbLsLsmbRsbRsLsbLsLsLsLsmmmbRjbRsRjbRhbRgbLeb
LsbLibsbLsLgLsbLsLsLsLsmmmbsbLsLsLsLsmmmbLsbLsLgLsLsLsLeLsLsmmmbLsLsmb
LgLsLsmbLgLsLgbLsbLebLebLebLebLebLgbLebLsLsLembLsLsmbLsbLsbLsLsmbLsLsm
bLsLsmbLgLsLsmbLsLsLsmmbLsbsbsbRsLsbLgbLsLsmbLsLsLgmbLsbLsLsmbsbLsLiLs
LsmbLsbLsLsLsmmbLsbRsLsbLsbLsbRcRsmbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bsbRgRsmbLsRsbLobLebLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRgbRsbRgbRsbRibLsbLgLsLsmbLgbLibsbLgbLibLsbLcbLiLgLsbLgLsbsbLgbLgbLsb
LsbLgLibLgLsbLgbLgLsbLsLsmbLgLsLgbLgbLsbLsbLsbRsLgbLgLsbLgLsbLgbLgbLsb
LsbLsbLgbLgbLgbLgbLgbLgbLgLsbLsbLsLsmbLsbLgbLsLsmbLsbLsbLsLsmbRcbRhbRg
bRibRibRiRsmbLcbLcbLeLsbLgbLgLsbLgbLsbLibLsLsmbLgLebLsbLgbLgRsbLgbLsbL
sbLsbLsbLsbLsLiLgbLibLebLsLsmbLsbLsbRsbLibLgbLsbLgbLgbsbLsbLsLsmbLsbLg
LsLsLsmmbLgLsbLebLebLibLibLgLsbLibLibLibLgbLsbLsLsmbLibLgbLgLsbLsLsmbL
iLiLsbRibRebRibRebRibRebRgbRebReRsRsmmbRgLsbRsbRsbRgbRsbRsbRgbLsbsbRsb
RsRsReRsmmbRcbRgbLgbLgbRjbRgRsmbsbRibRibRibRibRcbRibLsbLibLibLgbLsbLgb
LgbLgbLgbsbLgbLjLgbsbRjbLibLgbLsbLgbLgbLgbLebLsbRgbRsbRcbLgbRcbRjRcbLg
bLgbLibLhbLgbLgbRhbRibRsRsmbRsbRgbRgbLgbRsbRgbRibRgbRsbRgRsmbRgbRgbRsb
RgbRsRsmbRgbRgbRibRgbRsbRgbRsRsmbRgRibRsbRgbRgbRsbsbRsRsmbRgbRgbRgbRgb
RsRsmbRsbRgRsRhmbRibRiLsbRibRiRsmbRgRsmbRhbRebRebReRgbLcbLhbLgbLibRjbR
ebRebReRsmbRibRgbRgLsbLgbRcbLgbLjbLgbLibRibRibRgRobRibRgRsmbRibRgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLgbRhbRhRsmbRcbLsbLgbLsLibRcbRcbRibLsbLgbLibLcbLsbLsbLjbRjbLhbRgbRgbR
sbLgbLgbLibRsRsmbRgbLibLgbRgbRsbLibLibLibRgRsmbRsbRsbLibRsbRjbLgbLgbLg
bLsbLibLobRgbLsbRgbLsbRjLsbLcbLgbLgRsbLgbLgbLgLsbLhbLibRsRsmbLhbLibLjb
LibLhLsbRibRsbLsbRibRibRgbRibRgbRsRsmbRgbRgbRibRibRibRsbRobRobRsbLsbRg
bRgbLgbRibRibRibLsLsmbLgbLibLibLgbRgbLibLcbLgbLibLsbRgbLjbLgbLsbLhbRgb
LhbLgbRgbRsbLsbRsbRibLsbLsLsmbRjbLgbLgbLgbRjbLgbLgbLibLibRibRgbRgbLsbR
ibRibRgbRgbLsbLcbLhbLibRjRsmbRibRsbLcbRjbLgbLgbRibsbLcRsbLobLibLsbRibL
ibLgbLgbLsbRsbLobRgbLgbRgbRgbRibRibRobRgbLjbRiRsmbLgbRsbRibLiRsbLibLib
LgbRsbRgbLgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bRsbRcRgRebsbRsbLsbRsLsbRsLsbsbRsbLsRsbRsbRsLsbRsbRsLsbRsbLsbRsbLsbsbR
sbRsLsLsLsmmbLsRsLsbRsRsLsmbLsRsbRsbRsbLsbRsbRsLsRsRsLsRsmbRsLsbLsRsbL
sbRsbRgbRsbRsbLsbRgbRgbRgRsmbLjbLhLsbRcbRgbLsbLsLobLcbLibLibLgbLeRsbLh
LiLcbLgLibRsbRjbLjbLibLjLsmbLgLsbLgLsbLibLhbLcLebLsbLibsbLiLsLsmbLibLj
bsbLsbLgbLibLibLibLjbLcbLcbLjLsmbLcbRhbRcbRibRgbRcLsbRhbRhbRcbRgbRoRsR
smmbRcbRobLibLhbLsLsmbLsLsmbLgbLgLsLeLsbLebLsLebLebRjbLhLsLsmbLibLgLiR
sRsmbLjbLibLjbRibLjbRgbRgbRsbsbRcbRibLibLcbRsbRgbLiLibLsLeLcLebLiLsbLc
bReReRgbLiLgbLgLsbLgbRsbRsbsbsbsbRsbRgbLsbsbsbRsLsbsbsbsbsbLgbLibsbRhb
LhbLcbLibsbRjbRjLhbRsRsRsmmbRgbRjbLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLjLibRsbLgbRgbRgbLibLibLgLsbLgbLgbLgbLgbLhbLgbLgbRjbRjLsbRcbRcbRibRib
RjbLcbRibLgbLgbRgbLhbLsbRjLsbRsbRsRsmbLsbsbLsbRsbsbsbRgRsmbRcbLgbRsRgR
ebLgbRebRsbRsbRgLgbLiRsbRjbLibLiRsbLgbLgbLgbLgbLcbLobLibLibLibLsbLoLsm
bLgbRibRcbRcbRibRibLiLsLsmbRsbLgbLobLgbLibLebLobLgbLibLgbLgbLgbLobRgbR
sbRcLsbRibRiLsLsmbRgbLsbLebRhbRgbRibRebRhLsbRebRibLsbRibRsbRsbLibLjbRi
bRjbRibRebRcRibLsRiRgbLibsbLgbRjRcbRobRgbLibRibLibRibRiLsbRobRoLsbRgbR
hbRibRiLsbRsbLgbLibLiLsbLsbRjbLgbLibLsbLgbLgbLgLsbLiLsbLibRibLgbLcbLgb
RjbRcbRiLsbRibRgbRibRobRoRsmbRibRgbRibRibRsbLgbRibLibLibRgbRobRibLibLi
bLiLsbRibRhLsbLibLiLsbRsbLgbRgbRcbLhbRgbRjbRjbRsRsmbRgbRgbLibLgbLiLsLs
mbLgbLgbLibLsbLgbLibLibRjbRibRibRcbRibLibRgbRibRgbRgbLsbRibRibLsbsbLcb
LiLsbLgbLgRsbLibLibLgbLgbLgbLsbLgbLibLgbLgbLgbLgbLjLsmbLsbRsLsLsmbRsRs
RsRsmmmbLgLsLsmbLgbLsLsLsLsmmmbLsLsmbsbLgLsbsbRsbLgbLebLhbRsLsbRjbLsbL
ibRjRsmbLjbRgbsbLgLsReRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bsbsbsbRgRsmbRgRgRsRsRsRsmmmmbLjbLebLiLsLsLgLsLsLgLsLsLgLsmmmbLgLsLgLs
LibLjLsmbLibLsLsLhmbLhLsLsmbsbRsLsLsmbLgbLibLibLibLebLiLsLsLgLiLsLgLsm
bLibLibLgLgLsbLiLgbLgbLcbLgbLiLgLsbLibLgbLgRsbLgbLebLiRsbRsbLhbsbsbRsb
RiRsRsmmbRiRgbRgRsmbRsRsmbRsRsRsRsmmmbsbLsbsbLsbRgRsmbRsbRsbLebLgbLiLg
LsbsbLsbRsbRibRgRsRsRsmmmbRgbRgbLibLiLsbLibLibLcbLiLgbLibsbsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bLsbLsbLgbLgLsbLgbLgLsbLgbLeLsRsbLgbRsbLgLsbLgbLgbLgbLsLsmbLsbLsbLgbRj
bLsbLgbLgLsRsbLgLsbLibLsbLibLibLgbLgbLsbLgbLgbLgLsbLsLsmbLsbLsbLsbLgLs
bLsbRhRsmbRibRebRcbRgbRcbRcbRhRsmbRibRobRgbRgbRibLibLibLhLsbLibLgbLgbR
ebRsbRgbLsbRgRsmbRhbRgRsmbRgbRgbRgRsmbRgbRgbRiRsRsmmbRgRsmbRiRsRsmmbRi
RsmbRgRsmbRgbRibRgbLsbRsbRibLsbRgRsmbRgbRgRsmbRsbRsbLsRsbRgbRgbRgbRgbR
gbRsbsbsbRsbRsbLsRsbLsLsmbRsbRgbRsbRebRibLcbLobRibRobRobLibLobLcbLiLsb
LiRsbLgbLgbLgbLgbLibLibLiLsbLhbLhbRjbLhbRjbRiRsLsmbRebRsbRiRsmbRibRgbR
sRsmbRjRsmbRgRsmbRgRsmbRibRibRibRiRcbRibLsbLjRsbRibRgbRgbLjbRibRibRgRs
mbLgbLgbRibRibRgbsbRjRgbRgRiRsmbRibReRsmbRgLsbLhbRhbLjbLgbsbRsRjbRjbRi
bRgbRgbLsRsRsRgRgmbRsbRiRsLsmbRebRibRebRgbRgRsmbRgbsbsbLibRcbRiRsmbRgb
RgbRsbLsbRiRsmbRsbRibRgRsmbRsRsmbRsRsmbRhbRsRsRsmmbRgbRgbRhbRebRgbRcbR
gbRebLibLcbLgbRjbRibRjLsbLsLsmbRjLsbLcbRiRsmbRsRsmbLjbRgbRebRiRsmbRibR
ibRsRebRebRebLobRcbRebRiRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bsbRsRebsbRjbLiLsbRibsbLgbLsbLibLsbRobRgbRibRgbsbRibRiRsmbRhbRiRsmbRsL
sRsbRhbRiRsmbLhbRcRsmbRcbRebLibLcbLcbLobRebRibRsbRiLsbRibRibRibRhbRoLs
bRhbRcbRibRcRsmbRibRiRsmbRibRgbRgbRiRsRsmmbRgbRgbLobLhbRjbRsbRgRsmbRgb
RsLsbRibLgbRhbRoRsmbLiLsbLgLsbLcbLhbLcLsmbLiLiLhbLiLeLsRsbRcbRsbLhRsbL
ibRjbRhbRcbLebLhbRcbReRsmbRibLibLibRgbRcbsbRgbRibRibRcRibRibRibRgbRsRs
mbRsbRsRsmbRsbRhbReRsmbRibRibRhbRibRgbRebRebRjbRibRibRebRcRsLsmbRjRsRs
mmbRgbRiRsmbRgbRibLjbRobRgbRiLsbRobRgbLcbLobLgbLiLiLsbLcbLibLgbLoLsmbL
ibLgbLoRsbLsbRcbRibRgbRcbRibRgbRsRebRibRibLibRibRiRsmbRgbRibRsbRibRgbR
gbRibLjbLhRsbRgbLgbRgbRobRjRsmbRibRibRsbLebRhbRibRcbLsbRgbRsRsmbRiLsRs
RgbRgRsmbLcbLhbRcbLcbLcbLjbLibLiLsLgLsLsRsmbLiLsLebLeLebLgbLhbLcRsbRsR
smbLjbLoLsmbLhbLibLjbLobLgbLibLgbRibLcRsbLgbLgbLgbLgbLgbLcbLibLgbLibRi
bRgRibLgbRiRsmbRgRsReRgmbRibRsbRcbRibLjbLibLobLcbLsbLebLiRsbRibRiLsRgb
RibRgbRcLsLsLsmmbRgbRsbLsbLsbRibRgbRgLsRsRebRsRiRsmbRgbLjbRhbRgRsmbRgR
smbRgbRebRhbRhRsmbsbLgbLgbsbRebRiRsRsRgmmbRsRsRsmmbRgbRsbRgRsmbRibRsRi
RsmbLibRhRiRsmbRibRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bRsLsLsmbsbLiLsbRsRsmbLibLibRcbRcbRibRibRcRebLebLibLibLeLsbRibLoLsmbLg
bLebLgbRcbRibRgRsmbRibRsbRibRcbLgLsbLgLsbLsLgLsbLgLibLsLibLgbsbLebLsbL
ibLgLsbLibLsLsmbLebRcbRcbRsbLsbLhLsbLibLgbLgbLgbLgbLibLgbLhRsbRsbLibRh
bRiRsmbRiLsRsbRgRsmbRibRgbRibRgbLsbRgbRjbRhRsmbRibRcbLibLibLhbRgbLgbLi
bRjbRibRibRibLiLsbRibRcbLsbsbLeLsLsLsRsmmbLsbRhbRjbRsbRibLibRcRsmbRibL
sbRobLgbRiRibLgbRsRcbLsbLcbLiRsbLcbLsbLsbLeLsbLgbLiLgbLiLsbLibLsbLsbLi
bRjbLibLibLebRsRsmbRiRsmbRiRsmbLhbLgLsbLibLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRsRsmbRgbRsLsbRgRsmbRsbsbsbRibRibRibRgbLiLsbLebLebLsbLsLgRsbLgbRsbReb
RhbRhbReRsRiRsmmbRibRgbRsbsbRsbsbLsbRgbLsRsbRgbRgbRsRsmbRsRsmbRibRebRg
bRcRsmbRibRiRsmbRgRsRsmmbRibRgbRebRsbRiRsRiRsmmbRgRsmbRgRebsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLebLgbLibLgLsLsmbLebLgbLibLibLcLsmbLgLsbLibLgLsbLiLsbLibRgbLsLobLibLi
bLgLsbLgbLgbLibLsbLgbsbRobRibRgbRsbRgbRibRibRibRibRiRsmbRgRsRgRiReRgRs
mmbRgLsbReLsLsLsLgmmbLsbRjbLibLgLgLsbRsbsbLgLgRsbLgbLsbLgLgLsbRsbLsbLg
LsLsmbLgbRsbLgLsLsLsmmbLgLsbLsbLgLsLgbLsLsmbLsLibLgLsbLgbRobRgbRibRgRs
mbLsbRgbRsbRgRsRsRsRgRsRsRsmmmmmmbRgRsRsmmbRsbRsbLsbRsRsRsRsmmmbRsbLsR
sbRsLsbLsbRgRsmbRsRsRsmmbRgRsRsmmbRgbRsbRsbRgRsmbRsRsmbRgRsRsRsRsmmmmb
RsbRiRsmbRgRsRsRsmmmbRgRsRsRsmmmbRsRsRsmmbRgbRgbRgbLcLsmbRhbRgbRgRsRsR
sRsmmmmbRsbRsRsmbLsbRgRsRsmmbRsbRsbRgbRgbRsRsRsRsmmmbRgRsRsmmbRgbsbLib
LsbRibLeLgbRibLsbRsRsmbLsLsmbRsRsRsmmbRiRsRsRsmmmbRsbsbLjbRcbRgRsmbRob
LebsbLsLsmbLgLgbLjLgbRibRibRgRsRsRsRsRsRsRsmmmmmmmbLsbRiRsRsmmbRsRsRsR
sRsmmmmbRsRsRsmmbRsRsRsmmbRgRsmbRiRsRsRsmmmbRgbRhbLebLebLiLsbLgLsLsLsL
sLgLsLsmmmmbLgLsLsLsLsmmmbLsLsLsLsLsLsLsmmmmmmbRsLsLsLsLsLsLsLsLsmmmmm
mmbLgLsLsmbLibLibLgLgbLgLsLsLsLsmmmbRsLsLsmbLibLsLsmbLsLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bsbRcbRcbLcbRcRsmbRhbRobRgbsbLebLibRsbRgbLgbsbRgbsbLebLibLsbLsbRsbLgbL
sLgbLgbLeLsbLsLgbLibLsbLgbLgbLgbLgbLgbLsLsmbLsbRsRsmbLsRsbsbRsbRsbLsRs
bsbsbRsLsbRsbRsbLsbLsRsbsbsbLsbsbsbsbsbsbRsRsRsmmbLsLsmbRsRsmbRsbsbsbR
sbRsLsbLsLsmbLsbsbsbsbsbLsbRsbLgRgbsbsbLsbLiRsbRcRsmbLobLoLsLsmmbLibRo
RsmbRebRcRgbRsRsLsmbLjbsbLiLsbLebLiLgbRiLsbLsRcbRiRebRhbLibRibRibRgbRc
RsRsmmbRhbRcbsbLgbRebRibRiLsbRcbLebLibRcLsbLebLibRibRgbRsbRgbRgbRsbRcL
sbRsbRjbRjRsLsmbRgbRsbRgRsmbRhRsmbRcRebRibRsbLjbRgRebRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
bLsbsbRobLjbLjbLsbsbRsbRsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
bLhLsLiLibLsbLsbLibRcbRgLsbRgbRobRhbRebRsRsmbRgbRibRcbRebRgRsmbRgLsbRi
ReRibRgbRgbRibRobRcRiRsmbRgbRibLsbRgbRsRebsbLobLibLgbLgbLjRsbLcbLjbLhb
LgLsbRjbRjbRcbRgbRgbRebLgbLebLgLiLsLibLsbLibLcbLsbLjbLibLgbLibLibLhLib
LsbRsbLjbRebLebLgLsbLgLibLeLiLsbLsbLgbLibLibLibLibLibsbLjbLhbLibLsbLib
LiLebLgbLibLiLsbRjRgbLoLibRgbRgRibRiLsLsRsRsRsmmmbRsRoRsmbRibLsbRcbRib
LgbLebLeLgbLgLibLiLibLgLsbLgbLgRgbLsbLsLebRjbLgbLibLcRsLcbLibLgLsLebRs
bLsLgbLiRsbLebLgbRebRcRsmbRibRiRiRibRibRibRibRgRcbLsbRhbRobRibRibRhbRi
bRibRgbRgRiRsRgmbRiRgbRgLsbRgRsmbLebLoRsbsbLgbRibRhRsmbRgbRgbRgbRgbRib
RibLibLgLeLgbLibLebLhRsLgbLcbLgbLgLsRsbLiLsLeLsbRcRsRsmmbLhbRebRibsbLg
RsbLibLiLcLiLsbLibLhLsbLgbLsRsbRsbLgbLgLsRsbRebRibRiRsmbRhbRcLsbRcbRcR
ibRgLsbRibRsLsbRcRebRsbsbsbRhbLjLgbLhbLjbLsbLeLsLsmbLgbLjbLsbRjbRiLsLs
mbLsLsmbRgbLsLsmbLjbRcRgRsmbLjbLcbLhbLsbLgbLebLibRgbRgbRibRibRiLsbRgbR
ibRibLjbLcbLibLsbLgbLsbLgbLgRsbLgbRsLsbLjLsmbRjRjbRibLjLgbLibLhLgbLgLs
bLibLibLgbLgbLgLsbLgbRsbRhbLjbLibLhbLjLsLsmmbLhbLgbLibLhbLgLsbLsRsbLiL
iLhbLhbLibRgRsmbRjbLibRjRsmbRibLjbLhbLhbLgLsbLgbLgbRsbLsbRibLibRjRsmbR
hbRiRsmbRgbRiRsmbRoRsmbRcbRcbRiRibRgRsmbRgRsmbRgbRibsbRsRsmbRibLgbLcLs
mbLsRsLsbRsRjRsmbLcbLgLsbLibLibLibLibLebLgbLhbLsbsbLibLgLgbLjLcLsLsmmb
LsbRgRsmbLcbLibLsbLgbLgbLgLsbLsbLgbLgbLiLibRcbRcbRibRgRsRimbRibRgbRibR
gbRibRgbRgRsmbRgbRcbsbRibRsbRcbLgLibLiRsbLgbLibLebLgbLgbLgLsbLibLgLsbR
hbRcbLsbRgRsmbRebRgReRibRcbRgbRibRibRgbRgbRibRgbRgbLcbRjRjbRjbRibLibLj
bLhbLhbLsRsbRgRgbRgbRgbRibRgbRibReRsmbRjbRcbRibRhbRgbRibLebRgRgbRgbReb
sbRibRhbRibLjLsmbLhbLgbLgLsbRibLsLjbLgbRgbRcbRgRsmbRcbRgRsmbRiRsRsRgmm
bRgbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bLebRgbLibLhbRiRsmbRhbRjRibRibRibRcbRsbLeLibLhbLibRibLiLsbLebLsbLhbLib
LiLsbLibLibRsbLjLiRsbLsbLibLhbLhbLgbRhbRibsbRhbRebRgbRibRibRhbRibRiRsm
bRibRgbRibRcbRibRgbRibLoLsmbLibLhbLibLgbLebLcbLgbLsLsmbLhbRsRsmbRibLhL
sbLebLibLibLibRgbLibLibLibLgLibLgLsbLibLgbLgbLsbLibLgbLebLebLgbLiLhLgb
LgbLgbLgRsbLcbLjbRhbRebRgbRgbRgbRsRsmbRsbLgbRgLsbRibRgbLsbLibLibRjbReb
RibRgbRgbRobLgbRgbRgbLcbLebRsLsbRsbLebLgbLgbLgbRgbLcbLsbRsRhbLgbsbRgbR
sbLsRsbRgRsmbRgbLgbLsbLhLsbLebRgbRibRibLhbLhLsbLcLsmbLsbRjRibRgbRhbsbR
ibRibRcbRsbRcbLgbLhbLjbRgbRgbRgbRgLsbRgbRgbRgbRibLibLebLibLibLgbLhbLgb
LibLsbLeLsbLhbLibLhLsbLibLjbLoRsbRiRsmbRgbRgbRgbLsRsbLgbLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
bRgbRjbRgRsmbRgbRiRsmbLcbRjbLcbLibLgbLiLsbLgbLgbLiLsbLibLibLiLebLgbLgb
LsLgbLoLsmbRcbRibLsbLhbLibLibLsbRhbRgbRibRhbRcRsmbLcbRsbRibLcbLoLsmbLg
bRibRhbLibLsRibRibLcbRibRibRgbRsbLjbRhLsbRsbRibLibRgRsmbLibRibRibLcbRi
bRiRsmbRgbRiLsbRhLsbLgbLibLibLgLsbLgLsbLgbLsbLsLsmbLgbLibLiLsbLibLgbLg
bLeRsbLibLgbLgbLiLsbLiLsbLgbLsbLibLgLsbLgLsbLgLsbLgbRjbLsbLibRjbLiLsbR
jbRgbLebRjbLhLsLsmbLgLsbLibLibRjbRibLcbRibRibRgLsbRgRsmbRsbRibLjbRibRg
bRgbRhbRibRiRsmbRibRibLjLsmbRibsbLjbRgbRsRsLsmbRgRsmbRgbRsRsmbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
bRibLcbLebLibLsLsmbLibRsbLcbLobRibLoLsmbLibLcLsmbLgbLobLcbsbLibLhLsbLi
LsbLcbsbLcbLcbLibLibLcLsmbRoRsmbRiRsmbRibRsRgbRsRsmbRhRsmbRgbRibRcbRob
RgbRobRibRibRibRiRiReLsbRoRgbLsbLhbLibLhbLebLibLjbLcbLjbLjLsmbLsRsbLib
LsLgRsbLsbRoRsmbLobLiLsLhLeLsbLgRsbsbLhbLhbLhRsbLcRsRsmbRgbLcbLiLsbLcb
LiRsLsbLgbLcbLcRsLsLiLsbLiLsbLeLsbLibLibLgbLcLsmbLgbLcbLgbLcLsmbLcLsmb
LebLiLgLsLibRibLobLiRsbLibLgbRsRsmbLgbLiLsbLhbLhbLcbLgLiLsbLibLibLgbLg
bLiLsRsbLgLsbLibLeLsbLibLebLgLsbLiLiLsLsRsmbLgbLgbLiRsbLhbRibRebRcbRcb
RgbRgbRgbRgRsmbRgbLjbsbLcbLhbLibLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 133827; End: 134327;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bLibLibLibLibLibLhbLgbLibLgbLgLsLsmbLgLsbLibLibLibLibLgbLebLgLsLsLsmmb
LgbLsbLgbLgLsbLgbRsbLiLsLsmbLsbLiLsbsbLgLsbLgLsbLibLgbLgbLgbLgbRsRgRsm
bRgbLebLiLgbsbLgbLgLsLsLsmmbLsbLgLibLgLgRsbLsbLgbLgLsbRjbReRsmbRibRgbR
gbRgRgRsmbRsRiRsRsmmbRibRibRibRibRgbRgbRgRsRgmbRsbRsRsRsRsmmmbRgRsRsRs
RsmmmmbRsbsbRsRsRsRsmmmbRsRsmbRsRsRsmmbRgRsmbRiRsRsmmbRsbRsRsmbRsRsRsR
gmmbRgRsmbRgRsLsmbRgbRgbRsRsmbRibRibRiRsRgRsmmbRibRgbRiRgbRgbRibRgRgbR
gbRgLsbRgbRibRhbRsRgRibRibRgRsmbRiRsmbRibsbRsRgbRsRsmbRgbRgRsmbRibRibR
gRsmbRgbRgbRsbRgbRgbRsbRibRsRsmbRgRsmbRgbRsRsRgmbRibRgbRgRsRsRgmmbRgRs
mbRgRsmbRgRibLsRgRsmbRgRgbRibRibRgbRibRgRsmbRsbRsbRgbRibRgbRgbRibRibRh
bRibRibRiRsmbRibRsbRgRgRsmbRgRsmbRsLsbLsRsRsmbRsbRsRibRsbRsRebRgbRgRsm
bRgbRgbRibRgbRhbRsbRgRsmbRibLsbRgbLsRsRgbRhbLsRgbRebRiRsmbRebRiRgbRibR
gbRhbRgbRgbRgbRgbRgRsmbRiRsRgmbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bsbLsbRsbRsbsbLsbLsLsRsLsmbRsLsbsbLsbLsLsmbLsRsbLsRsbLsLsLsmmbRsbsbLsR
sbsbsbLsbRsbLsbsbLsbsbLsbsbsbLsLsmbsbLsLsRsmbsbLsLsmbsbLsLsmbLsLsmbRsb
sbRsLsLsLsmmbLsLsLsmmbLsbLgbRsbRsbLsbsbLsbLgRsbLibLobRgbRgbRgRsmbLgbRs
bsbLsRsRsmbRsbRsbRsRsmbLsRsbRsRsmbRsLsbRsRsmbLsRsbsbLsbRsbLsbRsbLsbRsb
LebLobRibRobRgbRiRsLsRsmbRgbRhbRgRsmbRgbRgRsmbRsRsRsmmbRsbRgRsRsmmbRsb
LsLsRsmbRsbLsRsbRsRsmbLsbRsRsRsmmbLsRsRsLsmbLsLsRsmbRsLsbRsRsmbLsRsbRs
RsmbLsLsRsmbLsbLsRsbLsRsRsmbLsbLsRsbsbsbRsbLjbsbRgbRebRiRsmbRhbRgbRgbR
gbRgLsbRgbRsbRsbRsRsmbsbRsbRsbRsbLgbRsbRsRsmbLsRsRsmbRsbLsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRgRsRsRsmmmbLgbRsbRgRsmbRiRsmbRcRsmbRibRiRgRebRcbRiRsmbRiRgbRcb
RebRebRibRcRsmbRiRsmbRibRebRebRcbsbRibRibRgRsRiRsmmbRibRibRsRsmbsbLcbL
iLsbLiLsbRgRsRsmmbsbRgbLcbLiLsbLsbLibRgbLsbRjRsRsmmbsbRsbRgbsbsbRsRsmb
sbRgRsRsRsmmmbRsRsRsmmbRgRsRsmmbRiRsRsmmbRiLsbRhRsRgmbLsRsRsmbLhbLsLib
LiLsLsmbLhbLgLsbLibLhbLgbLibLibLhbLibLgbRobLoRsbRiRsRhmbRiRsmbRebRibRg
bRiRsmbReRhRiRsmbRhbRiReRsmbRiRsmbsbLsbRebRgRsmbRsRsRsRsmmmbRsbRgRgbsb
RiRsmbRiRgRsmbLcLsmbLhbLgbLibRsbRibRsbsbsbLsbLsbsbRsRsRsmmbRsRsRsmmbRs
bRgbRiRsmbRgbRgbRgbReRsRgRgmbLsbRgbRsRgLsbRibRgRcRsReRembRhbRgbRhbRoRs
RsRgmmbRibRibRiLsbRgbRgRsmbRgRsmbRgbRiRebRebRgbRgbRibLsbLibLibLgbLiLsb
LiLsbLiLsbLibLiLsLsmbLibLgRsbRsLcLsLgmbLibLibLgLsbLgbLibLgbLcbLgLsbRiL
sbRiRsmbRiRsRembRgRsRgmbRiRiLsbRgRsmbRhRibRgbRgbRgRebRiRgRsmbRibReRsmb
RibLibLgbLsLgbLibsbLibLgbRsbLgbRcRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bsbsbsbLcbsbLsbsbLsbsbLsbLsRsRsmbsbsbLsbRsbLsRsbLiRsbRsLsbRsbRjbLcLsmb
RoRsmbRcLsbReRsmbRcbRiRsmbRsRsmbsbRsbLsbLsbRhbRibRhbRgbRibRibRhRsmbRiR
smbRiRsmbRebRiRsmbRgbRhbRgRsRembRgLsbRibRobRhbRebRebRcbLiLsbLibLiLhLeb
sbsbRsRsmbsbLiLsbLsLsmbLgRsLsbRsbLgbLsLsmbLgLsbRsLsLgbLibLgbLgbLgbLgLs
bLgLsbLiLsLsmbLibLeLsbLibLiLgLgLsLsLsLiRsmmbLgLsbLiLsbLeRsbLibLcbLibLc
LibLiLsbRsRsmbLgbLiLsLsmbLgLsbLsLebLibLibLiLsbLhLsbLiLibLgLhbLiLsbLiLs
bLibLgbLhLsbLhbLibLhbLiLsbLiLsLsmbLiRsbLiLebRgLsbLebLebRsLsLeLsbLgLsbL
eLsbLgbLsbLgLgbLeRsbLsbLgbLgLsbLsbRibLiLsbsbsbsbRsbRsbsbsbRcbRsbRcLsLs
mbLjbRjbRcLsRsbLhbsbRhLsbRsLsbRsbLjbRibLsLjbRhbsbsbsbLsbRsbLsLsmbLsbLs
bRsLsbLsRsbLcbRobsbLcbLibLhLsbLibLiLsbLeLsbLgLgLsbLsbLiLsLsmbsbsbRobRg
bRiRsRsmmbLsbRiRgbRiReRgbRebRhbRcbRgbRcbRebRiRiRsRiRsRhRsmmmbReReRsmbR
gRgRebRibRsbRiLsbLibLgLgLsbRibRgbLiLsbLgbLgRsbRgbRjbLibRjbRgbRibRibLsb
sbsbLjLjbLiRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bLsbLsbLsbLsbLsbLsbLsbLsLsmbLsLsLsLsmmmbLsbLsbLsbLsbsbRsbRsbLsbRsbLsbL
sbLsbLsbLsbLsLsRsmbLsbLsLsmbLsRsbLsbLsbLsbLsbLsLsmbLsLsmbLsLsLsmmbsbLs
bRsbRsLsbLsbLsbRsLsbLsbLsbLsbsbLsbRsLsbLsbLsbLsLsmbRsbLsbLsbLsbLsbLsbL
sbLsbLsLsmbLsbRsbLsLsmbLsbLsbLsbLsbLsbLsbsbRsLsbLsbLsbLsbLsbLsLsmbLsbR
sLsbLsbLsbLsbsbLsbRsbLsbLsbLsbRsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsbLsbL
sbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsLsmbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsbLsLsm
b

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bsbLsLsmbLibLgbLibLibLcLsmbLgLsbLgbLsbLgLsbLsLsmbLsbLsLsLsmmbLsLsLsmmb
LsbLsbLsLsLsLsmmmbLgLsbLsLsLsLsmmmbLgLsLsmbLsbLgbRsbRcLsRsbLsbRsbRsbRs
bLsRsbsbLibsbLibRhLsbLjbLhbLhbLgbLsbLgbLgbLgLsbRsbRibRjbLibLoLsmbLibLi
bLeLobRobLgbLcbLsRsbLibLgLsbLgLsbLsbRsLgbLsLsmbLsbLsbLgbLsLsLsmmbLsLsm
bLsLsmbLgbLibLhbLsbLsLsmbsbsbRsRsRsmmbsbRsbLsbRsbRsbRsRsRsmmbLsRsbsbLs
LsmbLgLsbLibRsbLsLsmbsbsbLsbsbRsLsLsmbLsLsLsmmbRsbLibRsRsmbLjLsLsLsLsm
mmmbLibLgLsbRsRsLsmbLsbLsRsRsmbRsbLsRsbRsbLsLsmbLsbLgbLsLsmbLgLsbLgLsb
RjbRcbRiRsmbRiRibRibRgRebRgbRobRhRiRibRsRsRsRsRemmmbLgLsbLsbsbLsbsbsbL
sbLibRgbRjbRsRiRsLsRsmbRibRiRsRiRsRsmmmbRibRiRhRsmbRibRebRgRsmbRsLsbRe
bLsbRsbReRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRgbRsRsRsmmbRgbRgbRgbRsRsmbLsbRsbRgRsRsRsRsmmmmbRsRsmbRgbLsRsbRgbLobR
cbLobLoLsmbLcLsmbLeLsbLibLebLgbLebLebLcbLeLsbLebLebLhLsbsbsbsbLsbLebLe
LeRsbLgbLebLebLgbLsbLebLebLgbLebLebLibRsbLsbLsbRsbRsLsbsbRibLibLgbLgbL
eLsbLiLsbLsLgbRsLsLsmbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bLcbLobRsbRobRsbRsbRobRoRebRoLsbLgbLcbLcbLibLiLsbLhLibLgbLiLgbLeLsbRgb
RcbRibRgbRhLsbRibRhbRcbRcLsbRibRgbLobLibLjRsbRsbLobRobRjbRebRcbRebRoRs
RembRibRgbRobRibRiRsmbRgRsmbRcbRgbLibLgbRcbRgbLcbRsLsbRcbRgReRsmbRibRi
bRgbRebRhbRcbLibLibLcbRgbRhbRibRsbRiRsmbRgRgRebRsbsbRgRsmbRgbRsbLjbLgb
RsLsbRgbRsbRgbsbRsRsmbRsbRsRsmbRsbRgRsmbLsbRgbRgbLebLgbLsLjbRibRgRsmbR
sbLobLgbLiLsbLgbRjbLebLgbLebLgbLsbLsbLsLgbLsLsmbLiLsbLgbLsbLsLgbsbLgLg
bLgLgbRsbLgLgbLsbLsbLgLsbLiLibLibLobLoRsbLhbLcbLobRgbRibLsbRiRsmbRibLs
b

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bLiLebsbLeLsbRiRsmbRcbRibRgbRibRobLsbLhLiLsbLibLebRgbLgbRgbRcLsbRibRib
RibLcbLebLgbLsLsmbLsbLsbLiLgbLcLsmbLsbLcbRcbRibLcbLibLebLibLibLobLcbLi
bLebLeLeLsbLsRjbLhbLibLgLsbLibLsbLcbLcLiRsbLibLibLibLhbLibLibLgbLsLsLs
mmbRsbLgbLgbRsLsbLeLsLsmbLgbLsbLibLsbRjbLebLibLibLibLgbLgLiLsbLgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRsRebRebRgbLgbLibLibLibLibLebLcbLhLsbLgbLibLibRjbLeLsbLibLgbLhbLgbLhb
LobLebLiLsbLgbLibLibLibLeLsbLiLsbLibLhbLibLgbLgbLibLibLcbLgbLibLsRsbLs
bsbLsbRjbLgbLsbRcbRebLgbRgbLjbReRsmbRcbRcbRgbRibRgLsbRiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLebLgLsbLsbLgRsbLgRsLsbRibRcbLsbLjLsmbLgbLsbLiLebLgbLjbLgbLgbLgbLsbLi
bLgbLsbLsbRgbRgRsRsmmbLsRebLjbLibLibLgRsbLgRsbLgbLsbLgbLgbLgbLgbsbsbLs
bLsLgbLsbLgbLibLsLgbLgbLgbLsbLjRsRsmbLgLsbLgbLibLsLsmbLgbLiRsbLjLsRsmb
LgbLebReRgbLsbLgbLibLibLiRsbLgRsbLjbRsbLebLiRsbLcbLhbLiRsbLgRsbLgbLebL
iLsLsmbLebLeLsLsmbLcbLibLeLsbLibRibRcbRhbRhbRibRhRsmbRjbRibRjRsmbRjbRg
bRjRgbRjRgbLgRsbLibRhbRhbRiLsbRebRibRhbRibLcbLibsbLiLsbLibLibRjbRibRob
LibRjbRibRsbLibRhbRebRibRcbLcbLibLibLibLgbLibLgbLhbLibLibLcbLsbLibLibL
ibLgbLjLhbLibLhbLibLibLibLjRsbRebRcRsmbRgbRiRsmbRgRsRsmmbRhRsmbRsbLjbR
ibLjbLibLibRibRcRsmbRiRsmbRsbRiRsmbRibRibRibLsbRjbRhbRgbRgbLibRjRcbRib
LgbLibLibLibLiRsbLibLibLibLjbLibLibRcbRjbRhbLjbLibLgRgbLgbLsLsmbLgLgbL
gbLgRsbLgbLgRsbLgLgbLhRsRsmbsbRgbLjbLibLibLibLcbLcbLcRsbLiRsbLgbLgbLib
Lhb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRgbsbRgbRgbRgRgRsmbRgbRiRsmbRibRiRsmbRibRibLgbRibRsRsmbRgbRgRsmbRibLg
bRsbLibLibLgLgLsbLgbLibLibLgLsbLgbLibLibLgLsbRgbLgLsbsbRgRsRsmmbRiRsmb
RgRgRsmbRiRsmbRibRgbRibRgRgbLsbLsRsRsmbRibLgbRiRsmbRgbRibRgbLjbRsRibRg
RsRsmmbRibRgRsRsRsmmmbRgbRgbRgbLjbRgbRgRsRsRsRgRsRsmmmmmbRiRgRsmbRgRgb
RgRgbsbRgbRgbRiRsmbRgbLsbLhbsbLibLgLsbLgLsLsmbLiLsLsmbLsbRiRsmbLjbLjbR
ibRiRgbRibRibRgbRibRgRsmbRgRsRsmmbRsRsRgmbLjbLebLiLsbRsbLjbRjbRcRsmbRi
RsmbRgRsmbRibRiRibRhRsmbRebRebReRsRiRembRebRebRibRsbRsbRgRsRimbRhRsmbR
gbLjbLibRibRgbRgbRgRsRsRsmmmbRgbRgRsRsRsmmmbRibRgRsmbLjbLibLibLgbLibLi
bLibLsbLgbRgbRibRgbRibRgLsLsmbRgbRiRsmbRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bRebLsbRgbsbLjbLjbLcRsbRebRibRiRsmbRibRgbRibsbLjbRsRsRsmmbLibRhbLibReb
LibLcbLibLcbLgLsLsmbLibLgLgLsbLgbLsbLcbLeLsLgbLgbLgbLgLgLeLsbRgbLsRsbL
cLsmbsbRjbLsLsmbLiLsLgbLsbLjbLsRsbRjbLjLsmbLjLsRgmbLsLcbRibRcRsmbRgbRg
RsLsmbLjLsLsmmbLhbLebLobLibLiRsbLgLsbLsLsmbLibLsLgLgbLsRsbsbsbsbLiLsRs
bRcbLcbRsLsbLcLsmbsbLcRsbLhLsbLibLibLiLsbLgbRsbLgbRsbLiLsbLsbLhbRcbLcL
smbLcbLhbLcbLgRsbLgbLsLgLebLgbLgbLibLiLsbLgbRjbRcbRcbRiRsReRiRsRsmmmbL
jbRcbLjbLebLibRsbLcbLibLibLgbLgLsLsmbLibLiLeLsbRebReRsRsmmbRebRebRgRsR
sRiRsmmmbRcbRebReLsbRgbRhbRcbRiRsmbRiRgbReRsRsmmbRiRsmbRibRgRgbRcRsmbR
ibRebRhbLjbLibRsbLjbRcbLjbRcbLsRsbRhRsRsmmbLsRsRsRsLsmmbRjbRjRgRsRsmmb
RebLhbLcbRjbLhbRhbLcbLibLibRjbLhRsbLcbRcbRibReb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bLsbLsLsmbLsLsmbLgLsbLgbsbLgbLiLsbLibRsbLhLiLiLeLsbLsRsbLeLgLsLgbLsRsb
LsbLsLsLsLsLsLsLgmmmmmbLsbLgbLsLsmbLgbLobLhbLobLiLsbLsLeLcLsmbLeLeLgRs
LgLiLsbLibRcRsmbRebRcbRcRsRsRgRsmmmbRgRsmbRcLsbRhbLiLsLsmbLsLgLeLsbLiL
hLeLgRsLsLsmbLibLeLsbLgLsLsmbLgbLjRsLsLsmbLiLibLibLgbLiLsLsLsLiLsLeLeL
sLsLsmmmmbLsLebLeLgLsLsLsLsmmmbLgbLibLgLsLsmbLgLsLiLebLiLsbLhbLibLibLi
LsLsLsLsLsLsmmmmmbLibLgLsLgLgLgLsLsmbLgLsLsLsLsLsLgmmmmbLiLsLsLsLsmmmb
LcLsmbLhbLhbLiLsbsbRgbLgbLsbLsLsmbLsRsbsbLiLibLsRsLsbLsLsmbRgbLsLsLsLs
LsLsLsLsLsmmmmmmmmbLgLsbLsbLsLsLsmmbLsLgLsbLsLsmbLsbLsbLsLsmbRhbLjbRhb
LjbRcbRiRsRimbRibRhbRgRsRsmmbReReRebRsbRcRsmbRcRsmbRibRibReRsRgReRsmmb
RsbRgbRsbRsbRgbRsRebLcbLhbLgbLiRsbLiLsLsmbLiLibLeLsLsLgmbLiRsbLgbLjbRi
bRjbRhbRiRgRgbRibRsbReRsLsRsmbRgbLsbRhRsmbLgLsbLjbLcbLiLsbLsbLiLsbLgLs
bLgbLgbLgLsbLgbLgbLjRsbLgbLhLsbLibRhRgRsmbReRsmbRiRibRcbRcRsRsmmbRsbLi
bLiLsLsLsLsLsmmmmbLsLsmbLgLsLsmbLgRsRsmbLgbRcRsmbRiRsRsmmbRgbRsRsRsRsR
sRgmmmmbRgRsmbRgbRiRgbRibRibReRsmbLgLibLgLsLsmbLsLsmbRsbRsbLjRsbLsRsbR
hRsmbLcLsmbLiLiLsbLebLcLsmbLgbLiLiLgLibLebLoLsLsmmbLibLjLsmbRcbRibLjbL
jbRjbRhbLjbRhbRibLjbLibLibLgRsbLgbRiRgRgRsRsRsRgmmmbRiRgRsRgRsmmbLsRsb
Lsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bRibRibsbRiLsbLsbRibLgbsbRibLjbRhbRibRibRoLsbRiRsRsmmbRcLsbRcbLcLibRgb
RibLibLiLibLhbLiLcLebLiLebLhbLobLjbLibLoLsmbLibLcbLgbLobLsbRcbLiLibLib
LiLibLiLgLsbLiLsLgLeLsLsmbLsbLsbRobRjbLebLiLsLiLhbLiLibsbLsbRsbLibRibL
gLebLgbLgbLsRsRsmbLgLebLsLsmbLsbLgbLibRgbLiLsbLibRjRsmbRcbLgbLsLgbLgbR
cbRhbRsRcbRgbRgRsmbRgbRhbLsbRhRgRsmbRgbRgRsmbRsbRgLsbRgbLjbLgbLsRsbLgR
sbLhbLibLebLibLgLsbLsbLoLsmbRsbLgLsbLiLsbLibRebRibRgbRgbRcbRibRibRgbRi
bLgbLebLcRsbLsbLibLiRsbLgbLibLcbLibLcbLsLsmbLcbLibLcLiLsLsmbLhbLgLsbLg
RsbLibLgbLgbLgbLsbLgbLgbLgLgbLeLsbLgbLgbLgLsbLgbLgLgLeLsbLgbLgbLgbLibL
gbRobLjbRjbRsLhbRjbLibRjbLhLsbLgbLgbLibLgbLgbLibLiLgbLgbLgLgLeLsbLgbLi
bLgLebLgbLgbLgLsbLgbLgLsbLgLsbLsbLgLeLsbLebLgbRcbLjLsmbRcbRibRgbRgbRib
LjbLibLibLiLsbLgLsbLsbLebLgLiLsLgbRsbLgLeLebLibLgLsbLebLgLsbLgbRsbRjbL
ibRobRibLsLcbLiLsbLsbRcbRgbRibRibRsbRcbLsbRhbRgbRgRsmbRsbRgbRgbRsRsmbR
gRibRgRebRsbRsbRibRgbRgbRibRgbRgbRibRiRsmbRgRsmbRibReRiRsmbRgRsmbRgbRs
bRsbRgbRgbRebRgRgRsmbRsRsmbRsRsmbRgRsmbRsbLsbLsRsRsmbRsbRgRsRsmmbRgRgR
smbReRebRgRsLsmbRibRgbRibRibRibRgbRiRsRsmmbRhbRiRsRgmbRgLsbRibRhRsmbRi
bRgbRgbRgbLibLjbRjbRobLibLhLsbLiLsbLgbLgbLibLgbRobRhRsmbRgRgRsmbRebRsb
RsbRebRgReRgRsLsmbReReRhReRiRsRhRgRgRsRsRsRsRsRsRsmmmmmmmmbRgRsmbRgRsm
bRgRsmbRebsbRgLsbRsbLjbRibRibRgbRgbRgbLsbRgbLjbRibRhbRgbRsbRibLjbLibLi
bLgbLgbLgbRjbLjbLhbLcbLgbLibLiLsbLibLiLsLsmbLjRsRsmbRibRibRibLsRgbRgbR
ibRgbLgbLiRsbLcbLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRhbRsbsbRiRsmbRhbRiRsRhmbRiRibRiRiRsmbRiLsbLhbLibRcbRcRsmbRgbRebRgbRi
bsbsbLgLsLsmbRebRobRhbReRsmbRibRgRsmbRgLsbRebRsbRebLcbRiRsmbLcbLhbLgLs
LsmbLibLibLhLsLcbLhbRebLcbLcbLibLgbLgbLobRgbLibLcbLibLobLcbLoLsmbLebLe
bLibLcRsbLcbLibLobLobRsbRcbRcbLjbRiRsLsmbLsbLcbLibLcbLhRsLgLsLsmbLjLsm
bLgLsbRsbReRsmbRhbRebRhLsbLsbRjRsRsmmbRsRgRsRsRsRsmmmmbRibRcbRcbRibRcL
sbRgRsmbRiRsmbRibRiRsmbRiRsmbLibRjbRsRgRiRcbRoLsLsLsmmbLibLoLsmbRibLoR
sRsmbLibsbLcbRhbRcbLsbReRsLsmbRgbRsLsbRgbReRsmbRsbRebLgbLjLsmbLibLjbLi
bLibLibLjbLibLibLgbRsbRcLsbRibRibRibRsbRcbRibRiLsbRibRgbRhbRhRsmbRiRsm
bLsbLibLcbLhLsbLibLcLsRsmbLgbLgLgbLgbLgbLsRsbRsLsbRsLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRsRhbRgRsRgRsRiRimmbRgReLsbReRsmbRiRsRsmmbRsbRsRsRsmmbRsRsRgmbLsRsRsm
bsbRsbRgLsbRibRgbLibLibLibLoRsbLhbRsbRhbLgbLibsbRhbsbRsRsmbRsbLibLgbLs
bLsbRjbLibRcbRibRsRgbLsbRibRibRgRsmbLsbLsLsmbLhRsbLsbLhbLibLgRsbsbLgbL
ibRcbRibRiLsbLibLibLibRobRibRgbRgRsmbRgbRobRgbRgbRibRibLebLsbRibLsbReb
RgbRiLsbRibRibRsbRibLcbLsbLgbLgLsbLibLgbLgLsbLibLibLhLebLsLsmbLsbRsRjR
smbLsbLjbLgbLgbLgRsLsbRsbLgbLgLsbRsbLgbLhLsbLgbLsbLgbLgRsbRgbRsbLibLsb
LgbLgbRsbLgbLibRgbLiRsbRgbLgbLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLsbLeLgbLsbLibLobLoRsbRiRsmbsbRebReRsmbRebRcbRhbRibRiLsLsmbRgbLgLsRsb
LcbLhbLebLibLibLcbLebLibLhbLeLebLgRsbLibLhLsbLebLebLibLeLsbLeLebLgLeLs
bLeLiLsbLebLsLebLgLsbLgbLeLgRsbLgbLgLsLsmbLsRsbRsbRcbRgLsbRgLsbLsbRsRs
mbRsRhbRebsbRebLhbLcLsLsmmbLhbLgbLhLsbLebLgLsbLgLsLsmbLgbLibLeLsbLibLc
LsmbLebLgbLcbLeLsbLobLibLobLibLiLebLibLebLgbLgLgLebLgbLebLgbLgbLebLibL
hbLhbLibLibLgLcbRsLibLgbLgbLhbLhLsbRjbRhbRiLsbRhbRgRgbRsbRgRsmbRgLsRsb
RsbRsRgRsmbRgbRsbRsRsmbLcbRcbLcbRjRibRcbRgRsmbLoLsmbLhbLibLhbLibLebLgb
LgbLeLsLebRcbRebRhbRibRiRsmbRgbRgbRgbRiRsRsRsmmmbLhbRsRsmbRibRgRsmbRgR
smbRsbRgRgbRgRgRsmbRiRsmbRgbLjLjbLoRsbLhbsbLcbLsbLcbLgbLeLhbLcbRjbRibR
jRsmbLcRsbRhbRcbRibRebRibRsLsRibRgRsmbRgReRsmbRgbRgRsmbRgRsRsmmbsbLcbR
gRsmbRiRsmbRsRsRsmmbRgRsmbRgbLjbsbRsbRhRsRsRgRsmmmbLobLcbLibLibLibLibL
ibLhLsbLcbLibLebLebLhbLibLiLsbLibLibLibLibLgbLebLeLeLhLebRsbLsbRjbRjbR
oRsmbRjRgbLhbRhRsmbRjbRcbRgbRebRibRibRibRibRgLsbLsRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bLsbLibRgbRgRsmbRcbLibLjbRebRibLgbRibRiRsmbLibRebRobRhbLhbsbLiRsbLibLs
LsRsmbRjbLjbRjbRjbLjbRjbLjbLjbLcLsmbRjRsmbLsbLsRsbsbRjbLibLgbLibRjbLgb
LobRobLebLcbsbLsLsmbRgRsmbRsRsmbRibRibRsbLobLcbLibLgbLhbLcbLibLibLiRsb
LibLiLsRsbLibLibLibLgbLiRsbLiLsbsbLsbLobLibRcbRhbRgbRibRibRibRebRibRjb
RjRgbLjbRsRsmbLsbRgRsmbRsbRjRibLsbRsRgRsmbLeLsbLibLib

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bRgbRsbRsbRhbRgRsmbRsbRsbRsbRsbRsRgbRsbRsbRgLsRsbRgbLjbRibRiRsmbRsbRsL
sbLjbRsbLoRsbLcbLcLsLsmmbLibLibLhbLcbLibLcbLobLiLsbRsLsLsLsmmbLcbRibLc
bLcbLhbLgbLgbLgLibLiLsbLgbRjbRobRibRibLsLobLibLcbRibRobRgbRobRgbRebRoL
sbRibRgbLiRsbRgbRcbLhbLoRsbLibLhbLhbRjbRoLsbRgLsbRibRoLsbRgbLeLsbRjbLh
RsbRsbRcbRsbRsRsmbRgbLjbRhRsmbRibRgbRgbRsRgbRgRibRsRsmbRoRsmbLibRhbLib
LjbRsRsLsmbRgLsLsmbRgRsRsmmbRsbRiRsmbRgbLsbRibLobLobLsbLjRsbLobLibRiRs
mbRibLgbRibRibRgbRgLsbRgbRgbLjbRibRibRgbLgbRibRibLibRhbRgbRjbLgbRgRsmb
RgRsmbRgRsRsRsmmmbRibRgbRgbLjbRgbRsRsmbRgRsmbLjbRsbRgRsmbRsbRgbRsbRsbs
bRsbRsRsRsmmbRgRgbRsbRiRsmbRgbRiRsmbRsLsbLsbRsLsbRibRgRsmbRibRgRgReRgb
LsbRsRsmbRoRsmbLcbRgbRibRgbRiRsmbRgbRgRsmbRgbLjbLibRjbLjbsbRgbRgbRgRsm
bRgbRgRsmbRibRcbRhbRibRjLsbRgRsRsRgRsmmmbLsbRsRgbRjbRsbRsbRebRiRsmbRgb
RgbRibLiLsbRibRiRsmbRibRhbRsRsmbRgRsmbRgRsRgmbRsbRsbRgRiLsbLsbRgbRiRsm
bRibRgLsbLsRgbRibRibRgbRgbRsRsmbRgRsLsmbRiLsbRibRgbRcbRibRgbRgRsRjmbRg
RsmbRgbRgRsmbRsRsmbRibRgbRsbRibLsbRobLgbRibRgbRgbRgbRibRgbRgbRgbRsbRgb
RgbRiRsmbLgbRibRsbRsbRsbRgRsmbRebRgbRgLsbRibRibLsbRgRiRsRsRgmmbRhRsmbR
gbRsbRgbLsbLgbRgbRgbRgbRgRsmbRgbRgRsmbReRsmbRgbRgRsmbRgbRcbRjRsmbRsbRi
LsRsbRgbRgbRgbRgbRsRibRibRcbRiRebRgbRcbLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bLebLjbsbRibLcbLhbLibLiLsbLibLgbLcbLsRsbLebLibLcbLhbLgbLgLsbLgbRibLebL
ebLibRibLgLsbLjbLebRcbLhbLcbRsbRhbLjbsbLiLgbLsbRjbLcbLsbLsbLhLsbLibLcb
LebLcbLebLibRsRjbRcbLebLibLibLcbLcbLeRsbLhbLcbRgbsbRoLsbLsbRobRgbReRsR
gmbRgbRhbRhbLgbLebRcbRhbRgbRhRhRgbRibRhRsmbRgRgbRgbRebRgbRgbRgbRgLsbLi
bLebLgbLjLibLgbLjbLibLibLcbLibLgbLibLibRjbLiLsbLhbRibLjbLibLiRsbLgbLhL
sbLhbLeLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bLobRcLsbRibRhbLjbLhbLebRcbRgRsmbLcbRjbRcbLhLsLsmbLcLsmbRcbRjbLcbLcbRj
bRhbLjbLcbLiRsbLobLhbLcRsbLgLsbLibLgbLhbLgbLcbLibLcbRoRsRsRsRimmmbRgbL
hbLiLsbRjbRibRcbLibRibLcbLebLibReRsmbLcbLcbLgbLibLsLhbLiLhLsbLibLsbRcR
smbLcbLcbLcbLgbRsbRjbRebRibRhbRhbRcbLsRsbRibRibLcbLhbLebLjLsmbLcLsmbLi
bLcRsbLiLsbLcbLhLsbLhbLgbLsLsmbReRiRsmbRsbLcbLibLobRgRsmbRgbRgbRgbRgbL
cbLcLsmbLgbLebLibLgbLgbLcbLgbLibLibLibLcLsmbLgbLcbLibLgbLsbLibLibLhRsb
RgbRibLjbLcbRjbRcbsbsbsbRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bLgbsbLgLsbLsLsmbLsbLibLsbLebRgRibRibRsbLgbRhbReRsmbLgLsbRcbLibLgLsbLs
LsmbRjbRhbRgbRsRsmbRgbRsRsmbLsbRibLcbLibLibLgLsbLsbLgRsbLgRsbLibLsLsLs
RsLsmmbLgbLsbLsbLcbRsbRgbLgLsbRibRsbsbRsRibRsRsmbRcbLgbRsbLjbLsRobLgRs
bRsRsRsRgmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsRsmmbRgbRgbRsbRgRsmbR
cbRsbLgbLgLsbLiLsbLgbRsbLcbRsbRsRsRsRsmmmbRgLsbRsRsRsRsmmmbRgLsbRsRsmb
RgRsmbRsbRgbRsRsRsmmbRsRsRsmmbRsbRhbLgLsbRcbLibRsbRgbRgbRgRsRsRsRsRgmm
mmbRgLsbRsRsRsmmbRgbRsbRibRobLsbLibLsbLsbLgLsbLsLsLsmmbLsLsLsmmbLgbLsb
LgbLsbRobLgRsbRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bRgbRebRgbRibRsRsmbRcbRiRgbRebRibRobRsRhRibReLsbRgbRiRsmbRsbLgbLjLsmbL
iLsLsmbLgbLgbRsLsbLsbsbLibRcbRsbRhRsmbLcbLebLhLsbLgbLgbsbsbLhLsbRcbRjR
sRsmmbLebLebLsbLibLsbRcbLjbLcLsmbLgbLcbLebLebLebLiLgbLebLebLgbLibLebLg
bLsbLhLsbLobRjbReRsmbRgRsmbLcLsmbRcbRiRsmbRibRebRibRsRibRobRhReRsmbRgb
RgRgRsmbRgRiReRsmbRsbRsbRsbRgbRsbRsbRsRsmbRiRsmbLebLcLsmbLhbRhbLsRobRc
bRebRebRiRsmbRhRsRsmmbRgRsmbLjbLcLsmbLibRjbLeLsbRjRsRsmmbRjbRgbRgbRsbR
sRsRsmmbRsbLcLiLsbLcLsLsmmbLhbLsLhbLgLsbLgLsbLgbLsbsbRjbLjbRjbLcbRgbRs
bRjRebLsbRcbReLsRsbRgbRgbRgbLcLgbLibLebLcbLibLgbRcRsRsmmbLjbRcbRsbLobL
ebLgbRsLsLsmbLsLsmbRjbLcbRsbRcbRsLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bLsLsmbLgbLibLibLhbLobRcbRhbLgbRobRiLsbRgRsmbRgbRibRsLsbRgbRsRgbLsbRgR
smbRgbRsbRsRsRsRiRsmmmbRsbRgRsmbRgbRibLsbLsbRsbLsbRsbRibRibRgRsmbRibLs
bRhbRgbRibRiRsRsmmbRgbRgRgRsmbLsbRgRsmbRgbRgRgbRgbRgbRgbRgRsmbRibRgbRg
bRgbRibRibRgbRgbRiLsbRgbRgRsRsmmbRibRibRgRsmbLgbLsbLsbLibRgbRgRsmbRgbR
gRsRsmmbRgbRgbRsbRgbsbRgLsRsbRibRibRgbRjbRibRhbRebLibRibLibLgLsbRsbLeb
LgbLsbsbLsbRsbLgbLcbLsbRibLsbRibLsbLgLsbsbLgLsbRsbLjLsmbLgbLgbLibLgbLs
bLsbLsLsmbLsLsLsmmbLsbLsLsmbLgbLsbLsLsmbLsLsmbLjbRsRsLsmbLcLsmbsbRjbLi
bLibLjbRsbRibRgbRobLgbLibLobRsRebRebRibLjbLsLsmbRgbLsLsLsmmbLsbLsLsmbL
sLsLsLsmmmbLsbLebRebLiRsbRjbRjbLhbLgLsLibLibLgbLibLgbLsbRsRsmbLjbLsbRi
RsRsRsRsRsRsmmmmmmbRgRsRsRsmmmbRibRsbRibRhbRsbLsbRjRsmbRcRsRsRsRsmmmmb
RibRgRsRsRsmmmbLsbRsRsmbsbRiRsRsRsmmmbLsRsRsmbRibLsbLcbLsLsmbLibRsbLsb
LgbLiLsbRibRgbRibLsRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bLibLgLsLsmbLsbLebLgLiLsbLgbLsbLibLibLgbLsbLgbRsLsbLsLsmbLebLebLebLebL
ebLibLebLgbLibLcbLiLsbLjLsmbRcbLibLibRsRsRsRgmmbLibLibRibRcbRgRsRsmmbR
gbRgbLgbRibLgbRebRebRebRsRgbReRsmbRiRsRimbRebRiRsmbRibRibRebRibRebRhbR
gbRebRebRgRsLsmbRsbRibRibRiRibRgRsmbRiRsmbRgRgRsLsmbRibRhbRiRsmbRibRgb
RgRsmbRgbRgRgbRebRhRsmbRibRibRgRgbRgbsbRgbRibRibRgbLsRsbLsbRsbRiRsmbRg
bRgbRibRibRibRgbRgLsbRgLsbRsRsmbRsbRgbRebRebRebRebRgRsmbRibRsbRebRebRe
RibRgbRgRsmbsbRsRsRsmmbsbRgRsmbRsRsmbRibRgbRibRgRsmbRhRsmbRgRgbRgbRgRs
RsmmbRibRgbRsbRgRsRsmmbReRiRgbRhLsbRgRsmbRibRgbRsbRebRhbRibReRsmbRgbRi
bRibRgbRhRsmbRibRibRgRsRgmbRiRsmbRhRsmbRibRgRgbRgbRiRsmbRgbRgLsbRiRsmb
RsRgReRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bRsRgRibRgbRsbRsbRsbLcbLgbLoRsbRsbRjbsbsbsbLsbRsLsbLsbLjbLebLgLsbLsbLg
bLsbLsbLgLsbLibLgLsbLgbLcbLgbLgbLgbRsLsbLsbLsLsmbLgbLgbLsbLibLsLsmbRgb
LsbLsbsbLsRsbsbLjLsmbLsLsmbLsbsbLgbLgLsbLibRsbsbLsLsLsmmbLgLsbLibLibLg
bLgbLgLsbLsLsmbLgbLsLsLsmmbLsbLsLsmbLsLsmbLsbLsLsmbsbLsLsmbLiLsbLcRsbL
gbLibLibLibLgbLgbLibLgbLsbLsbLgbsbLsbsbRsLsbLsLsmbLsLsmbsbLsLebLgbLsbL
sLsmbLsbLgbLhbLibLcbLibLgbLsbLibLsLsmbLgLgbLsbsbLsLsmbLgbLiLsbLhLsbLsL
sLsmmbLcbLsbLcbLibLibLibLibLibLibsbLgbLsbLgbLgbLgbLgbLsbLgbLgbLgbLiRsR
smbLgbLhbLibLgbLiLiLeLsbLgbLgbLibLsbsbsbsbLibLgbLgbLsbLsLsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRsLsbRsLsbsbRsRsLsmbRsbLsbRgRsmbLobLobLgbLobLgbLgbLibLhbLsLsmbR
jbRgbRiRsRembReLsLsLsmmbRgbLibRsbRiLsRsbLsbRgbRebLobLhbRsLsbRibRibRsRs
RsmmbRgbRgRsRsRsmmmbRgRsmbLibRebRebRsbRgRsmbRsbRsbRsRsRgRsmmbsbRhRsmbR
cRsmbRsbRsRsmbRsRsRgmbRgbRgbRibRobRgRsmbLoRsbRibRcRsmbRgbRiRsmbRsbRgRg
bLsRsRsmbRibRsbsbRgbRsRsmbRsRgbRsRsmbRsRsRsRgmmbRsbRsRsmbsbRsRsmbRsRsR
smmbRsbRsRsRgmbRsbRsbRsbRsRsRsmmbRgbsbLsbRsbRsbRsRsRsmmbsbsbRsRsmbRsRs
mbLsbRsbLsRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRsbRsbLsbRsbsbRsbRsRsRsmmbRgbRobLhRsbLobRcbRibRibLgLsbRobRiRsmb
RgbRhbRgbRobReRsReRgmbRebRhbRgbRsbRgbLjbLibRcRsmbLcbLibLibLibLiLsbLgbL
ibLiLsbLgbLgbLibLgbLibLibLgbLebLibLgLsbLiLebLgbRebsbLsbLsLibLibLibRcbL
hbLcRsbLgbLibLiLsbLibLgbLgRsbLgbLgbLgbLgbLgLsLsLsmmbLgLsbLebLgbLgbLgLs
bLsbLgbLgRsbLgbLgbLibLibLibLibLgbLibRsRsmbLgbLgbLibRebRhbRcbRgbRibRibR
gbRibRsbRgbRsRsRsmmbRgbRibRgbRhbRhbRsRsmbRebRhbLsbsbLgbRibLsbLcbLibLib
LsLsmbLiLsbLgbLgLsLsmbLgLebLsRsbLibLibLcbRsbRgbRgLsbRibLsbRsbRcbRibRsb
RibRgbRgbRgbRgbRsbRiLsbLjbLibLiLsbLgbLgbLgbLgbLgbsbLgbRebLebLgbLgLsbRs
bLiRsbLjbRcbLjbRibRgRgbLgbRiRsRsmmbRsbRgbRsbRiRsmbLjbLcbReLsbRhbLsbLjL
smbLsbLibLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLgbLsbsbLsbLgLgbLsLsLgLsmbLsbLsLsmbLsLsLgLsLsmmbLgLsLsmbsbsbLsLsmbRsL
sLsmbRsbLsbLsRsbLsLsmbLsbLsbLsLgbLgbLgbLsLsLsLsmmmbLsLsmbLgLsbRsbLsLsL
sLsLsLgLsmmmmbRsRsRsmmbLsLsLsLsmmmbLsbRsLsbsbLgbLgbLsLsLsLsLsRsmmmmbLg
LgLsbLsLgLsbLsLsLsLsLsmmmmbLsLgRsbLgLsbLsLsLsmmbLsbLsbRsbsbLsLsmbLgLsL
sLsLsLsLsLsLsmmmmmmmbLsLsLsLgLsLiLsmmbLsLsmbLgLsbLgLsbsbLsbLsbsbLsLsmb
LsLsLsLsmmmbLsbLgLsbLebLebLebRobLsbLgLhbLgbsbsbLsbLsbLsbLibLgRsbRsbLib
sbsbsbsbsbLgLsbLsLsmbLgLsLsRsmbLgbLsbLsLsmbLsLgbLsLsLsmmbLsbLiLsbLsLsL
smmbLsLsLsLsmmmbLsLsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbLsbRsLsLsmbsbLsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbRsRsmbsbsbRsbLsbsbsbsbsbRsbsbsbLsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbs
bLsbsbsbRsbRsbsbsbsbsbLsbRsbLsbLsLcLsLimbLjbLgbLiLsbRsbLsbLhbLgbsbLgbR
sbLebsbRgbRgbLsbLgbLibLibLibLibLibLibLgbLebsbLgbLibLgLsbLgbLgbsbRsbLsb
LsLgbsbRsbLgbLcLeLhbLibLgbLibLgLsbLibLsbLsRsLsbsbLsbLsbsbsbLjbLibRsbLs
RsbRsbLsbRsbLsbLsbLsLsmbRsLsRsLsbLjLsmbLjbLcbLoLsmbLjbLsbLgRsbLsbLgbsb
sbLsbsbsbLsbLsbRsbsbRsbLsLsmbLgLsbLgbRsbsbRgRsmbLgLsbRibRiRsmbLsbLcbLh
RsLsbLgbsbsbLgRsbLibLibLcbLibLsbLgLsbsbLsLsRsmbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bLsbRsbRsbRsbLsbLebRsbRsbLsbLsbRsbLsbRsbRgbRsbRgbLsbRsbLobLsbRebLsbRsL
sLsmbRsbRsbRsbLsbRsbRsbLsbLobRebLjbLobRgbRgbLsbRsbRsbRjbRebRobRsbLsbLs
bLjbLjbLsbLobRsbRsbRsbLobLobLobRebLsbRsbRjbLsbLebLobRjbLsbRebRsbRsbRjb
LsbRsbRobRsbRibRsbRsbRebLsbLobLobRsbLsbLsbLebLsbRobLobLobRjbRjbLobLcbR
cbRobRjbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRibRebRgbRsbRgbRhbRgRsmbLsRsbRebRgbRiRsLsmbRgbLsLgbLgbLibLhbLibLgbLgb
LgLsbLsbRcbRibRgbRiLsbRgbRsbRibRebRebRgbRgbRgbRgRsRsmmbLsbLsbReRgbRgRg
RiRsmbRgbRibRgRsmbLsbRsbReRsmbRiRsmbRgRsmbRibRgbRebReReRibRibRgbLibLib
LgbLhLsbLibLgbLibLibLibRjRhbRjRhbRibRibLsLsLsmmbRgRebRhbReRsmbReRsRsmm
bRsbRgbRsRsmbLgbRibRsbRibRsRgRsmbLsbRgbRibLgbRgbRgRgbRiRgbRibRiRebRgRs
mbRhbRebRhbRebRgbRibRhbRibRgRsmbRiRsmbRibRgbRiRsmbRibRibRebRgbRibRgbLs
bRebRibRiRgbRibRebRiRgbRgbRibLebLjbLibLgbRhbRsRsmbRiRsmbRiRsmbRgbsbRsR
eRsmbRhRsmbRibRgRibRgbRgRsmbRgLsbLgbRibRibRibLgbLsbRebReRsmbRibRibRiRs
mbRebRebRgbRgbRibRhbRgbRgRsmbRgbRgbLgLsbRibRhbRsbRebRebReRsmbRibRgbReR
ibLsbRgRsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bsbLgbLsRsbRjbRhbRibRibRgbLsbRgbLsbRgbRgRsmbLsbLjbLgbLibRsbLgbLibRsbRg
bLcbLsbRgbLhbRsbLgRsbRsbLgbLibLhbLibLibLgbLsbRsbLibLgLsbLgbRgbLibRsbRs
bLgbRibLgbLcbLibRgbLibLibRjbLibLsLhbLgbLsbLgbLibRgbLsbLcbLsbRsbLgbLibL
sbLibLsbLibLsbLsbLsRsbLhbRibLsbRsbLgbLgRsbLibRsbLgbLibLgbLgbLjLsmbLgbL
gbLgbLgbLgbLgbRgbLibLibLgbLgbLebLiLgLsLsmbLgbLgbLsbLgbLibRsbLibLgLsbLg
bLsRsbLibLsbLobRhbRsbRgbRibRsbRgbLobRibLiLsbLibLgbLsbLibRgbLibLgbLibLg
bLcbLhbRgbLibLgRsbLgbsbRsRsmbLgbLgbLgbRsbLibRsbLgbRsRsmbLibRsbLibLsbLs
bLgRsbLsbLgLsbLsbLgbLsbLgbLgbRgbLibRgbRgbRhbLhbLgbRgbsbLibRsRsmbLjRsbR
sbRsbRgbRgbLhbLibLibLibRsbRibRcbRgbRgbRgbRgbRsbLsbLjbLibLsRsbLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLobLgbsbLsbLsbRsLsbLibsbRebLjbLgbsbRcbLjLsLsmmbLobLcbRcRsmbLebLjbRhbL
cbLcLsmbLebLcbLibLibLcbRibRcbRcbRobRhbRcbRsbRcbRiRsRgmbsbRgbLjbRebLjbR
jRsRsmmbLjbRibsbLjbLjbRjRgbRgRsmbRgRsmbLhbRgbRsbsbRjRsmbLibRiRsmbLibRi
bRgRsLsmbRsLsbLsLsmbLgbLibRhbLsRsbRsRsRsmmbRsbLsbsbRgRsmbRsbRsbRgbRsRs
mbsbsbRgbLsbRgbRgbRsLsbRjRsmbRgbRsRsmbRgLsbLgbLhRsbRcbLcLsmbLcLsmbLibL
ibLibRsbRibLsbLjLobLcbLsbsbRibsbRgbsbsbLsbLsbsbLsbsbRgLsbLsLjbRjRsmbRi
LsLsmbLsRsbLjbLibLiRsbLsLsLsmmbRjbsbsbRiRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLgbRsRsmbLgLsbLgbLsLsLsmmbLiLgbLgLsbLibLebLibRsbLsbLsbRsbsbsbLsbsbLsL
sLsLsLsmmmmbLgLsLsLsLsmmmbLgLsLebLsbLsbLsLsLsmmbRobRcbRoLsbRgbLcLsLsLs
mmmbLcbRgbRibRibRcbRhbRibRibRobRibRcbRobRibRhLsReLoLcbLgbRhLsbRobRibRg
bRgbRibRgbRjLgbRgbRgbRcbRhbRgbRhbLgbLcLsmbLgbRgbLcbRibRoLsbRiRsmbRgbRi
bRobRsbRcbLgbLcbRibRibLgbRibRgLsbLgbRebRobRgbLgbRibRjbRcbLibLgbLsbLgbR
gbLsLgbLsbLgbLobRsbRibRibRgLsbLibRibRibRsbLsbRgbRsRsmbRibRhbRebLgbRjbL
jLsmbRjbRhbRgbRjLsbRsbRsbRgbLsRcbRibRibRjbRibRibRsbRgbRibRiRsmbRibRjRs
mbRgbRibRcbRgbRiLsbLibLibLibLibLebLgbRgbRgbsbRsRgbLibLgbLgbLgbLsLsLsmm
bLgLsbLgbLgbLgbLgbLsLsmbLsbLiLsLsmbLsbLiRsbLiLsRsbRibRibLibLibLgLsbLgb
RcbLjLsmbRobRjRsmbRsRibRibRgbRgbRibLgbLsRsLsbLjLsmbRsbRhbRjbRcbRgbLsbR
sbLcbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgLsLsmbLsbLgbLgbRsbLibRjbLjb
LgbRsLsLsLsmmbLgLsbLsbLgbLgbLgbLibRibRibLhbLgbLhbLsbRibLgbLgLsbLjLsmbs
bLgLsRsbRgLsbLgbLibLgbLsRsbLgLsbLsbLgbLgbLibLibLibLsbRibLsbLibLibLsLsm
bLsbLgLsbLibLsLgbLsbLgLsbLsbLsbLgbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bRsbRjbRsbRiRgbRsRsRsmmbRsRgRsmbRgLsLsmbRgRsmbRsLsRsbLjbLsbRgbRsbLjbLe
bLibRsRsmbLiLsbLgLsbRsbLibLiLsbLiLsbLebLjLiLsLgLsLsLsmmbLeLsbLeLgbLsLg
LsLsLsLsLgLgLsmmmbLiLcbRsLebLibLgbLibLhLsbLebLibLcbLebLebRgbLebRcbRebR
gRsLsRsmbRibReRsmbRgbRgbRebRhbRgbRgRsmbRgbRibRgbRibRgbRgbRgRsmbRiRsmbR
gbRgbLsRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRibRiRsmbReReRsmbRebRiRsRgRsmmbRgbRibRibRibRibRhRsmbRgbRgbRgRsmbRebRg
RsmbRgRsmbRhbRibRgRsmbRsRiRsRimbLsbLcbRcbRebRhbRebLgbRcbRibRgRsmbLgbRs
bRsLsbRiRsmbRgbRsRsmbLsbRsbRsbRjRiLsRsbRgbRhbRibRgbReRsmbRebRebRebRibR
gbRiRsmbRebRsbRibRiRgRsmbRsRsRsmmbRgbRsRsmbRjRsmbRsbRibReRsmbRsbRiRsmb
LjbRcRsmbRobRcbRhbRibRcbRibRhbRibRhbRibRcbRgbLibLibRcbRibLsbRgRsmbRgbR
sbRsRsmbRgRsRgRsmmbReRsmbRebRhRsmbRiRgbRsbRibRsRsRgmbRiRsmbRgbRgbRgbLj
bRhbRibRoRsmbRhbRibRgLsbRgRsmbRgbRgRsmbRebReRsmbRebRgbLjbRobRsbRgRsmbR
gbRgbRibLibLgbLobLibRjbRibRgRsmbRsRsmbRgbRjRsmbRibLsbRhbRibRibRsbRibRi
bRiRsRsmmbLsRsRsRgRgRsRiRsmmmbRebRibRebRsbRiRsmbRgRsRsRiReRsmmmbRsbRjL
sRsbLgbRhbLgbRsbRgbRiRsmbRgRgRibRsRsmbRibRgbLjbRiRsmbRsbRjbRgbLsbLgbRe
RsmbRsRgRebRebRiRsmbRsbRgbRsbLjbRgbRibLgbRebRgRgbRibRiRsmbLsbRibRibLgb
RgbRsRsRsRsRhRsmmmmbRebRgRsmbRsLsbRebRebRiRsmbRebRebRibLsbRjLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRibLsLsmbRcbReRsmbRcbRcbRebRhbRgbRgRsmbRsRsLsmbsbRebRiRsmbLgbRcbRcbRo
bRibRibRobRobRebRebRsRibRgbRgbRcbRibRobRsbLobRcbLcbLgbLobLhLsbLgbLgLsb
LiLebLgRsbsbLcbRebReRsmbRiRhRsmbLsbRcRsmbRiRsmbRebRibLhbLhbLibLcbLcbLi
bLebLobLibLibLibLebLibLjbRhbRibRhbRcbRcbRibRibLibLcbLiLcbLsbRebLibLibL
cLobLgbLibLibLgbLgbLsLgbLgLebRebRgRsLsmbLoLsmbRhbRebLibRibLjbRebRibRcb
RebRibRgbRibRgbRgbLsbRibRibRebLsbLgbLoRsbLgbRsbRcbRhbRhbRibLibRibRgbLg
bLsbLibRhbLhbsbLibRjbLgbLsbRjbRiRsRsmmbRjRsmbRcbRhbRebRibRibRgbRibRibR
hbRiRsmbRgLsRsbRiLsRgbRgbRibRibLibLgbLgbLcbLibLcRsbLibLibLobLibLgbLibL
gbLhbLibRsbRhbRhbRjRibRibLsLsmbLeRsbLhRsbLcRsbLhbLgbLebLibLibLibRgbRjb
RgbLsLgbRjRibLgbRsRgbRgbRgbRebLsLsRsmbRgbsbsbRibLibLsLgLsbLgLsbRhbRsbR
jbRibRgbRibRibRhbRgbLgbLgbLibLibLgbRsbRibRibRgbRiRsmbRgbLsRsRsmbRsbLib
RibLgLsbLsLjLsmbsbRhRsmbRjRibRebRebRhbRhRsmbRgbRhRsmbRgbRgRsmbRsRsmbRg
bLjbRhRsmbRhRgRsmbRebRebRiRsmbRgbRgRsRgmbLsbRsRsmbRsbsbRebReRsmbReRsRg
mbRiRsmbRgRsmbRiRsmbRsbRgbRgRsmbRgbRgbRgRsmbReRsmbRiRsmbRiRsmbRibRiRsR
smmbRgRsmbRsbRhRsRsmmbRibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bLsbLeLsbLibLgbLibRsbRibRsLsbRsRsmbLgbRsbLiLsbLsLsmbLsLsmbRgbLibLibLeb
LgbRsbLebLhbLibLcbRobRiRsmbLjLsmbLibRgLsbLiRsbLcbRgbLsbLsLsmbRcRsmbRgR
smbRiLsbRsbRibRsRgLgbRsRhbRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRebRsbRgRsmbRibRgbRsRsRsmmbLsbRsbRsbRsbRgRsmbRgbRgbRiLsbRgbRebRebRgbR
sbRsRsmbRgbRsbRsbRgbRgbRibRcbRcbRcbsbRobLcbLibLcLsmbLgbLcbLgbLcbLcbLib
LibLhbLgbLcbLgbRibLgbRcbRibRibRibRgRsmbRgRgRsmbRgbRgbRebRgbLjbLibLcbRg
bRibLsbLobLhbRjbRgbLsbRiRsmbRcbRibRcbRsbRibRiRsmbRibLhbRcbRiRsRgmbRgbR
ibRgbRibLobLcbLibLibLibLobRsLibLebLcbLibLebLgbLibLgbLibLgbLcbRsbRcbRgb
RgbRgbRgbRsbRsbRgbRgbRsRsmbRibRibRsbRgbRcbRsbRibRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bRebRibRsbLibRcbLjbLgLsLgLsLsLgLsmbLsLsmbLsbLgLsbLgLsLsLsLsmmmbLgbLgbL
gLsLgLsbLgLsbLgbLsbRsbLsLsLsmmbLgLsLsLgmbLsLibLgLsbLibRjbLibRsbLibRgbL
gLsLsLsLsLsLsmmmmmbLgLiRsLsbRgbLsLibLsbLiLsbLsbLiLsRsLsRsbRsLsbLibRsbL
gLsLsLsLsmmmbLibLsLsRsLsmbLgbLsLebLeLsLsLsLsLsmmmmbRsRsmbRgLsLgbLibLgL
sLsmbRsLsLsLsLsLsLgLsmmmmbsbLgbLgLgLsbLsLsLsLsLsmmmmbLgLsbRsLsLsLsLsLs
LsLsmmmmmmbLgbLiLsbLsbLiLsLgLsbLsLsmbLsLsLsLsLsLgLsLsmmmmmbLsLsLsmmbLi
LsLsLsmmbLiLsbRsbRjbRibLeLsbLgLsLsLsLsLsLsLsLsLsmmmmmmmmbLgLsbLgLgLsLs
mbLgLsbLgLsLsLsLsLsmmmmbLsLsLsLgLsLsmmmbLgLsbLsLsmbLsLgLsbRsLgLsLsmbLh
LsbLiLsLsmbRcbRebRsbRgRsmbRsRsmbRgRsRsRsRsmmmmbRsLsRsbRgRsRsRsRsRsmmmm
mbRgRsRsmmbRgRsRsRsmmmbRgRsRsRsmmmbRibLjbRgRgbRiRsRsmmbLsLsRsmbRsRgRsR
sRsRsRsRsRsmmmmmmmbRgRsRsmmbRgRsmbRgRgbRgRsRsmmbRiRsmbRgbsbRsRsmbRibLi
bRsbLibLgLsbLsbLsLsmbLsbLsbLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbLsLgLsL
sLsmmbLiLsbLsLsmbRsLsLsmbLebLibLhbRgbRgbLcbLsLsmbRebLiLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bRsRsRsmmbRobRcRsmbRcbRhLsbRibRcRcbRibRcRsmbRiRsmbRcbRibRgbLsbRcbLsbLo
bLibLgbLsbLiLgbsbLsbLsbLsLsmbLsLsmbLsbRcbRibRebRsbRgbRhbRgbReRsLsmbRgb
RgRsmbsbRgbRgbRhbRibRibRebRhbRibRgbLsRsbRsbsbLsbRsbRibRibLsRgRsmbRcbRi
bRsbsbRiLgRsbRgLsbRsbRsbsbRgbRgRsmbLsbRcRsmbRibRcbRcRsmbRgbRcbRcbRibRc
RsmbRcRsmbRibRsLsbRibRgbRiLsbRgLsbLsbRgbsbsbRcRiRsmbRgLsbRgbRcbRgbRebR
ibRiRsmbRcRsmbRhbRcRsmbRoRsRcmbRiLsbRcbRebRibRcbRobRgbRobRgbRsbRgbRjbR
sbReRibRhbLhbLibLibLgbLibLgbLibLibLibLibLgbRsbLibLhbLibLsbRebLibLibLhb
LgbLebLgbLibLibLibLgbLibLgbLibLcbLgbLgRsbLgbLgbRjRcbLsbRsbRsbLjbLgbLib
RcbLgRiRsmbRebLsbRibLebRebRgbRgbRebRgbRgbLsLcbLgbLgbLgbLgbRsbRjbRobRib
RgbRibRcbRibRjbRibRsbLcbLibLgbLgbLgbLsbRjbRcbRibRgbLgbLibLgbLsbLsbLgLs
bLsbRcbLjbRibRgbRiRsmbRibRgbRgbLsbRiRsmbReRsmbRibRgbLibRibRhbRgbRiRgbR
iRgbRgbRgbRiRsmbRsbLjbLjbLibLgbLgbLgbLibLgbLibLgbRibLibLgbRjbRgbRsbLib
LgRsbRcbRibLjbRiRsmbRgRsmbRgbRgbRgLsbLsRsbRgbRgbLgbRsbLsbRjbRiRsmbRibL
hbLibLibRjbLgbRjbRibsbRgbRebRgRsmbRgbLsLsmbLjbRiLjbLibRebReRgbRiRsmbRg
LsLgbRiRsmbRgLgbRibRgbRsbsbRsRsRembRgbRgRsRgRsmmbLsbRgbRgLsRsbRgbRgbsb
RibLjbRebsbRgbRgbRiLsRgbRgRsmbRibRgRsmbRgbLibRibRcbRibRibRhbRhLsbLjLgb
LibLgbLebRibRhbRgRsmbRgbRibRsRsmbRsbRibRcbRibRsbLibRibRgbRjRgRsRgRsmmb
RgRsmbRsRgbRgbRgLsbLjbRibRcbRebRgbLgbRibRgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bRjbRobRcLsbRiRgRsRiRsmmbRiLsbRsbRibLsbLsbRiRsRsmmbLjbLibLjbLgbLcbRsbL
jbLgLsbLgbRsRsmbLhbLebLiLsLsLsmmbLsbLsbRhbRjRsRsmmbLobRcbRgbRgbRcbLsRs
bRsRsmbRhRsmbsbRobLsLsmbLiLsbLibLsLebLibLgLiLiLsbLeLsbLibLgLsbLgLsbLgb
LebLibLibLgbLiRsbLsLsmbLgbLibLgbLhbLiLsLsmbLgbLgbLgbLibLgbLiLsLgbLeLib
LiLeLsbLiLsbLiLsLiLsLeLiLsbLsbLgbLibRibRgbRibRgReRgRiRsmbRsRebRibRsbRg
bRsbRobRibRibRibRgRibRgRsmbRiRsRgRgmbRgRgRsmbRgbRgbRgRsmbsbRgReRsmbRib
RsbLjbLsbLgLibLebLgbLoLsmbLsbLiLiLibLibLgbLobLibLsbLjLcRsbRsbRibRgbsbR
gbRgbRjRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
bRjbRgbRgRsmbLhbRgbRibRgbLjLsmbLjbRibRcbRhbRgbRibRgbLjLsmbRgbRcbRsbRhR
smbRobLsbRcbRgbRibRibsbRibRgbRcbRsbRjbLcbRgbRsRhbRebRsRsmbRcbRgbRhRsmb
LibRsRsmbRjbLsRsbLjbRebRiRsRsRsRgRsmmmmbLgLsRsbLjbLsRsbRcbRgbLebRgRsmb
RgbLjbRiRsmbLhLsbLsbRjRsmbRsRgbLebLjbRcbLsRibRsbRcbRjbLsbLjLsmbRhbRgbs
bLjbRcbLsbLjbLgLibRhbLcbLiRsbRgbRgbLsbLcbsbRjRsmbLgbRhRsmbLhLsbRjbRiRs
mbRsRsmbLsRsbRjbLgbRjbRgRsRgmbLjbLebRebRiRsmbRcbRgbLsbRibsbsbLsbRsbLjb
RsRjbRibLjbsbsbLjbRgbLebLgbLibLhbLcbLjbLsRsbLsRsbRgRsRsmmbLhbRsRsmbRjR
hRsmbRgRsmbRibRsRiRsmbRibRgRsmbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bsbRgbRgbRsbRgRsmbRgbRsRsLsmbRgbRgbRibLsbLebLgbRebRibRibRgbLhbLibLebLg
bLiLsbLjLebRsbLcLsmbRiRsmbLebLibLsbLsbLsbLibLsbRibRhRsmbRibRsbRsbRsbRg
bRgRsmbRgbLibLhbLibLgbLiLsbLibLsbLiLsbLgbLsbLsLgRsbLgbLebLibLibLibLibR
gbLibLibLsbRgRsmbLebRcbLebRgbLgbLgbRsbLsbLsbLgLsbRgbLgLsbRjbLsLsmbLgLs
bLgbLsbRcbRsbRsRsLsmbReLsbRgbRebLjLsmbLeLsbRibRobRgbsbRhbRgbRgRsmbRgbR
gbRibRgbRgRsmbRebRibRcbRgbRgbRibRgbRsRsmbRsbLibLebLgbLibLibRsbLibLsbLe
bLgbRsbLcbLgbLgbLgbLgbLgbLgbLibRgbLgLsLibRsbLhbLgbLgbLgbLibLhbRebLibLc
bLsbLgRsbLgbLhbRsbRgbRibRibRibLsLsmbRebRgbRibRibRibRiRsmbRibRebRibRibR
gbLhbRobRibLsbLibLebLiLsbLibLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
bRgbRgbRibRgbRgLsbLobLhbRhbRgLsbLcbRgbRhLjbLibLibsbLsbLibRjbLiLgbLgbLi
bLhbRobRgbLjbLibLibLgbLgLsbLsbLsbLhbRjbLsbRcbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bsbLgbLiRsLsbLiRsLibLibLibRjbLcLsmbLcbLibLeLsbLhbLibLiLsbLiLibLibLibLi
LcbLobLibLibRgbLobLibLobLcbLhbLibLhRsbLhbLcbLeLebLebLiLgLgbLgRsbLgbLsb
LibLhLgRsbLibLgRsRsmbLibLiRsbLsbRibRcbRcbRcRiReRibRgRebRcbRibRgbRcbRib
RibRebRgbRibLobLcbLsbRcRsmbRibRibRibRsbRobRgbRhbRibRgbRsbRibRiRiRsmbRe
bRiLsbRgbRibRhbRgbRibRibRgbRiLsbLsbRibLsbRobLsbRibRibRibRhbRibRgbRobRg
bLibLibLgbLgbLebLhbLjbLsbLsLgbLgbLsbLgbRsbLgRsbLgLsbsbLgbReRsmbRgRgbRe
bRiRsmbRgRcbRgRsmbRibRgbRhLsbRgbRgbRiRobRsbLjbLibLhbLsbLibLiLiLsbLibLi
bLgbLcRsbLsbLsbLcbLhbLgbRsbRsbRjbLjbLcbRibLobLhbLcbRgRoLsLsmbRgbLsbRsb
LgbLibLibLibRcbRgbLcbLibLgbLgbRgbRibLgbLobLibLgbLiLsbLgbRsbLgbRsbLgbLg
RsbRgbLibLgRsbRiRsmbRjbRgRsRsmmbRsbLsbLgbLgLsbRsbRsbLsbLsLsmbsbLsLsRsm
bLsbLgbRsLsbLsbLibLiRsbLcbLebLiLsbLhbLhLeLgbLcbLobLhLsbLiLsbLcbLeLeLsb
LhLgLcbLibLibLhbLcbLhLsbLoRsLsbRhRhRsRsmmbRebRcbRibRibRgbRgbRibRgbRobR
hbRebReRebRiLsbRibRibRibRobRibRibRgbRiRibRsRsmbRgbRgRibRcbRibRsbLsRsbR
obLcbLibRobLcbLibLcbLibLibLsbRcbRibRibRibRsLgbRsbRiRsmbRgRsmbLibLibLib
LgbLebLibLgbLgbLgbLiLsLsmbLgbLibRgRsmbRibRgbRgbRgbLeLsbLibLgbRhbLibLhb
LibRgRsmbRebRibRibRgbLsbRiLsbLsbRjRsmbRiRsmbRibRibRgbRgbRibRgbLsbRibLg
bLsbLobLhbLiLsbLhbLibLgbLibLibLsbRsbRgbRibLgbLsbLibLeRsbLibLgbLgbLiLsb
LsbRsbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134329; End: 134829;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bLsbRsbRibRiRsmbRsRsRiRiRsmmbRgbRsbLsRsbLsRsRgbLsbRsbRibRgbRsbLsRsbRsb
RsbRsbRsbRsbLsbLsRsLsbRibRebRibReRsmbRibRibLsRsbLsRsbRgbLcbLibLibLibRg
bRjbRgRiRsmbRgRsmbLcbLsbRibRjRsRsmmbsbLsbLjbRsbLibLibLhbLsbLibLgbLgbLg
bLgbLibLgbLiLsbLibLgbLgbLgbLibLsbLgbLgbLgbRsbLgLsbLibLibRsbRjbLhbLgLsL
gbLsLsLsmmbLgbLiLsLsmbLibLgLsbLgbLgbLgbLgbLgbRsbLiRsbLgLsbLgbLsbLgLsbL
sLgbLibLgbLgbLibLgbLgbRsLibLsLgLsbLgLsbLgbLibLgbLgbRsbLgbLsbLsbLgbLgLs
bLsLsLsLsmmmbLgLsLsmbLiLsbLiLsbRsLsbLsLsLsLsLsmmmmbLsbLhbLgbLgbLgLsLsm
bLgbLibLgLgbLibLiLsbLgLsbLgbLgbLsLgbLgLsbLgbLgLsLsLsmmbLgbLgbLgbLgbLgb
LgbLgbLgLsbLgbLsRsbLsbRsbLgLgLsLsmbLgLsbLibLgLgLsbLsLsLsmmbLsbLiLsbLgb
LgbLgbLgbLgLsbLgbLgLsbLgLsbsbLgbLgbLgLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bRsbRjRsmbRsbRjbRibRgRsLsmbRobRibRibRgRsRsmmbRsRsRsmmbRsbLgbRsRsmbRsbR
sbRsbRsRsmbLsRsbRsbLsRsRsmbRsbLsRsbRsbLsRsRsmbLsRsbRsbRsRsLsmbLsbsbLsb
sbLsbsbLsbsbsbLsLsLsmmbLsLsmbLsbLsRsLsbLiLsbLhRsLsbRebRgRsmbRgbRsLsbRs
RsmbLsbRsbLsRsbRsbLsbRsRsmbRsbRsbLsRsbsbsbLsbsbRsRsmbRsbLsbLsbLsbRsRsm
bRhbRibRgbLsbLibLsbRsbsbLsbLsLsmbsbLgLsLsmbRsLsLsmbLsRsbRsLsbLsRsbsbRe
b

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRgbRgRsmbLsLsmbsbRgRsmbLsLsmbLcbRibLjbRibRhRsmbRgbRgRsmbRgRsmbRsbRibR
cbRhRsmbRcRsmbRibRebRibRibRiRsLsmbRibRibRebRibRibRsRsReRsmmbRgbRgbRibL
ibRhRsmbRsbReRhbRibRiRsRsmmbRibRgRsmbRibRibRgbRibRgbRibRiRsmbRiRsmbRib
LjbLobLgbLiLsbLgbLibLgbLiRsbLgbRsbRiRsRsRsmmmbRsbRsRsmbRsbRsRsmbRsRsmb
LsLsRsmbRibRgRsRsRsRgmmmbRiRsmbRibRgRsmbRgbRsRsRsmmbsbRgbRsRoLsbRobRib
RgRcbRhRiRebRebRebRgbRgbRibReReRibRiRsmbRgbRgbLsLsLsmmbLibLebLiLsbLibL
gbLiRsbLiRsbLibLhbLibLebLhbLgbLebLgRsbLgRsbLgRsbLiLsLsmbLibLsbRjRgRsRs
mmbRiRgRsRsRsmmmbRiRsmbRiRsRgmbRsRsmbRsRsRsRsRgRsmmmmbRsRibLcLsmbLgbLc
LsmbsbRibLgLsLsmbLsbLsLiRsbLcbLebLgLsLsLsRsmmbLgRsbLgbRiRsRhmbLcbLcRsL
sbLibLibLibLiRsbLgbLeLsbLhbLgLsbsbLsbLsbRjbRsbRsbRsRebLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLcRsLsbLebRiRsmbRgbReRsmbRiRsmbRgRsmbRgRsmbLsbsbsbsbLsbRsRsmbsbsbsbsb
RsbRsbRgRsRsmmbRsRsmbRgbRibRgRsmbRsRsmbRsbRibsbRgLsLsmbLcLsmbLsLcbLcbL
cbLcLsmbLeLebRsRsmbRcbLibLibLgRsbLsbLibLibLgLgbLgLsbLsbRjRjbLcLsmbRjbL
ibRibLibRcbRiRsmbLcbRcbLibLgLsLsLsLsLgLemmmbLgLsbLgLsLsLsmmbRsLsbLsLsm
bLsLsLsRsmmbRsLsLsmbLsLsmbLgbRsLsLsLsLsmmmbRsLsbLhbsbLiLsLsmbLsLsmbRsR
sRsmmbRibLsLsmbLibRhbRsLsbLhbRjbRibsbRsLsbLjbRoLsbLsbsbLsRsbRgRsmbRsRs
mbRsbRgRsmbRsRsmbLgbRsbRiRsmbRiRsmbRhbLibRcbRiRsmbRhRsmbReRsmbRebRhRsR
smmbRiRhbRcLsbRcbRiRsmbRgRsRsmmbRiRsmbRgbRhRsRsmmbRibRiRsmbRgbRibLjbRi
bRsRgRsmbRsLsbLhbRiLsbLcbLcbLhLsbLhbRsLobLibLcbLcbsbLcbLcLsmbLgbLoLsmb
LsbLhbLebLibRjbRobRgbRgbRiRsmbRgbRgRsmbRgbLcbLibLibLibLiLsbLibLibLibLi
bLsLsRsmbLiLgbLibLsLsmbLiLsbLgbLibsbRcbLcbLiRsbLibLebLibLibLhbLebLiLsb
LiLsbRjbLjbRjRsRsmmbRhbLoLsmbLsbRjbLibLibRcRsmbLhbRcLsbLjbRcbRiRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bLsbLsbsbLsbRsbRobRgRoLsbLgbLgbLsbLgbRgbRgbRhLsLsRsmbsbRgRsmbRibRhbLsR
oLsbLgbLsLsmbLsbLsLsLsmmbLsbLsbLsbLsbLgbLgLsbRoRsmbRgbRsbRcbRcbRebRiRs
RimbRgLsbRgbRgbRgRsRsmmbRiLsRsbLsRsReRsmbRgRsRsmmbRgbRgbRgRsmbRsbRsRsm
bRsLsbRsLsbLsbLgbLsbLsbLsbLgRsbLsLgbLgbLhLsbsbLsbLgbRobLsbLgbRebLsbRsb
RgbRgRsmbRobRoRebRgbRsbRsbRsRgRsmbLobLiLsbLibLibLsLsmbLgRsbLhbLibLeLsb
LcLsmbLhbLebLsLsLembLgLsLeLsbLgbLibLiLsbLibLebLsLebLgLebLgbLibLibLebLc
LsmbLibLibLibLebLgbLeLsbLsbLibLibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRgbRgRsmbRgRsRsmmbRgbRgRgbRgbRcbRgbLsbLjbLiLiRsbLibLgbLsbRjbLiRsbLgLs
bLsbLsbLgbRobRhRsmbRgbRibRibRgbRibRhbRsRibRgRebLsLsmbLjbRgbsbLsLsmbLib
RcbLjbLjLsmbRobRibRgRsRsmmbRibLsbRsbRsbRsbRsbsbRsbLsbsbsbsbLibRsbsbRjR
gRgbRgRsRsRsmmmbRgRsmbLsLsmbRsbRiRsmbRjRsRgRgmbRcbRcbRgRsLsmbRibRgbLsR
sbRgbRsRsRsmmbRsRsmbRgRsmbLsRsRsmbRsbRsbLsRsbsbsbRgbsbLgbsbRsbRsbsbRsR
smbRgbRsRsmbRsbRsbRsbRgRsmbLhbLhbLcLsmbLcLsmbLgbLgLsbRsbLsbLgRsbLsbsbs
bRsLsbLsbLebsbLsbLsbRsbRsRsmbLhbLgbLcbRcbRcRsmbRibRebLsbLiLsbLibLobRib
RgRsmbRsbRibLebLhLsbLebLibLibReRsmbRgbRobRibRibRcbRiLsbRcbRebRibRgbRgb
LsbRiLsbRgRsmbLsRsRgbRgbRebLsbRgbRsbRgbLjbLsbLgbLibLgLsRsbRsLiLsLgbLgb
LgbLgbLgRsLsbLgbLjRsbLgbLgRsbLgbLiLsbLgbRobRhbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bLgbLgLsbLgbLsLsmbLsLgLgLsbLgbRjbLhbLgLsbLgLsbLsLsmbLgbLsLsLsmmbsbRsRs
mbLgLsbLsRsbLgLsLsLsLsmmmbLsbLcbLgLsbLhLsLsmbRobRibReRsLsmbLsReRsmbRib
ReRsRgRsmmbRibRgRsRsmmbRgLsRgRsRgmbRibRgbRgRsmbRsLsbLsbRgRsmbRibRsRgRs
RsRsmmmbRgbRgbRgRsmbRgRsmbRsbRgRsmbRsRsmbRsRsmbRsRsmbsbRsbLsbRgbRiRsmb
RiRsLsmbRgRsmbRsRsmbRsRsRsmmbsbRsRsmbRsRgbRsbLsLsmbsbsbRibLcbRcbLcbRcb
RjRsmbLibLsbRcbRiRsmbRobRjbRebRhbRsRgReRsmbRgbRgRsmbRsRiRsmbRgbReRsmbR
gRsmbRiLsbLibRsRsLsmbRgRsRsmmbLsRsbLsbLjbRibsbRsbRibRsbRhbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bRgRsmbRsRsmbRsbRsRsRgmbRgbRgbRsLsbRibLsbLsbLebLhbLebLobLgbRjbLibLhLsb
LobRebLgbRsbRgbRiRsRgmbRsbRgbRsbsbRsbRsbRsRsmbRgbRsbLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bRsbRsLsbRsbLsbLsLsmbLsbLsbLsbLsbsbRsbLsbLsRsbRsbRsbLsbLsbRsbLsbRsLsbL
sbsbRsbRsRsmbRsbRsLsbLsbRsbsbsbLsbRsbLsRsbRsbRsbRsbRsRsLsmbsbLsbLsbLsb
sbsbLsbLsbLsbsbsbLsRsLsbsbRsbLsbRsbLsbRobRjbLsbRjbReRsmbRjbLsRsbRsbRsb
RobRhbLobRobLsbLobLobLcbLcbRebRobLobLsbRobRjbRsbRebRcbRobRebLebRhbRsbL
sbRobRsbRebRcbRsbRebLobRobRobLsbLobLsbLobLobLcbLobRgbsbRobRebRebLobLob
LebRobRobRcbLebRibRobRobLcbRobLobRobRobRebRobRobRobRhbRcbLobRebRgbRebL
obRhbLebLobRobLebLebRibLibLobLebRobLobLsRsbRobRsbLsLobLsbLoRsLsbsbRobR
sRsLsmbLcbRobLeLobLobLobLobLebRebLebRebRebRoRobLobRcbRobLobRobRebRgbLo
bRcbLsbRjbRibRsbLobRobLobRebRibLebRjbRebLobRobRobRobRobLobLobRibLobRgb
LebRobLgbLobRobRobLobLcbRobRobRjbRcbRcbLsbLobRebRcbRgbLcbRobLcbLsbLcbR
ibRhbLgbRsbLgbLsbLobLebRgbRebLebLibRibLobLobRebLebLebRcbRgbRcbLhbRsbLo
bRebLjbLsbLebLgbLibLobLsbRobRobRcbLsbRobRsRibRibLobRebLcbRcbRobLsbLobR
ibLobRebRcbRebRebRcbLobRibLobRcbLobLcbRebRobRibRcbLcbLobRebRcbRobRsbRo
bRobLsbLgbLobLcbLobRobRgbRibLjbRobLobLebRcbLobLobLibRobRebRebLgbLebLhb
RebLobRobRebLebLcbRebLobLhbRobRobRhbRobLsbRobLebLobRobRebLobRebLebLebL
obRobRcbLobLhbRgbLcbRebRobLobLgbRebRobLobRobRcbLobLgbLibLebLobRobRcbRo
bLobRobRobLebLsbRobLebRgbRobLcbRobRhbLobRobRhbRobRobLobLebLcbLcbRibLgb
LobRibLcbRcbLhbLebLgbRibLebRobLobLobRcbLobRebLsbLibLobLebRobRobRibRobL
sbLebLibRebLgbLobLebLebRebRgbRobRobLobRobLgbLcbRobRobRobRobLobRebLibRo
bRebLsbLsbRhbLibLibLebLobRcbLjbLcbLobRebRebRobRobRobRjbLjbRebRobRebLeb
RibLobLobLibLgbLgbLebRhbLebRhbLebLobLsbLobRobRobLobRsbRcbRobLsbLebLebL
sbLobRebRebLebLcbRobLobRcbRsbLobRebLobLobLobLgbRebRcbRsbRsbLibRobLobRo
bRobLcbLcbLebLobLibRebLcbLebLobLebLgbRcbRcbRobLebRcbRgbLobLcbLcbLebLib
LjbLebRcbLsbLebLobRibRgbLobLobLobRcbRebRebRgRsmbLsbLsbRsbRcbRebLibLebR
obLibRhbLjbRobLobRibLgbLebRcbRhbRobRebLsbLobRcbLobRgbLcbRobLebLsbRobLo
bLobRobRcbRebLibLobRebLgbRebLebLibRebLebRobRobRibLebRhbRobRgbRebRibLgb
RsbLcbLsbLgbLobRobRebLibLjbLobLobRobLobLcbRobLebLsbRgbRobRhbLobRobLobL
ebLcbRobRhbLcbRebLobRobRobRcbLebLobLcbLobLjbLgbLobLgbLobLcbRebRibRobRc
bLobRcbRgbRgbLsbRcbRobRobLibLobLobRobRobRobLebRebRsbLgbRsbLibRgbLjbLgb
RobLobRsbLebLobRobRsbRobLobRobRcbRcbLobLebLibLsbRobLobRobLcbRebRibRhbL
obLibLcbLobRibRgbRobLobRsbRobRobLsbRsbLebRobRebRobLobRobLebRibRobLobLo
bLsRsbRobLebLgbRhbRcbLobLobRobRebLcbLobLsbLobLibRjbLobLobLebLsbLibLibR
obLsbLsbLcbRobLebLobRobRebLobRcbLobRebRibLcbRebRobLebLcbLebRobRsbRobRe
bRebRobRebRebLobRsbRcbLebRsbRobRcbLobRsbLobLobRobRibLebRobLgbRebRebLgb
Rob

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bsbRsbsbsbRsLsbRsbsbsbsbsbLsbRsbsbsbsbRsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLibLibLhbLibLcbLsLsmbLcbLsbRhRsLsmbRhRsmbRibRibLjbLibLibLebLibLjLgbLj
bLiLsbRcRsmbLhbLiRsbLibLsbLcbLgRsbLgbRsLsbLiRsbLiLsbLiRsbLgLsbLiLsbLjL
iLgbLgLsbLiLsbLgbLsbLgLsbLgLsbLsbsbLgRsbLgbLgbLgbLgbLgLsbLgLsbLsbLsbLg
bRsbRjbLjLiLsbLgLsbLsLiRsbLhRsbLjLsmbLibLibLgbLiLsRsbLibLiRsRsRsmmbRgb
LcbLiLsbLgbLiLsbLgLsbLgbLgbLsbRsLsbLgLsbLgbLgbLibLcbLcbLcLsmbLibsbLiRs
bLgbLibLobLiRsbLgbLibLibLgbLgbLgLsbLsbLsLsRsmbLgbLsRsbLgLsbLgRsbsbLgbL
gbLgbLibLibLhRsbLcbLgLsLsLgmbLgRsbLibLgLibLibLibLgLgbLgbLebLgbLgbLgLsb
LibLgbLgRsbLgbLgbsbLgbLgLgLsbLgLsbLgRsbLgRsbLgbsbRsLsbLhRsbLcbLcbLobRe
bRibRcbRcRsmbRiRsmbRgbLibLibLibLhRsRsmbLsbLgLebLebLgbLgbLgbLjLsLsmmbLi
bLhLsRsbLjbLiLsbLibLjRsbLjbLjbRjLsbRcbRibRjRibRibLgbLibLibLgbLgbLsbLgR
sbLsbLgbLgRsbLgLsbLgbLgbLiLsbLhbLcbLibLcLsmbLiRsbLhRsbLhbLibLhbLibLjbL
ibLiLibLiLsbRcbRcRsmbLsbLjbRgbRiRsmbRsbLibRjbLcbLgbLgbsbLsLsmbLibLgbLg
bLsLgbLsbLgLsbLgRsbLgLsbLgLsbLgbLgLsLsmbLgLsbLsbLgLsbLsbLsLsLsmmbLsbLs
LsLsmmbLsbLgLsLsLsmmbLsbLgRsbLsbLsbLiLsLsmbRjbLhRsbsbLiLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRibLjbRibRiRsRsRsRsmmmmbRgbRgbRgbRgRsRsmmbRgbLgbRibRgRsmbLibRjRgRiRsm
bRgbLsLebLibLiLsbLibLgbRjbLgLsbRibRhbRhbRibLiRsbLibLgbLgbLgbRsbLsbLiLs
bRsbLsbRiRsRsRsRsRsRsRsmmmmmmmbRiRsmbRgbRgbRgLsbLjbRjbRgbRsRsRsmmbRsRg
bRgbRsbRgLsbRgRsmbRsRsLsRsmbRgbRgbRgbRgbRsRsmbRgRsRsRsmmmbRgbRgbRiRsmb
RgRsmbLjLsmbRgRsRsmmbRsRgbRgRsmbRgRsRsRsmmmbRgRsmbRgRsmbRgbLjbLiLsbsbR
gRsmbRibRsRsRgmbRibRgRsRsmmbRibRgbRgbRgbRobLsLsmbLjbRgbRgRsmbRsbRibRgL
sRsbRgbRgbRgbRgbRgbRgRsmbRgbRgbRsbRsRsRsRsRsmmmmbRgRsmbRsRsmbRiRsmbRgb
RgRsmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bLjbLibRgLsbLgbLebRiRsRsRsmmmbLjLsmbLibLgbLhbsbRebRebRsbRcRsmbRsbLjbRe
RsmbLgbRcbLgbRebRgbLjbLiRsbRibLjbRhbLjLsmbRiRgRsmbLjRgRgRsmbRebRibLobR
cbRebRsRsmbReRsmbsbRhRsmbRsRsRsRsmmmbRcbRgbLjbLibLjbRgbRjbLsLsmbLsbLgb
RhbRgbRgLsbsbRsbRiRsLsmbsbRsbLgbLibLhbRjbRjbLcbRcbRsbLjbLcbLgRsbLibLiL
sbLhRsbLibLebLgRsLgbLeLsLebLebsbRjRgRsmbRhbRebRibRibRebRhRsmbRibRhRebR
ibRebRgRsmbRibRiRsmbRcRsmbReRsmbLcbLsbLibRcLsbRjbRiRsRsmmbLjbRhRsRsmmb
RjRsmbRibLhbLgbRjbRsbRsRsRsRsmmmbRsbRgRsmbRibLjbLibLibRhRsRiRsmmbsbLjb
LibLibReReRgbReRsmbLibsbRsRsmbRsbRgRsRsmmbLjbRibRiRsmbRhbRiRsRsmmbRibR
ebRibRgRgbRhbLebLcbLhbLcbLebLiRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bLgLgLsLhLsLsRsmbLsLsLsLgLsLsLsLsmmmmmbsbRsbLgbsbLgLsLsmbRjbLcbLhbLibL
iRsLsbRebRiRsRsmmbRcbRcbRcRibRibReRgRgRsRimbRiRsRsmmbRibRhbRgbRibRibRe
RibReRiRsmbRibRiRsRsmmbRiRsmbRsRsmbRiRsmbRgLsbLgbRhRsmbRgbRgRgbRcLsbRg
LsRsbLsbLjLsmbLjbRhLsbLjLsmbLibLgbLibReRsRiReRgmbsbLgLsbLsLsLsLsLsmmmm
bLgLgbLsLsmbsbRgbLsLgbLgLsLsmbLgLsbLgLsLsLsLsmmmbLsbLsbLiLsbRsRsmbLgLs
LsLsLsmmmbLsbRjbLcbLiLsbLiLsbLibLebLibLsbRsbRsbLsLsmbLgbLsRsLsbLiRsbLi
LsLsmbsbLgLgbLeLeLsLsLembLgbLibLsLsLsmmbLiLsbLgbLibLibLhLsbLgbLebLibLe
LeLiLgbLobRhbLibLiLsbLcbLibLibLiRsbLsbLiRsbLjLgbLiLsbRgRsmbLhbLgbLiLsb
LsbLsbLsbLsbLgLsLgbLiLsbRgbLiLsbLibLiLsbLebLibLibRiRgbRcRsmbRebLsbLiLs
bLgLsbRsbRsbLsbLsbLsLgLhLgLeLeLsbLibLgLsLsmbRibRibRiLsbRiRsmbRgRsmbLhb
LobLjLsLsLsLimmmbLgbLjRsbLgLsbLibLjLibRsbLjbLibLgbLgLsLiLsLeLsLgLsbLgL
sbLsLsLgmbLibLibLiLsLgRsbLiLgLsbLgbLgLgLsLgLsLsLsmmbLgbLsbLsLsmbLibLgb
LgRsbLcbRiRsRsmmbLsbRhbRiRgRiRebRgbRgRsmbRibRgbRgRsmbRiRsLsmbReRgbRgbR
gLsbRgRsmbRgRsmbRgRgRsmbRsbRgRsRsRgmmbRgRgRsRsRsmmmbRiRsRgRgRsRsmmmbRs
RsmbRgbRgLsbsbLjLsmbLiLsLsmbRebRjbRiRsmbRhRsRsmmbRhbLgLsbRcbRebRibRcbR
gRgbRgbRgbLsRsRsRsmmbRiRsmbRhbLsLgLsbLiLsLsLsLsmmmbLiLsLsmbLibLgbLibLg
LsbLibLsbLebLibLgbLjLsLsmmbLgbLgbRjLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLsbRgRsmbRibLjLcbRjbLjbLjbLgbLgbRjbLibLibRsbRibLibLibLgbLgbLgbLcbLgbL
sbLobLeRsbRibLgLsbLjbLgbRsbLibRibRhbRsbRsbRsbRibLgbRibsbRiLsbRgbRibRib
LsbLjLsLsmmbLsbRhbLjbRhbRgbRgRsmbRgRsmbRgRsmbRibRgbRgbRgbLgLsbLjLsmbRj
bLjbRibRsRsmbRgRsmbLsbRibLsbLsLsLsmmbRhbRsbLsLsLsmmbRsRsmbRsRsLsmbLsRs
RsmbRsLsRsbRsRsRsmmbLjbLgbLibRsbRjbRiRsmbRgRsRiRsmmbRsRsRsRsLsmmmbRgbR
ibRgRsmbRgbRgbRobRcbLjbLcLsmbLcbLibRhbLibLibLhbRcRsmbRhbRgLsbRgbRgLsbL
jbLjbLcbLibLcbLibRibRhLsbLgbRsbRibRibRgbLhbRcbRgRsRsmmbRgRsmbRgbRgRsmb
RsRsmbRgRsRsRsRgRgmmmbRgRsmbRsbRsRsRsLsmmbRgbLsRsbRiLsbRhbRibRsLsbLcbL
iRsbRjbRiRsmbLjbRhbRgRgbRgRgbRgRsRsmmbRgRsRsmmbRibRgbLsbRsRsRsmmbRgbRs
RsRsRsRsRsRsmmmmmmbRgbRsbRsRsRsRsmmmbRsbRgRsmbRgbRsbRsbLsRsbRgLsRsbRsb
LsRsbLsbRgRsmbRgRsRsRsRgmmmbRgRsmbRgRsmbRgRsmbsbRgbRsRsmbRsbRsRsRsRsmm
mbRgRsmbRibRibRibRgRgRsmbRiRsmbRibRgbRibRgbRibRiLsbLcbLebLsLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bsbsbsbLsbRgbRsbLsbLebLibRebRiRebRcbLcbLjbRgRsmbLsLsmbRiRsmbRcbRibRcbR
hRsRsmmbsbRgbRsbRibRiRsmbRoRsLsmbRjbRibRibRibRgbRgRsRsmmbRibRcbRhRhbRi
bRiRsRsRsRemmmbRiRsmbRibRgbRsbRgbLobLiLsLsmbRjbLibLibLsbLibRjRcbRibLgb
LgbRcbRhRsmbRcbRibRibRibRibRhRsmbReRsRsmmbRcLsbRsRsmbRgbRebRcbRsbRibLg
bLobLibRjbRcbLsRsbLjbLcbRsRsRsmmbRhRsmbRgbRsRsmbRsRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bLgbLgbLgbLgbLibLibRobRibRibLgbLcbLgbRsbLibLgLsbRgRsmbRjbRsbRibRibLgbR
ibsbsbsbsbRgbLsbLjbsbRibRibRgbLjbRsbRibLsbRgbRgbLjbRgbRgbLibRibRsRjbLj
bRjbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLhLsbsbLsLsLsLsLsmmmmbLeLsbLgbRgbLibLebLgLsbLgbLeLebLgLsbRsLsbRcbRhRs
mbRiRsLsmbRhRsmbRebsbRgbRgbLsbRsbRiRsmbRibRiRsRsmmbRiRsmbRhbRcRsmbRgbR
ebRibRhbRebRcRhbRgbRibRgRgRsRsmmbRsReRsmbRcRsRsmmbLiLsbRjRsRsmmbLcbLcb
RsRsRsmmbRiRsmbRgRsmbRgbRcRsLsRsmbRgbRhRsmbRgbLhbLcbLibLhbRgbLsLsmbReb
LjLsmbRcLsbRibLjbLcbLiLsbLgbLgbLsbLgLsLsmbsbRjbLibRhbRibLebsbLcLsmbLiL
sbRgbLcLsmbLhbLibsbLibLhbLebLibLsLgLeLebLgLsbLibLgbRcbRobRobLcLsmbLibL
ibLebLgbLhbLhbLgRsRsmbLgbLiLeLsbLiLsLebLgbLsbRobRcRsmbLcbLhRsbLiLsbLib
LebRhbRiRsmbRobLhbRhbRebRhbRhRsmbsbRgbRsbLjLjbLcLsLsmmbRcbLcbRcbLcbRsb
LsbLhbLhLsLsmbLiLsbLhbLebLeLsbLeLsLgbLgLeLsbRsbRjbLcbLoRsbLhbLjbLgbLib
LiLsbLgLsLsmbLgLebLhbLgLsbRcbRebRcbRcRsmbRiRiRsmbRgRsmbRibRcbLebLibLiL
sbLgLsbLibLgbLgLebLibRhbRobRgbRhbRsbRibRgRsmbRgbRobRiRsmbRibRcLsRsbRib
RcbRhbRhbRhbRhRsmbLhbLiLibLibLsbLsbLsbLgLsLsLsLsLemmmbLjLsLsmmbRcbRcRs
mbRibLiLsbLhRsbLoRsbLibLibLebLgbLgbLibLebLeLsLiLsbLebLiLsbRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bRsbRsbLsbsbsbRsbRgRsmbRsbRsRsmbRsbRsRsRsmmbRsRsRsmmbRsRsmbRsbRsRgRsmb
RgbLcbLcbLcbLcLcbLgbRobRiRsmbRoLsbRoRsmbRibRibRgRcbRibLgbRebLgbLibLibL
ibLibLibLgbLgbLgbLgLsbLsLcLsmbLibLjbLsLsmbLibLsLsmbLiLsbsbLsLsLsmmbsbL
sLgbLgbRjbRcRsRsmmbLsbRsbRsRsmbRgbRsbRibRsLsbRibRibRebRebRebRebRebRcRh
RsmbLsbsbLsLeLebLjLsLsmmbRcbLgbLibLjLgbLgbRsbsbLsbLsLsLsmmbLsLsmbLgLgL
sbLiLgLsbRsLsbsbLsbLsRsLsbLsbLsLsmbRjbLcbLeLsbRobRiRsmbRgbLjbRsRhbRjbR
iRsLsRsmbRsRsmbRgRsmbRsRgbRsRsmbRsbRiRsmbRhbLgbLibRibRcbLsLsLsmmbRsbRi
ReRiRgbsbRsRsmbRgbLgbLcLsmbLobLhLsbLiLsbRjbRsRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bRgbRgbRgbRgbRgbRgbRsbRgbRgbRgbRhbRiRsmbLgbRgRsRsRsRimmmbRgbRsbRibLibR
gbRibLibRgbRibRiRsmbRgRsmbRgbRgbRgRgRsmbRsbLjbRjRsmbRibLsRsbRgbRsbRgbR
gbRsRsmbRgbRgbRgbRgRsmbRsbRgRsmbRgRgbRgbRgRsmbRgRsRsmmbRgbRgLsbRgRsRsR
immbRgbRsRsmbRgbRsRsRsRsmmmbRsLsbRgRsmbRgbRgRibRgbRiLsbLgbLjbRjbRibRib
RibRiRgbRgbLcbLebLibLebLgbRjbRibRgRsmbRgbRgRsmbRsbRgRsRsmmbRsbRsbRibRs
bRgbRibRgbRsbRgbLjbRibRgbRgbRsRsmbRsbRgbRgRsmbRibRgRsmbLgbRibLjbRjbRsR
gbRsbRgbRgRgRsmbLsRsRsmbRsbRhRsmbsbLsbRsRsmbRsRsRgRgmbRgbRgbRgbRiRsmbL
ibRsbRgbRgRsRsmmbRgRsRsmmbRibRgbRgbLibRcbLhbLgbsbsbRsbRsRsmbRsRsmbRgbR
gbRgbRsbRsbRsRsmbRgRsRsRsRemmmbRsbRgbRibRibRebRsLjbRcbLobRcbLcbLsbRobL
sbRiRsmbRobRgbRibLibRobRibLebRibRobRgbRsLsbRgRsmbLsRsbRgbLcbLcbLibLgLs
bLsbLobLgbRiRsmbRiRsRsmmbRcbRibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bLgbLebLebLcbLsbRjbRjRgRsRgmbLsbsbRgRsmbRhbRebRgbRcbRebRobsbLgbLsLibLi
bRgbRobRibLjbLhbLcbLgbLcbLibLgLsbLebLibLeLsbLebLobLebLibRebRiRsmbRibLi
bLebLcbLebLcbsbLobLibRjRiRsmbRiRsmbRebRibRcbLebLiLcLsmbLeLsbLgbLhLsbLi
LsbLhbRibRebRhbRhbRgbLsbLhbLsLsLsmmbsbLebLebRsLgbRibLibLhbLebLibLiLgLs
bLjbLjbRsRjbLeLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bLibRsRsmbRsbRsbLcbLibLibLhbLgbLibRibLjLsmbLsLsLsmmbLibLcbsbLebLhLsbLi
LsbRcbLjLgLsbLcbLcbLobLibRsRjbRhRsmbLjbRcbLjbRcbRibRcbRgRsmbLibLibLcbL
cbLibLebLiLsRsbLibLebRhLsbRibRibRibRibRibRgbRibRibRhbRiRsmbRibRgLsbRcb
LsbRibRgbRsbLcbLhbLhbLcbLebLibLibLhbRcbLsbRcbRibRgLsbRgbRcbRibRiRsmbRg
bRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bRsRsRsRsRsmmmmbLsRsRsRsRsRsmmmmbRsRsRsRsRsRsmmmmmbRsbRgbLsLsmbLgLsLsm
bLhbsbLiLsbRsbRgbsbLhbRobLsLsmbLsLsmbRjRsmbRhbLsRsbRsRsmbRsRsRsmmbRgRs
mbsbRsRsmbLsLsmbRsbLsbRsRsmbLsbLsbRsbRsbRgbRcbsbLgRsbRsbRgbRgRsRsmmbRs
RgRsmbRsRsmbRsRsRsmmbRsRsRsRsRsmmmmbRsRsRsRsRsRgRsmmmmmbLsRgbRsRsmbRgb
RsbRgbRebLgLsbLsbRgRsmbsbsbRsbRsRgRsRsmmbRgRsRsmmbRcbRsRsmbLsbRibRcRsm
bRcbLsbLsRsbLsLgLsbLsLsLsmmbLsLsmbLsbLsLsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bRhRgRsmbLcbLcLsmbRebLcbLhbLsbLcbLsLsmbLebLibLhLsbLsLgLsbRsRgRsmbLjLgb
LhbLcbLebRsbLgLsbLiLibLiRsbLcbLibLcLsmbLsbLsbsbLsLsmbRsLsLsmbRcRgRhbRo
RsRsmmbRcbRiRcRsmbRcbReRsmbRiRsmbRobRobRobRsbLhLsbRjRjbRhbRibLcbLebLhL
sbLebLeLsbLeLsbLgLsbLcbLiLsbLibLgLsLsmbLsbLsLsmbReRsmbLcLsLgmbRsRsmbRj
bLjLebLibRobRcbLsbLsLhLsbRcbRhbLjbsbsbRjbRhbRcbLgLsbLhLsbLsbLsLsmbRcRh
RsRsmmbLsLsLjmbRhRsmbLjLebRcbLcLsmbRjbRjLsbRibLjbLcbRcbLjbLsLsLsLsmmmb
sbLhbLsbLsLgLsLsmbLjLgLsbRcRsRsmmbLibLjLiLgLsLsLsmmbLcLsmbLgLsLsLsmmbL
hLsbRcbLebLcbLibRjbRjRsmbLebRjbLiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bRjLsbLsRsbRsbLsRsRsRsRsRsRsRsmmmmmmbRiLsRsLsbLibLhLsbLibLgbLgbLsbLsbL
gbLsLsRsLsmbLsLsmbsbLsLsLsLsLsLsLsmmmmmmbRsRsLsLsLsmmmbLgbLsLsRsLsmbLg
LsLsLsLsmmmbRcbRibLsRiRsmbRgRsRsRsRsRiLsRsmmmmbRgbRgbRobRsbRebLgbLsLsL
smmbRsLsLsmbLsbLsbLgLsLsLsLsLsLsLsLsLsmmmmmmmmbLgLsbLsLsLsLsmmmbLsbRjb
RsbRiRsmbReRsmbRgRgRsmbRibRibRgbLibLiLsLhbLsbLibRebRiLsbRjLsbRsRsRsRsm
mmbRgbRibLsbRjbRcbRibRgbRibLgbLjbRibLsRsLsbsbRgbLsbRsbRgbRgRsmbRebRhbR
ibRgbRsRgRsRsmmbRgbRsbRsbRgRsmbRgRgbRgbRgbRhLsbRiRsmbRibsbRsbRgbRsRsmb
RsRiRsmbsbRsRsRsmmbRgbRibRsLsbLsRsbRgbRgbLjbLebLgLsbLibLsbLcbRgbRsbRhb
LsbLsRsbLibLcbRjbLibRjRebRsbRiRsmbLgRsbRgLsbLsRsRsRsRsRsmmmmbRgRsmbRgb
LjbLhbLibLgLsbLgbRibRibRibRibRsRsmbRebRebRgRsmbRibRsbRsRgbRsbRiRsmbLgb
LcbLhbRsbRibRgRsmbRsRibRsbLhbLgbLebRgRsmbRhbRiRsRsRsmmmbRiLsbLgbRhbRib
RsbLgLsbRgRsmbLgLsbLgbLsLsLsLsLsmmmmbLgLsLsLsLsmmmbLjbRibRiLsRsbLsLsRs
mbLsLsmbLiLgbRjbLgLsLsLsLsLsmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRgRsmbRgRgRsRsRsmmmbRiRsmbReRsRsRimmbRebRebRiRsmbRebRebRgRsmbRiRsLsmb
RgRsRsRemmbRebRgRsmbReRsmbRgbRgbRgLsRgRsmbReRsmbRgReRsmbReRsmbRgbRibRe
RsmbRhbRgbRibRebRibRebRgRsRsmmbRsbRgbRiRsmbRsbRgRsmbRsbRebRgRgbRsbRgbL
sbLsbLsbRsLsbReRsmbRhRgbRiRsRsmmbRgbRgRsmbRibReRsmbRebRiRsmbRibRsbRebR
ebRhRgbRgbRgRsRiRsmmbRiRsmbReRsRsmmbRgbRgbRiRsmbRebRsbRiRgRsmbRibRiRsm
bRsbReLsbRsbRiRsmbRiRsRsmmbRsbRgbRsRsLsmbLsbRsbRsbRgbRsbRibRsbRiRsmbRi
bRgRsmbsbsbRsbRsbRsbRsbRiRsmbRebRibRgRgbRgbRgbRsbRsbRsbRhRsmbRgbRsbRiL
sbRiRsmbRgbRgbRsRsmbRibRibRgbRiRsmbRgRsmbRiRsmbRiRsRsmmbRsbRgbRsbRibRi
bRgbRebRibRgbRsRsmbRsbRsbRibRiRsRsmmbRsbRgRsRsRsmmmbRibRgRsmbRgLsbRsRs
mbLsbRsbRsbRgbRhRsmbRsRsmbRibsbRibRgbRgRsmbRgbRgbRsbLsbRgbRsRsmbRebRib
RebRgbRgbRsRsmbLsbRgRsmbRsRsRsmmbRgbRsRsRgRsRsRsmmmmbRsRsRsRsRsmmmmbRs
RibRibRgbRgbRsRgRgRiRsmbRgRiRsmbRhbRgRsRsmmbRgRsmbRgRsmbRsRgRsmbRjLsbR
gbLsRsRsmbRiRiRgRsRsmmbRibRgbRgRgRibRgbReRsmbRiRsmbRgRhbRgbRgbRhbRiRsm
bRebReRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLsbLsbLcbLgLsbLgbLjLsLsmmbLiRsLsbLibLgbLgbLgbLsbsbLsLsmbLsbLsbRsbLgRs
bLsbLsbLgLsbLsbLsbLibLgbLgbLoRsbLgbLibLibRsbRsbsbLsbLgLsbsbRsLsbLsbLsb
LsLsmbRsLsbLiRsbLhLsbLsbLgbLgbLgbLibLibLiRsbLibLgbLgLsLsmbLgbLebLebLsL
sLsmmbLsLgbRjbRibRsbRsRsmbRsbRsRsmbRsbRsbRsbLsbLjbsbRjbLcbLibLsbLcbLcb
LjbLibLgbLgbLgbLgbLsLsmbRsbLsbLsbLsbsbsbsbLsLsmbLsbLgbLsbLsLsmbLgbLibL
gbLgbLibLibLgbLgbLibLibRjbRcbReRsmbRiRsmbRgbRgbRgbRgRebRebReRibRiRsmbR
cbRcbRiRsRsmmbRibRibLcbLibLebLsbLcbLibLeLsbLibLgbLsLeRsbRsbLgbLgLsbLhL
sbLsbRcbRcbRebLsbRjbRgRsmbRgRsRsmmbRsbRgbLsbLsbRsbRsbRgbRgbRsRsmbRsRsR
smmbLgLsbLgbLibLibLgbLsbLgbLgbLsbLsbLsbLsbLsbLsbRsbLibLsbLibLgbLsbRcLs
bRiRsmbRhbRibRibRgbRgbRgbRiLsbRiLsRsbRcbRcbRibLibLgbsbLgbLsbRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bLsRsRsmbRsRsmbRsbLsbLsbRsbRsbRgRgbRsbLsbRsRsmbRsbRsbRsbRsbsbLsRsbRsbR
sbRsRsmbRsRsmbRsbRsbRebRebRiRsmbRgbLsRsbRgbRsbRsRsRiRembLsRsbRsRsmbRsR
sRiRsRsmmmbRsRsRsmmbRsRsmbRsRsmbRsbRsbRsbRsRsRsRsmmmbRibRibRsbRsbLsbRs
RibRebRibRsRsmbRibRgRsmbsbRsbRsRsmbRsbRebsbRsbRebRibsbRgRsmbRibRgbRcbL
cLsmbLeLsbLibLibLhRsbLhbLhLgbLoLsmbRiRgRibRsRsmbRsbsbsbRobRebLhbLcbRsR
smbRgbRjbRobRgRsmbRiRsmbRebRsbRhRsmbRibRsRsRimbRibRsRsmbLsbRsRgRibRsbR
iRsmbRgbLsbRsbRsbsbRsbRgbsbRsbRsRsRsmmbRsbRsbRsbLsRsbLsRgbRsbReRsmbReb
RhbRibLsbReRsRsmmbRsbLsbRsbRsRgbRsRsmbRsbRsRebRgbLsbRsbRsbRsbRebRgbRsb
RsRebRgbRgRsmbRgbRsbRsRsRsmmbRgRsRsmmbRebRiRsmbRgRsRsmmbLjbRibRgRibRsb
RebRgRibRgRsRsmmbRibRjbRgRsmbRgbRsRgbRsRsReRimbRgbRsbRgLsLsmbLgbRibRgb
LobLgbLibLgLibLsbRsRsmbLibLsbRgbRibRgbLsRebRgRsmbRibReRsmbRebRgbRgbRib
RebRibRibRiLsbRsRsmbsbRgLsbRsbRiRgRibRcbLhbRebRsbRsRebRibRgbRsRgRhRgRs
mbRsbRsbRhbRgRsmbRibRgLsbRgbRgbLjbRhbRgbRgbRsbRebRsbReRsLsmbRgbRsbLjRs
bLgRsbLgLsbLibLgbRcbLibRsbLgbLjbRjbsbRiRsmbRsbRsbLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bLgbLgbLsbLgbRjbLhRsbLoLsmbLhbLgLsbLgbLgbLgbLsbRsRsmbRjbLcLsmbRcbRiRsm
bRibRebLsbRobRhbRhbRgbRgbRjRcbLgRsLsbRgbRjbRiRsRsRsmmmbRgRsLsmbRibLsbR
gbRibRgbRsRgbsbLibLgRsbRcbRhbRoLsbLibLgLsbRsLsbRcbRhbLjbRjRsmbReRsmbLs
bLjbRgbRsRsmbRgbRsRgbsbRiRsLsRsRsmmbRiRsRsmmbLjbRibLcbLiLsbRobRebRgbRo
bLgLsbLgLsLsmbLgbLgRsLsbLsbRcbRibRcbRsbLibLiLsbLiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLcbLsbRcbRebLebLsLsmbLcLsmbLhLsLebLeLsLsLsmmbLgbLsLsmbLhbLgbLiLgbLsLs
mbLcbLcbLeLsLsmbLgLsbLsLsLsmmbLgbLsLsmbLsLsmbLsbsbLgbLsbsbLgbLgbRebReb
RgbRcLsbLibLeLibLgbRsbRsbRsbLgbsbLsLsLsmmbLibLsbLsLsLsmmbLsbLgbRsLsbsb
LiLsbsbLgbRjRcRsmbRhbRebRebLsLsmbLjLiLsbRcbRibRsbRsRsRsRgmmbRsRsmbLsbR
cRsmbRcbLhLebLeLsbLhLsLsmbLcbLgbLcbLibLeLsLsmbLibLsbRsLsbLgLsLsmbLgLsL
cbLobLgbLcLgbLcLsmbLibRsbLgbRsbLgLsLsmbLcLsmbsbLsbLcbLcLsmbLiLsbLiLgLi
bLibLsbsbLsbLgbRsbLgLsLsLsLsmmmbLcbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLgbsbLebLsbsbRgbRsRgbsbLsbRsbRsbRgbRgbRibRibLgbLobLcbLiLsbLgbLe
bLgRsbLibLiLsbLsbLiRsLsbLgbRcRgbRiRsmbRibLsbRsRsmbRebLsbRsbLsLsLimbLjb
sbLsbLsbRgRsmbRebRsLsbLgbRjRsRsmmbRjbRgbRibRibRhRsmbRibRiRsmbRsbRsbRsb
LsbsbRibRgRsLsmbRsbRgbRsbRgRsRsmmbRgbRiRsmbRgRsmbRgbRsbsbRsRsmbRsbRsbs
bRibLgbLiLiLsbLsbLsbRsLsRsbLsLsmbLsbRibRiRsmbRgbRibRsbRjbsbsbLsLsmbRsb
sbLcbLgLsLsmbLsbsbLsbLsbLcbLgLsbLibLgbLibLcbLgbsbLiLgbLsbRsLsRsLgRsbLg
bLjLgLsLsLsmmbLgbLgbLgLsbLgbRsLiLsbLgRsbLgbLgbLibLgbLgbLgbLebLgbLibLgb
LeLsRsbLibLgbLcRsRsmbRjbLebLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bRebRsbLobRsbRibRcbLibLobRobRebLebLebRebLgbRobRgbRebRobLgbRobLebRebLob
RebRobRobRobRebRobLgbLobRobLcbRobLobRobLobRebLgbRgbRobRobLobLobLgbRebL
obRobRebRobRebRcbLebLibLcbRobLsbRebRebLebRcbLcbLibLgbLobRcbLobLobLcbRg
bLobRobLebLobRebRobRgbRibRcbLgbLobRebLebLobLobLobLcbRcbLobRibLgbLobLob
LebRobRobRgbLobRibRebRobRobLobLebLebRobRgbRebRcbLobRobRcbRobLcbRgbLobR
ebRobLgbLgbRobRobRgbRobLibLobLebLebRibRebRcbLobRobLcbLobLibRobRsbRobLo
bRobLhbRobLcbLobRibLebLibRebRobLsbLobLebRsbLobRebRgbLebRobRobLobLobLcb
RobRibLcbRobLebLebRgbRsbRibLibLebLgbLobRebRibRgbRebRobRgbRcbLcbLobLobR
obRebLebRobRgbLcbLobRcbLcbLobLobLjbRobRobRobLsbRcbRebRobRibLobLibRobRo
bLobLgbLsbLibLibLcbLobRcbLebLgbLobRebRobRobRobRebLobRsbLcbLebLebLibReb
RcbRobLobRhbRobRibRgbRobRobRebRcbRcbLgbRobRobLcbRobLebLebLobLebLobLobL
obLcbRebRobRobLebLebLobLcbLcbLobLebLobRcbLebLcbRebLobLsbLobLcbLobLcbRi
bRsbLobRibRibRsbRcbLebRcbRobRobRgbRgbRobLobRcbLobRcbRebRobLibRobRsbReb
LobLcbLobRibRebRobLebRgbLobLebLibLgbLhbRsbRcbLebRebLobLobRobRebLebRebL
obLibRebRgbRobRobLobRobRebRebRebRobRebLobLebLebLebRobRobRsbLobLgbLobLo
bRibLsbRcbRobLibRobLobRobLobLobRhbLobLibLibRebLobLobRobLgbRobLobLobRob
RcbLhbLobRobRibLobRobLgbLebRobLebLobLibRobLobRobLcbRebLobLobRobLebLcbR
cbRobRhbRobLsbRebLgbLebRgbLgbLgbRibLebRgbLobLobLobRibRobRobLobRobLcbRe
bLebRobRobLebRsbRebRibLobRobLobRcbLobLibLobRebLcbLobLobRobRcbLobRhbRsb
LobLobRobLebLobLsbLebRebRgbRobLobLcbRobLobRgbLgbRobRobLobRobRobRcbRhbR
gbLobLgbRebRobLgbRebRobLebLebRcbLcbRgbRcbRebLcbRobRobLobLcbLobRobRcbRo
bRebLebLcbLgbLobRobLcbLibLobRibLobRebLgbLobRobLgbLobRobLcbRobLibLebRgb
LcbRebRobRgbRobLobRebLebLcbRobRibRcbLibLebRcbLebRobRobRebRobRebRobLobL
obLcbLibRebLgbLobLcbRgbLebLebRcbRcbRebLcbRobRibRibLcbRebLobLobLebRibLg
bLobRsbLebLobRibLebLobRcbRibRjbRcbLobLobLobRobLgbLobLgbLebRebLobRebReb
RsbLcbLibLebRibRgbRobLcbRibLebLobRobRebRobRsbLobRcbRobLobLsbLobLobLebL
obLobRcbRobRobRcbRebRobLcbLobRobLebLobRobRebRobLebLobLsbLibRcbLobRcbRe
bRobLobRobLebLobLebLgbRsbLcbLebRcbLsbRcbLcbRebRobLcbLsbRgbLcbRebRebLeb
LcbRebRobRobRebRobRibLobRobRebRcbRobLobRebLobRobLebRsbRebLibLobRcbLgbL
obRobLibRobLibLcbLobRobRcbLcbLobLobLibRobLgbLobLsbLebRgbLebLcbRhbRgbRe
bRcbLobRcbRobLsbRobLcbLhbRebLobRobRobLobLsbRobLobLsbLcbLebRobRobLobLcb
RobLobLcbLebLcbLobRgbLebLgbLebRsbRebRgbLjbRsbRebLobLhbRcbRobLobLgbRobR
cbRcbLgbLcbRobLcbLsbLobLobLcbLebLhbRibRebLcbRhbLsbRebRcbLobLcbLobRgbRe
bRobRcbRobLobRcbRobLebRobLobRebRibRobRgbRobRebRcbLgbRobLebRhbRebRibLob
RobRebRobRebRhbLobLobRebLobLgbLobLcbRhbLsbLobLgbLhbLobLobRibRibRsbLobR
cbLobLsbRsbLcbRibLobLobRobRebRibLsbRobLobLcbRcbRebRobLebLsbRobLcbLhbLe
bLgbLobRcbRobRsbRebRobLebRcbLobRebLcbLobLcbLgbRobLobLobLobLebLebRcbRgb
LobRcbLobLgbRebRebRhbRibRcbRibLcbLhbRebLobRibRobLcbLobLobLgbLsbLcbRebL
obLgbRibLobLebRibRobRobLobLebRebRsbRcbLobRcbLobLcbRcbRobRebRgbRobRebLc
bRibRebLebRgbRebRcbRobLobRcbLobLebRebLebRebRibLobLebRibLebLebRcbLobRob
LebRebLobLobLsbLhbLcbRobRobRobRobRcbLibLobLcbLsbRobLobLhbLobLibLebRobL
ibLobRobRobLobLobLobRibLibRibLcbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRebReRsmbRibReRsmbRebRiRsRsRemmbReRsmbRibRgbRebRgbRsbLjLsmbRebRibRhRs
mbRebRhRsRsmmbRibRgbsbRjLsRsbReRgbRgbRebRebReReRsRgRgRsmmbRebRebRebRgR
smbReRsRgmbRsbRgbRebRebRsbReRsmbRsbRebRebRgbRibRibRibRibRebRsbRibLsRsb
sbRibRgRsmbRibRgbRiRsRsmmbRibRebRibRiRsRsmmbsbRsRsmbRgRgbRebRsRsmbRebR
ibRibRiRsmbRhbRgbRgbRgbLsbRibRiRgbRibRebRibRibRsRsRsRsmmmbRsbRebRhbRib
RibRibRsRgbRgRsRsRiRsRsmmmmbRibRibRebRibRibReRsmbRgbLsRibRibRgbRibRibR
ebRibRebRibRebReRgbRgbRgRgbRibReRsmbRebRhbRiRsmbRibRiRsmbRibRibRgbRibR
ibRgbRebRibRibRgRhbRsbRhbRibRhbRibRebRibRiRibRebRiRsmbRgbRibRiRsmbReRs
mbRibRibReRsmbRibRgbRsbRibRgRgbRibReb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bRsbRibRgbRibLjbLcbLibLsbRgbLibLsbLjbLsbLsbLgbLgbLgbLiLsbRgbLsbLsbLgbL
gbLsLsmbLsbsbLibLibRsbRsLibRibLjbLibLgbLsbLsbLibLgbLibLgLsbRgbLcbLgbLg
bLsbRsbLibRsbRsbLibLibLgbLsbLsbLgbLgbLgbLgLsbLgbLgbLgbLgbLsbLsbRsbLibL
gbLgbRgbLibRsbLsbLibRibLibLibLibRibRgRsmbRgRsmbRgbRgbRgLsbLjbLcbLibLsb
LgbLiLsbLgbLgbRgbRgbLibLibLgbLgbLibRgbLibRgbLibLgbLgbLsbLgbLcbRsbLibRs
RsmbLibRsbRsbLgbLibLgbLgLsbLibLgbRgbLcbLsbLgbLsbLgbLgbLiLsbLgbRiRsmbLi
RsbRgbLgbLibLgLsbLgbLgLsbLibLibLsbLsRsbLibLsbLgRsbRgbRcbRibLibLgbLibLh
bLsbLgbLsbLgbLgbRsbLgbLibRsbRibRibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLjbRhRsmbRoRsmbRcbRhbRhbRgbRobsbRcbReRsmbLhbLiLcLsmbLgLsRsbLibLiLsbLc
LibLgbLiRsbsbsbsbLcbLebLgRsbLibRcbRhRsmbRebRhbRcbReRebRiRsmbRcbRibRhbR
hbRcbRcbRcbRobLjRsbLjbRsbLgLsbLgLsLebRsbLgbsbsbLjbLsbLgbsbLcLsmbLcbLgb
LgLsbLgLsbLsbRsLsbLgRgbLgbLiLsbLsbLibRjbLsRcbRibRcbRhbRcbRibRibsbRhbRi
bLsbRcbRoRsmbRcbRobRcbRhLsbRibRgLsRsbRiRsmbLiLsLsmbLjbLhbLgRsbLibLcbLi
bLiLsbLgRsbLobLhLibLgLsLgbLgRsbLiLcbLibLcRsbLibLibRjbLhbRibLcbRibRcbLi
bLjbLgbLjbRebLjbLibLibLhLgbLibLebLibLibLgLsbLgbLibsbsbLiLsbLcRsbRebRhR
sLsmbRhbRibRcbRgbRibsbRgLsbRibLsbLebLhLsbLgbRibRcbRcbsbRhbRhbRhbRoRsmb
RibRhRsRiRsmmbRiRsmbRibsbRiRsmbRiRsmbRibRgRsmbRibRcbRibLgbLcbLgbLhbLjL
smbsbLcbLiRsbLgbRcbLsbRebLebLiLiLsbLgbLibLsLgbLhbLcbLibLiLiLsLiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLgbLgRsbRhbLgbLibLcbLgbRiRsmbRgbRgbLibLibLsbLgbLgbRsbRjbRibLjbLhbLgbL
ibRcbLibLsLsLsmmbLsLsLsmmbLgLsLsmbLsbRsbLgbRgbLebLibLgbLgLsbLibLiLsbLg
bLjLsmbLgbRsbLsLsmbLjLsLsmmbLgbLsbRgbLgbLsLsmbLsLsmbRgRsmbLsLsLsmmbLgL
sLsLsmmbLgLsbLgbLgbLgbLsLsLsLgLsmmbLgbLgRsLsLsmbLsbLiLsbLgbLgLsbLsbLsR
sbRgbLgbLgLsbRsRsmbLsLsmbLibRsLsbLgLgbLgbLibLgbLibRgbRibLibLgLsbLsLsmb
LgbLsbLgbLsRsRsLsmbLibLgbLgbRjLsbLibRjbLibLibRsbLgbLgbLsbRjbLiRsbLgLsb
LgLsbLgLsbLgbLsLsLsLsLsmmmmbLsLsLsmmbLgbLsLsRsmbLsbRibLgbLgbLgbLgbLgbR
ibRhbRgbRibRcbRiLsbLgbRsbLhbLibLibRibLgLsbLibLibRgbLcbRibLgbLgbsbLsbLs
LsRsmbLsbLgbLgbLiRsbLgbLiLsbLibLjbLibLgbLibRsbLjLsmbLsLsmbsbLgbRgbLgbL
ibLibLhbLjLsmbLebLibLsLsLsmmbRjbLibLiLsRsbLibLibLgbRiRsmbRgLsbLsbLsbLs
LsmbRgbLsLsLsmmbLgbLibLibLgbRsbLsbLsbLibLgLsbLibLiLsbRsbLibRsbLibRiRsL
smbLsbLcLsmbRiRsmbRgbLsLsmbRibLsbLjbLjLsmbLgLsLsmbLgbLiLsbRsLsbsbRgbLi
bRsRsmbLsbLgLsbLgbLgbLibRcbLgbLhbLsbRibLsbLsbLsLsmbLiLsbLgLsbLiLsRsbLg
bRobLeLsbLobLsLsLsLsLsmmmmbLsLsLsmmbLgLsRsbRsbLgbLibLgLsbLjLsmbsbLiLsb
LgRsbLgbRsbLgbRibRibLgbLsbRsLsRsLsLsLsmmbLgLsLsmbLgLgbLgbLgbRsbLibLibL
sbLibLgLsLsmbLgbLgbLsLsmbLsLgbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bRibRibRiLsbRibRgbRebRibRhbRibRgRibRibRiRsmbRiRsRembRgRgRibRgbRgbRibRe
bRgbRsbRsbRsRsRsmmbRsbRsbRgbRgRsmbRibLebLhLsbLsbRibRgRsRsRsmmmbRgRsmbL
jbLsbLibLibRgbRibRgbRgbRibRsLsbLgbsbRiRsLsRsRsRsmmmbLjbLgbLsLibLgLgbRg
bLiLsbRsLsbLiLsLsLsmmbLsLsmbRsLsLsLsLsmmmbLibLeLsbLhbLhLsbLgbLebLebLcb
LibLhbLibLcbLiLsbLibLgLgLsbLgbRcRsmbRsbRebRgRsmbRhRsmbRiRsmbRebReLsbRh
RsmbRgbReRsRgmbRgRgbRhbRhRiRsmbRgbRsbRsbRebRgRsmbRibRgbRibRibRibRibRgb
RgbRsRsRsLsmmbLsbLjbLcLsmbLjLgbLjLsmbRgRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRhbLsbLgbRcbRgRsRsReRsmmmbRebRhbLsbRgRsmbRhRibRgRsRsmmbRhbRebReLsRsbR
sLsbRibReRsmbRebRibRiLsbRebRhLsbRiRsmbRgbRgRsmbRebRebRgRsmbRsRsmbRcbRs
bRgLsbRebRiRgRsmbRibRibRebRebRsRgbRebRgbRibRgbLsRsbRhRgbLsbRebLibRebRh
bRhbRhbLcbRsRcbLjbRiRsRsmmbRibLgbRiRsmbRcRsmbLsLsmbLibRsbRcbRibRgbLsRs
RsRsRsRsRsRsRsmmmmmmmbRsRsmbRgbReRsmbRibRibRibRhbReRsmbLebRebRcRsmbLib
RebLibRhbRebRibRgRsmbLsRgRhbRibLsRsbRibLsLsRsmbReRgRsmbRibRibReRsmbRsR
gbLsbLjbRebRgbRiRiRsRimbLsbRebLsRsbRgbRiRsRsmmbRgRsRimbRiRsmbRhbRhbRgR
sRsLsmmbLsbRsbRibRgbLgRsRebRebRgRsmbRgbRiRsRsmmbRsLsbRsLsbRebRsRsmbReb
LgRsRsmbReLsbReRsmbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRgbRgLsbsbRgRsmbRgRsmbRgbRibRebRebRebRgRsmbRibRgbsbRgbRgbRsbRgbRgbReR
sRgRsmmbRiRsmbRgRsmbRgRsmbRgRsmbRgRsmbRgbRgbRsRgbRgRsRsmmbRgRsmbRebRiR
smbReRsmbRibRebLsbRiRsmbRsRsmbRgbRgbRgbRsbRgbRsRsmbRibRgbRgbRebRgRsRsm
mbRibRibRibRiRsmbRiRsmbRibReRsmbRibRgRsmbRsbRgRsmbRgRsRsmmbRgRsmbRsbRg
RsmbRgbRgRsmbRgbRibReRsmbRiRsmbRibRibRibRiRsmbRgbRibRobRhbRebRibLjbLib
LibLgbLibLcbLibLibLgbRhbRhbRsbRgbRgRsmbRgbRgbRebLiLsbLgRsbRhbRibRibRib
RgbRgbRgbRibRcbLsbRibRgRsmbRsbRsbRgbsbsbsbLsbRibRgbReRsmbRiRsRsRsmmmbR
ibLibRcbRsbRiRsmbRsbsbRgbLjbRcbRebRgbRibRgRsmbRiRsmbRiRsmbRiRsmbRgRsmb
RgbRgbRgRsmbRsRsRsmmbRsbLsbRiRsmbRsbReRsmbRebRibRhRsRsmmbRgbRgRsmbRgbR
gbRsRsmbRsRsmbRsRsmbRgbRgRsmbRsbRsbsbsbRsRsmbRgbRsbRsRsRsRsmmmbRhbRiRs
RsmmbRibRiRsmbRgRiRsmbRgbRgbRgbRgbRsRsmbRsRsRsLsmmbRsRsmbRgbsbRgRiRsRg
RsmmbRgbRibRhRsmbRibRiRsmbRgbRibRgRsmbRgbRgRsmbRsLsbRgbRgbRebRibRebRiR
smbRibRgRsmbRgbRgbRgbRsbRgbRgRsLsmbRgRsmbRibReRsmbRebRhbRebRiRsmbRhbRi
RsmbRgbRcbRgbRibRgbRgbRiRsmbRgbRgbRgbRiRsmbRebRebRibRiLsbRebRcbRcbRibR
gbRibRgRsmbRibRiLsRsbRsbRibRgbRgLsbRiRsmbRibRibRgbRibRibRgLsbRsLsbRibR
ibRibReRsRsmmbRgRsmbRgRsmbRgRgRgbRgbRgbRgbLsbRsbRgbRiRibLgbRsRsmbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bRgbRibLebLcbLibLibLiLebRsbRibRiRsmbRibLgbRibRibLgbRibLsbRgbLgLibLgbLg
LsLsmbLibLgbLsbLgLsbLsLsmbRsLsbLsLhLsbRgRsmbRjbLgbLgbLsbRsbRibsbRibRcb
RibRebRsbRobLsbRhbRibLgbLhLsbLsLgbLgbLibRsbLibLsbLgbLgLsbLgbLgbLeLsbRs
RgbLgbRebReb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRcbRsbRebRibLgbRibLhbLhbLgbLcbLgbLgbLebLcbLgbLsbLgbLgbLibLhbRgbLgbLcb
LiLsbLgbLgbLsbLgbLgRsbLhbLgbLgbLibLibLgRsbLgLsbLibLsbLgbLgbLgbLgbLsLeb
LebRibRgbRgbRgbRgbRgbLsbRgRsmbRgRsmbRgRsmbRgbRgbLsbRibRsbRibRibRgbRgbR
sRsRsmmbRsbRsbLcbLgbLobRgbLibLcbLgbLibLgLsbLibLhbLsLsmbRjbLjbRjbRibRgb
RsRsRsmmbRgbRgbRgbRgbRsbRibRibLsbLibLebLsbLhbsbLibLgbLibLgbLibLibRcbRi
bRgbRgbRgbRsbRgbLsbRgbRgbRgbRgbRgbRgbLgbRebRibRgbRgbRgRsmbRgbRgRsmbRgb
RgRsmbRibRgbRgbRgbRgbRgbRsbRgbLsbRhbRibRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbR
gRsmbRsbRsRsmbRsbRgbRsRsmbRibLsLsmbLgbLiLsbRgbRgRsRsmmbRsbRsbRsbRsbRgb
RsbLsbsbRgbRgRsmbRsRsRsRsmmmbRsRsRsmmbRibRgbRgbLcbLgLsbLibLibLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLgbLsLsLgLsmbLgLgLsLsLsLsmmmbLgLsbLsbLsLsLsLsLsLsLsLgLsLsmmmmmmmbLgLs
LgLsbLsbLhbLebRiRsLsRsmbLcbLgLsLgRsLsLsmbLsLgbLsLsLsmmbLhLsbRsLsLsLsmm
bLgLsbRsbLebRsbLgLsbLibRjbReRsmbLcLsmbRsLsLsLgLsLsLsLsmmmmbLiLsbLsbRcb
RibRcRsmbRibLcbRibRiRgbRebLebLibLgbLgbLsLsmbLsLebLibLiLsbLgLsbLiLsbLgb
LebRsbRcbLhbRibRsRsmbLsRsRsRsmmbRsRsRsRsmmmbRsRsRsmmbRgbRiRsRsmmbRgbRg
RsmbRiRgbRsRsmbRgRibRgRsmbRebRibRiRsRgRsmmbRiRsmbRgLsbRsRsRsmmbRgbRgRg
bLsRsbRsbRgRsmbRiRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bLsbRcbRibRcbRibRhbRibRibRibLgbLcbLgbRjbRibRobRibLibRibLjbRiRsmbLgbLib
RebRhbRgbRgbRcLsbRibRsbLibRjbRibRgRsRsmmbRiLsbRgLsbRiRsRsRsmmmbRibLgRs
bRibRhbRibLgbRsRsmbRibLgbRiRsRsRsmmmbRgbRsbRgbRibRibRgbRhbRsRsmbLibRhb
LsbLjbRjbReRsmbLgRsbRiRsmbRgRgRsmbRibReRsmbRhbRebRsRgRgReRsmbRibLgbRib
RibLsbRibsbRsbRgRsmbRcbLhbLibRiRsmbRgbRgRsLsmbRsLsRsRsRsRgRsmmmbRgRibR
ebRebRiRsmbLsbRibRgLsbLgRsbRibsbRhbLgbLhbLhbLsLsmbRgbRjbRiRsRsmmbRebRg
bRsbRibRsRsRsmmbRgRsRimbRsRsLsRsRgRsmmbRsRebRsbRsbRsRsLsmbsbRsLsbRsRsR
gmbRebRcbLgbRgLsbRhbRsbRgbRsRsmbRsbsbRgRhbRgbsbsbsbsbsbLsbRsLsLsmbRsbR
sbLsbRsLsbReRsmbRgRibRebRhbRgbRebRsLsbRsbRgbRcRebRebRebRsbRebReRsmbRib
RibRhbRibRebRgRsmbLsbRgbRibRibRcbRcbRibRgbRibLjbRgbRgRgbLsbLjbLgbRsbsb
RibRgbRsRsRsmmbRsRsmbRsbRsbRsbRgRgbRsbReRsmbRibRibRsbRgbRibRhbLsbLjLsm
bLjRsbReRgRsRsRgRsmmmbRsbsbRgbLibLibLsbRjbLsbLsLsmbRsRsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bsbLcbRgbRgbRgRsmbRebRibLgbLhbLcLsLsmmbLgLsbLcbLebRjbLsbLsRsbLsbLsbLsb
LsbRsbRcbRibRibRobRibReRcbRibReRsRgRemb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
bLgbLibLeLsbRgRsmbLsbLcbLsbRjbRcbRsRsmbLcbLcbLhbRgbLgbRcbRsRsRsRsRgRsm
mmmbRhbRgbRibRgbRiRsmbRgRsmbRiRsmbRgRgbRgbRibRhbRgbRjRgbRgbRgbRcRsmbRi
bRibRibRibRgbRsbRibRsbRgRsmbRgbRibRhRsRsmmbRibRoRsmbRebRsbRcbRibRiRsRs
mmbRgbRsbLgbRebLsbRcRsmbRgbRgbRcRsmbLibRibRebRibRibRgbRibRjbRsbRibsbRo
bRgRsmbReRsmbRgbLsbLsbRsRsRsmmbLsbLsLibLjbRibReRsmbLsbLsRsbRsRsRsmmbRs
RsmbRcbRcbRgbRibRcRsmbsbLgbLhbRsRsmbRjRcRsRsmmbLgbLsbsbLebLsRsbLiRsbRs
bLeLsbLjLsRsmbLhbLgbsbLsbRgRsRsmmbRiRsmbRiRsmbRgbRcbRsbRcbLjLjbRebRsRs
RgRsRsmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bRhbRibRibRgbRhbRgbRgbRgbRgbRibRibRebRsbRhbRhbRiLsbRgbRgbsbLibLjbLibLe
bLgbLibRgbRhRsmbLgbLibRibRgbRgRsmbLsRsbRibRgbRsbsbRgbRgbRgbLgbLibLgbRg
bRgbRibsbRgbLiLsbRgLsbLgbRsbLsRsLsbRsRsmbRsbRsbRgbLsbRsRsRsmmbRsbRsRsm
bRsbRgbRhbRgbRgbLebLibLebRsbLgbRsRsmbRgRsLsmbRgbRibRgbRibRgbLibLebLebR
ibRgbRgRsRsmmbRgRsmbRsRsmbRsRsmbRsbRsbRgbRgRsmbRgbRgRsRsmmbRsRsRsmmbLs
bRibRgRsRsmmbRgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
bLibRgRsmbRgbRgbRgbLjbRibRsbRhbRibLibLgLsLsmbLiRsbRibLiLsbLibRibLiLsbR
jbLibRebRcbLgbLcbRjLsbLjbLibLiLsRsbLibLgbRjbRibRiLsbRibRibRgbRgbRgRsmb
Rgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
bRsRsmbRibRsRiRsmbLsLsLsmmbLhbLsbLsbLgbLsbRsLsbLsLsmbLsLsmbLsLsmbRsbLs
RsLsRsbLsbRsbLsbLsbLsLsRsmbLsRsLsbLsRsbLsbLsLsmbLgbRsbLsbRsbLsRsbLsbLs
bLsLsmbLhRsbRsbsbLibsbLibLcbLcbLibLibLeLibLgLsbRjbLcbLcRsbLibLeLsLebLe
LsbLibLgLsbLgbLhbRcbRcbRhLsbRibRibRibRebRibRibRgRsmbRsbLobRibRibRgbRhb
LibRgbRhbRibRibRgbRibLgbLibLibLebLsbLhbLibLsbRobRibRgbRibRsbRgbRgbRibR
ibRgbRibRgLsbLsbRcbRgbRgbRobLebLibsbLibLgbLgbLibLsbLgbLibRibLibLibLibR
gbRibRgbRebRgbRgbLsbLibRsbLibLibLgbLibLgbLgbLibLibLgbRibRobRhbLgbLgbLg
bLgbLgbLibLibLgbLibLibLgbLsbRjbRibRgbRsbRibRgbLgbRibLebLibLgbLgbRibRjR
gbRhbLibLgbLhLsbLgbsbLgbLsbLsLsmbLgbLgbLgbRsLsbLgbsbLiLsbLgbLibLgbLiLs
bLibLibRibRibLsRsbRibLibLjbLibLjbLjLsmbLgbLibLsLsLsmmbLibLibLsLibLgbLs
bLgbRsbRibLsbLibLjbLjLsmbRhbRebRibRgbRsbRobLgbLgbsbLibLgbRjbLobLibLibL
gbRsbLibRibRgbRcbRgbRibRibRsRgbLcbRibLhbLgbLibLsbLsLibRibRgbRibRibRibR
gbsbRibRibRgbRibRgbLibRgbRiRsmbRibRibRgbLsbRibRiLsbLgbLjbLsLsmbLsLsLsL
sRsmmmbLsbLsLsmbLsLsLsRsmmbLgbLgbRsbLsbLsbLgLsbLgLgbLibRsbLcbLgLsbLibR
sLsbRebRhbRibRibRibRiRsmbRgbRiRsmbRgbRibRgbRibRsbRibRibRiRsmbRgbRgbRgb
RgbRiRsmbRgRsRsmmbRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 134831; End: 135331;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bLgLsbLsbLgbLgLsbLgbLgLsLsmbLiLsbLgbLsLsLsmmbLsLsmbLgLsLsLsmmbLgLsLsmb
LgLsbLgLsbLsbLgbLgbLsLsLsLsmmmbLgLsLsmbLgLgLsbLgLsbLgLsbLgbLgLsbsbRsbL
gbLgRsbLgLsLsmbLgbRsbLgLsLsmbLsLsmbLgRsLsbLgLsbLgLsbLsLsmbLsbLsbLgLsLs
mbLsbLgLsbLebLgLsbLgbLgbLsbLsLgbLsLsLsLsRsmmmbLiLsbLibLgbLsbLsLgLsbLib
LgbLsLsLgmbLgbLsLsmbLibLgbRgbLiLsbLgbLsLsLsmmbLsLsmbRsLsbLgLgbLsLgbLsL
smbLsbLgbLsbLgbRsbRsLsLsLsmmbLsbLibRsRsmbLgbLgbLsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bsbLsbLsLsmbRsbsbRhbLibRgRsLsRsmbLgRsbRsbsbLgLsbLcbRiRsmbRibRibRsRsmbL
sRsRsLsmbLsbRsbRgbRsbRsbRgbLsbRsRsmbLsbsbsbsbLsbLsbRcbLjbRiRsmbRgRsmbL
jbRgbRgRsmbRgRsmbLjRsbRgbRgbRgbRgRsRsmmbLsRsbRsRsmbRsRsmbRsbRgbRibRiRs
RsmmbRsLsbRgbLiLsLsmbRebRgRsmbLsRsbLobLiLsLobLgbLjbLibLgbLsbRsLiLsbRsb
sbLgbLgbLgbLgbRcbRoRsmbRiRsmbRsbRgbRgLsbRibRibRgbRgRsmbRgbRsbLcbLgRsbR
ibRgbRgbRsbRsRsmbsbsbLsRsLsbsbsbLjLgLsLsmbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRibRiRsmbRebRibRibRiRsRsmmbRgRsRsmmbRiRgRsRgRsmmbReRsmbRsRsmbRgbRgLsb
sbRobRgbRcbRgRsmbRgRsmbRgbsbRsRsRsRsmmmbLhRsbReRsRgRgRsmmbLhbRoRsmbRgb
RcRsmbLgbsbRcRsRsmmbLsLsRsmbRhRsRsmmbRgbLsbsbRiLsbRiRsRsmmbRibRiRsmbRj
RsmbRiRsmbRibRgbLjbLhRsbRjRiRgRsmbRcbLgbRcLsbLsLgLsbLibLsbRjbLibRibLib
LhbLsbRcRsmbLcLsmbLcLsmbLibRjbRsRsmbRiRsmbsbRsRsRsRsmmmbRsRsmbRsRsmbRi
RsmbLsLgLiLsbRiRsmbRgbLsRibLgbRiRsmbRsRsRsLsmmbLjbRgRsRsRsmmmbRgRsmbRh
bLsLsRsmbRgRsmbRsRsRsRsRsRsmmmmmbRgRsRsmmbRsRsRsRsmmmbRsRsRsRsRsRsmmmm
mbRiRsRsLsmmbRgRsmbsbLsRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsRsRsRsRsRgmmmmmmb
sbRsRgRsmbRgbRsLsbLsRsRsRsmmbRsRsRsmmbRsRsRgRsRsRsmmmmbRsRsRsmmbRsRgRs
RsmmbRsRsRgRsRsRsRgRsRsRgmmmmmmbRgRgRsmbRsRsRsRgRsRsRsmmmmmbRsRsRsRsRs
mmmmbRsRsRsRsRsRsRgmmmmmbRgbRgbRsRsmbRsRsRsRsmmmbRgRsRsRsRsRsmmmmmbLsb
RibRsRsRsRsRsmmmmbRibRsbRiRsRgRsmmbRsRsmbRsRsRsRsmmmbRsRsRsRgRsRsmmmmb
RsRsRsRsRsRgRsRsReRsRsRgRsRsmmmmmmmmmmbRsRiRsmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLsbLgbLsLsmbLgbRjbRgbRibRsbLsbLsbRibRibLsbRibsbRibRiRsmbsbsbRsbsbsbsb
LsbsbRgbRsRsmbRsRsmbsbLsbLsRsLsbsbsbRsbsbRsbsbRsbsbsbRibRgLsbRcRsmbLhL
sbRjbRcbRcbRhbRobLcbLgLsbLgbLsbLeLsLsmbLgLsbLiLsbLibLsLsmbLgLsLsmbLgLs
bLsLsLsmmbRsbLhbLcbLiLsLsmbLhLsLsLsmmbLibLcbLiLsbLiLsbLiLsbLiLsbLgbLib
LgbLiLsbRgbRcbRhbRebRibRibLsbRiRsmbRgbRgRgRsmbRgbLhbRiLsbLhbRoRsRsmmbR
sbRhbRiRibRebRcbLgbRcbRgRsmbRibLsLsmbRcbLibRjRiRsmbRiLsbLsbRgRsmbLsLsm
bRsbRsRsRsRsmmmbsbLsbsbsbRibLsbsbRibRiRsmbLgRsLsbRgRgRsmbRsbRibRsRsRsR
iRsmmmbRcbLiLsbLeLsbRibRibLibRcbRhbLgbLcLsmbLiLsbLoLsmbLcbLiLsbRjRsmbL
cbRibRibRgbLhbRsRobLcRsbLsRsbRibLiLsbLjLcbLgbLcbLgbRcbLibRsRsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bLiLsbLgbLiLsbLsLsmbLgbLgLsbRcRsmbReLsbsbRsbRibRibRcbRhRsmbRgbsbRebLsR
sbLsbLsLeLgLhbLgbLgbLgLgbLsLsmbLgbLsbLsbRsbRiRsmbRibLcLsmbLcbLgbLibLgL
sLsmbLsbLgbLgbLgLsbLoLsLsmmbLgbLsbLsbRgbRobRebRhbRsbRebRibRibRibRibRgb
RiRsmbRgbsbRsbRsbsbsbsbRgbRgbRsbRebRebRjbRcbRebRsRsmbRsRsmbLsbLibLibLs
bLebLsbLcbLgbLebLiLsLsmbLgLsRsbLgLsLsmbsbRhbRibRoRsmbLiRsbLobLiLsbLhbL
gbLhLsbLgbLebLsbLibLhLsbLsbLgbLibLgbLsRsbRgbReRsmbRibRgRsRgmbRibReRsmb
RgRsmbReRsmbRsRsRsmmbRsbLsRsbRsLsbRebRsbRgbRhRsRsmmbRibRebLhbLebLiLsLs
mbLibLgbLibLibLibLsbLibLiLsbLgbLgbLibLgbLgbLgLsbLsLgLsbLgbLgLsLsmbLiLs
bRsLibLgbReRsmbLjLgbRhRsmbRsLsbLgLsbLjLsmbRsLsbLgbLsRsbRjbsbLeLsbLsbRc
bLjLjbRcbRhbRibLeLsbLsRsbRsRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRjbRgbLsbsbsbLsbRjbLsbsbRsbLsRsbLsbLsbRsRsmbLsbsbRsLsbsbsbsbRsRsRsRsm
mmbRsbRsbsbRsLsbRsbRgRsmbLsRsRsmbRsRsRsRsmmmbLsbRibLsLsmbLsRsbsbRiRsRs
RsRsmmmmbLsbLsbRibRobRibRiLsbRgRsmbRgRsmbRsbRsbRsRsmbRsRsmbLsRsbRgbLib
RsbLsLibsbRgbLjbRiRsmbLsRsRsmbRgRgRiRgRsRsRsmmmbRiRsRsmmbLgbRgbLiLsbRj
bLjbLsbLsbRsbLsbLsbLsbLgbRsLgbLgbLsLgbLhbLgRsRsmbRiRsRsmmbRgbRsbLjbLjb
LebRjbRiRsmbRcbRgbRgbRgbRibLgbLibLgbLebLobLibLgbLgLsbRebRibRibRgbRsbLs
bLgLsbRsbLgLsbsbLsLsmbLsbLsLsmbLsbLsLsmbLsLsLsLsmmmbRsLsLsLsmmbLsbLsLs
LsmmbLsLsLsmmbLebLcbLsbLgRsRsmbRjbRgbRibRibRsbRebLcbLgbLcbLibLsbLibLgb
LgbLgbLgbLsbLgRsbLgLsbLsbLgbRsbLsbLgbLsbLgLsRsbLsLsmbLsbLsLsLsmmbRsbLs
bsbRsbRsbLgbRsLsLsmbLsLsmbLsLsLsmmbLsbsbLsbLsbLsRsbLsLsLsmmbRsLsbLsLsL
smmbsbLsbLsRsbLgLsbLgLsLsmbLsLsmbRobRibLgLsbRcbLgbLjbRsbLsLsmbLsLsLsLs
LsmmmmbLsbLgLgLgLsLsLsLsmmmbLgbRebRiRsmbRibRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bLcLsmbRjbLgbRoRsLsmbRgRsmbRibRibRhbRebReLsbRebRgbRgbRgRsmbRsbRgRsRsRs
mmmbsbRgRsmbRsbRgRsRsmmbRsRsLsmbRgbRhLsbLsLsRsmbRiLsbRcRsmbRibRibRgbRe
bRibRgbRsbRiRsmbRgbRiLsLsmbRgbRsRsmbRgRsmbRgRsmbRibRsbRgbLsRsbRsbRgbRs
RsmbRgRsmbLjbRsbRibRjbRiRsLsmbLcRsbRhbLgRsRsmbLcRsbsbsbLiLsbLcbRcbRebR
iRsmbRebRibRiRsmbRgRsRsRsmmmbRgRiRsmbRebRibRgbRiRsmbReRsmbLsbRiLsbRgLs
LsmbRgbRgbRgbRgbRgbRiLsbRgbRsRsRsmmbRibRgbRgbRibRiRsmbRhRebRibReRsmbRh
bRhRsmbRgbLeLsLsmbsbLibRgRsmbRjbRcLsbRgRsRsmmbRgRsmbRibLiLsbRjbLcbLibL
ibLsbRcbRgbRiRsmbRobRiRsmbRibRibRebRiLsbRhbRebReRsmbRgRgbRiRsmbRgRsmbR
gRsRgmbRgRsmbLcbRgRsmbRibRsbLgLsbRhRgbRibRgRsRsRsmmmbRgbRgbLjbRibRgLsb
RgRgRsmbReRsRembLcbLhbLiLsbLibLgLsbRjbLibLsbLcbRgbLibLsRsLsbLibRgbRjRs
mbLcLsmbRgbRhbRiLsbRiRsmbRgbRgbRsbRgbRibRgRsmbLsbsbLsbRsRsmbLjbRsbRiRs
RimbRibRibRibReRsmbRgRsmbRsRsRsmmbReRebRsRiLsLsmbRgbLcbRjbLibRgbLobRhb
sbLjbLhbLibLoLsRgRsmmbRebRebReRsmbRebLsRsRsRembLsbRsRsmbRgLsbRsRsRsmmb
RsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bLobRsbRcbRjbRjbLobLebRhbLobLgbLebRobLobLhbLsbRgbRobLibRjbLobLcbLjbLeb
RobLebRobRsbLgbRobRobRobRibLobRebLcbLebRebRobLcbLcbRebRobRobLebLobRobL
sbLebRobLebRgbRebRobLobLobLobLcbLjbRobLobLebRobLebRobLjbLgbRcbRobLobLc
bRhbLebRebLhbRjbLobRobLcbLebRebRibRebRcbLobLobRobRsbRebRcbRobLebLjbLob
RebLebRebLjbRobLobRebRebLebLjbLobRobLcbRgbLobRibLobLcbRcbRobLobLcbRebL
obRibLobRebLobRhbRobLobLebLcbLsbLgbLcbLobRebRgbRobLebLsbLobLebRcbRobRo
bLobLsbRcbRsbLsbLebRobLobLobLjbRgbRobLobRibLcbLobLobLgbLobLsbLobRebRob
RjbRcbLobRsbLobRgbLcbLcbLobLebLibRobLebLebLobLebLobLgbLebRobRibRebLebL
ebLebRebLsbRobRsbLebLcbLgbRobLebRgbLobRgbRibRobLobLebRcbLebLibRobLibRe
bRcbRibRcbRobRgbLsbLsbLcbLobRobRsbRobRsbRebLobRsbRobRebRsbRobLobLcbLsb
LebLibLibRobRobLobRcbRibRebLebLcbLobLobRcbLobLobLobRebRobLgbLebRibRebR
cbLibRobLebLebRgbRhbRcbRebLobRobLobRgbRebLobRebRcbRcbLobLebLobRcbRebLs
bLobLgbLobLgbRobLobRebLebRcbLebLebRebRcbLobLobLobLcbRcbLobRebRobLibLcb
RcbRobRobLcbLgbRgbRobRobRobLgbRebRobLsbLgbRcbLobRebRobLcbLobRsbRsbRsbR
obRobRebRibRobLcbLebRcbRcbRgbLgbRcbLobRjbLcbLcbLhbLhbRhbLebRobLsbLebRc
bRobLjbRibLebRobLobRgbLobRibRobRobLjbRsbRhbLobRibLebLibLebRsbLsbLebRcb
RibLhbLibLobLebRhbLobRobRobLgbRebRobLcbRobRobLobLebRobRsbRobLebLcbLobL
obLebLobLobLibRebRobRcbLobRobRobLobRobLcbLcbRobRcbRebLebLcbRibRobRibRc
bLebLobRobLgbRibRibRobLcbLcbRebRebLebLebRebLobLobLcbLebRebRebLcbRobLgb
RebRebRhbRobLebRobLobLhbLobRobRobLsbLebLobLcbLebRibLobRebLobRhbLhbRebL
ebRcbLhbLobRobRgbLebRobRobLjbLobLebRcbLobLgbRibRebLebLobLgbRcbLibRcbLc
bLgbLobRobLobRobLcbRobRobRobRobRebRebRobLcbRebRobRjbRibLgbRhbLobLibReb
RsbLsbLobLobRobLebLsbLcbLobRcbRebRebLcbLcbRebLebRebRobRebRcbRobRebRebR
obLsbLebLgbRobLcbRcbLgbLobRobLebRcbRcbRcbLobLcbRebRebLcbRcbLobRebLsbLs
bRebRebRobLobLebRsbRobLcbRibLobLobRcbRobRebRobRsbLgbLgbLebRgbLcbRobLcb
LsbRgbLebRgbLcbRcbLobLhbLobLcbRobRcbRobLcbLebLibRebRcbLobLebLsbLebRebR
obRobLsbRibLebLobLcbLcbLobLebRgbLebRcbLobRcbLebRibRobLobLobRgbRcbLobRi
bRebRobRebLibRibLgbRebLobLobLobLibLobLobLsbRsbLsbLsbLibLobRobLobRgbLgb
RobLcbLhbRobRobLebRibLobRebLobLibLgbRobLebRcbLebRobRcbLibLebRebRobRcbR
gbLibRibLgbRebLgbRsbRobRibLhbLobRsbRobRibRibRcbRebLcbLobRobRobLobRobRi
bLebRhbRobLcbLcbLobRobLgbRobRobLibLebRobLobLsbLobLobRcbRobRobRcbRobLob
LgbRebLcbLhbRebLobLibRebRcbLebLobRobLhbLibLsbRobLobLobLebRobLobRebLebR
cbRebLebLebLobLcbRcbRebRobLgbLobRebLobRobRobLobLgbLebRgbRebRebRcbLobLe
bRcbRobLcbRobRobRobRgbLebRgbRobLebRebRobLhbRobRcbRobLobLgbRobRobRobLob
LebLobLebLebRgbLebRobRebRgbLcbLobLgbLobLebRcbLebRcbLibLobRgbRobRobLobL
ibRebRgbLcbRgLsbRobRobRebLobRobLobRibRobLebLebRcbLobLobRcbLobRcbRebRob
LobRobRobRebLobLobLhbLebRobLebRibRcbLibLobLobLobRobLobLgbRgbRobLgbLebL
obRhbRobLibLibLcbLebLgbRobRobLhbRobRhbRcbRebLgbLibLcbRebRibLobLcbRcbLe
bLcbRobLobRebLgbRcbRcbRgbLcbRhbRobRobRobLebLcbRebRebRobLibRsbLcbRobLsb
LebRobLobLebLobLobRjbLsbLobLobLobLobRobRobLsbRcbLebLsbLobLobRobLhbLobL
obLobRibLobRobLobRjbLsbRobLibRibRcbLsbLobLebLjbRibLobLebRcbRebRebLcbRo
bLobLcbRibLobLcbRibLobRebLibRobLobLobLebLcbLobLebRcbLobLobLebRibLcbLob
RebLobLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bRjbRobRgLsbRobLeLsbLhbLibRsLsbRsLgLsLsLsmmbLgbLiRsbLcbLhRsbLiLsbLhbLh
bLgLsLsmbLgbLsbLsLebRebLjbLebLeLebLcbRjbRibRgLsbRibRibRhbRibRcbRibRibL
hLsbRsbRgbReRsmbRsRebRcbRebRgbRsRsmbsbLsbRcbLsbRiRgbLjLsmbLobLsbLibLcb
LhLibLcbLhbLhbLhbRsLibLsbRsbLsbLsLsLsLsmmmbLhbRgLsbLgLsbLibRibRjbLeLib
RsbLobRgbLcbLhbLgbLibLibLiLsbLibLeLsbLebLiLsbRibRjbLsLobsbLjLsmbRjbRcb
RibRgbRebLibLsbLcbRgbRjbRhbRibRgbRiRsmbRgbRiLsbRgbRgbRgLsbLeLsbRsbLsLg
bLibRgbLsbLsLsmbLeLsbRgbRiRsmbsbLhLsbRjbRcbRibLiLsbLebRsbLibLgLsbRsbRj
bRsLsbLsbLgbLibLgLsLsmbLsLgbLgbLebLhLsbRibLibLebLgbRsLsLsLsRsmmbLsLsmb
LgLsLibLsLsmbRsbLgLsbLgLsbLgLcbRibRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRgLsbLobsbLeLgbLgbLibRsbLgbLhbLhbLibLiRsbLgRsbLebLgLgLsbLgRsbRgbLibsb
LcLsRsmbLibLibLiLsbLibLhLsLsmbLgbLibLibLsbLgbLibLcbLibLcbLhbLiRsbLgbLi
LgbLiLeLgLgbLibLibLibLibLebLhbLcbLhbLibLcbLibLhbLibLgbLgLsbLgbLgbLsLsm
bLgbLcbLibLhbLsLcbLgbLgbLsLsmbLiRsbLsbLsbRsbLcbLcbLsbRcbRebRcbRibRgRsm
bRgbRgbRsbRsbsbsbLibLibRhbLjbRgbLcLsmbReRsmbRsbRgRsmbLsbLsbRsbRsbLsbRs
bRibRgbRsbRiLsRsLsbRgbLsbsbRsbRsLsbRgbRebLsbRgbRgLsbRsbRsbsbsbRsbRcbLs
bLcbRebRibRsbRgbRsbRsbRsbRsRsmbRsbLsbRsbRsRsmbRsbRgRsRsmmbRiRsmbRiRobR
obReRgbLsbRsbRsbLgbRsLsbRgbRgbLsbLjbRcbRiRsmbRsRsmbRsLebLibLcbLcRsbLgL
sbLgbLgbLgbRjbRebLsbRcRsmbLgbRsbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLiRsRsmbLsbLsbLgbLiLsbLgLsLgbLsLsLgLsmbLsLsmbRsRsmbLsLsLsLsmmmbLgLsLs
LsRsLsLsmmmbLgLsLgLsLsmbLgLsbRsbsbLsbRsbLgbLsLsmbLsbLsbLsbLsbLgRsbLgLs
bLsLsLsLsLsmmmmbLsLsmbLsbLsLsmbRsRsLsmbLgLsRsLsRsbLgLsbLgLsbLsLsmbLgLs
LsmbLiLsbLsLsLgmbLgbLsLsLsmmbLsLsLsmmbLsLsLsmmbLhbLgLiLsLgLiLeLsLiLsbL
iLsbLsbLhbLobLobLhLsbLcbLcbLgbLgbLiLgLebsbLeLsbLebLebLiRsbRcbRcbRibReb
RibRibRcRsmbRiRsmbRibRcbRhRsmbRsRibRcbRibRcbRibLjbLibLgbLgLsbLgbLjLobL
sLsmbLgbLibLibLhRsbLsbRjbRhbRhbRgbLjbLhbLgLsLgLsbLgbLgLsLsmbLgbLgbLsbL
sbLsLsRsmbLgbLiLsbLiLsLsmbLgLsRsbLsRsbsbRsbsbLsLsLsLsmmmbLsbLsbLsbLsbL
gLsLsmbLsbLsLsLgmbLgbLsLsmbLsLsmbLgLsbLgRsbLsbLsbLsbLsbLsLsLsmmbLsbLsb
LsbLgbRsbLsbsbRsLsbLsbLsLsLsmmbLgbLgLsbLiLsbLibLgbsbLsLsRsmbLsbLgbLsLs
LsLgmmbLsLsmbLsLgbLgbLibLsRsbLgbLsLsLsLsLsLsmmmmmbLsLsmbLsLsmbLsbLgRsb
LsLsLsmmbLsLsLsLsLsmmmmbLgLsLsRsmbLgLsbLsLibLgLibLsRsbLsbLgLsLsmbLsLsL
sLsLsmmmmbLsbLsLsLsLsRsmmmbLgLsLeLsbLgbRobRebRhbRcbRiRsmbRiRsRsmmbRiRs
RsmmbRhbLibLhbLgbLibLibLibLibLcbLobLibLgRsbLgRsbLebLgLsbLebLgLsbLiRgbR
ibLjLsLsmmbLiRsLsbLcbRobRhbRiLsbRibRgbRibRibLjbRsbLjRsbLcbRsbLsbRiRsmb
LjbLiLsbLiRsbLgbLjbLhbLibRcLsbRibLibLjbLgbLibLibLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRgbRgRsRsmmbRibRgbRgRsRsmmbRobLibLibLibLibLhbRcbRsRgRsmbRiRsmbRhbRsbR
ibRsbRiRsmbRibLiRsbLgbRsbLsbLiRsbLibLjbRsLsbLgbLgbLgLsbLhbLgbRebRgbReb
RgRsmbLsRsbLsLsmbRsRsmbRsbRgbRsbRgbLcbLibLgLsbLibRjbRibRiRsmbRibRibReb
sbRebRsbRgbLsbLsbRgRsRsmmbRgbRsbRgRsmbRgbRgRsmbRgRsmbRgbRgbLibLibLgbLs
bRsRgRsmbRjbRibRgbRgRsRsmmbRgRsRsRsmmmbRgbRiRsmbLsLjLsmbsbRgbRgRsRsRsR
smmmmbRgRsRgmbRibRsRsmbRibRgRsRsRsRsmmmmbRgRsmbRibRibRgRsRsmmbRiRsmbRs
bsbRsRgbRgRsmbRgRsRsmmbRgRsmbRgRgbRgbRsbLjbRiRsmbRgRsRsmmbRsRsmbRgRsmb
RibRgRsRsRsmmmbRgRgbRibRgbRgbRgRsmbRgRsmbRgLsRsRsRsRsmmmbRgRsRsmmbRsbR
ibRgbRgRsmbRgRsRsmmbRgRsRsmmbRgbsbRgRsmbRgbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bRhbRgbRjbsbLiLsbReRsmbLjbRhbLjbRjRgRsmbRcbRibRibLjbsbLjRgRsmbRibLsbLj
bLiRsLsbRoRsmbLjLsmbLcbLgLsRsbLiRsbReRsmbLgLsRsbRibRiRsmbRiRsmbRgRsRsm
mbRibRsRsRsmmbRebRgbRibRgbRiRsmbRiReRsmbReRsRimbRibRcbRcbRebRibRcbLsbL
iLsbLebLjbLjbLsbRiRsRsmmbRiRsmbRiRsmbLjbRjRibLjbLhLsLsmbRgbLjbRebRhbLc
bRjbLiLsbRjbLsbsbsbRgbLsLsmbLsbLsRsbRcRiRsmbRgbRebRiRsmbRiRsmbRsRsmbRi
bLjbRebReRsmbRibRebRsbRobRgbRebLsbLjbRobLcbLhbLgLsLsLsmmbLhLibLibLiLsb
LgRsbLiLsbLsLsmbLgbLibLgbLibLibLsbLgbLibLgbLibLgbLibLgbLgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bRjbLgbLsLsLsLsmmmbLibLsLsLsmmbLgbRjbLiLsLsmbLgLgbLibRsbLgLsbLgbLiLsbR
eRsRsRsmmmbRibRiRsmbRibRhbRcbRcRsmbRiLsbRsRsRsmmbRiRsmbRgRsmbRibRebLsb
RibReRsRsmmbRgbRgLsLsmbRiRsRimbRebRjRibReRhbRhRsmbLsRsRgRsRhmbRgRsReRh
mbLobLhRsbLibLibLiLsbRibLgLsbRjRsmbLgbLgLsbReRsmbRgbRgbRgLsLsmbLgbRiRs
mbRgbLgLsbRgLsbLgLsbLsLsLsLsLsLsLsmmmmmmbRgLsbLsbsbLgbLsbLgbRgbRhbRebR
ibLsLjbLsLsmbLsRsbLgbRjbLhbRsbLibLiLsbRibRgbLibRjbLibRhbLibRjRsmbLgbLg
LsbRjbRebLiLsLsmbLgLsLsLsLsLsmmmmbLgLsLsmbLibRgbLhLsbLibRgbLhbRhbRiRsm
bLjbLgbLgbRjbLgbLibLibRoRsmbLibRibLsbRibLgbLjbLiLsbRgbLjLgbRjbRcRsmbRg
bRebRcbLgLsbRcbRcbLsbLoRsbLibLsbLhLsbLsbRibLsLsmbRibLgLgbLjbLiLsbLibRj
bLsLsLsmmbLiRsbLjLsmbLibLibLiLsbRjbLhLsbRjbLhLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLcLsmbLcbLcbRgRsmbRibRibLgLsbLhbLgbLibLibLibLebRibLgLsbLibRcbRibLjbRh
bLibRibLebsbLjRsbRsLsbLibLsbsbRjbLgRsLsRsbRsbRsRsmbLsbRsbLsbLsbLsLsmbL
sbLsbLsbLsLsLsLsmmmbLsbRsLsbsbRsbLsRsbLsbLsbRjbLibLgLsbLsbLsbRsLsbLgLs
LsLsLsLsLsmmmmmbLibLgbLsLsmbLgLsLsmbLsLgbRcbRhbRibRibRibLgLsbLsLibLibR
cbRhbLjbLsLsmbRcbRgbRsRibRsbRgbRibLjbRcbRgLsLsmbLgRsLsRsLsbRgLsRsRsRsm
mbRgRsRsRsRsRsmmmmmbLsRsbRsbRiRsRsmmbLjbLeLsRsbLsbLgLsbLsLsLsmmbLsLsmb
LsLsLsLsmmmbLsLsLsRsmmbLsLsLsmmbLgbLgLsbLsbLsLsmbLsLsmbLsRsbRsLsbsbLsb
sbLsbLsbLsLsmbLsbLsbLsLsLsmmbLsLsLsLimmbLibLgbLsLsmbRobRhbRibRobRibLhb
LobLsbLcbLibLiLgbLsbLgbLgbLgbLcbLibRjRsmbRcbLgLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRsbLsLsLsRhmmbRsRsLsmbRibRcbRsRsRsmmbRsbRhRsRsmmbLcbLhbRjbLcLgbLibLsb
LhbLgLsbLibLobLcbLhbLiLibLgRcbRibRcbRibRgbRebRebRgRsmbsbRsbLsbRsbRsbsb
LsbsbsbsbLsbsbRsbsbsbsbsbsbLsbsbsbsbsbsbLsLsLsLsmmmbRsRsLsRsRsmmbRsbLs
RsbsbLsbRsLsRsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRiRsmbLibLgbLibRgRsmbLsLibRobRsbLgbLsLsmbLgbLgLsbLiLsbLsbLgRsbRsbLgbL
jbLgbLsbLgbLgbLsbRjbRibRibRsbRgbLsbRgbRsRsmbRsbsbLsLsmbRsbLibRjbLibLsb
LgLsbLibLgLsbRsbLsbLgbRjbLjbsbRsbRiRsmbRsbsbsbRgRsRsmmbRgbRgRsmbRgbRgR
gRsmbRgRsmbRgbRgbRsRsmbRgbRgbRsbRibRgbRgRsLsmbRibRgbRhRsmbRgbRgLsbRibR
ibRgbRiRsmbRgbRgbRibRgbRgbRibRibRiRsmbRhbRhbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bRjbRcbRcbsbRcbRgbsbRibLcbRcbLcRsbLcbLibLhbLibLiLsLsLcmbLebLhLsbLiLsbL
eRsLsbLeLsbLgLeLsbLgRsbRcbRjRsmbRcRsRsmmbLibsbLcbLibLiLsbLsbLgLsLsLemb
LgbLeLsbRjbLsbsbLcbRcbRsbsbLsbRhRsmbRcRsRsmmbRibRibRiRsmbRiRsmbRgRsmbR
ibRibRcbRebRebRgbLebLebLsLcbLcbLobLibLhbLsbLsbsbRgbLgLsbsbRcRsmbLcbLgL
sbLgRsbLiLgbsbRjbReRsmbRjRgbLsRsbRibRiRsmbRibRgRibRiLsbRsRsRsmmbRiRsmb
RgRsmbRgbRiRsmbRhbRibRgbRibRiRiLsbRgbRgbRibRibLjbLcbLibLibLgbLibLgbRjR
gbRjbLcbRebRibsbRjLsbRibRibRhbLjbRjbLcRsRsmbLcbLiRsbLhbRjbRhRsmbLibRgR
smbRgRsmbRgRgRgbRibLibRebLhbRiRsmbLjbRjRsmbRjLsbLiRsRsRsmmbLjbRoRsmbLc
bsbLcbRcbLcbRhbLcbLhbRiLsbLcbRgbRjLsbRjRsmbLjbRcbLhbRjRsRsmmbLibRgbLiR
sRsRsmmbRebLcbLcbLiRgbRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bReRsmbRsbRsRsRsRgRsRsmmmmbRgRsRsmmbLsbRsRsRsRsRsRsmmmmmbRsRsRsRsRsRsR
gRsRsRgRsmmmmmmmmbRiRsmbLibRibRhbRsbRsbRibRsRgbRgRsRsmmbRsbRsRsmbsbRsb
RsRsRgRsmmbRgLsbRsRsRsRsRsRsRimmmmmbRibRsRgRgRsmbReRiRsRembRiRsmbRsRsm
bRsRsRgReRsRsRsRiReRimmmmbRgbLsbRsRgRsRiRsRsmmmbRiRiRibRgRsRsmmbRsRibR
gbRsRsRsRsRsRemmmmbRsRiRsRsRimmbRibRibRgRsmbRgbRsRsReRgRsRimmbRibLsLsR
sRsmmbRsRsRsRsRiReRsmmmmbRsRsRsRiRsmmmbRgbRibRgbRsRsmbRsRibRsReRsmbRiL
sbLgbRibRsRgRsmbRsRiRiRsRgRgmbRibRgRsmbRibRibLsRsLsbRsRsRgRiRgmbRsbRiR
smbRsRsRsmmbRgbLsbRibLibRsRhbLgbRiRsmbRsRsRhRsRsRsmmmmbRgRsmbRsRsRsmmb
RgRsRsRsmmmbRsRsRsRsRsRsRsmmmmmmbRgbLsLsmbLebLcbLhLsbRiRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bLgbRhRsmbRgbRgRsmbRiRgRsmbRiRsmbRgRsmbRibLebLiLsbLobLgRsbLjLsmbRjbRgb
RgRsmbRgRsmbRgRsmbRgLsbRibRsbLsRsRsmbRibRibRgbRibRibRgbRgbRgbRibRgbRsb
RgbRsLsbLsRebRgRsmbRiRsmbRgbsbRiRsmbRgRsmbRgRsmbRgRsRsmmbLebLibRgbsbRi
RibRsbReRsmbRibRibRsbRgbRgbRibRgbLjbRibRsbRgbRgRsmbRibRgbRhLsbLibLibLi
RsbLebLgLsbsbRcRsmbRgRsmbRsRsmbRgbRsRsmbRgRsRsmmbRgRsmbRebRgbsbRsbsbsb
sbRsbRgReRsmbRgRsmbLsRebRgbRgbLsbLjbRhRsRsmmbRgbRsbRhbLsRgRsRsRgmmbRiR
smb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bLebLcbsbsbLibLhbRjbLcbLebsbsbLhbLjbLjbRcRsmbLeLsLsmbLeLsLsmbLebLeLibL
ibLibLcbLjbLebLhbLhbLibLgbLoLsmbLebRsbRobRibRgRibRiLsbReRsmbRebRiRsmbR
iRsmbRcbRibLeLgLsLebLsbLgbLsbLsLsmbLsLsmbLibRebLgbLibLebLibLcbLobLcbLc
bLibLeLhbLeLsbLebLgLsbLgLsbLgbLcbLeLsbLcbRjbRibRhbRgbRcbRebReRsReRiRsm
mbRiRsmbRiRsRsmmbRiRiRgbRiRsmbLsLsRsmbLsbLsbLhbRsRjbRsRcRsmbRibLjLsmbL
ibLibLeLebLhLsbLibLibLgLsbLiLsbLibLibLgbLcbLibRgRsmbRebRiRsRimbReRsRiR
imbRebRgRsmbReRsmbRebRiRiRsmbReRsmbRgbLjbLibLgbLgbLgbLebLibLgLsbLjbLib
LgbLibLibLibLhbLgbLibLgbLiLsbLebLibLibLibLjLsmbLebLgbLhLsbLibLebRjbRob
ReRibReRsReLsmbRgRsmbRiRsmbRibLsRsbLsLsmbLsbRsbsbRibRcRsmbRgbRobRgbLeb
LibRibRcbRgbRobRsbLebRgbLobLsbRcbLjbRgbLsbLjbLcLsmbLgbLiLsbLgLsbLebLcb
LgLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bRibLgbRibLsRibRiRsRimbRibRiRsReRembLibLibLiRsLsbLoRsbLobRibRibRibLcbR
cbLcbLiLsbLjbLhbRibRhRsmbLibsbRsbRsbRsLjLsmbLhLsbLgLgLsRsbLcbLsLibRcbL
obLgbsbsbRsbLibLibLibLibLgbLibLibLiRsbRsRcbRcbLgbRhRsmbRiRsRiRsmmbRibR
gbRibRibRgbLibRcbRcRsmbRibRhbRgbLiLsbLgbLibLiLsbLibRiRsmbLsbLgbLiLsbLi
RsbLcbLgbRcbRiRsRsmmbRiRsmbRgbRibRibLcbRibRhbRgbRibRsRgbRgbLibLebLiRsb
LhbLgRsbLsbLibLibLgbLoLsmbLsRcbLcbLibLhbLibRgbLiLsbLgLibLgbLiLsbLibLib
LibLiLsbLibLibLibLgLsbLgbLgLsbLiLsbLibLcbLibRibLib

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bLsbLgbLsbLibRcbRibRsRsRsRsmmmbRsRsmbRsRsmbRsRsRsRsRsRsRsRsRimmmmmmmbR
sbLsRsRsRsRsRsmmmmbRsRsmbRcbLebLobLgbLsLsLsmmbRsbRsbsbLgbRsbLsLsmbLgbR
sRsmbLebRsbLgLsbRobRobRsbLhbLiRsbLgRsRsmbRsbLgbLgbLgLsbLgLsLsmbLgbLsLs
Lsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bRibLcbRjbLjLsmbRsbRjbLsbLgLsLsmbLsLgbLibLhRsbLebLsbLibLsLsmbRsbLeLsbL
cbLcbsbLgbLiLsbRsLsbLibLcLsLsmmbLgbLjLgLsbLeLsbLibRcbRcbLcLsLsmmbRjbRo
RsmbLsbLhLsbRsRjbLebRsRcRsmbLjbRcbLjbLiRsbRcbRcbLcbLjLgLsLsmbLiLsbRjbL
hLsbLsLibLcLsmbReRsmbLebLjLsLsLsmmmbRcRsmbRiRsRsmmbRgRgbLcbLibLhbLgLsb
RcbRibLsLsmbRiRsRsmmbLibRhbLcbLebLgbRibLjbLeLgLiLgLsbLgbLiLsbLibLiLsbL
hbLhbRjRsmbsbRiRsmbLsLsmbLsLsLsLsmmmbLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bLsLsLsRsLsRsmmbLgLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsmbLsLsLsmmbLsbL
sLsLsLsmmmbLsLsmbLgbLgbLgLsLsmbLsLsLsLsLsLsLgLsLsmmmmmmbLgLsLsLsmmbLgL
sbLsLsLsLsmmmbRgLgLsLsLsmmbRsLsLsLgLsLsLgLsRsmmbLsLgLsbLiRsbLgLgLsLsLs
LsLsmmmmbLgLsLsLsLsmmmbLsLsLsLsmmmbLsbLgRsRsLsmbLgbsbLsLsmbLgLsbLsLsLs
LsmmmbLiLsbLsbLgLsLsLsLsmmmbLsLsLsmmbLgLsLsLsLsLsmmmmbLgLsLsRsLsLsLsLs
mmmmbRsbLsbLsRsbLsbLsRsbRsRsmbLsLsLsLsmmmbRsLsbLsbsbLsRebLsRsRsRsRsmmm
bRsRsmbRsRsRgRsmmbRhRsRsRgRsmmmbLsRsRsRsmmbRsRsRsRsRsmmmmbLgbLsLsLsLsL
sLsmmmmmbLgLsLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmbLgLgLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRgRsmbRsbRgbRsbRgRgbRiRgbRebRebRgRsmbRibRibRgbRgRsRsmmbRebRsRsmbRibRg
bRebRebRhbRgRsmbRgbRsbRibReRsmbRgbRgbsbRgRsmbRibRgbRsLsLsmbRgbRgRiRsmb
RebRebRgRsmbRiRsmbRgbRgRsRembRhbRibRgRsmbRibsbRsRsmbRgbRibRgRsmbRsRgbR
iRsmbRebRibRgbRebRhbRibRgbRgRsmbRgRsmbRebReLsbRebRebRebRibRgRgRsmbRhbR
gbRsRsmbRgRsmbRibRgbRsRebRibRibRibRiRsmbRgbReRsmbRgLsbRiRsmbRhbRibRibR
gbReRsmbRebRgRsmbRibRgRsmbRgbRebReRsmbRgRsLsmbReRsmbRgRsmbRhbRhbRiRgbR
gRsRsmmbRsbRsbRsRsmbRsbRgbRebRhbReRsLsmbRgbRsbRsbRsbRgRsmbLsRsbRiRsRsm
mbRebRibRibRgbRjbRgRsRsmmbLsbRhbRiRsmbRibRibRiRsmbRgbRsbRgbRsbRhbRsbsb
RgRgbRibRsRgRgbRsRsmbRgbRgRsmbRsRibRgRsRsmmbRiRsmbRibRgbRgRsmbLsbRsbLs
bRebRibRgbRibRibRgRsmbRsbRsbRgbRsbRhbRsbReRsmbRibRgbLsbRgbRebRibRibRib
RibRsbRsbRsbRibRibRgbRibRiRsmbRsRgbLsbRsbRsbRsbLsbRgbRgbRgbRgRsmbRhRsm
bRhbLsLsmbRsRsRsRgmmbRibRgbRgbRhRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLgbLgbLsbLsLsmbLsLsmbLsbLsbLsbLgRsbLsbLsbLsbLsRsLsbLsbLsRsLsLsmbRsLsb
RsbLsbsbLsRsbsbRsRsLsmbLsLgbLsLsLsmmbLsbLsbLsLsLsLsmmmbLsLsmbRsRsLsmbL
sbsbRsbsbRsbLsbLsLsmbLsbsbLiLsbLibLgbLibLibLgbLsbLiLsbLsbLobRgbRjbsbRg
bLgLsbLgbLiLsbLiLsbLgLsbLobLgbLgbLgbRcRsRsmmbRhbRgbRcbRsbRebReRsmbRcRs
mbRcbLibLibLgbRcRsmbRgbRsRsRsmmbRsbRgLsbRgbsbRgbRgbRgbRsbRgRoLsbRcbRcL
sbRgbRiRsmbRsLsbLsLsmbRibRgRsmbRsbRgLsbRgbRiRebLibLjbRibRhbRgLsbRibRib
RiLsbRsbRgbRgRsmbLsbRgbRgbsbRsbRsRsmbRsbRsRsRsRsmmmbRsbRsbLsRsbsbLebRs
bsbRjbRjbsbLsbLsbsbRsbsbLsbsbsbsbsbsbRsbRgRsmbRsbRsbLjbRsbLsbsbLsLsmbL
sbLsbsbLsbLsbLsRsbLsbLsbLsLsmbLsbsbRsbsbsbsbLsLsmbRsbsbLhbLsRsbRsbRgRs
RsmmbRsbsbRsbRsRsmbRsRsmbLsbLhbLsbLsbLsbLsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bsbLjRsbRcbLsbLobLgbRsbLiLsbLibLiRsbRobRcbRgbRcbRgbRsbRhbRobRobRgbLcbL
ibLibLobRsbLgbLgbLgbLibRsbRibRobRiLsbLjbLgbRjbRgbRsRgRgRgbRiRibRiLsbRe
bRgbRgbRebRebsbRebRsbLsLsmbRebRgbRcbLoRiRibRsRsmbRibRibRebLoRsbRcbRiRs
mbRgRebRibRhRsmbRsRiRgRebRgbLibLsbLhbLsbLibLgbRjbLjbLsbLgLsbLibLsRgbRi
bRhbRibRgbRibRsbRibRsRgRsmbRsbRgbRgRsRsmmbRebRebReLsbRibRsRhRsmbRhReRs
RsmmbLsLibReRsReRsmmbRsbRgRsRgmbRgbRsbRsRebReRsmbLjbReRsmbRsbRsbRebRgR
ibRgbLcbRebRebRgbRhbRebRgbLgbRibLjbRebRsRsRsRiRsRsRsRsmmmmmmbRibRsLsbR
sbRgLsbReRsmbRgbLsbRsbRsRiRsmbRgbRebReRiRebReRsmbRsRsRsmmbRsRibRgRsmbR
sLsRsbRgRsmbRgbRgbRsRsRsmmbRgbRsRsRsRsRsmmmmbRsbRgbRsbRgbRsbRsRsmbRsRs
RsRsRgmmmbRsRiRsmbRgRsmbRgbsbRsRsRgmbRgbRgRsmbRgRsRsmmbRsbRsRsRsRsRsmm
mmbRsbRsRsmbRgbRsRsRsRsRsmmmmbRsRsRsmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bRjbsbRibRsRsmbRsRsRsmmbsbRsbRiRsmbLibRsRobLebRjbLhbLiLsbLgLgLsbLsLsLs
mmbLsLsLsLsLsLsLsmmmmmmbLsbLgLsbRhbLhLsbLibLgRsbRibLcbLibLibLgbLgbLsbL
sLsLsmmbLsLsLsmmbLsRsbLsLgLsRsbLhbLiRsbLgLsbLibRjbLibLgLsbLsbLgLsbsbRc
RsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLgbRsbRsbLsRsbsbLsLeRsbLsLsLgmbLsbLebLcbLeLibLcbLhLiLsbLgbLsLsmbLsLsL
imbLebLgbLsbRsbsbsbsbLsbLgLsbLebLcLsmbLhbLibLibRsLsbLibLibRsbLcLsmbRjb
ReRibRibRgbLsbLcLgbRgbRcbRjRsmbsbRibRibRgbLibLeLsbLibLcbLcLsmbLhbLebLs
bRgLsbLibLibRibRgRsmbRiRsmbRiLsbRibRgbRgRsRsmmbRgbRibRhbRcbLjLgbRebRib
RibRibRhbRcbRibRgRsmbLeLsbRcbRebsbRibRhbRiRsRsRsRgRsmmmmbRibRibRibRibR
iRsmbRibRibRcbLhbLeLsbLhbLeLsbLebLebLsbRgbsbsbsbsbsbRsbsbsbsbLsbsbLsbs
bsbsbLsbsbRsLsbsbsbsbsbsbsbsbRsbsbsbRsbLsbLsbsbsbsbsbRsbsbsbsbLsbLsbLs
bRsLsbRsbLsbRsbRsbLsbLsRsRsmbRsbLsbRsbRsbLsbRsbLsbLsbLsbRsRsmbLsbsbRsb
sbRsbRsbLsbRsbLsbRsLsbLsbRsbRsbRsLsbLsbRsbsbsbLsLsmbsbRsbLsbLsbRsbsbLs
bLsbLsbLsbLsbLsbsbLsLsRsmbLsbLsRsRsmbsbRsRjbsbsbRsbLsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bLsLsLembLsbLsLsLembLgbLgLsbLjRsbLjRsbLibLjbLibLcLsmbRibLgbLiLsbLgbRjR
jbLgbLibRjbLgLsLgLgbsbRgbLgLsbsbLgRsbRgbLibRsLsbsbLsbRsbLgbLibLgRsbLjR
sbRsbLgbLgLgLsbLiLsbLgbRjbRgbLjbLibLjbRibRjbLeLsbRsbLhbLhbLibLibRsbRiR
smbRsRgbsbRsbRsbRgbsbsbsbsbRsbLebLibLgbLsbLjbRsRgbRsbLgLsLgbLsbRsbsbLi
bLjbRjRibRgLsbRsbRgbsbLgbLgbLgbLibLgbLeLgbLeLibRgbLgbLgbLibLibLebLsbLj
RsbRgLsLsmbRcRsmbLeLgLsLsmbLgbRsbLibLgbLgbLgbLgbLjbLiLsbLsbLgbLebLibLj
bLsbLibLgbLgbLgbLgRsbLgLsbLsLgLsbLgRgbRibLgbLgLsLsmbLsLsmbLsLsmbLsLsLs
mmbLgbLsLsLgmbLsLsLsLsLsLsmmmmmbLsbLsLsLsLsLsLsLsmmmmmmbLgbLgbRgbLsLgL
gLsbLsbLsLsmbLgLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bLebRibRebRgbReRsmbRiRgbRsLsbsbRsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRgbRsRgbRgRsRgRsmmbRgbRebRgbRibRebRgbRebRebRibReRsRsmmbRibRhbRibRgbRe
bRebRsLsbRebRibRibRibRgbRibRgbRebRhbRibRhbRgbReRgRsmbRibRibReRsmbRebRi
bRgbRgbRgbRebLsRsRebRibRgbRibRibRsbRebRibRibRhRsmbReRgRsLsmbRgbRgbRsbR
gbRgbRibRibRebRhbRebRiRgRsRsmmbRiRsmbRibRibRhbRebRsbRgbRibRibRibRibRgb
RebRebRibRgbRibRgbReRibLsbRibRgbRgbRiRsmbRsbRgbRiRsmbRsRebRhRsmbRebRib
RsbRgLsbRhbReRsmbRhbRsbRgbRiLsbRgbRiRsRgmbRibRgbRsbRgRsmbRgbRibRiRsRem
bRebRibRibRgRsmbRiRsmbRebRibRsbRibRibRebRebRiRsRsRsmmmbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bRgbLsbRgbRibRobLsbLgbLibLibLgbLsbRebRibRibLsbRibRsbRibRgRsmbRgbRgbRgb
RcbRgLsbLibRsbLiLsbLhbRsbLsbRsRsmbLgbLgLsbRsbLgbLgbLgbLgbLgbLgbLgbLgbL
gRsbLsbLsLsmbLgLsbLgbRsbLgbLgbRsbLgbLgbRsbLsbLgbLgbLibLgbLgbLgbLgbLgLs
bLgbLgbLsbLsLsmbLgbRsbRsbLsbLgbRgbRsbLgbLibLgbLsbLsbLgbsbRsLsbLsRsbRsR
sRsmmbLgbLibRsLsRsLsRsbLgbLsLsmbLsbLsRsbLsbLsbLsLsLsRsLsmmbLgbRgbLsbLg
LsLsLsmmbLsbLsLsLsmmbRsRsmbRcbLibLgLsbLsbRsRsmbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLebRjRsmbRibRebRebRebRebRgbsbLgLsLsmbRcbsbRcLsbLsLsmbRibLcbRibRjRsmbL
jbLibLsbRibLibRgRsmbLhbRgbRibLsRsbRsbRsRsRsmmbLgbRhbLjLsmbRjbRibsbLjLg
LsLsLsmmbLcbLiLsbLsbsbRsLsbRsbRjRsmbLcbLibLcbLgbLgbLhbRjbLjLcLsmbLcLsL
smmbsbLhbLiLsbLgRsbRsRgbsbsbRsRsmbRgbLsLsLimbLcbLgbRibLiLsbLibLibLcbLc
bLgbLsLgbLcbLcRsbLcbRhbRjRgbRgLsbRcbRebReRsRsmmbRibRiRsmbRiRsmbRjbRcbR
iLsbRcbLsRcRibRiLsbRibLobLcLsmbLjLsLsLsLsLsmmmmmbLibRcbRhbReLsRsRcbRhb
LiLsbLcbLeRsbRhbRcRsRsmmbLibLjbLiLsbLgLcRsRsmbLjbLibLgRsbsbLibRjbLsbRj
bLhbRjbLhbRjbRibsbRsLcbLcbLsbLgLsLsmbLebLibRhRsmbRibRgbRcbRiLsbRsbRibL
sLsmbRgRsmbLjbRibLjbRjRsmbLjLsmbLhbLiLsbLibLibLgbLgbLibLcRsbLgbRjbLhbR
gRsmbLhLsbLebLgbRjbsbLjLsmbsbRgRsmbsbLsbRsLsRsbLsbRsbLsbRsbsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsbLibLgbRibLhbLiLsLsmbRjbLgLsbLjLgbLsLsLsmmbRsLsRsRsmbLibRsbLsbRsbRi
bLgbLsLsmbLsbRgbLibLgbLibLgLsbRhbLiLsbLibLibLgbLgLsLsLsmmbLsLsLsLsLsmm
mmbsbLjLsmbLsbRgbLgbRsbLgLsbRsRsmbRjbRgRsmbRgbLsLjbLibLsbLgbLsRsbLsLsm
bLibLibLgbLibLibLgbLibLgbLibLsbLgbLibLjbRsbRsbRsbRsRsmbLgbRgbLibLgLsbL
sbLgbLgRsbLgbLsbLsLsmbLsLsmbRsRsRsRsmmmbLsbLgbLgLsLsmbRjbRsbLgLsLgbLgb
LgbLgLsLsLsmmbLgbLgbRsbLgLsbRjRsmbLeLiLsLsmbLsLsLsmmbLjLsLsmmbRibLsbLi
bLsLsLsmmbLsLsmbRiRsRsmmbLibLiLsbLeLsbLibLhbLgLsbLsLsLsmmbLgbLsLsmbLsL
smbLibLsbRsbRsbRsRsRsRsRgmmmbLibLgRsbLsbLsbLibLgLsbLsbLsLsmbLsbLiLsbLg
LsbLsLsLsLsmmmbLsbLsbLsLsmbLsbLsRsLsLsLsmmbLsLsmbLgbLgbLgbLsbLgbLsbRsb
RsbLibLsbRsbsbLjLsLsmmbLgbRgbLsbsbLgbLsLsmbLgLsbsbLgbLsLsLsLsLsLsLsLsm
mmmmmmbLsbLsbLgLsbLsLsmbLsLsmbLgbLgLsbLibRibLsLjLsmbLgbLsLsmbLjRsLsbRs
LsbRsRsmbRsLsbRsLsLsLsLsmmmbLsRsLsbLsbLsLsRsLsmbLsLsLsmmbLsbLsLsmbLsLs
LsLsmmmbLgLsbLsbRsbRgbLgLsbLsLsmbLsbLibLsLsmbsbLsbLsLgLsbLsLsLsmmbLsLs
mbLsRsbsbsbLsbLsRsLsbLsLsmbLgbLgbLibRiRsmbLsbLsbLhLsbLsLsmbLsLsmbLsLsm
bLsLsmbLgLsLsmbLsLsmbLgbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bLsbLibLibLgbLibsbLibLhbLibLibLiLsLsmbLsbLgbLgLsbLgLsLiLsbLgbLcbLgLsLs
mbLgLsbLsbLgbLsbLgLsbLgLsbLgLsLsLsLgLsmmbLsbLibRsbLiRsbLjLebRsbLibLiLs
LibLiLsbLgbLiLsLhbRibRsLsRsRsmbsbRgbRsRsmbRsbRsLsbRsbRgRsmbRgbRgbRgbLj
bLibLhbLiLsbLsLgbLebLeLsbLebLibLiLsbLebLiLsbLgLsbLgbLiLsbLgbLgbLgbLibL
ebLiLsbLgbLhbLibLibLgLsbLsLsmbsbsbLgbLsLsmbLgbLsLsLsmmbLsbLgbLgLsbRsbL
ibRsbRjbRibRsbsbRibRgRsRsmmbRgLsRsbRsbRgbLeLsbLgLsLsLsmmbRgbRsRsmbRgRs
RsRsRsRsmmmmmbRiRsmbRebLgLsbLebRcbRebRgRsmbRgbRgbRgbRsRsmbRsbRgRsRsRsR
smmmmbRgbRsRsmbRsRsmbLcbRgbLhLsLsLgLsLsmmbRsLsLsLgLsLsmmbLsRsLsLgLsLsL
gmbRsLsbLgLsbLibRsLsbLhLsLsmbLsLsmbLgLsbLgbLsLgLsLsLsmmbLgLsLgLsLsLsLg
LsmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbRsRsmbLiRsbRjbRibLeLsLsmbLibLsbLgLsLgb
LgbLibLgbRobLhLsbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRsbLgbLgLsLsmbLgLsbLibLsbLjbLhLsbLeRsbRsbRjRsRgmbRgbLsbLgbLibLsbLibLe
bsbRhbLiLsbLgLsLsLsLsmmmbLgLsLsmbLsLgbLsLsLsmmbLsRsbLgLsLsmbLgbLsLsLsm
mbLgLsLgbLibLgLsLiLsbLiLebLgbLgbLhLgLsLsmbLebLgbLibRebLjbLiLsLsmbLsbLe
bLebLibLhbLsRsbLiLgRsbLebLebLibLgLsbRsbLgLgLsbLeLibLibLgRsbLgLsbLgbLgb
LgbLsbsbLibLhbLiLsbLgLsbLgLsLibLgLsbRsLsLsmbLibLgRsLsRsbLsbLebLhbLebLg
bLgLgLsbLiLsLsmbLsbLgLgLsbLgLgLsbLgLgbLgbLiLsLgbLeLsbLiLsbLsbRsbLgLsLg
LgbLebLhbLsLsLgmbLiLsbLibLgLsLgLsbLebLgLsbLibLsLsmbLgLgLsLsmbRsbLgLsLg
bLibLebLgbsbLsLsLsmmbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bLibRsbLibRgbLgbRhbRjRsRsmmbRibLgbRsRsRsmmbRsRsRsRsRsmmmmbRibRsbLsbRsR
smbRibLsRsbRibLsbLebRgbRibLjbLcbLibReRsmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmm
bLsbRsRsmbLsbRsbRsbLiLsbLsLsmbLibRibRsRiRsmbLjbRibRgRsmbRgRsRsRsRsRgRs
mmmmmbRsRgRsRsRsmmmbRgRsRsmmbRgbRgRsmbRibRebRibRjbRhbRiRibRgRsRiRsmmbR
iRgRgbRiRgRsRsRsRsmmmmbRsbRebLiRsbLibLhLsbRsbLsbRsRsRsmmbLsRsLsRsbLsbL
sbRsbRibReRsmbRgbRgbRgRsRsmmbsbRgRsmbLsbRgbRgbRgbLsRsbRcbRiRsmbRgRsmbR
iRsmbRgbLsLsmbRhbRibRsbRgRgbRiRhRsRsRgmmbRgbRhbRsbLjbRcbLcbRhRsmbRiRsR
smmbRebsbsbRsbRsbRsRgRsRsmmbRjRsmbRhbRebRibRsbRiRsRsRsRsRsRsRsRsmmmmmm
mmbRsRsRsmmbRgbRhbLjLsLsmmbLsLsLsmmbLsLsLsmmbLsLsmbLgbLsbLsLsmbLsbLgLs
LgLsLsLsmmbLgLgLsbLgbLiLsbLsbLgbLiRsRsmbLhbLgRsbsbLsRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRsbLsbRgbRgbRgRsmbRgbLsbRgbRsRsmbRgbRsRsmbRgRsmbRgbRsbRgbRgbRgRgbRgbR
ibRibRgbRsbRibLgbLcbLibLgbLibLiLsbLgbLgbLsbLgbLsLsmbLgbLibRsRsmbRsbLsb
LibLibLgbLibLgbRsbRjbRgRsRsmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRgbRsRsRsm
mbRsRsRsmmbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsbsbRgbLsLsRsmbRcbLgbLiLsbRiRsm
bRsbRgRsRsRsmmmbLsbRsbRsRsmbRsRsRsRsmmmbRsRsRsRsmmmbRsRsRsmmbRgbRsbRsR
sRsmmbRgbLsbRsRsRgRsmmbRsRsRgLsmbRsRsmbRsRsRsmmbsbLcbLhLsbLebLsbRgbRib
RsRsRsmmbRsRsRsRsRsRsRsmmmmmmbRsbRsbRsRsRsmmbRgRsmbRgRsRsmmbRsbRsRsmbR
sbRsRsRsRsRsmmmmbRsbRgbRgbRgbLsRsRsRsmmbLsbRsRsRsRsRsRgmmmmbRgLsbRsRsR
sRsRsRsRsRgmmmmmmbRgbRgbRgRsmbRsRsmbRsbRibLsbRgRgbRsRsmbRgbRsRsRsRsRgR
gmmmbRgRsmbRgRsRsRsRsmmmmbRsRsRsmmbRgbRgRsRsRsmmmbRsbRsRgbRsRsRsRsRsRs
RsRsRsmmmmmmmmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bRsRcbRibReRsmbRgbRsRsmbRgRsRsRsRsRsmmmmmbRgbRibLsLsmbRibRiRsRsRsRsmmm
mbRgbRgRsRgRsRsmmmbRibRebRiRsmbRgRsRsRgRsRsmmmmbRgRsmbLsLgLsbRgbsbRgRs
RsRsRsRsRsmmmmmmbRsRsmbRgbRsRsRsmmbLsRsRsmbRsRsRsRsRsRsRsRsRsmmmmmmmmb
RiRsRsRsRsRsmmmmmbLsRsRsRsRsRsmmmmbRiRsRsmmbRgbReRsmbRiLsbLsbLgLsbLsLs
LsLsLgLsmmmbLgLsLsLgLsRsmbLgbLgLsLsmbLgbLgbLsbLgLsLsLsLsLsmmmmbLgLsLsm
bLsLsLsmmbLsbLsLsmbLgbLgLsbLsLgLsbLgLsbLsLsLsLsLsLgLsLsLsmmmmmmbLgbLgL
ibLiRsbLgbRgRsmbLsLiLsLsmbLiLsbLsLgLsbLgLsbLgLsLsmbLhLsbRibRobLibLgbLg
LsbLiLsLsmbLgLsLsLsLsLsLgmmmmbLsRsbLiLsLsLgmbLgLsLsmbLsbLsbLsLsmbRcbRg
RsmbRsbsbRiRsRsmmbRgRsRgmbRebLgbLobLeLsbLiLsbLibLeLsbLgbLsLsLsLgLimmbL
sLiLsbRsLsLsLsLsLsLgLsLsmmmmmbLgbLibLsLgLsRsLsbLiLgLsLsmbLgLgLsbLgLsLs
mbLsbLibLiLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLgbRsLsbsbLsLsLsLsLsLsLsLsLsLs
LgLsLsLsmmmmmmmmmmmbRsLsLsLsmmbLiLsLsmbRgLsLsmbLiLsbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsmmbLgLsbLsbLibsbsbRsbRibsbsbsbsbsbsbLsbLsbLsbRibRebRsbRsRsmbRib
RebRsbRebRiRsmbLsbLsbRgRsmbRebReRsmbLsbRgbRsbRebLibLjbRsbRgRsLsmbLsbRg
bRsRsmbRsbRgbLsbRgbRcbLebRibLsbLebLibRsLibLgLsbRgbRsbRsLsbRgRibRebRjbR
hbLsLsmbLobLgbLiLsLsmbLibLibLgLsbLcLsmbLibRhbRobRhbRibLsLsLsmmbLsLsLsm
mbLsLsLsmmbLsLsLiLsmbLsLgbLiLsbRsbLibLibLiLsbLsLeLsbLgRibLsbRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bRebLobLjbLcbLibLsRsbLibLgbLhbLhbLhbLibLhLgbLebRjbLsLibLhLsbLibLhbLibL
gbLhLhLiLeLsbLgLebsbLebLsbLobRibRgRsmbRgbRgRhRsReReRsmmbRgbRgRsRsmmbRc
b

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
bsbRgbRibRibRiRsLsmbLsbRcLsbRcbRsbRibRebRibRcbRgbRibRhbRgbRibLsbsbRjbR
ibRcbRhbRiRsmbReRsmbLsRsLsbLhbLgbRsbRjbRjRhRsRsmmbRgRsmbRgRsRsRgRsRsmm
mmbRibRiLsbRgbRgbRgbRgbsbRgbRibRgbRhbRhbRhbRcLsRsbLibRiLsbLcbLgbLibLib
LgLsbLsRsbLeLsbLiLsbLeRsbLgbRsRsmbLgLsbLgLsbLgRsbLiLsLsmbLsbLhbLgbLgLs
bRebRcLsbRcbRibLgLsbLiLsbLiLsbLgbRcbRcbRgRsRcmbLhbLibRibRsbLibLsRsbRgR
smbRsbRebLhbLgbLjLsLsmmbLsbRhbRcbRgRsRsmmbLibLibRsRsmbRcbRsbRobRgbRibR
ebLibRebLgbLsbLibLgbsbLjbRibRsbLjLgbLgbLgbLsbRjRjbLebLgbRsRsmbRiRibRiR
smbRsRebLibRibRcbRibRibLgbLjbLibLsbLgLhbLgbLgbLhbLebLgLiRsLsbRgbLibsbR
jRsmbRjbRhbRgRsmbRcRsRsmmbRhbLsLsmbRhbRhbRibRebRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bRibRsRsmbRgbRgbRgRsRsmmbRsbRsLiLsbRiRsmbRsRsRsmmbRsbRgRsmbRsRsmbRsbRg
bLsRsbRgRsmbRsbRgRsmbLeLsbLibLgbRsbRgbRsRsmbRsRsmbRsRsmbLiLsbRgbsbRgLs
bsbLsLsmbLsbRgbRgbRgRsmbLgbRsRobRgRsmbLibRsbLgLsbRsRsmbRsbLgbRgbRsbRsb
Rsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bRgbRibRiRsRsmmbLjbRjbRibLcbRibRgLsbRhbRiLsbRgbLebLsbRebRibRibRgLsbRib
RiRsRsmmbRcbLibRcbRibRibLibLibLgbLhbLhbLsbRgbLibLibLgbLibLibLgLsLsmbLg
bLgbRgbLibLcbLibRgbRhbRgbRibLsbRibRgbRgbRibRgbRibRhbRibLiLsbRibRhbRgbL
gLsbLjbLibLiLsbLibRhbLibRjbLcbRhbRgbLjbLgbLgbsbRgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
bRgbRgbRgbRgbRibLsbLcbLibLibLgbLibLsRsLsbRjbsbRjbRebRibRgbRgbRibLgbLhb
LgbLjLsmbLsLibLebLibLsbRiRsmbLsLgLsbLgLgbLhbRibLgbLhbRhbsbLebLgRsbRibL
ibLsbLsbLiRsbRibRebLgRsRsmbLjbLgLsbLgLsLsLsLsLsLsmmmmmbLgbRsRsRsmmbLiL
sbRsRsmbLcbLgbLibRgbLibLjbRcbLsLcbLcRsbLjbLibLhbRsbRsbLgbLibRgbLjLsLsL
sLgmmmbRsbLgLsLsLsLsLsLsmmmmmbRsbLibsbLsbLcbLcbLiLsbLibLibLebRsbRgbLib
LibRcbRgbRgbLjbLhbLibLibLibRsLsbLhbLgbLiLsbRsbLgLsLsLsLsLsLsmmmmmbLibR
gRgRsRsmmbLhbLgbLibRsbLsLsmbLibLsLsRsRgRsRsmmmbLibLhbLibLgLsbRsRsmbLsL
smbLsRsbLsLsLgmbLsLsmbLsLsmbLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbLsLgLs
LsLsLsLsLsLsLsLsLimmmmmmmmbLgbLibRsbLsRsbLjbRibRcbLcbLibLiLsLgLsbLibLg
bLibRgbLgbLibLjbRgbLgLsLsLsmmbLgLgbLgLsLsLsLgLgLsLsRsmmmbLgbLiRsbLsbLi
bLgbLsLsmbLsLsmbRsbLgLsbLiRsRsmbRibLibLibRsRsmbsbLgLsbLhbRiRsRgmbRibRs
bRsRsRsRsRsRsRsRsRsmmmmmmmmbLcbsbLgbLsLsLsLsLgLsLsLsLsmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135333; End: 135833;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bLsLsmbLgLsbLsbLgLsbLsLsLsLsmmmbLsLsmbRsLsbsbLsLsLsmmbLsbLsbLgbLgLsbLg
LsLsmbRsLsLsmbLgbLsLsmbLgbLsbLgLsLsmbLsLsLsLsmmmbLgLgbLgbLsLsLsmmbLsLs
LsLsmmmbLgbLgbLgLsbLgLibLsLsmbLsLsLsmmbLgLsbLgRsbLsLsLsmmbLgLsLsLsmmbL
sbLgLsbLgbLgbLsLsmbLgLsbRsLsbLsbsbRsbsbLsbLsbLsLsmbLgbLebRebRgRsmbRgbL
sbRgbRsRsmbRsRsmbsbRsRsRsRgRsRsRgmmmmbRgRsmbRsRsRgmbRgRsRsmmbRsRsRsmmb
RibRsbsbRgRsRsmmbLsbLsbRibRsRsRsmmbRgRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bLcRsbReRsRsRsRsRgmmmmbRsbRsbRobRgbLobLibLeLibLiLsbRsbLobLebLibLgLsbLi
LsLgLibLgbLibLgbRsLsbLgRsLsLsmbLgLsbLgbLsbLsbLsRsbsbRsbLsbLsLsLsLsmmmb
LsLsLsmmbRsRsmbsbLsbRsbLsbLgRsbLsRsLsbRsbLsbLsRsbRsbLsbsbLsLsmbLsbLsRs
bsbLsbRsbLsbLsbLsReLsbLcbLsbLsbRsbLibRgbsbLgbLsbLsbLgbLgLsbLiRsbRsRgbL
gbRsRcbRibRcLsbLsbLgbLgbRjbRgbLobLibLiLiLsbLgLsbLibLiLsbLhLsbLeLhbLhbL
eLsRsbRsbRsbLgbRsLsbRsbRsbLibsbLsRsbLsbLsbLsRsbLsbLsbRsbsbLsLsLsmmbsbR
sbRsLsbsbLjLsLsmmbRgbRcbRgRsmbRsRsmbRsbLgbLsLibLsLsLsmmbLsbRsbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRgRsmbRsbRsRgbRsRsRsRsRsRsRsRgRsRsRimmmmmmmmbRcbLebRsbLsbLiLgLs
LsLiLgLsmbRsRsRsmmbRhRebRgRgRgbRsRsRsmmbRiRsRgRsRsmmmbRsRsRsRsRsmmmmbR
sRsRsRsmmmbsbRsLsbRsRsRsRgRsmmmbRsbRsbRiRsLsmbRiRsRsRsRgRsRgRsRgRsRsLs
RiRimmmmmmmbRsRiRsmbRsRgRgRsmbRsRhRgRsRsmmbRgRgLsRsRsRsReRemmbRibRgRgR
smbLsbRsRsRsRsRsRsRsRsRsRsRgRgmmmmmmmmmbRsRsmbLjbLgRsbRcRgRsmbRsbRobLi
bLgbLjbLsbLsLsmbLsLsLsLsLsLsmmmmmbLgLsLsLgmbLsLsLsLgRsmmbLgLiLsLibLebR
gbLsbLsLsLsmmbLsLsmbLeLgbLiLsLsmbLsLsLsLgmmbLgLsLsLsLsLsLsLsLsLiLgLsmm
mmmmmbLebLiLeLebLeLsbLeLsbLeLsbLsbLsbLsLsmbLsLsLsLsmmmbLsLsLsLsLsmmmmb
LibLsLsLsLsLgmmmbLibLeLsbLiLeLsRsbLibLsLsLsLsLsmmmmbLsbLsbLsLgLsLsmbRo
bRcbRiLsbLjbLibLibLiLsbLiLsbLgLgLibLebLhbLhbLiLsbLgbLeLsbLebLibLiLsbLi
bLgLsLsLgLimbLeLeLebLsbRobRiRsmbLcbLsbLiLsbLhbLebLgbLsbLgbLsRsLsLsLsLi
mmbLsLsLsmmbLgLsbRsLsbLgLgLsLebLebLebLebLgLsRsLsRsLsLsLsmmbRjbLgLsbLgL
sLgLsLgbLibRjbLiLsLgLgLsbLsbsbLgLsLgLsLgLeLsbLebLsLebLsLebLebLeLsbLsLs
mbLsbLgbLiLsLsmbRibLibRiRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bRjbLhbRobLeLsLsmbRjbRcRsmbLsLsmbLjLgbLsLsmbLobRiLgbLgLsbRoLsbLiLsLsmb
LgbLcbRgbLibLsRhLsbLsbLhbLsbLsLgLsLsmbLgbLsLsLsmmbLibRjbLsbLhLgLgbRjbs
bRhbRibLsRsRsmbLiLsbRcbRibRsRsmbRgRsmbRsRgbRibRibsbRcbLsbRsRsRsmmbLiRs
LsRsbRibRsRsRsRsRsmmmmbLiLsbLiLsLsLsLsmmmbRjbRcbRibLiLsbRjbRgbLcLsmbRj
bRiRsRsRsRsmmmmbLsbLjbLcbRjbRhLsbLsRsbLcbRoRsmbLsLsRsmbLibLsLsLsLsmmmb
LiLsRsbLebLgbLiLsLsmbLiLgbLsbRsRsmbLsbLsbLiLsLsmbRcbRiRsmbRgLsbLibLhLg
bLsLsLsLgLgmmbLibLiRsbLjLsLgLgLgmbLiLgbLibLiLsLsmbLibLgLsLsLsLsLsLgLsL
gLgRsmmmmbLibLibLibLsLsLsmmbsbLsLgbsbRsRsmbLsLsLsLsmmmbLiLsbRcbsbRsRsm
bsbRsbRsRsRsRsRsmmmmbLsbLgbLsLgbLiLgLsLsmbLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRgbRgRsmbRgLsbRgbRibRibLjbLiLgbLiLgbLsLgbLgLsLsmbLgLgbLgbRsbLsb
RcbRgRsmbRgRsmbRgRgbRiRsRsmmbRhbRsbRgbRgbRibRhbLobLgbLiLsbLgLgbLibLibL
sLsRsmbRsbLibLgbLgLsbRsbRibRjRgbsbLiLsbRsRobRgbsbLiLsbLsbRsbLgbsbRjbRi
RsRsRsmmmbRgbRgbRibRgbLgLsbRibRgRsmbRgbRsRsmbRsRsmbsbRgbRgbRsRgbLsbReb
RiRsmbRiRsmbRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bRsbLiLsbLgbRhbLjbRjbRcLsbRibRgbRhbLgbLsLsmbLgbLsRsbLsLsLsmmbLgRsbLgLs
LsmbLiRsbLgbLsbLsbLsbLgLsRsRsRsmmbLsLgLsLgbLsLsLsLsLgmmmbLsLsmbLsLgbLs
LsLsmmbRsbLsLsmbLgbLgLsbLsLsLsmmbRsbLsbRsLsbRsbLsbLsbLsLsmbLsLsLsmmbLi
bLibLgLsbLsLsLsLsmmmbLsLsmbLsLsLsLsLsmmmmbLsLsmbRsLsbLsLsLsmmbLsLsLsLs
LsLsmmmmmbLsLsLsmmbLsbLsbLsbLsLsLsmmbLgLsLsLsLsmmmbRsLsbLsLsLgLsLgLsmb
LsLsLsmmbRsLgLsLsmbLgbRsbLsLsLsLsLsLgLsLsLsmmmmmmbLgbLgLgbLiRsbLeLsbLi
bLgLgLsbLsLsLgLsLsmmbRsbLsLsmbRsLsbLgRsbLsLsLsLsLsLsLsmmmmmmbLsLsmbLgL
sLsRsLsLsLsLsLsmmmmmbLsLsLsLsLsmmmmbLgbLsLsLiLsLsLsLsmmmmbLiLsbRsRsmbL
iLsbLsLiLsbLgLsbLsLsmbLsLgLsbLsLsLsmmbLsLsLsLsmmmbLgbLgbLsRsbLgLsLsmbR
sbLgbLgLsLsmbLgLsLsLsLsLgmmmbLibLgLgLsLsmbLsLsmbLsLsLsLsLsmmmmbLsLsmbL
sLgbLsLsmbLgLsbLsLibLgLsbLgLgLsbLiLsbLgLsbLsbLsLsmbLsRsbLsLsLsmmbLsLsL
smmbLsLsmbRsLsLsmbLsbLgLsLsLgLsLsmmbLsLgLsbLsLsLsLsLsmmmmbLgLsLsmbLsbL
gLsLsLsmmbLsRsRsmbLsbLsLsmbRibLibLsLsLsLsmmmbLsbsbLgLsbLgbLgLsLsLsLsLs
LsLsmmmmmmbLgLsbLgLsbLgLsLsmbLsbLsLsmbLsbLsbLsLsLsLsLsLsmmmmmbLsbLsbLg
LsbLsLgLsLsLsLsmmmbRsbLsbLsbsbsbRsbsbLsbsbRsbRsbsbLgLsbLgLsbsbLibLgLsL
smbLsLgbRsLsRsbLsbLsbLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRgbRgLsbRjRsmbRsbRsRsRsmmbRsRsmbRgRsmbRiRsmbRibRsRgRsmbRgRsLsRsmbRhbs
bRibRiRgbRgbRsLsbRsLsRsbRibRsRiRsmbRgbRibRgRsmbRsbRsbRgbRibRgbRgbRibRg
bRgRsmbLjbsbRsbRgRsmbRibRgRsmbRiRsmbRgbLgbRiRsLsmbRiRsmbRgRsRsmmbLsRiR
smbRgbRgLsbRgbRiRsRsmmbRibRgRgRsmbRibRgRgbRgLsRsbRsbRjbRgbRgbRibRibRib
RsRsRsmmbRiRsmbRiLsRsbLgbRibRiRsmbRgbLcbRjbLjLsLsLsLsLsmmmmmbLsRsbRibL
jLgbRjbRcLsbLibLebRgbRiLsbLhLsbLsRsbRibRgRgRsmbRiLsbsbRgRsRsmmbRgRsRsR
sRsRsRsRsmmmmmmmbRibRiLsbRibRiRsmbsbRjbLebRsbLsbLiLsbLsbRhbLjbRcRsRsmm
bRgRsRgRsRsmmmbRsRsmbLsRsbRgRgRsRsRgmmbLcbRibRibRiLsbRibRibRjbRcbRibRg
bRgRsmbRsLsbRsRsRsmmbRsRsmbRiLsRsRsmbLsRsbRgRsRsmmbRgRsRsRgmmbRebRhbRe
bReRsmbsbRgRsRsRsmmmbRibRibRibRsLsLsmbRsLsbRsbRsRsRsmmbLsLsmbRiRsmbLsR
sRsLsmbRgbRgbsbRibsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bLcbRebLebRcbLobLobRobRibLobRebLhbLcbRibRobLhbRobLobRobRgbRobRobRobRcb
LobLsbRhbLebLobRcbLcbRgbLebLobLobRibLobLobLobLibRcbRebLcbRhbRgbRobLebR
ebRcbRibLobLhbLobLebRobRcbLebLsbLcbLgbRobRobLobLebRsbLgbLobRcbRcbLgbRo
bRcbLsbLobRebRobRobLcbLobRcbLebLobLibLobLibRobLobLebLebLsbRgbRgbLobLgb
RgbRgbRebLobLcbLhbLebLcbLhbLobRebRhbLebLcbRibLsbRebLobLebRobLcbLobRebL
ibRibLobRobRgbRgbLebRcbRobRobLebLcbRcbLobRebRobLcbRgbLsbLebLhbLobLhbLi
bLobRobLobLibLobLobRobRebLobRgbRcbRobRcbRobLibLebRobRcbLobRcbRobRobLeb
LebLebLebRobLibLcbRobRebLobLobLobRobLgbRebLobLcbLobLcbRcbLebLhbLebRobL
obLobRcbRobRcbRibLgbRobRobLebRibRcbRsbLsbRcbRobLobLobLebLebLcbRgbLgbLe
bRobLcbLgbLibRibRebRjbRgbRobLobLcbRobRobRobRibRobRcbRobLgbRgbRibRobRob
LobRebRobRsbLobRebLcbRobRobRobRebRgbLebLobLobRobLebRcbLebRobRobLobRhbL
obLobLobRobLgbRebLebRgbLsbRhbLebRobLobRobRebLebLobLsbLibRobRsRjbRebLgb
LcbLibRebRobLobLcbRobRobRobLobLcbLebLobLcbRebLcbRobRgbLobLibLibRsbRcbR
obRebRobLobRgbLhbLcbRgbRobLobLibRibLgbRcbRcbRgbRobLobRobRebLebLcbLebLo
bLcbRebLebRcbRobLjbLobLcbRobLobLebLobRobRobLcbRjbRebLgbLebRebRobRobRib
LibRobLobRibRebRcbRobLsbRobLcbRobRebRobLebLobLibLobLsbLobRebRsbRobLobL
obLsbLebLcbLcbRobLebLobRibRobLcbRobLibLebRobLobLobLgbLcbRcbRebLibRcbLi
bRobRcbLebLgbRobRebRcbRebLebRobRcbLebLobLcbRcbLcbLebLcbRebRibLobLsbRob
LgbRgbRobRcbLebRcbRcbRibRgbLgbLobLobRobLebRobLcbLobLebRibRebLebRcbRjbR
sbLibLebLobLobRobLebLebRgbLobRcbLobLgbLgbLobLcbLgbRgbRobLibLobRobLobLc
bRebLobLcbLobRebLsbLobRebLobLobRcbRebRebRcbLobRobRjbLgbLcbLobRjbLsbRob
RebLjbRibLcbLobRobRebLobRobRebRibRobLcbRgbLhbLobRobRobLobRgbLibLgbLcbL
ebRebRobRobLobRebLjbLjbLobLobLobRobLobRobRobRgbRcbRebLibLobRobLebLcbRe
bLcbRobLobRcbLobRobRibLebLobRebRobLjbLobLcbRobLobRobRsbRebLebRcbLobRob
RibRobLobRcbRgbRobLcbLobRebRobRobRobRgbRhbLobLebLebLjbLebRcbRcbRobLebR
obLobLcbLobLsbLgbLsbRobLobRcbLebLobRibLcbLgbLcbLebRcbLcbRobRobRebRobRj
bRobRobLobRobRobLobRsbLobLobLgbLsbLcbLobRcbLobRobLobLobLobLgbRobRcbLob
LcbRobRcbLobLobLebRcbLsbLobLobLibLobRcbLjbRobLobLebLebRgbLebLcbRibLobL
ebRsbRobRgbRobLobLebRsbRobLobLobLobLobRibLebRobLsbLibRobRcbLobLgbLobRe
bRebRebLobLibRobRobLobLobRebLibRebLebLgbLcbLobLobLgbRibLsbLobLcbRgbLeb
LsbLobRobLobLobLobRebLobLcbRcbLsbRobRcbRobLobLebRobRgbRobRobRobRcbLibR
gbLcbLobRebLobRcbRibRebLgbLobLcbRgbLobRobRcbRebLebLebLibLcbRobRobLibRc
bLebLobRobLcbLcbRobLobRobRsbLcbLobLebLibRobRobLcbLcbLobLsbRgbRebLjbRcb
LobLobLobLobLhbLebRjbRcbRobLobLsbRebRobLgbLebRobLsbRcbRobRobLobRsbRibL
obLibLebLgbRcbRhbLobLobLobRobLobRebLobLobLobRobLcbLsbLobRibRibRcbLebRc
bRebRobLhbRebLcbRobRobLobRcbRgbRobLobLobLibLebLgbRobLsbRebLobLcbLjbLcb
LobRsbRcbLebLibLobRobLobLsbRobRcbRobLsbRibLcbLobLjbLcbLgbLebRsbLibLobR
cbLsbRgbLcbLcbRobLobLobLobLobRebRebLobLebRobLobRobRebLgbLsbRobRobRjbRe
bLcbRobLebLobLgbLebLebRobRobRebLcbRobRobLgbRob

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bLsbRjbLebRcbLebLsbLsLsLgLsmbLsbLsLsLsLsmmmbLibLebLcLsLsmmbLhbLibLhRsb
LebLiLsbLebLgbLgbRibLebLgbLsbLsLgbsbRsbLhLsbLobLibLibRcRsmbLgbLebLibLi
bLibLhbLibLibLibLsbLgLsbLiLsLsRsmbRsbLgLsbLjLsLsLsmmmbRiRsmbLibLgLsbLi
RsLsbRjRsRsmmbLibLibRobRoRsmbRgbLhLsLsLiLsLsmmbLiLsbLibLebLibLibLgbLsL
gbRsRsLsLsmmbLgRsbRgRsmbLhbRgbRhbLebLgbLibLgbLgbLebLibLibLiLibLobLiLsR
gbLgbLiLsRsLsbRsbLibLcbRgbRgbLibLiLsbLsbLgbRcbLsbRhbRibLsLjLeRsbLsbLsb
LgbLsbRsLsbsbLsbRsbRsbsbRsRsmbLgbsbLgLsLibLeRsbRjRsRsRhmmbRsRibRibRsbR
iRsmbRgbRibLgbLhbsbsbRsbLiLgbRsbRebLebLiLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRgbLcbLiLsbLibLiLsRsbLiLsLsmbLibLhbLobRebRiRebLebLibLiLsbRgbLgbRhbLhb
LcbLgbLibLhbLibLcbLebLgbLibLgbLsbLgLsbRjbRibsbLjbRibRcRhbRcbLiLsbLjbLi
LsLibLgLgbLsbLsLsmbLgbLsbLsbRcRsmbRebRcRsLsmbLgbLiLsbLhbLebLgbLcbLhbLg
LsbLiLsbLsbLibLhbRsbRiRsmbLibsbLibRgbRgbLsbLjbRhbLjbLebLibLgLsbLsLsmbR
sbLhbLsbLiLsLsmbRebLibRjbRibLibRjbRgRsmbRsbLibRcbRsbsbLsbRsbLjbRiRsmbL
sRsRsmbRgbLsbRsbRsbRsRsmbLsbsbRsbRcbLjbLibLhbLsbLsbRjRibRgbRhbRibRebRe
bLebRjbRiRsmbRsbLcbLhLsRsbLibLhbLibLsbLiLsbLgbLgbRsbsbLsbLsRsbLsLsmbRs
bLsbLsbLgbRsLgLgLsLsLsmmbLgbRsbLsbLsLsmbLsbLsbLsbLgbLsbLgLsbLgLsbRsbLs
bLsRsbLsRsbLgbLibLobLibLcLsmbLibLiLsbLibLgbRgbLibRsLibLibLibLhbLgbLibL
ibLibLsbLiLsLsmbLsbLsLsmbLgbRcbRibsbLiLsbLsLcbLgbLhbLibLibLibRjbLiLsbR
sbLhLsbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bRibLibLsbLgbLgRibLgbLgbLsRsbLgLsbLsbLgLsRsbLgbLgbLsbsbLsbLsRsbLibLibL
ibLiLsbLibLgLgbsbRsbLsbLsLsmbsbLsLgRsbLgbLsLsmbLgLsLsmbLsLgbLsLgRsbLgL
sLsmbLsbLsLsLsmmbsbLgLsbLgRsbLsLsmbLsbLgbLhbLobLcRsLsbRsbLgbLsbLibLibL
cbLcbLibLobLhbLhbLibLcbRhRsRsmmbRobRoRsmbRibLebsbLhbLhbLhLsbLcbLibRsbL
gRsbLgRsbLgLsLsmbLgbRsbRsRsLsmbLsRsLsbLgbRjbLsbLiLgbLjbLsLsmbLsbsbsbsb
sbLgRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRgRgRsmbRgbRgRsRsmmbRgRsRsmmbRgRgRsRsmmbRgRsRsRsmmmbRibRgRsRsRsRsmmmm
bRsbRiRsmbRgbRsbRgRsRsmmbRibRgRsmbRsRsRgmbRgRsRsmmbRsbLjbRgRsmbRebRgRs
RsRsRsRsmmmmmbRgRsmbRgRsRsmmbRgbRgRsmbRgRsRsmmbRgRsmbRsRgRsRsmmbRgRsmb
RsRsRsRsRsRsRsmmmmmmbRgbRgLsbLjLjbLjRsLsbLibRsLsLgRsbLsbRsbLsbRsbRgbRg
bLsbRgbRgRsRsmmbRgRsRsmmbRibLjbLsRsbRsbLsbLsbRsRsmbLsRsRsmbRgRsmbsbRsb
RsbsbRibRiRsmbRsRibLsbLsRsbRgRsRsRsRsmmmmbRsRsRgmbRgbRgbRsRsRsRsRsRsRs
RsRsmmmmmmmmbRgRsRsRsRsRsRsmmmmmmbRgRsRgRsmmbRibRgRsmbRsRsRsmmbRgRsRsm
mbRsRsmbRsRsRsRsmmmbRgRsRsRsmmmbRgbRgRsRsRsRsmmmmbRgbRgRsmbRgRsmbRgRsR
sRsmmmbRgRsRsmmbRgRsmbRgRsRsRsmmmbRgRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bLibLsRsLsRsbRcRsmbsbLibLgbRgRsmbLsLsmbRibRebRgbRsbRibRhbRhRsRsmmbRhbR
obRhbRebRgbRgbLsRiRgLsbRiRsRembRgRsmbRsRsmbRibRiRsmbRgRsmbLcbLsbLgLsbL
ibLhbRibLgbLhbLgbLgbLgbLgRsbLobLsbLibRsbRibRibLsbRsbLgbLsLsLsmmbLsLsmb
LsLgRsbRsRgbLsLsLsLsLsmmmmbRhbLibRsRcbLcbsbRcRsmbLobLibRcbRhRsmbLjbReb
LjbRgRsmbLjbLibRjbRcbLcbLibLibLgbRsbLcbLsLsLsLgmmbLibLebRhReRsRembLhbR
gbRebRiRiRgbLgbRsbRsbRsbRsRebLsbRibRgRgRsmbRsRsRgRsRsRsRsRsRsmmmmmmmbL
sLsmbLhbRjbRsRsRsRsRgRsmmmmbRibRsRgRsmbRgbRsRsmbRsbsbLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bLsLsmbLiLsLsmbRjbRebLsRsRsmbLcbLiLsbRhbLeLsbLeRsbLibLgbLgbLgbRgRsmbLg
bLgLsLsLsmmbLgRsbLgLsbLgbReRsmbRiRsmbRgRsRsmmbRebLhbRibRcbRobLcbsbRjbL
iLsbRjbRiRsmbRcbRhbRiRsmbLibRibRhbLibRebRebLibLebLgLsbRgRsmbRjRsmbRcbL
cbLhbLibRgbLcbRjbLhbRebRcRsmbRibRebRhbRgbRcLsbLsbRcbsbsbReRsmbsbLjbLiL
sLsRsmbLsbRebRcbRobReRgbLsLsmbRcbRsLsbRobRebRibLeLsLsLsLgmmbLibLiLsbLg
bLiLsbLcbsbsbRhRsRgRsRsRsmmmmbRgbRiRsRsmmbRibRiLsbRgbRcbRebRebReRsmbLj
bLibLiLsbLhLibLiLsbLiLgbLebLibLeLebsbLsbLgLsbLsbLeLsLsLsLsLsLsLsmmmmmm
b

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLgLsLsmbLgLsLsLsLsmmmbLgbRsbRgbLjbLsLsLsmmbLsLgLsLsLsmmbLgLsLsmbRsbLi
LsLsLgLsLsLsLsLsmmmmmbLibLibRsbLsLgbLgLsLsmbRcbRsRsmbLsbRgRsmbRsbRsbRs
RgbRsRsmbsbRsbRsbRsRsRsRsmmmbRsRsmbRgbRgRsRsmmbRsbRsLsbRsRsmbLsbLgbRjb
LobLiLsbLobRgbLjbRhRsmbLjbLgLsbLgLsRsLsbLiLgLsLsLsLsLsLsmmmmmbLibLgbLi
RsbLiLsLgLgLsLgLsbLgbRjbLcbRibRobLsRsRsmbRsbRgbRgRsRsRsRsRsRsRsRsRsmmm
mmmmmmbRsRsRsmmbRgRsRsRsRsmmmmbRgRsmbRgLsRsRsmbRibRibLhbLcbRsbLibLcbRs
LsbLibLibLibRsLsLsLsLsLsLsmmmmmbRgRsRsRsLsmmmbLsRsbRgbRsbRsbsbRsbRsbRs
RsRsmmbRsbRsRsmbRsbRsbRsbRsbRgbRgbRsbRsRsmbRsbRsbRsRsmbLeLsbLiLsbLcbsb
RsbRsbRsRsmbRsbRsbRsbRsRsmbRsRsRsmmbsbRsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRjRsRgRsmmbsbRiRsmbRsbRobRhbRhbRgbRgLsRsbRiRsRsmmbRebRgbRoRsmbRibRibR
cRsmbRgbRiRsLsmbRgbRsbRiRsmbLcbLibLcbLcbLibLiRsRsmbLeLgbLeLsbLibLhLsRs
bLhRsbLsbRobRhbRgRibRgbRcbRibRiRsmbRgbRgRsmbRsRsmbRiRsRsmmbRsRsmbLsbRj
bRcbRhbReRsmbLsbRibRhbRiRsmbRiRsmbRgRsmbRgbRibRsbLsLgbLebLibLibLeLsbLh
LsRsbLjbLcbLsbLgbLjbLgLsbLgbLibLgbLgbLgbLgRsbLgLsbLjbRibRjbRgbRgbRiRsm
bRsbRsRebRibLgbLebLgbLibLsbLibLgbLsbLibLcbLgbRsRsRgmbRgbRgbLibLsRsLsbR
cbRsbRgbRsbRsRsRsmmbRsbRsbRsbRgbRsRsRsRsmmmbLsRsbRsRsmbRsbRgRsmbRsRsRs
mmbLhbsbLgLsbLobLcbLobLibLsbRobRibRibRgLsbRsRsmbLjbLjbLgbRhRsmbRibLgbL
gbLsRsRsRsmmbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRsbRgbRsRgbRsRsmbLgbRgbRibRsLsbLsbLsbLsRsbRgbReRebRsbRsbRsRsRsRsRsmmm
mbRebRsRebsbsbLsLsmbLsbRsbsbLsbRgbRsRsmbLsbRsLsRsRsLsmbsbRgRsmbLsRsbRs
RsmbsbRsbRsbRsRiReRsmbRgbRibRsbRsRsmbRebRsbRgbRgbRiRibRsRsmbRsbRgbRhRs
mbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bRgbLjbRhRgbsbLsbLjbLjRsRsmbsbRjbLcbRgbRcRgbLcbLcbRsbRgRgRsmbRiRsmbLob
LoLsmbRgbLcLsmbLhRsbRsLsbLhbLoLsmbRgbRiRsmbsbRsbRcbRcRsRsmmbLcbLgLsbLs
bRibRiRsmbRebLcbLhbLibLeLsbLeLsbLcbLibLgRsbLjbLjLsmbRiRsRsRsmmmbRsRiRs
RsLsmmbRibLcbLibRsRsRsmmbRgRsRsmmbRgRsLsRsRsRsRsLsLsmmmmmbRibLcbLibLiR
sbRsbRhRsmbRsRsRsmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bsbRibRsRsRsmmbRsbRsRsmbLiLsbsbRsRsRsmmbRgRsmbRsbRebLsbLsbLiLsbRsbReRs
mbsbRsbRgRsRsmmbsbRsRsmbRsRsRsmmbRsbLsRsRsRsRsRimmmbRgbReLebRsRsRgmbRg
RsRsRgRsRsmmmmbRsRsRsRsmmmbRgRsRiRsRsRsmmmmbRsRsRgRgRsmmbRsRgRsmbRiRsm
bRsbRgbRsRsRsRgRgRsRsmmmmbRsRsmbRsRsRgRsRsmmmbRsRsRsRsRsRsRgmmmmmbRsRs
mbRsbRibRsRsmbRsRgRsmbsbRsRsmbRsRgRsRsRsRsRsRsmmmmmmbRgRsRgRsRgmmbRgRs
RiRgRsmmbRsRsmbRsbRsRsRsmmbRgbLsbRsRsRgRsRgmmbRsbRsRsmbRsRsmbRgRgbRsRi
RsRsmmbRgRsRsRsRsRsRsmmmmmmbRgRgRgRsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bRgbRsLsRsbRsbRebRsbRebRibLsLsRsRsmmbRgbRobRsRgbRgRsRsmmbRiRsRgRsmmbRs
RsmbRsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bRibRgbRgbReRsmbsbRgRsmbsbRibLjbLjbRjbLgRsbLgbRgbRgbLjbRjbLibLgLsbLsbL
gLsbLibRsbRibLsLsmbLgbRgbLcbRsLcbRjbLjbLjbLjbRhRsmbRibLgLgbLibLgRsbLgb
LgbRjbsbLibLibLcRsLsbLhbLjbRjbLjbLsLsLsmmbLibLcbLsLhbLgbRsbLjbLibRcbsb
sbLgbLcbLiRsbLiLsbLibRcbLeLsbLibRebLgbLibRgRsmbRcbRebLjbRsbsbLsLsmbLeb
LhbLhLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bLibLgbLgRsLsbLibLgbLibLhLsbLiLsbLgRsbLgbLibLibRgbLibLgbLebLgbLgbLibLi
bLiLsbLibLgbLsbLgbLgLsbLibLibLibLibRgbLgbLgbLibLgbLiRsbLgbLgbLibRsbLiL
sbLibLcbRhbRgRsRsmmbRgRgbLgbLjLgLgbLsLsLsLsLsLgmmmmbLsbLiLsbRsbLgbLhbL
gbsbLgbRsbLibLibRebReRsmbRsbLeLsLiLsbRsbLgLsbLebLibLsRsLsbLebsbLsLsmbL
sLsmbLibRsbRibRiRsmbLjbLibLibLgbRibLibLgbLibRibLjbRibLsbRhbLgbLibLibLi
bLgbRsRsmbRgbRiRgRsmbLjLsLsmmbLiRsbLcbLibLjLsmbRsRsRsRsRsRsmmmmmbLhbRi
b

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bLebsbRsLsbLsbLsbLsbRjbsbRsbLsbsbRhRsmbLsRsbRsRsRsmmbRsRsRgRsRsRsRgmmm
mbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
bRsbRsbRsLsbRsRibLjbLcLsmbRebRobLebLgbLhbRsRsRsRsmmmbRhRsRsmmbRiRsmbLs
LeLsbRjbLjLsmbRibLjbRebRsbsbsbRsbsbsbRhRsmbLiLsLsLsmmbRgbLcbRsRsmbLiRs
bLibLibLibLiLsLsmbLibLgLsLiLsLebLhbLiLsbLgbLebLhbLcLsmbRsbLibLgbRsbLgL
sLsLiLgmbLsbLobRgbRcbRibRsbRibLgbLebLibLgLsbsbLibLgbRsbLibLibLgbLiLsbL
ibLsbLgLsbLsRsbRjbRsRibLgLsLsmbLsbRcRcRsmbLjbLgbLsLgLsLsLsLsLsLgmmmmbR
sRsRsmmbRsRsmbRsRsmbReRsmbLebLiLsbLiLsbLibLhbLsbLcbLgbRsRsRgmbRsRgbRib
RgRsmbLgLsbRgRsRsmmbLiLsLsLsLsmmmbRsbLsLsLsLsmmmbLgLsLsLsLsRsmmmbRgbRe
bLsLsLsmmbReRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bLsLsRsRsLsLsLsLsLsmmmmmmbLiLsbLsLsLsLsLsLsRsLsmmmmmbLsLsLsmmbLsbLgLsL
sRsLsmbLsbLsLsLsLgLsLsLsLsLgLsRsmmmmmbLsLgbLsLsmbLsbLsLsmbLgLsLsmbLeLs
LsLgmbLgbLsLsLsLsLsmmmmbLsRsLsLsmbLsLsLsLsLsLsmmmmmbLsLsLsLgLsmmbLsLsL
sLsLsLsmmmmmbLsbLiRsLsRsRiRsmbRcRsmbLjbLeLsbLgbLgLsLsLsmmbLgLsbRsRsmbL
gLsLsLsLsLsmmmmbLgLsLsLsmmbLsLsLsLsLsLsLsLsmmmmmmmbLgLsLsLsLsLsLsLsLsL
sLsLsmmmmmmmmmmbLsbLsLsLsLsmmmbLiLsLsLsLsLsmmmmbLgLsLsmbLsLsLsLsmmmbLg
LsRsbLsbLsRsLsbLsbLgLsLsLsLgLsmmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRgRsmbRsbLsbRsbRibRgLsbRgRsLsmbRiRsmbRgbRgbRiRsmbRgRsRsmmbRgbRgbRhbRg
RgbRibRgbLsRsbRiRibRgRgRsRsRsmmmbRgbRsRsmbRsRgbRgbRgRsmbRsRsmbRsbRgbRs
RgRsmbRgbRgbRgRsRsRsmmmbRgRsRsmmbRsRgRsmbRsbRibRgbRgRsRsmmbRgbRsRsmbRs
bRgRsRgmbRgRsmbRibRibRgbRibRgbRgbRgbRsRsRsRgmmbRebRiRsRsmmbRgbRgbRgbRg
bRgbRsLsbRsbRsRsRsRsRiRsmmmmbRebRibRgbRgRsRsmmbRibRsRgRsmbLsRgRsmbRgRg
RsRsmmbRgbRsRsLsmbRibRgbRgbRibRgbRgbRgRsRsmmbRgRsLsmbRgRsRsmmbRgbRibRg
bRsRgbRgbRgbRgbRsRgbRiRsmbRgbRibRgbRibRgbRgbRgbRiRsmbRhbRibRgbRibRibRg
bRsbRiRsmbRsRsmbRgbRhbRgRsmbRgbRgLsbRsbRgRsmbRgbRgbRiRgbRibRibRgbRgbRg
bRibRgbRgbRgbRibRgbRsbRgbRgbRibRgbRgbRgbRsRibRgRsmbRgbsbRgRgbRgRsmbRgb
RgbRibRgbRibRgbRgbRibRiRsRsmmbRgbRsbsbRibRibRsRgbRibRgRsmbRgRsmbRsLsbR
gRsmbRsbRgRsRsmmbRibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bRsbsbsbsbsbsbLsbsbsbsbRsbLsLsLsmmbLsbRsbsbLsbLsbLsRsbLiLsbLibLibRsbRs
bLibLsbsbsbRsbLsLsmbLsbLsbLgbsbLibLiLsbLgbLibLibLgbLibLsbLibLgbLiLsbLg
bLibLiLsbLsbLibLibLebLgbLiLsbLsLsmbRjbsbRsbRiRsmbRsRibRibRsbRgRsmbRsLs
bRgRsmbRsbRcbRiRsmbRibRsbRibLcbLibLibLgbLibLsbLgbLibLgLsbLibLibLibLibL
gbLcbLibRgbLibRsRsmbRjbLgbLgbLgbLiLebsbRsbsbLsbsbsbLsbLsLsmbLgLsLsRsLs
mbsbLsbLsbsbsbLsLsmbRsLsbsbRsLsbsbsbRsbRsLsbLsbLsLsLsLsLsmmmmbLsbsbsbR
sRcbRsRsLsmbLsbLsbLsLiLsbLgbRsRsLsRsmbRsRsmbRsRsmbRsbLsbLsbLsbLsbLsbsb
sbsbLsbRsbsbRsbLsLsmbRsLsbsbRobRhRsRsRsmmmbRibLcLsLhLsmbLgbLgLsLsmbLgb
LsbLgbLibLgbLibRsbLgbLibLgbLiLsbLgbLgbLibLebLsbLgRsbLibLgLsbLibLgbLiLg
bLiRsbRebRibRgbRgbsbRsRsmbsbRgRsmbsbsbRsRsRsmmbRsbLsRsRsmbRsRsRsRsRsmm
mmbLsRsRsmbRsRsmbLsbLsbRsbsbsbRsbRsbRsRsmbLobLgLsbLsbLsbLsRsbLsbsbLsLs
mbLsbLsRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bRsbRsRsmbRsbRsLsRsbRsRsmbRsRsmbRsRsmbRsbsbsbRsRsmbRsbRsRsRsRsmmmbRsbR
sbRsbRsbRsbRsbRibRsbRsbsbRsbRsRsRsmmbRsbRsbRsRsRsmmbRsbRgbRsRsRsRsmmmb
RsbsbRsbRsRsRsmmbLsRsbRgbRsRsmbsbRsRsmbRgRsmbRsRsmbRsbLsbLsRsbsbsbLsRs
bRsRsmbRsRsRsmmbRgbRsRsmbRsbRsRsRsmmbRsRsmbRsRsmbLsbRsRsRgmbRsRsmbsbRs
RsmbRsRsmbRsRsmbRsRgbRsbRgbRsRsmbRsbRsbRsbRsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRsbRsbsbRgRsLsmbLsbRgbsbsbsbRgbRibLjbRcbLsbLjbLcbRsRobLcbRoRsmb
LjbLjLsmbLgbLiLsbLgbLgLsbLgLsLsLsmmbLgLsbLgLsLsLsmmbRsLsbLsbsbLgbLibRh
bRjbRobLibLgLsbsbLsLsmbRsLsLsLsLsLsmmmmbLsLsLsLsLgmmmbLsbLsLsmbsbLsbLg
LsLsmbsbLsLsLsRsLsmmbLsbsbsbLsbLsbLsbLsbLibLibLsbLsLsLsmmbLgLsbRebLebL
ibLiLsbLibLibLsbLibsbRsRsmbRsLsRsRsmbRsRsmbLsRsbLsbRsRsmbRgRsRsmmbRsRs
RsmmbRsbsbRsRsmbRsbRgbRsbLoRsbRebRibRcRsmbRsRsRsmmbLhLsLsmbLsbLsLsmbLs
LsLsLsLsLsLsmmmmmmbRsLsLsLsLsLsLsLsLsLsmmmmmmmmbLsRsLsLsLsLsmmmbLsLsLs
LgmmbRsLsLsLsmmbRcRsmbRiLsbRobLsbLibLgLsbLgbLsLsmbLsLsLsmmbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bRobLobLobRebLcbRebLobRcbRcbLsbRjbRebLebRobRobLobRjbRjbRobRcbLobRcbReb
LebRjbLcbLjbRjbRebLjbLjbRjbRsbLebLcbRebLebRjbLobLobRobRobLebLobLobLebR
jbRsbLcbRjbRobLjbLjbLobRebLebRibLobLobLsbLebLobLjbLebRebRobRebRobRobLe
bRobRobRobRsbLebLsbLebLobRebLobLcbLobLobRobLjbLobLebLsbLobRobRsbLjbReb
RcbLobLsbRebRcbRjbRjbLsbLcbRjbLebRebLebLjbRobRebRobRobRobLjbRobLebRebL
sbRjbRobLobRobLcbRsbLebRebRebRobRobLobRjbLcbLebRobRobRjbLjbRobRobRebLc
bRobRebLobRebLebLobLjbLebRobRcbRobLobLebLsbLcbRobLobRsbLcbLjbRobRebLjb
RobLobLobRobLcbRebRobLcbRebLobLjbRobLebLobLcbRjbLobRsbLobLcbRebRcbLebL
cbRobRjbRcbRjbRobLjbLobRobRobRjbLobRjbLobLobLebRcbRebRebRcbLjbLobLjbLe
bRobLobRebLobRobLsbLebRsbRobLcbRsbRjbRebRobLebLcbLebLebLjbLjbRjbLjbRob
LcbRjbLjbLobLjbLobRobRobRobLebLebLsbLjbRsbLjbRjbRobRsbRebLebLjbLjbRjbR
obLobRobRcbLebLcbRcbLjbLobLcbLebLobRjbRsbLjbRjbLebLsbLobLebRobLobRebLe
bLobLcbRjbRebRsbRobRobLebRobLjbRobRebRobRebLcbLjbRobRobLobLcbRobLsbLob
LobLjbLjbRebLobRjbLebRcbLebRjbRebRebLebRcbLobRjbRobLjbRsbLobLjbLsbRebL
obLebLcbRcbLobLsbLobLebRjbLobRobLebLobRjbRobLobRebRobLobRobRobRobRobLe
bRebLjbRebRobLjbLobRebRobLebLebRobRobLcbLjbLjbLsbLobLobRebLebLcbRebRob
RebLobLebRobRobLebRsbRebLcbRibLobRobLobLsbLobRibRebRibRobRjbRobRgbRsbL
ebLobLebRcbLobRjbRobLobRobLcbLobLsbRebRsbRebLebLebLobRobLsbLobLobRebLo
bLobLobLobLebRobLebRebRobRsbLebRobRobLgbLebLcbLibLobRebLobLjbRjbRjbLob
LcbRobLcbLobLobRgbLobLjbRobRebLcbLebLobLobLobRobLobRebLobRcbRobLjbLobR
cbLebLobRobLebLobRsbRjbLobRjbLebLobRobRobLebRobRobRobRibRjbLebLcbLsbLs
bRhbLobRsbLobLobLebRsbLebRobLebRcbLobLobLcbLobRibLjbRsbRobLobRebLobLob
LobLebRebRebRebLebRebLobRobLebRobRebRobRobLjbRsbLsbLcbLobLcbRcbRebRcbL
obRjbLebRebLcbRebRjbRobLobRebRhbLebLjbLgbLsbLebLcbLobLobLobRebRobLobLo
bLjbLebRcbRjbRgbRobLobRobLebLsbRebLobLcbLjbRcbRebRebRcbLjbLobLobLebLcb
LobRcbRibRcbRobRobLobLcbLebRobRobRobRcbRobLobRobRcbRebRebRcbLsbRobRcbR
cbLobRcbRsbLgbRobLobLibRjbRibRjbLobRobLsbRebLobRjbLjbLobRgbLebRobRobRo
bLobLcbRcbLobRgbRebRobLjbRobRobLebLobLobLjbRcbRobLebRebLobLebLjbRebRob
LebLebLobRcbLjbRebRjbLebLcbRebRcbRcbLjbLebLobLcbLjbRebRjbRebRcbLobLobR
ebLebLjbLibRjbRcbLsbLobLobLgbRebLcbLobLobRebLebRobRobLgbRibLcbRobRobLo
bRjbLobRjbRcbLebLjbRobLobLsbRcbRcbRobRobLebRobLobLebRjbLcbRebLebRobRsb
RobLobRobRobRibLobRobLebRebRobLjbRobRobLobLcbRobRobRjbLobRobLebRobRobR
sbRobRobLobRobLcbRjbRebRebLjbLobRebRjbRebLobLobLobRsbLobRjbLobRjbLobRe
bLobRobRcbRsbRebRsbLobLobRobLgbRobRebLjbRjbLsbLjbRjbRobRobLobRibLcbLib
LobRjbLcbLebLobLobRobLobLebLjbRobRjbLobRobLebRobRobLobRcbLobRjbRobLobL
obLobRobLebRcbRebLjbLobLcbLebLobRebLebLcbLjbLobRebLobRjbLjbRcbLobRjbLo
bRcbRebLebRjbRebLjbLobRcbLebLebRcbRobRobLobRobRebRobRebRjbLebRjbRebLib
LjbLebLebLjbLebRebLobRobRebRebRobRcbRebRebLobRobLjbLebLcbRcbLcbLebLebR
ebLobRcbLebRobRcbRobRjbLebLsbRobRobRobRebRcbLjbRobLobRebLebRebRjbRobRe
bLobLjbRobLebRebRobRjbLobLobLobLobRebRcbRcbRobLebRebRobRebLobRobRcbLob
RobRobRcbRebLobLobLcbLebLcbRcbRebRebRobRobRobLobLobRjbRjbLobRcbRobRcbR
jbLjbLebLobLjbRobLjbLcbRobLebLcbLobRsbLebRebLobRebRebLebLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bLsLsLsLsmmmbLsLsmbLgRsLsLgbLsLsmbLsLsmbLsLsLsLsmmmbLsbLsbLsbLsbLsbLsL
sLsLsLsmmmmbLsbLgLsbLsLsmbLsLsLsRsmmbLsbLgbsbLsLsLsLsmmmbLgbRsLsbLgbLs
LsLiLsmbLgbsbLsbsbLgLsbLgbLgbRsbLsbLsLgLsbLgLsbLsLsmbLgbLsLsLsLsmmmbLg
LeLgbRsbLsbLgRsbLsbLsLsRsmbLsLsLsmmbLgbRibRhRebRgbLibRgbRjbRsbLgbLiLsb
LibRsbRsbLhbLebRsRcbLsRgRsRsRsLsmmmbRsRebRsbLsbRsbRsRsmbRgRsmbRibRibRi
bRgRgbRsRsRgmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bRcLsbsbLsbLobRgbLobLcbLcLsmbLgbLgbLiRsbLgRsbLgbLobLgbLibLiLsbLsbRsbLi
bLgLsbLobRgRsLsmbRgbRhbRgRsmbRibRhReRsmbRgbRgbRgbRibRsbLsRsbRgbRgbRoRi
bRcRgRgRsmbRgRsmbLebLgbLibLsbLgbLgbLibLsbLiLsbLiLgbLhLsbRsbLsbLgbRsRgR
smbLgLsbLsRsbRsbLgbLebRsRsmbRgbRibLiRsbLsbLsbLsRsbLibLsbLgbLgbLgbRobRi
RsRiLsmbRsbRibRsbRebLjbLhbLgLsbLgRsLsbLebLibLgbLgbLebLhbLhbLibLcLgbLsb
RibRhbsbRsRsRsmmbRsbLsRsRsmbLsRsLsbLsLsmbRsbLsLsmbLsLsmbRsbsbsbsbsbRsb
RsLsbsbsbRsRsmbLsbLsRsbLsbLsRsbRsbLsLsmbRsbLsbRsRsmbLoLsmbLgbLsbLiRsbR
obRsbRiRsmbLsbsbsbRsLsbsbsbsbLsRsbRsbRsRsLsmbsbRsbsbRsRsRsmmbLsbRibRob
RgRsmbRhbRibRsbRgbRebLcbLgbLgbLibLibLgLsbLgLsbLgbLgRsbLsbLgbLgLsbLgLsb
LgRsLsbLgLgbLgbLgbLiRsbLsbLgbLibLsbLgLsbRcbRobRgbLsbRibRcbRgbRcbRibRiR
sRimbReRhRsRgmbRgbRhbRibRibRibRiRsmbRebRgbRgRsmbLgbRsbRebRgbLobLgRsLsb
RobRgbRibRebRiRsmbRibRibRibReLsbRibsbRiRsmbRgbRiRsmbRgRsmbRgRsmbRibRsb
LobRsbLgbLgbLgLsbLsbLsbLsbLsLibLsbLsbLsRsbLsbLobLibRgbLcbLibLgbRibRgbL
gbLcbLgbLibLgbLhbLibReb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRhbRebRebRiRsRsmmbRibRhbRebRgRsmbRibRgbRibRiRsmbRebRibRiRsmbRibRgbRsb
RgbRgbRibRgbRgRsmbRsbRgbRgRgbRgbRsbRgbRgbRiRsmbRgbRibRibRiRsmbRgRgbRib
RsbRgbRgbRibRibRebRiLsbRgbRibRibRgbRibRebRebRebRibsbRgbReRsmbRibRebRib
RebRgRsmbRibRebRibRgRgbRibRebRiRgbRsbsbRibRibRibReRgbRgbRibRebRibRibRi
bRsRhbRgRsRsmmbRibRebRebRebRibRhRsmbRebRhbRhRsmbReRebRgRsmbRgbRsRibRgb
RebRibRgbRgbRgbRibRiRgbRebRsRsmbRibRibRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLgLsbRsbLsLsLsLsmmmbLgbRgbLgbRgbLsbRsbLsbLgbLsbLsbLgbRibLgbLibRibLsbR
sbLsbRsbLgbLsbLsRsbLgbLsbLsLsmbLgbRgbLgbLgbLgLsbLgbLsbLsbLgbLsbLgbLgRs
bLsbLgbLibLsbLgRsbLgbRsbLgLsbLgbRsbLgbLgbLsbLgbLgbLebLgLsbLgbRgbRebRib
RibRibRibRgbRgRsmbRgbRgbLsLsmbRibRgbRcbRgbRgbRgRsmbRgbRgRsmbRgbRsbLgLs
LsLsmmbLsbLsbRsLsLsmbLsLsLsLsLsLsLsLsmmmmmmmbLsRsLsLsLsmmbLsbLsbLsbLsb
LsbLsRsbRibRibRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bRsbLjbReRsmbRibLeLsbsbLiRsbRjRcbRiRsmbRiRsmbRibRiRsmbRhRsmbRgbRgbRobs
bRcbRibLiLsbLhbRcbLebLhbLibLcbRibLgRsbsbRjbLjLgLsbLibLeLsbLgLsbsbLgbLi
LsbLibLcbRjRhbRcbLiLgbRjbRhbLhbRgbLsLsmbRibLgLsbLibRjbLibLiRsbRjbRibLg
RsbsbLjbLjLsmbRjbsbLsbRjbLiLsbLjLsmbRebRhbLcbLibRebRhRsmbRhbRcbRjbRsbL
ibRjbRibRcRsmbRiRgbsbLsbLjbRjbLsLsLsmmbRiRsmbLgbRcbRcbLibLsbLgLsbLiLsR
sbRjRgbLibLibLgbsbRjbRcbLjbRhRsmbLiRsbRjbLjbLgbRgRsRsmmbLjbLibRjRgbRgb
RgLsLsmbLgLsRsbLjbLcbRcbRibLibLjbLjLsmbRjbRhRsmbRsbRhbsbRhbRgbRgbRgRgb
LgbRibLiRsbRjRsmbLeLsbLibLcbLebLsbLhbRjbRcbRibRiLsRsbRibLibRebLhbLhbLi
LsbLibLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLiLsLsmbLsLsLsLsLsLsLsLsmmmmmmmbLgbLsbLsbLsLsmbLsLsLsmmbLsLsmbLsLsLsm
mbsbRsbLsRsLsbLsRsLsbLsLsmbLsLsLsLsLsLsmmmmmbLsLsLsRsLsLsmmmbLsLsLsmmb
LgLsRsLsLsLsmmbLsLsLsLsLsmmmmbLsLsmbLgbLsLsLsLsLsLsLsmmmmmmbLgLsbRsLsL
smbLsRsbLsLsmbLgbLsbsbLsLsLsLsLsLsLsLsmmmmmmmbLsbLsbLsLsLsLsmmmbLgLsLs
RsmbRsLsbRsbLsLsLsmmbLsLsLsLsLsLsmmmmmbLsLsmbLsLsmbLsLsLsmmbLsLsRsmbLs
LsLsLsLsLsmmmmmbLsbLsLsLsLsmmmbRsLsLgbLgRsbRsLsbLgbLgbLsLsmbLgRsRsLsmb
RsbLgbLgbLiLsLsmbLiLsbsbRgbLhLsbRgRsmbRsbRgbRgbLhbLiLsbLsbLgbLsLsmbLsL
sLsmmbLsbLsLsmbLgLsbRsRsmbRsRsmbLgbLsbLsLsmbRgbLjLsmbLgbLeLsbLsLsmbsbR
sLsbsbLsbLsLsLsmmbLsLsmbLgbLsLsLsLsmmmbLsbLsbsbLsbLgbLsbLsbLgLsbLsLsmb
LsLsLgLsLsLsmmmbLsLsmbLsbRsbLsLsmbRsLsbLsLsLsLsmmmbRsLsLsmbRsbLsbLsbLs
LsmbLsbLgbRgbLgLsbLgbLsLsLsmmbLsRsLsbLsLsLsmmbLgbLgLsLsLsLsmmmbLsLsLsm
mbLsRsbLgbLgbRsbRgbLjRsLsLsmbLsLsmbLsbLsLsmbLsLsLsmmbLsLsLsLsLsmmmmbLe
LsbLgLsbLsLsLsmmbLgbLibLgbLeLibLsLsLsLsmmmbLgLsbLobRsRgbRibRgbRiLsbLsb
RibRibRibRiRsmbRgRsmbRsRhRsmbRsLsbLiLsbRibRgbRgbRgbRsbRibLibLeLsLsLsmm
bsbRjbLsbsbsbLsbLiLsbLgbsbLgbLgLsbRgRsmbLsbRsRsLsmbLsbLsLsmbLsLsmbLiLs
bLsbLsLsmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bLgbLgLsbLgbLgbRgbRibsbRhbsbRgRgRsmbRgbLobLiLsLsLsLsLgLsLsmmmmbRsbLsLs
LsmmbRsbRgbRsRsRsRsmmmbsbLsRsRsLsRsRsmmbRsbRhRsmbLebLcbLgLsbLgbsbRgbRg
RsRsRsRsmmmmbLsbRsRsRsmmbRgRsRsmmbRsRgbRgbRgRsRsRsRsRsRsRsmmmmmmmbRibR
sRsRsRsRsRsRsRsmmmmmmmbRgRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsRsRsRsRsRsLsmmm
mmbRgLsRgRsRsRsmmmbRsbsbRhbLeLgbLhLsLsmbRsLsLsLsLsLsLsLsLsmmmmmmmbsbsb
sbLsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLcLsLsLgLsmmbRgbRsbRgRsmbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bLiLsLibLhbLeLgbLgLsLsmbLgbLgLebLebLgLsbLibLgLsbRgbLiLsbLeLsbLsLsmbLiL
hbLibLiLsbLsbLgLsbRsbLibLibLiLeLsbLgLgbLgbLgbLsLsmbLgbRsbLgLsLiLsLgbLe
bLibLgbLgLsLsLsLsmmmbLsbLgLsLsLgmbLibLgLsbLiLgRsbLsbLsLsLgLsmbLibLsLsL
smmbLgLiRsbLebLgLsbLgbLgLsRsLsRsbLeLsbLibLeLsbLebLgbLgLsLsmbLgLsbLhLsb
LeLsbLgbLgbLgbLgLsbsbLgLsLsmbLsLsmbLgLsLsLsLsRsmmmbLibLgbLsbLsLsmbLgRs
bLiLgLgbLgRsbRiRsmbLeLsbLebLgRsbLsLgLsbLsLsLimbLgRsbRgbLgLsbLsbLgLsbLe
bLebLgbRgLsLsmbLiLsLsmbRsbRgbLibLgbRsLsLsLsmmbLhbLgLsLsLsLsRsLimmmbLgL
ibLgLsLsLgmbRsbLgLsbLiLsRsbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bLsbLhLsRsbLibRgRsRsmmbLgbLsLsmbLsLsLsmmbsbLgLgbLsLsmbLgRsbLiLsbLiLsLs
mbLoRgbRhbRebRgbRsbRsbRsRsRsRsRsmmmmbRgRsRsmmbRsbRsRgRsRsmmbRsbsbRsbRs
bRgbsbRsRsmbRgbRibRibRsbRgRsmbRsRgbRgbRiRsmbRhRsmbRhbLsbRgRsmbRiRsmbRg
RsmbRibRgbRgbRgbRiRsmbRsbRibRgbRgbRebRgLsbLsRgbRgbRgbRgbRibRgbRgbRgbRg
bRgbRgbRibRgbRibRgbRhbRgRsRsmmbRgRsRsmmbRiRsmbRgbRgRsmbLsbRsRsmbRgbReb
RsbRhbRjRsmbRiRsmbLsLsmbRibRgbRgbRgbRsRsRsmmbRhRsRsRsRimmmbRgbRibRgbRg
RsmbRiRgRgbRsbRhbRgbRgRsmbRibRgbRiRgbRsbLibLcbRgbRhbRgRsRsmmbRgbRgbRsb
RsbRgRiRsmbLsbRcbRgRsmbRgRsmbRsRsRsRsmmmbRibRgbRgbRgbRgbRgRsmbRibRgRsR
imbRgbRgRsRsRsRsRgRgRsRsmmmmmmbRgRsmbRibRiRgRebRsRsRsmmbRgbRibRgbRibRg
RsRsmmbLsbRgRsmbRgbRsbRgbRgbRgbRibLobRgRsmbRgRsRsRsRiRsRsRgmmmmmbRgRsm
bRgRsRgRsmmbRgRsmbRsRsmbRgRsRsRgmmbRsbRgbRsRsRsRsmmmbRgbRgbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bLsbRobLebLibLobRcbLsLebLsbLgbLebLgbLgbLobLgLsbLgLhbRgbLhLsbLibLgbLeLs
LsmbLgbRibRibRgRsmbRibRcbLsbRcbRhbRcbRibLcbLibRsbLebLiLsbRsbLibLibRgbR
cbRibRcbRsLgbLebLibLsLsLsmmbLhbLebsbLgbLgbRsLsbRcbsbLibLiLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRsRsRsRsRsRsRsmmmmmmbRgbRgbRsbRsRsRsmmbRibRgbRsbRgbRgLsbRsbRgbRgbRgbR
gbRgbRgbRsRsRgmbRgbRgbRsRsRsmmbRsbRgLsbRsRsmbRsRsRsmmbRsbRsbRsRsmbRgbR
sbRsRsRsRsmmmbRgRsRsmmbRgbRsRsRsmmbRgRsmbRsRsRsRsRsRsRsRsRsRsRsRsmmmmm
mmmmmmbRgRsmbRsbRsbRsbRgRsRgmbRgRsmbLsbRgRsmbRgRsRsRsRgmmmbRgbRgRsmbRg
RgbRgRsmbRsRsRgmbLsRsRsmbRgbRibLsbRgRsmbRgRsRsmmbRgRsRsmmbRsRsmbsbLsbR
sRsRgmbRgRgbRgRsmbRgbRsbRgbLsbRgRsmbRgbRgRgRsmbRsbLsbRsRsmbRsbRgRgRsRg
mbRibRgbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbRsRsRsmmbRsbRibLsLsmbLcbRsLsbLcL
smbLgbLsbRobRsRsRsRsRsRsRsmmmmmmbRgRsmbRsRsRsRsRsRsRsmmmmmmbRsbRsRsRsR
gmmbRgbRsRsRsRsmmmbRgRsRsRsRsRsRgmmmmmbRgbRgbRsRgbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLsbLiLsbLgLsbLsLsLsmmbLsbLgLsLsLsmmbLsLgLgLsbLibLsbLgLsLsmbLgLiLsbLiL
sLsmbRsbLsLsLsmmbLgLsLsLgLsLsLsLsmmmmbLibLsLsLgLsmbLiLgbLsbLgLsLsLsLgL
sLsLsLsLsmmmmmmbLgLsLsmbLsLsmbLgLsLsLsmmbLgLsLsLsmmbLibRsLsLsLgmbLiLsb
LgLsLsmbLibLgLsbRsLsRsbLibLgLgbLiLsLsmbLsLsLsLsLsmmmmbLsLsLsLgLsLsLsmm
mmbLibLibLgLsLgLgbLibLsbLsLsLgmbLiLsLsmbLgbRsLsLsLsLsLsLgLsLsLsLsLsmmm
mmmmmbLiLsbsbLgbLgbLgbLibLgLgLsLsLsmmbLhbRsbsbsbLgLgLsLsLsRsmmbLsLsLeL
sLsLsLgLsmmmbLsLsLsLsmmmbLgLsLsLsLsLsLsmmmmmbLsLsLsLsLsmmmmbLibLiLsbLs
LgLsLsmbLgLsbLsLsLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmmbLsLsLsLsLgLsmmmbLib
LgLsLibLsLsLsLgmmbLsbLgLsbLgbLgLsLsLsmmbLgbLgLsLsmbRsLgLsLsmbLsLsLsLsm
mmbLgLsLibLgLsbRsLsLsmbLgLsbLgLgLsLsLsmmbLgLsbRsbLiLsbLeLsbLsLsLsLsLsL
sLsLsLsmmmmmmmmbLgLsbLgLgLgLgbLgLsLsLsLsLsLsLsLsmmmmmmmbRcRsRsmmbRiRgR
sRgRsRsmmmbRiRsRsmmbRgRsRsmmbRsbRgbRgRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsm
mmmmmmmmmmmmmmmbRgRsRsRsRsmmmmbRgRsRsmmbRgRgRsRsRsRsRsRsRsmmmmmmmbRibL
jbLsLsmbRiRsmbLiLsLsmbLsLsLsmmbRjLsbLsRsbLsLsLsLsmmmbLsLsLsLsLsmmmmbRs
Lgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bLhLgLgLsLiLiLsLgLsbLgLsLibLgbLgbLiLsbRgbRsbLsLsLsLsLgLsLsRsmmmmbLsLsL
sLsLsLsLsLsLsLsLsLeLsLgLsmmmmmmmmmmbLgLsLsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bRsRsmbRgbRgRsmbRgbRsbRsbRgRsmbRsRgbRgbsbLsLsLsmmbLcbLhbLibLgLsbLcbLeb
LgbLgbLhLsLeLsLeLiLsbLhbLjbRgbLcLsmbLgLsLsmbLsLgRsbLiRsbRgRsRgmbRibLjb
LibLibLebLiRsbLcbLebLiLsLgbLcbLibLibLibLgbLibLiRsbRgbRibRgbRjLsLsmbLsb
LiLsbLibLgLsbLhbLgbLgbLebLcbLgLsbLgbLsLibLibLhLsbLhbLibLibLibLibLebLhb
LebLebLiRsbLgbLgbLibLibLibLgbLgbLibLibLibLgLsbLcbLjbLsbLgLsLibLibLibLs
bLsbRsbLsLsmbLgbLgbLgbLgLsbLgbLsbRcbRgbRsRsmbRgbRsbRibRgRsmbRgbRibRgbR
ibRgRgbRgbRgbRgbRgRsmbRgbRsbRgbRgbRsbRgRgbRgbRgbRgbRgbRgbRgbRiRsmbLgbR
iRibLjLgbLgbLibLgbLgbRsLsbLgbLibLsLsmbRgbLgLibLiLsLsmbLgLgbRsbRgbRhbRi
bRibRsRsRsRsmmmbRgbRsRsRsmmbRgbLobRsbRiRsLsmbRibRgbRgbRgbRsRsRgmbLsbLs
bRgbRgbLibLibLsbRsbLsLgbRsbLsLsmbLgLsbLsLsRsmbsbLsbsbLsRsbLjLsmbLsbLsb
LsLgbLiLsLsLsLsRsRgmmmbRsbsbRgbRgRsmbRgRsmbRgRsmbRibRibRibRebReRebRgbR
gbRgbRebRiRiRsmbRebRibRgRsmbRgbRgRsmbRebsbLjbRhbRibRibRibRhbRiLsbRgbRg
bRibRibRgRgRibRgRsRhRsRsRgRsRemmmmbRebRiRsRgRsmmbRsLsbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bLgbLsbLibLgbLebLibLibLibLibLsbLibLgLsbLiLsbLibLibLibLgbRsLsbLcbLiLsbL
ibLibRsbRhbLgbLobLsbLsbLgbRsRsmbRsbRcbRibRgRsmbsbReRsmbRgbRgbLibLgbLsb
RgRsmbRiRsmbLgbRsbRibLgbLiLsbLsLsLsmmbRiRsRsmmbRgRsRsmmbRebRjbRgbRgbRj
RiRsmbRibRgRsRsmmbRebsbRsbRgRsmbRibRibRibRhbRjReRsmbLgbLsbLhbRsLsbRibR
cbRiRsmbRiLsbRsbRibRhRsmbLgbLgbLgbRsbRhRsmbRcRsmbRibLgLsbLsLsmbLibLgLs
bLgbLebLgbLgbRgbRibRibRsbLcbLsRsbRsRcbLgbRebRebRgbRjbRibLebRebLsbLcbLs
bLgbRebRiRsmbLsLhbLgbRgRsmbRhRsmbRibRibRgbRibRgbLsbRiRsmbRcbRgLsLsLsmm
bRhbRibRgbRiRsmbRgbRgLsRsbLgbLiLsbLgbLgbRsRsmbRgbRhbRsbRgRsmbRibRgbRib
RibLsLsmbLebLibLgbLiLgRsbLgLsbLibLsbLsRsbLiLsLsmbLibLsRsbLgbRgbRsbLibL
sbRgbRsRhbRgbRibRgbRiRsmbRsbRcbLibLsLsLsmmbRgRsmbLsLsmbLgLsbRgRsmbRjRs
mbLiLsbLsbRhbLgLsbRsLsLsmbLsRsLsRsbLsLsmbRhbLsbLsLsLsmmbRjbRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bRsbRsbLsbRsbRsbRhbReRsmbRgbsbsbRsbRsbRsRsRsmmbsbRsbRsRsRsRsmmmbRsbRgb
RgbRsbLhbLebRjbLibLcbRsRsRsmmbLsbLebLcbRgbLebRgbRgbLsbLsbLsbRibRgbRgbR
sRsRsRsRsmmmmbRsbRgbRob

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bLgLgbLiLsbRjbLhLsbRibRgbLjbRibRibRibLgbRsbsbLgbLgbLjLsmbLgbRjbLibRjbR
hLsbRibLibLibRibRcRsmbRiRsmbRiLsbRibRibRiLsbRgbRibRgbLibLibLibLsbLibRs
RsmbRjbRibRibRgbRgbRgRsmbRgbRgbRsbRgRsmbRgbRgbRibRibLibsbRgbRgLsRsbRsb
RiRsmbRgbRgbRgbLgbLjbLibLgLsbLgLsbLgbLgRsbLgbLgbLsRsbLhbRibRiRsmbRhbsb
RgbRibLsLsmbLhbRjRjbRgbRiLsbRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bLhbLjLsmbLsbLgLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmbRsbLsbLsRsbRsRsmbLsLsmb
LsLsmbLhbRgRsmbRgbRsRsRimbLcLsmbLcRsbRsbRibLibRsRsmbLsLsLsLsLgLgLsLsLs
LsLsmmmmmmmbsbLibLsbLsbLibRsbLsbLibRgbRhbLsLgLsLsLgLsLsLsLsLsLsLsLsLsm
mmmmmmmmbLgLsLsRsLgLsmbLsLsLsLsLsLsLsmmmmmmbLgbRjbRibRsbRsRgRiRgRsRsRs
RsRsRsRsRsmmmmmmmmbRsbLsbRgReRsRsRsmmmbRsRsRsRsRgRsRsRsRsRsRsRsRgRsmmm
mmmmmmmmbLsRgRsRsRsRsRsRgRsmmmmmmbRibRgbRsRsmbRiRsmbRsbRsbLsbLjLcbLibL
gbLebLibRsLsbLibLobLgbLsLgbLsbRsLsRsbRsRebLgRsbRsbRiRsRsRsRsRgRsRsRsmm
mmmmmbRobLgbLgLsbRsbLsLsLsLsRsmmmbRsRsRsmmbRsRgRsRsRsRsRsRsRsRsRsRsRgR
sRsRsmmmmmmmmmmmmmbRgRsRsRsRsRsmmmmmbRhbRgRiRsRsmmbRcbLcbRibLsRsRsRgmb
RhRsRhmbRgbLsbLjLsmbLhbLebRgbRgbRsbRgRsRsmmbLiLsbLgLsLsLsLsLsLsLgLgLsm
mmmmbLsLsLsRsmmbLsLsmbLgbRsbLsLgbLgLgLsLsLsLsmmmbLgLsLgbLiLsbsbLebLgbL
sbLsLsRsRsmmbLibLgLsLgLsLsLsmmbLgLsLsLsLsLsLsmmmmmbLsbLsLgLsLgLsLsLsLs
LgLsLsLsLsmmmmmmbLgRsbLsbLsLsLsLsLsLsLsLiLsLsLsLgmmmmmmmmbLhLgLgbLgLsL
sLsLgmmbLgLsbLibLiRgbRiRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 135835; End: 140335;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bRgRsRgRsRgmmbRgRsmbRgRsmbRgbRgRsmbRiRsRsmmbRsRsRsmmbRsRgRsRsmmbRcbLsb
LsLsLsLsmmmbLgLsLsmbLsLsmbLgLsbLsLsLsLsmmmbLgLsLsmbLgLsbLsbLsLsmbRsbLi
LgLsLsmbLsLsmbLgbLsLsLsLsLsmmmmbRsRsmbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbsb
LgLsbLgbLsLsRsLsLsmmbLsLsLgmbLsLsLsmmbLgbLsLsLsLsmmmbLsbLsbRsbLsLsLsmm
bLsLsLsmmbLibLgbLgLsbLsbLgLsbLibLgbLsLsLgmbRsbLsLsmbLsbLsLsLsmmbLiLsbL
ibLgbLgbLgbRsLsbLgbLsLsLsmmbLsLsmbLgLiLsbLgbLsLsLsmmbLsbLgLsLgLsbLgLsb
LgLsbLgLsbLgLsbLsbRsLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bLgbRgRsRsmmbLsbsbLsbLgLsLsmbsbsbLsbsbsbsbsbLsbsbsbsbLsbLsbLsLsmbLgbLi
RsbLsLsmbLsLsmbLcbLgLsbLibRsbRobRibRhRsmbLgbLobLgbLibRsbRoRsmbRgbRibRi
RgRsRsRsmmmbRgbRibReRsRgmbLsbRsRsRgRgRgRsRsmmmbRsbRebsbRgbRsRsmbRsRsRs
RsRsmmmmbRsbRsRsRsRsmmmbRsRsmbRsbLsRsbsbRsRsmbLsRsbRsbRsLsLsmbLsRsbsbR
sLsbLsbRgRsmbRgbLsbRgRsmbRsbRsbRsRsmbsbRsbsbsbRsbRsRsRsRsmmmbRsRsRsmmb
RsRsmbRsRsRsmmbLsLsRsmbRsbLsbRsRgRgbRsbRgbRsbRsbRibRgbRsbRsReRsmbRibRg
bRgbRgbsbsbLsbRsbRsRsmbRsRsmbRsbsbsbRsbRsbsbLsRsRsmbRsRsRsmmbLsLsLsmmb
RsRsmbRsRsmbRsbRsbLsLsmbRsLsbRsbRsbsbsbsbRsbRsRsmbLsRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRsRsRsmmbRsRsmbRsRsmbRgRiRsRsRsmmmbRiLsbRsRsRsmmbRsbRsRsRsmmbRgRsmbRs
bRgRsRsRsRsmmmmbRsRgRsRsLsmmbRgRsRembLsLsmbRibLsRsbRsRsRsRsRsRsRsmmmmm
mbRiRsmbRsRsRsRgmmbRsRsRsReRsmmmbRsRsRgRsRsRgmmmbRebRsReRsmbRebRebRsRs
mbRgRsRiRsRsRsmmmmbRebRibRsLsbReRebRiRebRgbRsRsRimbRsRebsbRebRsRsRembR
sRsRimbRsRebRgbLsRsbLsRebRsRibRsbRebLsRhbRibRebLsbRebRebRgRsRembRsRebR
ebReRsmbRgReRsmbRebRebRgRibRsRsRsmmbRiReRsRsmmbRebRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLibLibLsbLibLebLibLcLsLsmmbLsLiLsLsLsmmbsbLhLsbLiLsLsmbRsLsLsLs
LsLsLsmmmmmbLiLsLsRsmbLsLsLgLsLgmbLsLsLsLsLsLgLsmmmmbLhLsbLiLgLsbLibLs
LsmbLibLeLsLsLsLsLsmmmmbLibRsbLhbLiLsLsmbLiRsbLiLsLsLgmbsbLiLsRsLsbRsL
sLsLsmmbRgRsmbLiLgLsbLsbLiLsLsLsLsLgLsmmmbLgLsLgbLibLibLgbLiLsbLiLsbLg
bLsLiLsbLiLgbLhLgLgLsbLgbLgLgLsLsLsLsLsmmmmbLgbLsRsbRjbLibLibLiLsLsmbL
gbLgRsLgbLiLsRsbRjbRcRsRsRsRsRsRsRsRsRsRsRsRsRsLsRsLsRsmmmmmmmmmmmmmbR
sbLhLsLgLsbLsLsLsLsLsLsLsLgLsLsLgmmmmmmmbLgLsbRobLcbLsLsmbRobLsRsRsRsR
sRsRsRsRsRsRsRsRsRsRgRsRsRgRsmmmmmmmmmmmmmmmbLiLgLsLgLsLsmbLgLsLsLsmmb
LgLsLsLgLsmbLibLibLgLsLsmbLiLsbLebLgLsLsmbLgLsLsLsLsLsLsmmmmmbLgLsLsLs
LsLsRsmmmmbLiLsLsLsmmbLsLsLsLsmmmbLiLsLsLgLsLsLsmmmbLsbLsRsLsbLgLsLsLs
LsLsLsmmmmmbLgLsLsmbLiLsLsLsLgLsLsLsmmmmbLgRsLsLsLsLsLsmmmmbLsLsLsLsLs
LsLsLsmmmmmmmbLsLsLsLgLsLsLsLsLsLsmmmmmmmbLsLgLiLsLsLsLsLsLsLsmmmmmmbL
gLsLsLsLgLsLsLsLsLsmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbRgbsbRibRgbRgbLsbRgbRgRsRsmmbRgbRgbRsRsmbRsbRsRsmbRgRsmbRebRgbL
sbRgbRgRsRsRsmmmbRsbRgbLsRsRsRsmmbRsbRgbLsbRgbRsbRgRsmbRgbsbsbRgbRgbRj
RsmbLibLgbLsbLsbRgRsRsmmbRsRgbsbRsbLsLsRsRsmmbRgbRgbLgRsbRsRsmbRgbRsbR
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bLsLsLsLsRsLsLsLsLsLsmmmmmmmbRsLsLsmbLgbRsbLgbLsLsLsLsLsLsLgLsLsLsmmmm
mmmbLgbLsbLgLsLsmbLgLgbLsLiLsLsmbLsLsLsLgLeLeLiLgLgmmbLebRgbLgLsbRjbLi
bLgLsLsLsLsmmmbLgbLgRsLsLsmbLsLsLsmmbRsLsLsLsmmbLgLsbLgLibLsLsLgmbLgLs
bLgRsLgbLgLsbLgRsbLgLsLsLsLsmmmbLgLsbLeLgLibLeLgbLibLsbLgLsLsmbLgLsLsL
smmbLgbsbsbLsbRsbRsbLsbLsbsbLsLsRsmbsbsbRsbLsbLsbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bLsbRsRsRsmmbRsbRgRsRsRsRsRgmmmmbRgRsmbRgbRibRiLsbRgRsRsmmbRsReLsbRhRs
RsmmbRiRsmbRiRsRsmmbRgbRibRiLsbRsRsRsLsRsRsmmmbRsLsbRgRsRsRsmmmbRsRsRs
mmbRhbLgLgbRsbLgbLgbLgbLgLsLgbRsbLgLsLsmbLcbsbRibRgRsmbLsbRebRebRebReR
smbRibRibRhbRebRgbRgbRibRibRebRgbRgRiRsmbRgbRgbRsbRsRsmbRsRsRgmbRiRsRg
RsRsmmmbLsLsmbLsRsRsmbRgRsRsRsRsRsRsmmmmmmbRsRsmbRgRsRsRsRsmmmmbRibRgR
smbRibRgRsRsmmbRibLsbRgRsLsmbRgRsRsRsmmmbRgLsbRgRsmbLgbLjbLiLgbLgLsLsm
bsbsbsbRjbLgbLsbLgbsbLsbLsLgLsLsmbRsLsbRsbLgLsLgLgbLgbLsLgLgLgbRsLsbLi
LsLsLsmmbRcbLjbsbLgLsLgLsbLgLsLsmbLgbLebLhbRjbLibLgbRgbRgRsmbLhbRcbLsb
LsbRgLsbRgRsmbRsRsRsRsmmmbRjRsmbRhbRgbRebRiRebRiRsmbRebRsbRsbsbReRsmbR
eRsmbRsRgbRgRsRhLsmbRibRsbReRsmbRsLsbRgbRebRiRsmbRebReRsmbRgRebReRsmbR
sLsRibReRebRgRsmbRgRsmbRsRibRgRsRiRsRsmmmbRsRsRsmmbRiRsRgmbRebRebRebRs
bLsRiRsmbRebRsRgRebRebRiRiRsmbRebsbRiRebRgReb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bLebRobLobLcbRobRebRgbRobRebRobRcbLobRsbLobLobRobRobRibLebRibLsbRobLeb
RsbLobRebLobLebLebLobRebRebLcbRsbLobLobRobRobLobRebRebLibLobRcbLobRcbR
obLobLobLsbRcbRobLobLgbRibRcbLobRibLobLibRobLebLibRobRsbRobLsbLibLobLe
bRsbRcbRibLobLobLobLebRobRobLobLobLobLobLebRobRibRcbLgbLobRobRobRebLcb
LobRibLobRebLobLebLcbRsbLcbLobRebLibRobRebRibLebLsbLsbLobLobLobLcbRobR
obRcbLcbLgbLobLebLjbRebRobLgbLsbRgbRcbRebLibLobLcbRebRgbRobLebLibRcbRe
bRebRibLobRobRebLobRcbRcbRobLobRsbLcbLgbLgbRobLcbLobLcbLibRobRcbRobLcb
RebLobRgbLebRsbLebLibRebLobLcbLcbLobRebLjbLebLobLebRobRibRobLibLobRibL
jbLcbLobLobRebRcbLobRobRebRobLcbLibLebLebRibRobRobRobRcbLobLobRebRobRo
bLhbRjbLebRobRebLcbRobLebLebRcbLebLsbRgbLobRobLobLobLhbRcbLhbLjbLgbLob
LobRebLcbRobLebLebLobRsbRgbRsbLgbLebRibRebRobRobRebLobLobLebLebRhbRobR
obLebLebLcbRsbRobLobRcbLibLobRcbLebRobLobLobLobRebLcbRobLobLebRobLobLo
bLobRcbRebRcbLobRjbLobRobRobRebRobRebRebLobLobRgbRebRebRebRobRgbLobRob
LobRibLebRobLcbRebRobLobLobLibLobRobRobLobLobRobRobRcbLcbLobLcbLebRobL
obRibLobRibRobRibRobRcbLobLebRobRebLcbLobLobLcbRhbLebLobLobRobRcbLgbRo
bLibRobRebLobRobRobRobRcbLebRibLsbLibLobLobLebLcbLcbRobRobRcbLobLibLjb
LibRobRcbRobLobRcbLjbRhbLebRobLebRebLobRcbRcbLobRebRgbRsbRsbLobLhbRobL
obRobRobRebLibLgbRobLibRobLobRobLobRcbLobRcbRebLebLcbRobRsbRobLcbLobRo
bLebLebLebLebLcbRcbLcbRgbRobLobRcbRcbLebLcbRobLobLobRobLobLebLebRibLob
RobLobLcbRcbRebLgbRcbLjbRobRobRgbRibLibLebRebRobRobLebRcbRobRibRibLebR
cbRobLhbRobLobLobRibRebRcbRobLcbLebRcbRcbLobLcbLobRobRibLobRcbRobRebRe
bRcbLcbRobLebLebRobLgbRobLibRebLobLebLobRobRobLcbRobRobLebRcbRobLobLob
RibLebLobRobRebRgbLobRobRcbRobRobLobRibRhbRebRgbLebLebLibRobRebLcbRobL
cbRcbLobRobLcbRebLcbLobLobRgbLgbLobRobRhbRobRobRobLcbRcbRcbLebRcbLebRe
bRobRcbLgbLebLobLobRsbRcbRebRobRhbLobLobLobRcbLebRobRobLgbLobLobLobRob
RgbLcbLobRebRobRebLcbLobRobRobRgbLobRgbLebRsbRcbRobRebLcbLebRobRebRgbL
cbRobRebLcbRcbLobLsbRcbRobLebLobLebRobLobLebLobRcbLebRhbLobRobLobRibLg
bLebRobRibRobLcbRcbRgbRebRobLhbRebLobLobRebRebRobLgbLcbLobLibLobRebRob
LebRebRebRobRhbLobLgbLibRobLobRobLebLebLcbLobRibLcbLsbLobRebLebRobRibL
obLcbRobRebLcbRhbRebRibRobLibRgbRsbLobLgbLobRobLobLcbRebRcbRebLobRcbLc
bLcbLebRobLobRobRibLobLobLcbRcbLebLcbLcbLcbLcbLcbRebLobLobRcbLobLcbRcb
RgbRobLcbLobRobLobLhbLobRebLebLebLebRobRcbRobLebRibLobRobRobLobRebRgbL
obRobLgbRebRobRgbRebLobLebRobRcbRebRgbRcbRcbLibRobRobLibLcbRcbLobRobRi
bLobLobRjbLobRobLjbLebRobLcbRebRsbLobRobLobRsbRibRcbRsbLcbRcbRobRebRib
RobRobLebRjbRebLibRobRobLebRgbRibLhbRcbRebLebRibRobRobRcbLobRebLcbRibR
obLgbLcbRobRobRebRibLibLebLebRcbRobLebRobRjbLobLobLebRhbRibLobLebLobLc
bRcbLobLobLsbRgbLebRebLibRcbLebLebLobLobRebLibRsbRibRobLcbLebLgbRebRib
LobRobLcbRobLgbRebRebRgbRebLhbLcbLgbLsbRobLobRobRebLebRobLobRcbLebLobR
cbRebRebRcbRobLobRobLebLobRcbRobRobLebLebRobLsbRgbRobRibRcbRibLebLobLc
bRhbRebLebLobLebLobRgbLsbLibRcbRobLobLobLebLebLebLobLobRobRgbLcbRebLgb
LgbRcbRibRcbLobLobRebLibLsbRebRsbRebLebRcbRibRibRebLobRgbLebRebRobLobR
cbRibLsbLibLobRebLobLobLcbRsbLobLjbRebLebLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bsbsbRsbRsRsRsRsmmmbLsbRsbLsLiLsbRjbRibLjbLhLhbLiLsLsmbRsRsmbLsLsmbRgb
LsLsLsmmbRjbLebLjLgbLgbLoLsmbRsbRcLsLsmbLebLibLhLsbLebLhLsLeLsbLgbRsbL
sLsLsmmbLgbLgLsLsLsLsmmmbLiLsbRgLsbLjLsmbLebLgbLcLsmbRgRsmbLhbLiRsbRsL
gLsbLibLibLeRsbLiLsbLgbLgbRsRsLsLsmmbRjbsbLeLsLsmbRibLcbLiLsbLgbLibLeb
LgbLgbLgbLebLgbRsLsbLeLsbLgbLsLgLsbLibLsLhbLgbRobRgbRcRsmbLibLebLebLeL
sbLgbRsRsmbRsLsbLsLsLiLsLsmmbRsbLjLgLgLsLsLsmmbRsLsRsbRsbLjLsmbsbsbLsb
LsLsLsLsmmmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRcbsbLsLsRgmbRgbLgbRgbRgbsbRsbRsRsLsmbRsRsmbRsRsRsRsmmmbRsbRsRsmbRsbL
sbRsbLjbRhRsmbRgRsmbRsRsRsmmbRsRsmbRsRsmbRibLsLsLcmbRjbRibLibReRgbRgbL
sLsRsRsRsmmmbRgRsmbRsRsRsmmbRsRsmbRsbLsRsbRsRsmbsbRgRgRsRsmmbRsRsmbLgL
sRsbRhbLhbRiRsmbLjbRsRsmbRsbRsRsmbRsRsmbRgbRiRsRsRgmmbLgbRgRsmbRgbRgRs
RsmmbRgRgbRsbsbLsRsbRsRsLsRsRsRsRsmmmmbRsRsmbRgRsmbRgbRgbLjbRhRsmbRsRs
mbRgbRgRsmbRsRsmbRsRsmbRsbRsRsRsmmbRgbRgbLsbRiRsmbRsbRibRgbRgRsmbLsRsb
RsRsmbRsRsmbRsRsmbRgRsmbRsRsmbRsRsmbRgRsRsmmbRgRsmbRsLsbRjLsbLjbLhLsbR
cRsmbLjbLgbRhbLjbsbsbLcbLsRsbLsLsLsLsmmmbRsbLgbLsLsmbLgbRsLsRsbLsLsmbL
ibLoLsmbRebRibLjbRcbLhbLeLsbLiLsRsbRjbsbLsbsbRsbRhRsmbRsRsRsmmbLsbRsRs
RsmmbRgbRibLsbRgRsmbLsbRgLsbRsbRjbRhLsRsbRibRibRib

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLibRobsbLibLibsbLsbLibLgbRsbLgRsbLsRsbLsbLgLsRsLsRsbLsbLsLsmbLsRsbRsb
sbLsbRsLsbsbLsLsLsLsRsmmmbLsLsLsLsmmmbLgLsLsLsmmbLibLebRibLsbLjbLhbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRsLsLsmbLsbRsLsbRsLsbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsLsLsLsmmmmbRsL
sLsLsLsmmmbLsLsmbLgLgLsbRsLsbLsbRsLsbLsLsLgLsLsLsLsLsmmmmmbLsLsmbLgbLg
bRsLsbLiLsLsmbLgLgbLgbsbLibsbRsbLibLsLsLsLsLsLsmmmmmbLsbLsbLsLsLsLsLsm
mmmbRsbRgRsRsRsmmmbRsRsRsmmbRgRsmbRgbLsRsRsmbLsRsRsRsRsRsmmmmbRgbRsRsR
sRsRsRsmmmmmbRsRgRsmbsbRgRsRsRsRsRsmmmmmbLsRgRsRsmmbLsbRgRsRsmmbRgbRsb
RgbRibRgbRgRgRsmbRgbRsRsRsRsRsmmmmbRsRsRsRsLsRsRsmmmmbRgRsmbRsRsmbRgRs
RsRsRsmmmmbRsRsRsRsRsmmmmbLsRsbRiRsRsmmbRibRsRgRsRsmmbRsRgbRgRsRsRsRsR
smmmmmbRgbRgbRgRsRsmmbRgRsRsRsRsRsmmmmmbRgRsmbRgbRgRsmbRgbRgRsRsmmbRsR
gRsmbRgRsmbLsRsRsRsmmbRgbRgRsRsRsmmmbLobLgLsbRsLsLsLsLsmmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bLiRsbRsRsRsmmbLibReRsmbLhbLcbRjbRebReRsmbReRsmbRebRhbRibRsbLjbLgbLgbs
bLgbRebLcbRsbRgbLibLibRjRgbReRsmbLhbLiLsLsLsmmbRsbRgRsmbRsRsRsRsRsRsRi
RsmmmmmmbLhbsbRjbLiLsbLibLsLsLsmmbLsbLgbsbRcbRibRhbRiRsmbRebRcbRjRebLc
LsmbsbsbLhbRebRjRgbRgbLjbLibRjbRsbRhRsRsmmbRhbRgbLsbReRgbRgbRgRsmbRcRs
mbRibRiRsmbRibLsbLjbRebLjbLsbRsLsRsRsRsmmbLsLsmbRsRsRgmbLjbLgbLgbRjbRi
bLsbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bLgLsLsLsLsmmmbLsbLsbRsbRjLsbLibLjLsmbLgbRibLibLsbLgLsLsLsLsmmmbRsLsbL
sLsLsmmbLsLsLsmmbRsRsmbRgLsLsLsmmbLibRgRsLsmbRibRsRsmbLsLsmbLeLsLsmbRs
LsLsLsmmbLcRsbReLsbRebRcbLiLsbRibLeLsbLcLsmbLcbLibLjbLsbsbsbsbRgRsmbLg
bRjbLgbRgRsRsmmbRsbLibRjbLeLsbLsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLsbLgLsLgbLibLsbLgLsLgLsbLgLsLsLsmmbLibRsbLsLsLsmmbRgbRsLibLsbLibLgRs
bRgLsLsmbRjbRiRsmbRibRibRgbLibRiRsmbRibRgLsbRibRsRsRsmmbLsbLhLsLsLsLsm
mmbsbsbsbLsLsLsLsLsmmmmbLsLsLgLsLsLsLsLsLsLsmmmmmmmbRsLsLsLsLsLsLsLsLs
LsmmmmmmmmbLgLsLsLsLsLgLsRsmmmbRsLsLsLsRsmmbLsLsmbRsLsLsLsmmbLiLsLsLsL
smmmbLgLsLgbLgLsLsLsLsLsmmmmbLiLsbLsLsmbLsLsmbLibLibRibLsLsmbsbsbRsbRs
bRsbRgRsmbLjbLiLsLsmbLsLsmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsbLsLsLsLsLsLsL
sLsLsLsLgLsmmmmmmmmmbLsbLiLsLgbLsLgLsLsmbLgbLgbLiLsLgLsLsLsLsmmmbsbLsL
smbLiLsLsLsLsmmmbLsbLsLsmbLgLsLsLsLsmmmbRjbLsbLiLsLsLsLsLsLsLsLsLsLsLs
mmmmmmmmmmbLsLsmbLgLsLsLsLsmmmbRsbLsLsLsLsLgLsLsLsmmmmmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRiRsRsRsmmmbRsRsmbRgbRsRsRsRsmmmbRiRsmbRiLsbLgLgLgLgbLebRhRsmbLcbRsRs
RsRsmmmbRgbLgLgLsLsmbsbLgLsbLibLcbsbsbRsbLibRhRsRsmmbLcbLebLibRgbRcbRg
bRibLjbRhbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRebRgRsRsmmbRgbReRibRsbsbsbRsRsmbRebRsbRgbRgRsmbRgbsbRiRsmbRgRgRsmbRg
RsmbRsbRgRsmbRgbRgbRiRsmbRibRgbRsbRibLsbRibRibRibRgbRiRsmbRibRsRsmbLgb
LsbRibRibRhbRgbRgbLgbLjRsbRibRjbRiRsmbRjRsRsmmbLgRsbRebRgbRgbRgbRjRsmb
RgbRiRibRibRgbLibLjbLcLsmbLgRsbRgbRibRgbRgbRgbRibRgbRiLsbRsRsmbRgbRgRs
mbLjbLobRebRgRsmbRibRgbRsbRsRsmbRibLgbRiRibRgbRgbRibRibRjbRibLgbLgbRjb
RhbRsbRibRgbRiLsRsbLibRgbLibRgbLsLsmbRibRgRsmbRibRiRsRsmmbsbLgbRgbRibR
gbRgbRgbRgbRsbRsRsmbRebRebRiRsmbReRsmbRiRsmbRibRiRsmbRibRgbRsRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLgLsLsLsmmbLsbLjbLcbLiRsbLiLsbRsbRsbLjbLsRsLsRsbRgRsRsRsRsRsRgmmmmmbL
jbLibLsbLcbLsLsmbLsbRjbRiRsmbsbRgbLobLsLsLsLsLsLsmmmmmbLgLsLsmbLjbLibL
gLgbRsLsbRsLsbRebRiRsmbLjLsmbLcbRgbRiRsmbRsRsmbRsRsmbLebRhRsmbLibLgLgL
gLsLgbLsbLsLsmbLiLsbRsbLsbRsLsbRgRgRsRsRsmmmbsbLsLsmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bRgRsRsRsmmmbRiRsmbRsLsRsRsRsmmbRgRsRembLsbRsRsRgRsRsRhRsmmmmbRsRibRsb
RsRsRsmmbRsRsmbRsRsRsmmbRsbRsRsmbRsRgRsmbRgbLgRsbLsRsbRsbRsRibRgRsRsRs
RsmmmmbRsLsbRgRsRsRsmmmbRsRsRsRsmmmbRsLsRsbRsRgbRsbRsRsmbRsRsmbRsRsRsm
mbRsRsRgmbRibLsbLgLsLsLsmmbRsRsmbRibLsLsmbRsRsRsmmbRsRgbRgRsRsmmbLsRsL
sRsbRsRsRsRsmmmbsbRsbLsRsRsmbRsbRsbRsRsRsmmbRsRsRsRsmmmbRsRsRsmmbRsRsR
sRsmmmbRsRsRsRgRsRsRsmmmmmbRsRsRsRsRsmmmmbRibLgbsbsbRibsbLsLsRsmbsbRsR
sRiRsmmbRsRsmbLsbsbRsLsRsbRsRsRsRsmmmbRibLgbRibRibRsbRgbRiRsmbRibRsbRs
RsRsmmbRgRsRsLsRsRsmmmbRsbRgbsbLsLsmbRibRsbRiRsLsmbRjRgbLgbLhLsLsmbLcb
LhbLgbLsLsLsmmbLsLsLsLsmmmbLsLsLsmmbLsLsmbLsbLsLsLsLsLsLsmmmmmbsbsbsbL
sLsLsmmbRsbRsbLsLsmbsbLsLsRsmbLsbsbLsLsmbLsbLsLsLsLsRsmmmbLsLsmbLsLsLs
LsmmmbLsLsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbLsRsbsbsbsbsbsbRgbRsRibRgRiRgbRgRsRsmmbRsRsLsmbRgRsRsmm
bLjbRcbRcbRsbRsRebRsRsRgRsmmbRsRiRsRsmmbRsRsRsRsmmmbRgRsmbLsLsmbsbsbsb
Lsbsbsbsbsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bLsLsmbRsbLcbLcbLjbLeLsbLeLgLsbLebLgbLsLsLsLsmmmbLsLsmbLgbsbRcbLhLsbLe
bLebLiLsbRgRsmbLhbRhbLeLsbLebLjLgLsbLsbLsbRobLibLgLsbsbsbsbLsbLebRgbRc
bReRsmbRibLcbLcbLeLhbLebRsbLjLsRsmbLebRsRsmbLobLibLhbLibLjbLibRsbLgbsb
RibLibLgbLhbLjbsbsbsbLiLsbRsbLcLsmbLcbLjLebLibRgbLeLsbLjbLgLibLjbRjbLh
bLebLsLsmbRgbLcbRhbLcLsmbLebLhbLcRsbRiRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bsbRiLsbLcbLhbLgbLcbLcbLsRsbRhbRhRsmbLsLsmbLibLibLibLibLsbRsbsbsbsbLsL
sLsLsRsLsLsmmmmbLgbRgbLebLgbLibRiRibLcbLibLibLcbLcLsmbRsbLibRhbLebLiLs
bLhbLcbLibLcbRgbRcbRibRibRgRsmbRibRgRgbRibLsbRiRsmbRsRibRsRsRsRsRsmmmm
bRgLsbRgbRiRhbRebLibRsbRsRsmbRiRsmbRibRsRgbRgbRibRgbRgbLcbRibRibRgRsmb
RgbRgbRgbRgLsRsRsRsRsRsRsRsRsmmmmmmmbRibRibRjb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
bRsbLjbRgbLsLsmbLgLsLsLsLsLsmmmmbRgRsmbRsRsRgRgRsRsmmmbLgbLsLsLsLsLsRs
LsLsmmmmmbRebLhLsLsLsLsmmmbLsbLsbLsLsmbRsbRjbRibLibRibLiLsbLsLsLsLsLgm
mmbLhbLcbLgLsLsmbRibLhbRsRsLsRsmbRcRsmbLgbLjbRebRsRsmbRsbLcLsmbLgbRsbs
bRsbRsRsRgRsRsRgRsRsRsmmmmmmbLgLsLsmbLsLsmbRsLsLsLsLsRsLsmmmbsbLsRsLsb
RcbLjbLgLgLgLgbLsLhRsbRibLcbLsbLcbLjLsLsmmbRsLsLsLsRsmmbReRsRsmmbRsbRs
RsRsRsRsRsRgRsRsRsmmmmmmmmbRsbLiRsRsmbLsLsmbRsbLcRsRsmbLsLsmbLsLsmbLsL
sLsLsLsLsLsmmmmmmbRsLsLsLsLsLsmmmmbLsbLsLsmbRsbLibLibLhLsbLgRsLsbLsLsm
bRsbLsbRsbRibsbLsLsmbLsLsLgLsLsLsmmmbLsbLsLsLsLsRsLsLsmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
bLgLsbLsbLsLsLsmmbLsLsLsmmbLsLsLsLsLsLsLsRsLsLsmmmmmmmbLgLsLgLsbLsLsLs
RsLsLgLsLsLsLsRsmmmmmbLgLsLsLsLsLsLsLgLsLsmmmmmmbLgLsLgbLiLsLgbLsLsmbR
sbRobReLsbLgbLebLgLsLsmbLsbLgbLibLebLhbLgbLgLsbLsLsmbLgLsLsmbLsLsmbLsL
ibLhbLgbLsLgbLiLsLgLsbLgRsLsLsmbLgLsLsmbLsLsLsmmbLgbLgLsLsLsmmbLsLsmbL
gbLsLgLsLsLembsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRgbRgbRibRibRhRsmbRebRibRgbRebRgbRgRsmbRiRsmbRibRgbRibRgbRgRsmbRsbRgR
smbRgbRgRsmbRgbRgRsmbRgbRgbRgbRgbRibRgbRibRgRsmbRibRiRsRsmmbRgbRgbRgbR
gbRgRgbRgRsLsmbRsRsRimbRsbRsRsmbRgbRibRgRsRsmmbRibRgRsRsmmbRibRgbRsbRi
bRgbRibRibRgbRgbRgbRgbRgbRgbRibRgLsbRgRgbRsRibRibRgbRibRgbRgbRibRgbRsR
gRsRsRsmmmbRsRsRsmmbRgbRsRsRsRsLsmmmbRgRgbRgbRgbRsbRgbRsbRsbRsbRgRsRsm
mbRsbRgRsmbRgRgbRsRsRsmmbRibRgRsmbRgbsbRgbRsbRsbRgbRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLsbsbLsbLsRsLsbsbRsbLsbLsbRsbsbLsLsLsmmbRsLsbLsLsmbRsRsmbRsbLsLsmbLsL
smbLgbLibLsLsmbLsbLsLsmbLsLsmbLsbLiLsbLgbRsRsmbRgRsRiRsmmbRiRsmbLsRsRs
mbRsRibLcLsLimbLsLsRsmbLibLibLgbLobLobLsLsmbLibLgbLgLsbLibLsLsmbLgLsbL
ibLgbLgbLsbLsLsmbLgLsbLsbLibLgLsbLgbLgbLibLibLgbLibLgbLgbLcbRgbRobRgbL
hbRsbLgbLgbLsbLgRsbLgLsLgbLgbLgbRgbLgbsbsbLsbLsLsmbLsbLsLsmbRsLsbLgLsb
LsbLsbLsLiLsLibLsbLibLgLsbLgbLgLsbLibLgbLgLsbLgbLsbLgbLgbLgbLibLiRsbLg
RsbLgbLgbLgbLgbLgbLibLgbLibLsbLgbLibLgbLgbLsbLgbLgbLibLiRsbLgRsbRgbRgb
RibRcbRgbRgbRibRibRsbRibLsbRsbRcbRsbLibLjLibLgbLgbRgbRjbRgRsmbRsbRsRsm
bRgbRgbLsRsbRgRsmbRgRgbRgbRsRsRgmbRebRgbRsbRjRgbLjbRsLsbsbLsbRgLsbLsbR
gbRibRgRsmbRgbRsbRgbRibRsRsmbLsRsbRcbLsbRiRsmbRcbRibRibRibRsbRibRgbLgL
sbRgRsRsRsmmmbRgbRgbRsbRsbRgbLsbLgLgLsbLgbRibRcbRibRibRibRiLsbRgbRgbRg
bRsRgbRgLsbRgbLgLsbLsLsLsmmbLgbRiRsmbRibRjbRsbRsbRibRgbRsRsmbRsbRgLsbL
eLsbLsbLgbRsLsbLsRsbLsLsmbLsbRsbLibRsRsmbsbLjLsLsRsmmbRsRsmbRgbsbLsLsm
bRsLsbsbRsLsbRsbRsbsbsbLsbRsbLsRsbsbLsbsbLsbLsLsmbRsbRsLsRsbLsLeLsbLib
LgbLjbLgbLsLsmbLgbLhLsRsbLibLgbLgbLgbLsLsLsmmbRsLsbsbLgbLgbLgLsbLgbLgb
LgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRgbRsRsRsmmbRsRsmbRsRsRsRsmmmbRsbRsRsRsmmbRgbRsRgbRsbsbLsRsbRsR
sRsmmbRgbRsbRgbRgbRsbRsbRsbRsRsmbRgbRsbRsRsmbRgRsmbRsbRgbRgbRsbRsRsmbR
gLsbRsRgbRsbRsbRgbRsbRsbLsRsRsmbsbRsbRsRsmbRsbRsbsbRsRsmbRsRsRsmmbRsbR
sbRgbRsbRsbRsbRgbRsRsmbRsbRsbRsbRsbRgbRsbLsbRsRsmbRsRsmbRsRsmbRsbRsRsm
bRsbRsRsmbRsbRsRsmbRsRsRsmmbRsbRgbRsbRsbRgbRsbRsRsmbRsRsmbRsbRsbRsbRsb
RgbRgbRsbRibRsRgLsbRibRebRsbRsRsLsmbRgRsRgmbRsbRgbRgbRibRsbRgbRgbRgbRi
bRsbRsbRgRsmbLsRgbRsbRgbRgbRsbRsbRibRsbRgbRsLsbLsRsRsRimbLsbRiRsRgmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bLgbLibLgbRhbLjLsmbLsbRoRsmbRgRsmbRsRgRgRsRsmmbLsbRsRsRsRgRsmmmbRsRsRs
RsRgRsRsRsRsLsmmmmmmmbRsLsbRsRsRsmmbRsRsRsRsmmmbRiLsbLobLobRsLsbRibRsb
RsRsmbsbsbsbRsRsRsRsRsRsmmmmmbRgbLibsbsbRsbRgRsmbRgbLibRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLobRsbLebLibLebLsbsbLibLcLsLsmmbLobLsRsbLebLebLebLebLebLebLebLgbRjRsm
bLgLgLsbLsLsmbLibLgLsbLsLsmbLsRsbLeLsbLiLsbLibLsLgLsLsmbLgLsbLibRgbLoL
sLsmmbLeLsLsmbLiLsbLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bRiRsRsmmbRgRiRgbReLsRibRibRgbsbRgbRgbRgbRgbRgbRsRsmbRgbRgbRsbRsRsmbRs
bRsRsmbRgRsRsRgRimmbRgRiRsRsmmbRgbRiRsmbRgRsmbRgbRsRsRsmmbRgRgbRgRgRsR
sRgmmbRgLsbRsRibRsRgRsReRimbRebRgRsRsRgmmbRsRsmbRgbRgRgRebRgRsRgmbRgbR
sRsRgmbRsRsRgmbRgbRebRgRgbRgRsRgmbRebRgbRgRsmbRgRgRsRgRembReRsLsmbRebR
gbRgbRibRsRiRgbRibLsbRibRgRsmbRgRgbRgbRgRsRsmmbRibRgRgRsmbRgRsRsmmbRgb
RiRsmbRgRsRsmmbRgRsmbRibRgbRgbRsbRsRsRgRsRgRsRsmmmmbRsRsRgmbRhRiRsmbRg
bRgRsRsmmbLsRgbRcRibsbRiRsmbRibRgRsmbLsRsbsbRsbRgRsRsmmbRhbRsRsmbRgbRs
bsbRsbRgbRgbLsRgRsmbRgbRsbRsRgbRgbRgbLsbRibRsbRsbRgbRsbRgbRsbRsRsRsRsR
sRgmmmmbRgRsmbRsRsRsRemmbRebRgbRsbRsRsmbRgLsRsLsbRgbRgRsRsmmbRgbRsbRgb
RgRsmbRsRsRgmbRsRsmbRsReReRiRsmbRsRiRgbRgRgRiReRsmbRgRiRsmbRibRibRgbRs
bRibReRsRgLsmbRgbRibRsRsRsmmbRsbRsRgbRgbRsbRsbLsbRsbRgbRsRsmbRgbRgbRgb
RgRsRgRgmbRgbRgRsmbRgbRsbRsbRsRsmbRsbRgbRgbRgbRgbRsbRsbRgRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bRgbRibRiRgbRibRibRgbRgbRgbRgbRgbRgbRibRhbLgbLgbLcLsmbLiRsbLibLgLsbLgL
sLsmbLibLgbLgbLgLiLsbLgbLgbLgbsbLsLsmbLsLsmbLgLsLsmbLsbLsbRgbLsbLsbsbR
sRcRsmbLibLgbLsbLsLsmbLsbLebLibLgbRsRobRhbRhLsbsbRibRgbRsbRsRgbRibRhRs
mbRsbRibLsbsbRgRsmbLsbsbRiRgRsmbRgbRibRgRsmbRhbRibRgbRjbRhbRibRibRgbLi
bLcbLibLobsbLsbRcLsRsbRsRsmbRgLsbRsRsmbRgbRgbRgbRgbRibRebRibRibRebRebR
ibRhbRgbRiRsmbRgbRgbRgbRsRsmbRgbRgbsbLsbRibLjLsmbLgLsbLibLiLsbLgLsbLsL
gLsbLibLgbLgbLgbRjRsRsmmbRjbRiRsmbRgbLsbLibLgRsbLibLgRsbLibLgbRgbRibLg
bLsbLgbLgbLibLgbLgbLgbLsbLgbLgbLsbLgbLibLcbLgbLsbLjLgbRibRibRsbLgbLsLc
RsbLgbLibLgbLsbRcbRibRsbLsbRiRsmbRsbRgbLsbLsbLibLsbLgbLsRsbRjbLibLgLsb
RsRsLsmbLgLsbLsLsmbLgbRsRsmbLsbLsbLgbRsbLiLsbLgbLgbRsbLgRsLsbLgbRgbLib
LibLibLibLgbLcbsbRhbLsRsbLsbLibLgLsbLibLibLiRsbLsbLgbRsbLebLgbLgbRsbLs
LsmbLhbLgbLgbLibLgbLibRsbLjLgbLgbLsLsmbLgRsbLsRsbLcbLibRibRsbRhbRgbRib
RsbRibLsbRsRsmbLsbRebRibRsbReRsmbRiRsmbLsbRibRhbLsRsbLsbRibLgLsLsLsRsm
mb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bReRsmbRibRibsbRiRgRsRsmmbRebRiRsRsmmbRgbRibRiRsmbRebRebRebRibRibReRsR
smmbRibRiRiRsmbRgbRibRebRgbRhbRibRibRgbReRgbRibRibRgbRgRsmbRibRgbRibRs
bRgbRibRgbLsbRgRsmbRgbRgbRgbRsRsmbRgbRsbRgbsbRsRgbRsbRgbRgbRsbRhbLsbRi
bLgbRgbRebRibRgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLsbRhbRibLgbRsbLibLgbLsLsLsLsLgLsmmmbLsbLiLsLsmbLsbRibLsbLgbLsbLgbLsb
LsbRsbLsRsbLsLsmbLsLsmbLsRsLsLsmbLsLsmbsbLibLsbLsLsmbLsLsLsLsLsmmmmbLs
LsLsLsmmmbLsbLgbLgbLsbLsbLgbLsbsbsbsbsbRsbLsLsmbRsLsbLsbLiLsbLsLsmbRsb
LsLsmbsbLsRsbLsbLsbLsbLgbLsLsmbRsbLsLsmbLgLsLsLsmmbLsbLgbLsRsbLsLsLsLs
LsRsmmmmbLsLsLsmmbLgLsbLsLsLsmmbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLiRsbLsbLsbLcbLcLsmbLibLjLgbRcRsmbRibRsRsmbRhRsmbsbRgbRibsbLgbLcbLibL
cbRcbRhbLcbsbsbRjbLgLsbLsbLgLsbRibLsbLibRcbRibRibRgRsmbRgbLgRsbLsbLgbL
gRsRsmbRsRibReReLsbRibRebRgRsRiRsmmbRibRsbLoRsbLgbRobRgbLcbLibLgbRobRi
bRgbLibLsLsLsmmbsbRjbLjLgLsbRjbRjRsRsmmbRgbLibLsbRjbLibLsbRgbRibLjbRgR
smbRjRsRsRsmmmbLgLsbLiLsbRjbLgbRjbLeLsLsmbLgRsbLcbLcbRcbRebRiRsmbRiRib
RhbRjRhbLsLsmbLgbRibRcbRiRsmbRgbRibRebRiLsbLjLsmbLjbRhbRgRsRsmmbRibsbR
gRsLsLgmbLibRjbsbLhbLgbRgbLibLjbRebLjbRhbRgbLhbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsbLibLgLsLsmbRhbLgbRcbRibsbRiRsmbRcRsmbLsLsLsmmbLsLsmbLsLsLsmmbLsbLs
RsbLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsmmbLsbLsLsmbLsLsmbLsLsLsLsLsmmmmbLsLs
LsLsmmmbsbLsRsbLsRsbLsLsmbLsLsmbLsLsmbLsbLsRsLsRsLsLsLsLsLsmmmmbLsLsLs
LsmmmbLgbLsbLsLsLsmmbLsLsLsLsmmmbLgbLsbLsLsmbLsLgbLsLsLsLsmmmbLsLsmbLs
LsmbLgRsbRsLsbLsbLsbLgLsLsmbLsLsmbLsLsmbLgLgbLgLgbLsLsLsmmbLsbLsLsmbLs
bRsbLsbLsLsLsLsmmmbRsRsRsmmbLgbsbRgbLsbLsbRsRsmbLsLsLsmmbsbsbLsbLsLsLs
mmbLsLsmbLsLsmbLsLsRsLsmbLsLsmbsbsbsbsbLsLsmbLsbLsbLsbRsbLsLsmbsbLsLsL
smmbLsLsRsmbLsbsbLsbRsLsRsLsbLsLsmbLsLsLsLsLsmmmmbLsLsLsLsLgLsLsmmmmbR
sLsRsLsbLsbRsbRsLsbLsbRcbLebRjRgbsbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsRsmmmm
bRsRsRsRsmmmbRsRsRsRsRsRsRsRsmmmmmmmbLsRgRsRsmmbRgRsRhmbRsRgRsmbRgRsmb
RsbRsRsRsmmbRsRsRsRsmmmbRgbLgRsLsbsbsbLsLsLgLsLsmmbLgLsLsmbLsLsmbLsLsL
smmbLsLsLsLsLsLgmmmmbLgLsbLsRsLsbLgbRsbLgLsbLsLsmbLgLsbRsLsbLsLsmbLsLs
mbLsbLsLsLgmbRsbRsbRiRsmbRibLobRsRsmbLibLsLsLsmmbLsLsRsmbLsbsbLsLsLsLs
LsmmmmbLsbLsLsmbLsLsRsmbLsLsmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bRibLgbRiRsmbLgbRsLsbsbRgRsRsRsRsRsmmmmmbsbRgRgRsRsRgRsRsRsRgmmmmmbRgR
gRsmbRgRsRsmmbLsbRsRsRsRsRsRsmmmmmbRgRsRsRsmmmbRebRgbRebLgLsLsmbRgRsRs
RsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmbRsRsRsRsRsmmmmbLhbsbRiRsRsmmbLs
RsRsRsRsmmmbRsRsmbRjbRgRsRsRsRsRsRsmmmmmmbRgRsRsRsRsRsRsRsmmmmmmmbRiRs
mbRsbRsbRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsRsmmmbRgRsRsmmbRhbLiLsbRebRgRgRs
RsRsRsRsmmmmmbRgRsmbLsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsRsmbRsRsRgRsRsmm
mbRgRsmbRsRsmbLjbLcLsmbsbRiRiRsmbLsbRsRsmbRsbRsRsmbRsLsbLhbRgbRsbRsRsm
b

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bLgLgLsbRsLsbLhbLgLsbLgLsbLgRsLsbRgLsLsLsLsmmmbLiLsbLiLeLsLgbLibLgbLgL
sbRsbLgbRsLiLsLiLibLibLgLsbLsbLsbRsbLiLsLsLimbLebLsbLsLsmbRsLgLsLsmbRs
LsbLgbLibLgLsLsLsLsLsmmmmbLsLsLgLsmbLgRsRsLsmbRiRsmbLiLsbLsRsbLiRsLiLs
bLiLsRsbLsLsLsLgLsLgmmbLgLsLgLsLgbRsLsbLebLgbLcbReRsmbRsbRgbLhbLeLsbLs
LgLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRgRsmbRiLsbRibRiRsmbRebRebRhbRibRgbRgbRgbRgRsRimbRgbRsbRgbLsbRgbRsbRi
bRgbRobLsbRgbRsRsmbRhRsRsRsRsLsRsmmmmbRiRibRibRgbRgbRgbLsbRsRsmbRsRsmb
RgLsbRibRsbLsbLjbsbLgbRgRgRiRsmbLsRgbRsbRgRsmbRhbRgbRgbRiRsRsmmbRgbRiR
sRsRsRsmmmmbRsbRgRsRsRsRsRgRsRsRsRgmmmmmmmbRsRsRsRsRsRsRgRsRsmmmmmmmbR
gbRibRgbRgbRgbRgbRgRsmbRgbRsbRsbLsRiRsmbRsbRibRobRcbRibRibLsbRgbLgbLsb
LhbLsbRgbRibLhbLibLibLibRgRsRimbRibRsbRsbRsRsRsRsmmmbRsRsmbRsRsRsRsRsR
gRsRgmmmmmbRgRgRsRsRsmmmbRsRsmbRgRgRsRsmmbReRsmbRgbRsRsRsRsRgRsRiRgRsm
mmmmbRsRgRgRgbRgbRgbRgbRgRgbRhbRhbRibRibRgbRsRgbRiRebLsbRibRibRebRgbRg
bRibRgbRiRsRsmmbRibRibRiRgRsRsmmbLsRgRsRgRiRsRgmmbRgbRsRsRsRsmmmbRgRsR
gRsmmbRgRgRebRsLsRsRgbRsRsRsRsmmmbRsRsRgmbRgRgbRibRsRsRsRgRsRsmmmmbRsR
sRsRgRsRsLsmmmmbsbRsbRibRiRsRsmmbRgbLsRgRsRgRsRsRsRgRgRgmmmmbRgbRgbRgb
RibLsRgbLsbLsbRgbRsRsRsRsRsRiRsRgRsRsRsmmmmmmmmbRsbRgRsmbRsRsRsmmbRsRg
RsRsRsRsRsRsRsmmmmmmmbRsbRsRsRimbRsbRsRsmbRsbsbLibLiLsbLsLsLsmmbLsbLgb
LibRsbLgbLgLsbRsbLsLsLsLsRsmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLiLsLsm
mmmmmmmmmmmmmmmbLgbLsbRsLsbRsbRsbLsLsLsLsLsmmmmbLsLsmbLsLsLsLsLsmmmmbL
sLsmbLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsRsRsmbRsLsbLsbLgbLgLsLsLsLsLsLs
LsLsLsmmmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bLsbRsbLsLsmbRsbLsbRsbRsbsbsbLsbRsbRsRsmbLsRsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRgbRsLsbRsbLsbRsbRsRsRsRsRsRgmmmmbRgRgRsRsmmbRgbRgbRibLsbRiRsmbLsbLeb
LibLgbLibLgbRhbRhbRsRgRsmbRsRsRsRsmmmbLsRsbRsRsRsRsmmmbRibLsLcLsmbLibL
gLebLgbLebLgbLibLebLiLsbLiLsbLibLibRsbLeRsbLibLibLgbRsbLsLsLsLsLsmmmmb
LsbLgbsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLiLsLsmbRsLsRsLsLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmbLgLgLsLsLsmmbLiLsbLg
LgLsLsLsLsmmmbLiLsLgbLgLsLsLsLsLsLsmmmmmbsbLsLsLsLsLsLsLsLsLsLsLsLsLsL
sLiLsmmmmmmmmmmmmmbLsLsLsmmbLgbRsLsLsLsLsmmmbLiLsbLsLsLsLsLsmmmmbLsLsL
smmbLsLsLsmmbLgLsLsLsmmbLgLsbLsLsmbLeLsLsLsLsLsLsLsmmmmmmbLgLsLsLsLsLs
LsLsLsmmmmmmmbLiLsLsLsLsLgLsmmmbLsLsLsLsmmmbLebLibLsbLsLsmbLsLgbLiLgLs
bRsRsmbLjLgbLsRsbLiLsLsLsLgmmbLgLsLsmbLgbLsLsLsmmbLgLsLsmbLsLsLsLsLsLs
LsLsLsLgLsLsLsLsmmmmmmmmmmmbLgLgLsLsLgmbLgbRsLsLsLiLsmbLgLgLsLsLsLsLgm
mmbLsLsLgLsLsLsLsmmmmbLgLsbLgLsLsLsLsLsLgmmmmbLsbLiLsbLgLsLsmbRobRiLsb
sbLibLsLsLsLsLsLsLsmmmmmmbLsLgLsLsLsmmbLsbLsLsLsLsRsLsmmmbLsbRsLsbLsLs
RsmbLsbLibLsLsLgLsmbRsLsLsLsLsmmmbLgLgLsbsbRsRsLsmbLsLsmbLgLsbLsLsLgLs
mb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bLibLhbRhbLeLhbLeLgbLsbRsbRsbsbLsbRgRgbRgRsRsRiRsRsRsmmmmmbRgbRgRsmbRg
bLsbRgRgRsmbRsbLsbsbsbsbsbsbsbsbLsbRsLsbLsbsbsbRsbsbsbsbLgbRsRsRgRsRsR
sRsRgRgRsmmmmmmbRgRsmbRsRgbRgbRsbRsRsmbRiRsmbRgRsmbRgbLcbRjbRobRsRsmbR
ibRsRsmbRsRsRsRsRsmmmmbLsRsRsmbRsbRgRgbRgRsRgmbRiRsRsmmbRsRsmbRsRsRsRs
RsRsRsRiRsRsRimmmmmmmmbRgRsRsRgmmbRgRsRsLsRsmmbLsRsRsRgRsmmbRsRsRsmmbL
sbRsRgRsmbRsbRgRsRsRsRsRsmmmmmbRibRsRgRsRsmmbRebRgbLjbLgbRcRsmbLgLjbLc
bLsbLgbsbsbsbsbsbsbsbsbsbsbsbRsbsbRsbRsLsRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bReRsRsmmbRsbRgbRsRsRsmmbLsRibRsbRsRsmbRsRsRsmmbRgbRsbRsbRsRsRsmmbRsbR
sRsmbRsRsmbRsbLsbLsbLsRsbRsbRsRsmbRsRsmbLsRsbRsbRsRsRsmmbRsRsmbRsbRsRs
mbRsbRsRsmbRsRsmbRsRsmbLsbRsRsmbLsRsbRsbsbRsbsbsbRsRsmbRsbRsRsmbRsRsRs
RsmmmbRsRsmbRsRsmbRsRsmbRsbRsRsmbRsbRsbRiRsmbRibRgbRgRebRgRsmbRebRsbRs
bLgRsRsLsmbRsRsRsmmbRgbRsRsmbRsLsbRgbRsRsmbRsRsmbRsbRsRsmbRgLsbLsbsbRg
bRgbRsbsbRsbsbsbRsRsRsRsRsRsRgmmmmmbRsbLsbRibRgbReRsmbRebRebRgbLsbRibR
ibRiLsbRiRsmbRibRgbRgbRgbRgbLcbLhbLcbLeLgbLibLiRsbLebLebLeLsbLiLsbLibL
ebLiLibLibLgLsbLibLibLgbLgbRibRgbRgbsbsbRsbRsRsRsmmbRsRsmbRsbRsRsRgRsR
sRgmmmbLsRsbsbRsbRsbLsRsRsmbRsbsbsbRsbRsRsRsmmbsbRsRsRsmmbsbRsRsmbRsRs
RsRsRsRsmmmmmbRsRsmbsbsbsbRsRsRsRsmmmbRsRsRsRsmmmbRgRsRsmmbLsbLjbLhLeL
sLsmbLgbLibLibLhbLiRsbLhbLiLibRsbLcbLiLibLibLsbLsbLgLsbLiLebRjbRgbRibR
ibRgbRibRibRgRsmbRhRgbRgbLiLsbLgLsbLsbLgbRsbLgbLgbLgLsLsLsmmbLgLgLsLsL
smmbLgRsbLsbLgbLhRibRiRsRsRsRsmmmmbRsbRgbRgbLcbLgbLgLgbLgbLsLsRsmbLgRs
bLsbLgbLgRsbRsLsbLgLgbLeLsRsbRsbRgRsRsRsmmmbRibRsRsmbRgRsmbRgRsmbRgRsm
bRsRsRsRsmmmbLgbLsLsmbLebLsbLgLsbLsbLsRsbLsbRsbLgbLgbRsbLgbLsbLgbLgLsb
LiLsbLgbLsbLsLsmbLgbLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bRsRsRsRsRsRsmmmmmbsbRgbRsbRsbRcbRibRibRgRsRgRsRsRsRsmmmmmbRiRsmbRcbRs
bRsbsbRhRsmbRgbRgRsmbRsRsmbRsLsbLsbRsRibRsRsRsmmbRgLsbLgLsLsmbReRsmbRg
bRgbLebLgbLhLsbLibLgbRsRsmbLgbRsRsmbLgbRgbLsbLgbLgLsLsmbLgbRsRsmbLgLsb
RgRsRsmmbRcRsLsmbLgRsLsbLsbRsbRebRsRsmbRsRsRsRsRsmmmmbLsRhRsmbLsLsmbRh
bRsRgRsmbLgLsbLgLsRsbLgLgbLgLsLsmbLibLebLibLgbLhbLgbLibLhbLgbLgLsbRgRs
mbRcbRebRgRsRsLsLsmmmbRgbLsbRibLgLsLsLsLsLsmmmmbLsLiLsbLgbRgRsRgmbLsLj
bLiLsLgbLibLgbLgRsbLibRgbRhbLgbLgLsLsLsLsLsLgmmmmbRjbRiRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bRsbRsbRgbReRsmbRsRgbRsbRiLsbRgbLcbLgbLebLcbRgRsRsmmbRebsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bRsbsbLiLsLsmbLgbRsbLgLsbLgLsbRsbRhbLiLsbLiLsbRgbsbLsLgLsbLgLsbRsRebLi
bLhbLgbRsbLgbRgRsmbRibRibRsbLgbsbRsbLiLsbLgLsbLgbLgRsbLgbLsbLgbLibRsRs
mbRiRsmbLsbRibRibLsbRibLibRibRgbLsbLhbRgbRgbLsLsmbLibLgLgbLsbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bsbLsbRsbsbLsbLsbRsbRsbRgbRsbsbRsbRgRsmbRgRsRsRsmmmbRibRcbLhbLhbLhbLib
LsbRsbLeLsbLcRsbLhbLibRsbLhbLgbLhLsbRgbRgRsRsmmbRiRgRsmbRgLsbRebRebRiR
smbRibRiRgbRibRcbRibRibLsbRgbRgbLgLjLsmbLibLibLibLibLgbLibRgbLebLgLsLs
LsLsmmmbLsLgbRiRsmbLgbLsLgLsLsLgLgLgLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmm
mmmmmbRsbLiLsLsmbLsbLsLsmbLgbLgLsbLgbLgRsbLgLsLsmbLgbLgbLsLsmbLgLsbLib
LcbLebLiRsbLibLgbLibLsRsbRjbRsbRibRsbLjbRebLsLsmbLcbLhLsLgLsLsLembRgbL
cbLsbLibLsbLiLsbRsbLsbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsmmm
mmmmmmmmmbLsbLgLsbRsbLibLgbLsbLsbLsLsLsLsLsLsLgLsLimmmmmbsbLsLibLibLib
LsbsbLgLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140338; End: 140838;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
bLibLgbRsbsbLsLsLsLgmmbLgLsbLsbLgLsbLgLsLsmbLsLsmbRsLsbLsLgbLgbLgbLgLs
bLgbLgLsLsmbRsbLgbLsLsmbLsLsLgLsLsmmbLiLsLsLsmmbLgLgbLgLsbLibLgbLebRgb
RjbRsbRgRsRsRsRsmmmmbRgRsmbLsRsRsmbRsbRgbLsbRsRsmbRsRgbRgbRgbRsLsbRsbR
sbRsbLsRsRsmbRgbRsbRgRsRsmmbRgbRgbRsbRsbLsbsbRsRsmbRsRsmbLsRsbRsRsmbRg
RsmbRsbLsRgRsmbRgbRgbRgbLsRsRsmbRibRibRibRgbRsbRgLsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bRsbRsLsbRsbRsbLsbLjbRsRsRsRsRsRsmmmmmbRjRgRsmbLcbRebRsbRebRibRsbRobLs
bRsRsmbRsRsRsmmbRsRsRsmmbRsbRsRsRsRsRsRsRsmmmmmmbRsbRgRsRiRiRsRsmmmbRg
RsRsRsRgRsRsRgmmmmmbRsbLsbRsbRsbRsRsRsmmbLsbRsRsmbLsRsbRsLsbRiRsRsRsmm
mbRcbRhRsmbRgRsmbRiRsmbRsRsmbRsRsRsRsRsmmmmbRsbRsRsRsmmbRsRsmbRsbLsRsR
smbRsRsmbLsRsRsmbRsRsRsRsLsmmmbLsRsRsmbLsbsbRsbLsLsRsRsRsRsRsmmmmmbRsR
sRsRsRsRsmmmmmbLsbLsbsbRsRsRsmmbsbRsRsRsRsRiRsRsLsmmmmmbRgRsRsRsRsmmmm
bRibLgbRcbRgbRsbRsbRsRsRsRsmmmbRsRsmbRsRsRsRsRsRsRsRsRsRsLsRsmmmmmmmmm
bRsRsRsRsRsRsmmmmmbRsbRsRsmbLsbRsbLsRsbRsRsmbRsRsRsRsmmmbLsLsRsmbLsRsb
sbRsbRsRsLsmbRsRsmbRsRsRsRsRsmmmmbLsRsRsmbLsRsRsmbRsRsRsmmbLsRsLsbLsbL
sbLsbsbRsbsbRsRsRsRsRsRsRsmmmmmmbRgRsmbRgRsmbRsRiRsmbRcbReRsRsRsmmmbRg
RsmbRgRsmbRgRsRsmmbRsRgRsRsRsRsRsLsmmmmmbRgbRsRsmbRsRsRsRsRsRsRsmmmmmm
bRsRsRsmmbRsbLsbRsRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsRsRsmmbLsRsLsbRsRsRsRs
RsmmmmbRsbRsRsRsmmbLsRsbRsRsmbLsRsRsmbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsLsR
sRsRsmmbRsRsRsRsRsmmmmbLsRsbRsRsRsLsmmbsbRsbRsRsRsmmbRsbRsbRsRsRsmmbRs
bRsRsRsRsRsmmmmbRsRiRsmbRcbRebRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bRebRsReRebRsbRsReRsmbReRsmbRgbRhRebsbRgbRebRibRibRsRsReRsmmbReRsLsmbR
hbRhRsRsmmbReRsmbRhRebRobLgRsbLsLsLsLsLsLsmmmmmbLsLsmbLsbLsLgbLsbRjbLs
bLgLgbLgbLsbsbLsbLsbLhbLsLebRsLsLsLsmmbLgLsbsbRsbLgLeb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bRsRjbRibLiLsLgLsLsmbLgLsLsLsLgLgLsLsmmmbLgLsbRsLsLsLsLsLsLgLsLsLsLsLs
LsmmmmmmmmmbRsLsLsLsLsLsLsLsLsLsLsLsLgLsLsLsmmmmmmmmmmmmbLibRebRsRsRsR
sRiRsmmmmbLsRsRsmbRsbLcRsbsbsbLsbLsbLiLsLsLsLsLsLsLsmmmmmmbLgLsLgLgLsR
sbRsLgLsLsLsLsLsLsLgLsLsLgLimmmmmmbLgbRsLsbLsbLsLsLsLsmmmbRsLsLsLsLsmm
mbRsRsLsLsLsLsLsLsLsmmmmmmmbLsLsLgLsLsmmbLsLsLgLgmbRsRsRsmmbLsbLsRsbLs
LsLsLsLsLsLsLsLsLsLgLsmmmmmmmmmbLgLsLgLsbLsLsLsLsLsmmmmbRjbRhRgbRgLsLs
RsRsRgRsmmmbLeLsLsLgLsLsLsLsLsLsLsmmmmmmmbLsLsmbLhLsLsLsLsLsLsLsmmmmmm
bLiLsLibLiLsLgLgLsbLgRsLsLiLsbLsLsmbRhbLcLsLsmmbLgRsbLsLsmbLsLsLsLsLsL
sLsLsLsLsLsLsLsmmmmmmmmmmmmbLgLsLgLsLiLgRsbLsbLgLsLsLsLsLsLsLsLsLsmmmm
mmmmbRsRsLsmbLsLsLsLsLsLsLgLsmmmmmbLsLsLsLsLsLsLsLgLsLsmmmmmmmbLiLsLsm
bLsLsRsLsLgLsRsLsmbLiLgLgLsLsLsLsLsmmmmbLsLsLsLsLiLsLgLsLsLsLsLsLsLsLs
LsmmmmmmmmmmmbLiLsLgLgLsLsLgmbLsLsLsLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmb
LiLgLsLsLgLsLgmbLgLgLsbLgLsLgLsLsLsLsLsmmmmbRsLsLsmbLsbLsLsLsLsLsLsLsm
mmmmmbLiLsLsLgLsLsLgLsLgLsmmbLgLsLsLsLsLsLsLsLsLgLsLsmmmmmmmmbLsLsLsLs
LsLsLsLsLsLsmmmmmmmmmbLiLgLsLsLimbLhbLgLgLsbLsLsmbLsLgLsLiLgLsLsLgLgLs
LsLgLgLsmmbLgbLiLsLsmbLgLsLsLsLsLsLsLsLsLsLgLsLgLgLgLsLgLsLgmmmmmmmmbL
sbLgbLgLsLsLsLsLsLsmmmmmbLeLgbLhLsLsLsLgmmbLiLgLsLsLgmbLsRsbLgLsLsLsLs
LgLsmmmbLgbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsLsmmmmmmmmmmmmmmbLiLsLsLsLs
LsLsLsLsLsmmmmmmmmbLgLiLsLsLsLsLsLgLsLsLsmmmmmmbLhLsLsLsmmbLgLgLsLsLgL
sLsLsLsmmmmbLgLsLsLsLsLgLsLsmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bsbRsbRgbLgbRibRsRsmbRgRsmbRgRsRsRsmmmbRsRsmbRgbRsRsRsmmbRsbRgbRgbLsRs
bRsbRgbRgbRsbRsbRsRsmbRgbRsbRsbRgRsmbRgbRgbRsbRsbRsRsRsmmbRsRsmbLsbRgb
RgbRgbRsRsmbRgRsmbLsbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bsbsbRsbLsbRsbLsbLsbRsbLsbLsbRsRsmbsbsbsbRgbLoLsmbRebReRsRcmbLebLgbLib
LgbRcbLcbLibLibLsbRsbLsLsmbRsbsbsbRsbsbLibRiLsbLsLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRsbRebRebRgbRebRgRhbRgRsRgRsmmbRhRsRsmmbReRsmbRgReRsRsRsmmmbReRsRsmmb
LsRebRjRsRsRsmmmbRebRebReRsmbReRsmbRiRebReLsbReRgbReRsmbRgLsbRgRsmbRib
RgbRebRsLsLsRsRhmbRebReRsmbRebRebRebRebRebRsRsRsRsRsRemmmmbReLsbRgLhbR
ibRiRsmbReRsRsmmbRgbRiRsmbRgRsRsmmbRhRgRsRsmmbRgRgbRgRsRsmmbLsRsRsRgmb
RibRsRsRsmmbRiRsmbRebRebReRsmbReRsRgRsmmbReReRgRsmbReLsRibRebLsbRebReR
smbRebRsRsmbRsRsmbReRsmbReRgRsmbRibRebReRsmbReRsmbReLsbRsRiRsmbRiRsmbR
eRsmbReRsmbReRsmbRiRgbRibRebRebRibReRebLsbRjLsbRsRsmbRibRgRebRiRsRsRsm
mmbReRebRsRebReRsmbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bRebLcbRsbRebRsbRsRgRsRsRsmmmbRsbRsRsmbRsRsmbRgbRiRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bLsLgLsLsmbLsLsmbRsLsbLsLsLsLsLsLsmmmmmbRsLsLsRsLsmbLsLsLsmmbLsLsLsmmb
LsbLsbLsLsLsLsmmmbRsLsLsmbLsLsmbLsLsLsLsLsLsLsmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRgRsRsmmbRgRsRsmmbRsbRsRsmbsbRsbRsRsRsRsmmmbRgRsRgRsRsRsRgmmmmbRgRsmb
RsRsRsmmbRgRsRsmmbRsRsRsmmbRsRsRsmmbRgRsRgmbLsbRgbRgbRsRsmbRsRsmbRsRsm
bLjLgbRcRsmbLgbRhRsRsmmbRsRsRsRsRgmmmbRsRsLsmbRgRgRsmbRgRgRsmbLsRsRsRs
RgmmbRgRsmbRgbRsRsRsmmbRgRsmbRgbRsbRibRgbRsbRsRsRsmmbRgRsRsmmbRsRsRsRs
RsmmmmbRsRsLsmbRsbRgbLgbRebRsRsRsRsmmmbRiRsmbRiRsmbRgRsRsmmbRgRsmbRebR
sRsmbRhRsRsmmbRibRsRgRsRsRsRgRsRsRsmmmmmmbRibRgbRibRgRsRsRsmmmbRiRgRsL
smbRgbRgbRgRibRgbRgRsRsmmbRsbRgbLsbRiRgbRgRsmbRibRgbsbRgRsRsRsRsmmmmbL
gbRsRgbRibRiRsmbRiRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bsbRjbRgLsbRgRsRsmmbRgbLjbLsLsLsmmbRsLsbLsLsmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bRsLsRsbRsRgRsRsRsRsmmmmbRsRsRsRsmmmbRgRsRsLsmmbRgRsRsmmbRsRgbLsRsRsRs
RsRsRsRsRsLsmmmmmmmbRsRsRsmmbLebLebLgbLibLiLsbLebRjbRiRiRsmbRibRibRsRg
RgbRsRsmbRgRsmbRhRgbRhRsmbRgRsRsRsRsRsRsRsmmmmmmmbReRsmbReRsmbRebRiReR
ebRhbRgbRgbRsRsmbRgbLcbLibLibLgLsbLgbLibRibLiLibLgLsLsmbLgRsbLsbLsLsLs
mmbRsLsbLsbLsbLgLsbLgbLiLsbRgRsmbLgLsLsLsLsmmmbLsLsmbLsbLsbLsbLsbLsLsL
sLsmmmbLsLsLsmmbsbLgLgbRsLsbLsbsbLsLsLsLsmmmbLsbLgLsbLibLibLsLsLsmmbRs
RsmbLsbLsbLsLsmbLsLgLsLsLsmmbLsbLsLsLsLsmmmbLsbsbLgbLebLeLsbRsbLsbLsLs
RsmbLgLsbLgbLsLsmbLsLsmbLsLgbLsbLsLsLsLsLsLsLsmmmmmmbLgLgbRgbLiLsLsmbL
sLsmbLsLsLsLsLsLsmmmmmbLsbLsLsLsmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bLgRgRsmbLibRjbReRgbLsLsLsmmbLgLsRsbsbRiRsmbLiLsbRsbsbRjbLcLsmbLeRsbsb
LgbLcLgbLgLsbLgbLiRsLsbLgLgLsLsLsmmbLiLsbLiRsbLiLsbLgLibLsbLiLsLsmbLiL
sLsmbLsbRsbRcRsmbRgbLgbLsLsmbLsLsLsmmbLhLsbRcbLcLsmbLiLsbLibLebLibLiLi
bLgbRsRsLsRgmbLibLeLsbLibLgLsLsmbLsbLgbRcbLjbLjbLgbLibLjLgLsRsLsbRgRsR
sLsRsmmbRgRsRsRsmmmbRsRsRsRiRsRgRgRsmmmmbLcbLiLsbRjRsRimbLjbRsbRsLsLsm
bsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bRgRsmbRgbLeLsLsmbRcbRhRsmbRcbRebLibLgLgLsbLgbRcRsmbRiRsmbLhbRibRgbRsb
RgbLjLgLsLsmbRebLgbRhbLebLibLibReRsmbLjLjbLgbLibRebRgRgbRhbLgbLsbLibRj
bRcRsmbRibRhbRibRgRsmbRcbLibLgbRsbLsLsmbLsLsmbLsLsLsmmbRibRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLgLgLsLsLsLsLsLsLsLsmmmmmmmbLsbLiLsLsLsLsLsmmmmbRcbLiLsbLsLgLsLsLsLsm
mmbLgbRsLsbLsbRgRsmbRsRsmbRsbLsbRsbLsbRcRsRsmmbLjbRibRcbRiLsLsLsLsmmmb
RobLsRgRsRsRsRsmmmmbsbsbLiLgbRsLsLsRsmbLsLsLsLsLsLsLsmmmmmmbLgLsLsLgLs
LsLsLsLgLsmmmmbLgLsLsLsmmbLgLsLsLgmbRsLsbLgLsLsLsmmbLgLsLsmbRsRsmbLsLg
bLsLsLsmmbLsLgLsLgLsLsLsmmbsbLsLsLsmmbLsbLsbLiLsLsLsLsLsmmmmbLgLsLsLsL
sLgLgLsLsmmmmbLgLsLsmbLgbLsLsLsLsLsLsLsLsmmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bRiRsmbLsLsmbLiLsbRsRsmbLobLiLsbLsLsLsmmbLsbRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRgRsRgmbRgRgbRsbRgRsLsmbRgbRibRgbRsbRsbRgbRgRgRsmbRsRsmbRgRsmbRgbRgbs
bRgbLjbRiRsRsmmbRgbLsbRsLsbRsbRsRsmbRibRibRiRsRsmmbRgbRsbRsbRsbLsRsbRg
bLsbLsbRsbRsRgbRiLsbRibRgRsmbRsRsmbRiRsRgmbRiRibRgbRgbsbRsbRebRgbRgbRg
bRsRsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsmmbRiLsbLsbLsLeLsLsmbRsRsmbRsRsRsRsRsRsRsRsRimmmmmmmbLsbsbLsbLc
bLiLsbLgbLiLsLsmbLcbRgRgRgRsRsRsRgRsmmmmbLoLsmbLibLsbRsbRebRsRsmbRiRsR
smmbLhLsLsLsmmbLsLsLimbRjbRsRsRsmmbRsbRsbLeLsLsmbRsRsRsRsmmmbLsbRsRsmb
Ljb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bRsRsmbLsbsbsbsbRsbsbsbLsbLsLgbRsbRsLsbLsbsbLsLsLsLsLsmmmmbLsLsLsmmbsb
sbsbsbLsLsmbLsLsmbLsLsmbLgbLibLeLsbsbRhbLsRsbRsRsRsRsmmmbRsRsmbRsRsRsm
mbRsbRsRsRsRgRsRsRsRsmmmmmmbRgRsmbRsRsRsRsmmmbLsRgRsRgRsRsmmmbRibLsbRi
bLjbsbRgRsRsmmbRsRsRsmmbRsRsLsRsRsmmbRsRsRsRsmmmbRsRsLsmbRsbRsbRgLsbRi
bLjbsbRsRsRsmmbLsRsRsRgmbRsbRsRsRsmmbRsRsRgmbRgbRsRsRsmmbRsbRsRsmbRsRs
RsLsmmbRsRsmbRsRsRsRsRgRsmmmmbRsRsRsmmbRsRsRgRsLsmmbRsRsRsmmbRsRsRsLsm
mbRsbRgbRsbRsbRsRsmbRsRsRsRsmmmbRgRsRsmmbRibRsbRsRsRsRsRsRsRsRsRsmmmmm
mmmbRsbRsRsRsmmbRsRsmbRsbsbLsbRsbRsbRsLsbRsbLsRsRsmbRsbRsRsRgmbRsLsRsR
sRgRembLebLebLebLsbRsbLsLsLsmmbLsLsmbsbLsLsLsLsmmmbLsLsLsLsLsmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bsbsbsbsbRebRiRsmbRgbLhLsLsLsmmbRgRsRsLsLsmmmbsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bLjbRsbsbLgbRjbLibLiLsbLgLsbLgbRgRsRsmmbRjRsmbLsLsmbsbLgbLibRgbRjbRgbL
cbLgbLcLsmbLibLcbLibRgbRsRsmbRsLsRgRsRimbRgbLebLebLibLobLgbLibLgbsbLgb
RsbRsbLibRsbRcRsmbRsbRcRsmbLobLhLsLsmbLebLibLebLcLsmbLibLiLsbLcbLcbRcb
LibLgLsbRgbRgbLgLsLsmbLgbRsbsbsbRiRibLjbRcRsmbsbLcbLoLsmbRsbLsLcbReRsm
bRobLhLsbLebLcLsmbLebRgbRgRsmbRebRibRcbRgbRcbLsbLsLjbLsbLibLibRibRgRsm
bRebRoRsmbRsLsLsmbsbRsRcbRibLcbLhLsbLhbLsbRgRsmbLgbRgbLsbRsRsRsmmbRebR
ebRgRsmbRcbLjbLsbLcbLhLsbLiLsbLeLsbLeLsbLeLsbLibLiLsbRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bRsbRgbRgRsmbRgbRgRsmbRibRgbRgbLjbLcbLebLgLsbRjbLsLsmbLsRsbLsbLsbLsLsL
sRsmmbLgLsLsLsLsLsLsLsmmmmmmbLsbLgbLsbRibRgbRgbRsRsRsmmbRsbLhbRhRsmbLe
RsbRsbLgbLgLsbLibRcbLebsbRcbRibRgbRgRsRsmmbRsRsRsRsmmmbRsRsRsmmbLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bRjbRjbRsbRcbLhbLgLsbLebLhbLgbLsbLiLsbLobLoRsbLcLsLgmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bLcbRgbLgbLsLsRsLsmbRhbLsbLgLgLsLsmbLsbLsbLsLsLsLsLsmmmmbLsbLsbLsLsLsL
sLsLsLsmmmmmmbLgbLgbLcbRhbLibLibRsbRsbRsRsRsRsRsRsRsmmmmmmbRsRjRsRsmmb
LibLsLgbRsLsLsmbLsLsLsmmbLsLsmbLsLsmbLsbLgbRsbLsLcbRiLsbLiLsLgLsLsmbLs
LsLsRsmmbLhLibLibLebRhRgRsmbRiRgbLgLsRsLsRsbLgLsbsbRjbRiRsmbLjbLebsbLs
bLsRsbLsbLiLsLsmbRebLsLsmbLsLsmbLgLsLsmbLsLsmbLsLsLsmmbLsLsLsRsLsLsLsm
mmmbLiLsbLibRibLhbLgbLgLsLsLsLsRsLsRsRsmmmmbRebLobsbRsRsmbRsRsmbLsLsmb
LibLgLsLsLsmmbRsLsLsmbReRsmbRsRsmbRgRsmbRsRsmbRsRsRsRsRsLsmmmmbRsLsbsb
RsLsRsbRsbLebLgLsLsLsmmbLgbLcLsmbRibLcbLibsbLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
bLgLsLgbsbLsLgbLibLgRsbLgbLsLsLsLgmmbLgRsbLsLsmbLgLsbLgLsbRibRebRgbRsb
RiRsmbLgbReRsmbRsbRebLsbLebLebLsbLobLsLsLsRsmmbLsLsmbLsLsmbLsbLsLsmbLg
bLsbLgbLsbLgRsbLsbLsbLsLsmbLsbLsRsbLgLsLsLsLsmmmbsbLgLsbLgLgbLibLgbLgL
sbLsbLsLsmbLsLsmbLibLsbLsbLsbLsLsmbLsbLsbLsLsmbLsLsmbLgbLsbLjbLibLsbLj
bLcbLgbLgbLsbLgbRsbLgbLibLsbRsLgbLsbLsLsLsmmbLsbLsbLgRsbLsbLsLgbLgLibR
sbLibLsbLsbLsLsmbLsbLsLsLsLsRsmmmbLsLsLsmmbLgLsbLgbLhbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRgbRgbRsbRsRsmbRsbRsRgbRgRgbRsbRibRgbRsRsmbRgbsbsbRgbRsRsRsmmbRgbRgbR
sbRsbRsbRgRsRsmmbRsRsRsmmbRgbRgbRsRsmbRgbRgbRgbRsbRsbRgRsRsmmbRgbRgbRg
bRsRibRsRsmbRsbRsbRgbRsbRsRsRsmmbLsbRsRsmbLsRsRsRsRsRgmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLsLsmbLgLsbLsbLsLsmbRsbLsbLibLgbsbLsbLsLeLsbLgbLsbRsLsbLgLsbLgbLsLgbL
sLsmbLgbLsLsmbsbLgLsbLsLsmbLsbLsLsLsLsmmmbRsRsmbRsRsmbLgbLsLsmbLsLgbLs
LsmbRsLsbRsbLgbLgLsLsmbLibsbRgbLsLsmbLiLsLsmbLgbLgbLgLsLsmbLgbLsLsLimb
LgbLsbLgbLsbLsRsLsbLsLsLsmmbLgLsbRsRsRsmmbLsLsmbRsbLgbLsbLsbLsbsbLsLsm
bLsRsLsbLsLsmbLsbLsLsmbLsLsLsLsLsmmmmbLsLsLsmmbLsbLsLsLsmmbLsLiLsLsmbL
sLgbLsbsbsbsbsbRsbsbsbLsbRsbRsbLsbsbsbRsbRsRsmbLsbLsbsbRsRsmbRsRsmbLsb
RsbRsbsbsbsbLsbLsbLsbsbsbLsbLsbLsbsbsbRsbLsbsbRsbRsbsbRsbLsbsbsbsbLsRs
bsbRsRsmbsbsbsbsbsbsbRsbRsbsbLsbsbRsLsLsmbLsbLsbLsbLsbLsLsmbsbLsbLsLsL
smmbLsbRjbLebLsbLsbsbRsbLsRsbLsRsRsLsmbsbLsbLsbsbLsLsRsmbLsbLsbLsLsmbs
bLsLsLsmmbRsLsLsmbLgLgbLgLsbLgLsbLiLsbLibLsbLibLsbLsLsLsmmbLibLsbLgbLg
bLebsbLsbLsbRsbLsLsmbLsLsLsLsLgmmmbLsbLsRsbLsbLibLibLiLsbLgbLgbLibLsLe
bLsbRobRhbRgbRgLsbRsRsLsmbRsRsRsmmbsbRsRsmbRsbRgRsmbsbRgRgbRsbRsRhbReb
LsLeLsLeLgbLsLsRsmbLibRsLsbLsbLsLsLsLsmmmbLgbLgbLgLsLsmbLibLebsbLgLsbL
sbLsbLsLsmbLsLsmbLgLsLgbLsbLiLsbLsLsmbLgbLgLsbLsbsbLsbLsLsmbLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bRsbRgbRgbRgbRgbRsbRsbRsbRsbRgbRibRgbRgbRebRsbRsbRibRgbRibRsbRgbLsbRsb
RsbRibRsbRsRgbLsbsbRgRsRsmmbRsbRsbRgRgbsbRsbRgbRgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bLhbRobLcbRgRsRgRsRsRsRsRsRsRsmmmmmmmmbLsbRsRsmbRsRsRsLsRsRsRsRsRsRsRs
RsRsRsRsmmmmmmmmmmmmbRgbLebRsbsbsbRsRsmbRsRsRsRsRsRsRsRsRsRsRsRsRsmmmm
mmmmmmmmbRibRcbLibLhbRebLsRsLsbsbsbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsRsRs
RsRsLsmmmmmmmmmmmbLsRsRsmbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLgLsLsmbLsbLibsbRjbRgbRcbLibRcbRgbRhbLhLsbLgbLgbLibLhbRebLibLiLsbLcbL
ibLiLsbLcbLgLsbRhbRgbRgbRgbRibRobLsbRcbRiRsmbLobLibRjRsmbLgLsLsmbRibLg
LsbLsbLgbLsbLgLsbLgbLebLcbLebLhLsbLobReRsRsRimmbRiLsbRebRgLsbRjbRhbRib
RsbRebRsRsRsRsmmmbRiRgRsmbRsRsRsmmbLsbLeLsbLibRcbRibLsbsbLjbLsbRsbLsLs
LsmmbLgLsLsmbLeLsbLgLsbLcbRsbRgbLgbLeLsbLsbLeLsbLiLsLibLgLsLsLsmmbLhLs
bLgbLebLgLsbLcbLebLcLsmbLibRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bRibRgbRgbRgbRsbRgbRgbRsbRgRgbRsRsRsmmbRsRsmbRgRsmbRgbRgbRsRsmbRgbRsbR
sbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRgbRsbRsRsmbLsbRsbRsbRsbLs
bRgbRsRsmbLsbRebsbRsLsbRibRibRsbRsRsmbRsbRsbRsRsmbRgRibRgRgbRibRhRgbRs
RsRgRsmmbRibRsRsRsRsmmmbRgRsmbRhbRsRsmbRsbRsbRsbRebRsbRgRsmbRsRsLsRimb
RgbRgbRsbRsbRgRibRibRgRsmbRgbRgbRsbRsRsmbRsbRsbRsbRsbRsbsbLsbRgbRgbRsb
RsbRsRsRgmbRgbRgRgbRgbRgRsmbLsbRsRsmbRsbRsRsmbRsbRgbRsRsRgmbRsbRsbRsbR
sRgbRsbRsbRsbRsbRsRsRsmmbRsRsRsRgmmbRgRsmbRsbRsRsRsRgmmbRsbRsbRsbRsbRs
bRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bLsbLsLibLsbLsbLsRsLsbLibLibLsbLgbLgbLgbLcbLgRsbLhbLsbLjbRgRsmbLsbLiLs
LsmbsbLsLsLsmmbRsbLibLsLsRsRsmmbLsbRgbLebLibLgRsbLsLsRsmbLsLsLsLgLsLim
mbLgbLgbLgbLgbLsLsLsmmbLgbLsLsmbLhbLgLsbLsLgbLsLsLsmmbRjbRjbRobRsRsLsm
bRgLsbRibRgbRsRsLsmbLsRsbRgbLsbRibRsRgRsRsmmbRgbRiRsRsmmbRsRsmbRgbRibR
sbRibLgLsbLibRibRsRsmbLgbLsLsLsmmbLsLsRsLsRsRsmmbLsbLsbLgbLgLsLsmbLsLs
mbLsLsmbLsLsmbLsLsmbRsLsbLgbRgRsmbLsRsbRgRsmbRibRsLsbRsRsmbRgRsRgRsRsR
smmmmbRsbRsRgbLsbRsRsRsRsRsRsLsmmmmmbRibRgbLsbLsbLsbLebLgbLsbLiRsbRsbR
sRsRsmmbRsbRgRsRsmmbRsbRsbRibRgRsRsRsRsmmmmbRgbRibLsRsbLsbLsbRsRsmbRsb
LsLsmbLibLsLsLsmmbLsLsLsmmbsbLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsLsLsLsLsLs
mmmmmmbLsLsmbLsLiLsLgbLgbRgbLibLgbLgbsbLsbLgbRsbsbLsbsbLsLsLsLsRsmmmbL
sLsLsLsLsLsmmmmmbLgLsbLgLsLsmbLsbLebRgRsRsmmbRsRgbLsbLsbLsLsLsLsmmmbLg
LgLgLsbLsbRsbRgbRgRsmbLcbLsbLsLsLsLsLsmmmmbLsLsmbLiLsLsmbLgLsLsLsLsLsm
mmmbLsLsLsLsmmmbRsbLgLsRsbLsbLsbLibLgLsbLgbLsbLsLsLsLsmmmbLsLsLsLsmmmb
LsLsLsLsmmmbLsbLsLsLsLsLsmmmmbLsLsLsmmbLsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRhbRsbRsbRgbRsbRsbLebLsLibLgbRsbLsLgbLsLgLsLsLsmmbsbLsbLsLgbLgbsbLibL
sbLsbLsbRsbLsbLsbLsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLsLsLsmmbsbLsLsLsLsmmmbLgLsbLsbLsbLsLgLiLgbLgbLgLsbLsLsmbRcRsmbRibRsb
RgbLgbLsLsLsLsLsLsLsmmmmmmbRsbLibLsLsLsmmbLsLsLsLsmmmbLibRsLgbRjRsmbRc
bRibLsbLcbLibRcbRibRgLsbLiLgbLsbLgLgbLsbLgLsLsmbLsLsLsmmbLgLgbLgbLsLsm
bLsLgbLsLsLsmmbLgLsLsmbLsLsmbLgLsLsmbLsbLsLsmbLsbLgLsbLsLsLsmmbLjLgbLs
bLgLgbLgLsLsLsLsmmmbLeLeLibLsbLsbLgbLibLgbLgbLsbLsbLgbLgLsLsmbRsLsLsLs
LsLsmmmmbLgLsbLgbLgbLsLsmbLsbLgbRsbLgbLsbLsbLgbLgbLgbRsbLgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLgRsbsbRsbRsRsmbRsRsRsRsRsRsmmmmmbRsbsbRsbLjbRibLcbLibRjbLhbLiLsLsLsL
sLsLsmmmmmbReRsmbRsRsmbRsRsRsRsRsLsLsRsmmmmmbLsLjbLibRebLiLsbLgbLsLsRs
LsLsLsmmmbLsLsLgmbLibLjRsbLibRjbRcbRcbRsRsRsmmbLcLsmbLcbLibRebRgLsbRcb
RhbRhbRcLsbRibRhbRgbLibLibLibLcbRiLsbLibLibLiLsbRjRgRsmbRibRiLsbRgbRgL
sRsbRsLsLsmbLhbLgbLiLsLsLgLsLsLsLsLsLsLsmmmmmmmbLsbLobRcRsmbRibLibLgbL
sLgbLsbLgLsbLibLhb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsRsRsmbLgLsbsbLsbsbLsLsmbLsbLsbLsRsbLsbLsLsmbLsRsbRsbLiLsbLgbLsbLsLs
LsmmbLsbLsbLsLsmbLsLsLsLgLsmmbLsLsLsLsmmmbLsbRsLsbLibLgLsbLsLsmbLgLsbL
sRsbRsRsmbLsLsmbLsLsLgLsLsLsmmmbLsLsLsLsmmmbLsLsmbLsLsmbRsLsLsmbLgbRsb
LsbLgRsRsmbLgbLsLsmbLsbLsbLgLsLsLsmmbLsbLsbsbLsbLsLsmbLsbLsLsLsmmbLsLs
LsmmbLsLsLsmmbLsbLsbLsRsLsbLsLsmbLsLsLsLsLsmmmmbsbLsbLsRsbLgbLsLsLsmmb
LsbLsLsmbLhLsbLgLsRsbLsRsLsbRsbLsLsLsmmbRsRsmbLsbLsLsLgmbLsbLsRsbRsLsL
smbLibRgRsmbLsbLgbLsLsmbLsLsLsmmbRjbLsLgbLsLsmbLgLsbLsLsmbLsLsmbRsbRsL
sLsmbLsLgLsbLsLsmbLsLsmbLsRsLsLsmbLsLsmbLsRsbLsbLsLsmbLsbLsbLsbLgLsbLs
LsLsmmbRiRsmbRebLgbLsLsRsmbLgbLgLsbLsLsLsLsLsmmmmbsbLgRsbRgbLiLsLsLsmm
bLgbRsbRibLgLsbLibLsLsLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRgRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsmb
RibRgRsRsRsRsmmmmbLsRsRsRsRsRsmmmmbRsRsmbRsRsRsmmbRsRsRsRsmmmbRsRsmbRi
bLibLjbRsbRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRgRsRsmmbRiRsRsRsmmmb
RgRgbLsbRsRsRsmmbRsRsRsRsRsRsRsmmmmmmbRgRsmbRsRsRsmmbRgbLibLcbLibRgbRs
bRgRsRsRsRsRsmmmmmbRsRsmbRebLgLsLgbRiRsRsmmbLsbRsbRgRsmbRsRsRsRsRsRsRs
RsmmmmmmmbRibsbLibLsbLsbLsLsLsmmbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbRsbsbsb
sbRiRgRsRsRsRsRsRsRsmmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bLsLsmbLsbLgbRsLsRsbLsRsbLsLsmbLgLsbLsbLsRsbLsLsmbLgLsbRsbLhLsLsLsLsLs
mmmmbLgLsLsLsLsmmmbLsLgLsLiLiLeRsbRebRgRsmbRgbsbRgbLgRsbRiRsmbRsLsbLsb
RiRsmbRgbRsbRgbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bLsLgLgLsLsLgLgLsLsLsLsLsLsLsmmmmmmmbRsbRsbRsRsRsRsRsRsmmmmmbRsRsRsRsR
sRsmmmmmbRgRsRgmbLsbRsRsRsmmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmm
mmmmmmbRsbRsRsRgRsRsRsmmmmbRsbRsRsRsmmbRsRsRsRsmmmbRsRgRsRsmmbRiRsRsmm
bRgbLsRsRsmbRgRsRgRgLsmbsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsmmbLsLsLsLs
LsmmmmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsmmmmmmmbRsLsLsLsLsLsLsmmmmmbLsbLsLs
LsmmbLgbLsLgLsLsmbLsLsLsLsmmmbLgLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsLsLsLs
LsLsLsmmmmmmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bRebLgLjbRibRcRsmbRcbRcbLebLcLsmbRcbLobLsLeLsbRibRgRsRsRsRsmmmmbRgbReb
LgbLgbRcRibRsRsmbRgbRibLsRsRebRgbRebRgRsRsmmbRebRgbLebRgbRibRsbLgbRobL
gLsbLsbRcRsmbRebLibRgbRgRgbLsbRgbRsbRgbRibsbsbsbRsRsRsmmbRsRsRsmmbRsRs
RsRgmmbRgRsmbLgbRiRsmbRgLsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRsbRobLgbLibLsbRsbLebLgbLgbLgbLsLsmbLebLgbLsLsmbLsLsmbLsbLsLgbLsLsLsL
gmmbLibLibLgbLebLgbLsbLsbLeLsbLcbRgbRiRsmbRsLsbRiRsmbLsRsRsmbRsRsRsRgm
mbRsRsRsRsRsRsRsmmmmmmbRgLsRsbRsbRsbRgbRibRsRsRsmmbRgRsmbRgbRsRsRsRsRs
RsLsmmmmmbRsbRgRsmbRsRsRsmmbRsRsRsRsRsmmmmbRsRsLsRsRsmmbRsbRsbRsRsmbRg
RsRsRgmmbRsbRsbRsRsRsmmbRsRsmbRsbRsbRsbRsRsmbRsbRsRsmbRgRsmbRsbRsRsRsR
sRsRsmmmmmbRsRsmbRsbRsbRsRsRsRsmmmbRgbRgbRsRsmbRsbRgRsRsmmbRsRsmbRsbLs
RsRsmbRsRsmbRsbRebLgLgbLsLsLsmmbRsbLsbLsLsLsLsLsLsLsLgmmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLsbLsLsLsmmbLebLebLsbLgRsbLgLsLsmbRsbLebRgRjbLsbLeRsLsbLiLsbLibLsLsLg
LsLgmbLgLsLsmbRsRsmbRsbsbLsLsLsLsmmmbLsbLsLsLsLsLsmmmmbLsLsLsLsLsLsRsm
mmmmbLgbLsLsLsLsLgmmmbRsLsLgLsbLsbLgLsLsLsmmbLsLsLgLsmbRsbLsLsLsLsLsLg
LsRsmmmmbRsLsbRsLsLsmbRsRsmbsbLsbRsLsLsLsLgLgmmbLsLsLsmmbRsbLibLsLsLsL
smmmbRsLsLgLsLsmbLsLgbLsLsLsLgLsRsmmbLsLsLsLgRsmmbLsbLsLiLsbLsLsmbLgLg
bLibLgbLgbLsbLsbLsLsmbLgbLsLsLsLsLsLsmmmmmbLiLgLsRsbLsLsmbLsLgbLsLsmbR
sLsLsmbLgLsLsLsmmbLgbLsbLgbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bRsbRgbRgbRsbRebRgRsRsRsmmmbRgRsRhRsmmbRgbRsbRgRsmbRgbLjbLhLsbLibLgbLi
bLibLgbLiLsbLibLgbLiRsLsbLibRsbsbsbsbRsbLsRsbRsbRsbRsbRgbsbsbLsRsbRsbL
sbsbRebLibLibRsbLoLeLsbLibLhLsbRobRhbRhRsRiRsmmbRiRsmbRgbRibRgRsRsRsmm
mbRsRibRgRsRgmbRsbLsbRgbRsbRsbLsbRsbRsbRsRsRgmbRgRsmbLcbReLsRsbRsbLsbL
cLgLsbLgLsLsmbLcLsRsmbLsbLiLsbLsbsbsbsbRsbLiLsLsLsLiLsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bLsbsbLsbRsLsbLsLsLgmbLgLsLsmbLsLsLsmmbLsLsmbRsbRsLsbLsLsmbLsLsLsLsmmm
bLsLsmbLsbLsLsLsLsLsmmmmbLgLsLsmbLgLsLsmbLgbRsLgLsbLsbLsbsbLsLsmbRsbsb
LsLsLsLsmmmbLsLsLsLsLsmmmmbLsLsLsLsmmmbLsLsmbLsbLsLsmbLsbLsbLsLsmbLgbL
sLgbLsLsmbLgLsbLibLgbLgbLgbLcbLebLibLibLeLsbsbLsbLgbsbsbLsLsmbLsLsLsmm
bLsLsLsLsmmmbLsLsLsLsmmmbsbLgbLsLsLsLsLsLsmmmmmbLsbLsLsmbRsbRsRsmbReRs
mbRibRgRsReRgmbRgRibRgbRgbRiRgbRgbRgRgRibRgbRgbRibRgbRgbRgbRsRiLsbRgbR
gRsmbRgRsmbRgbRgbRsbRsbRsRsRsRsRsRsRsRsRgmmmmmmmbRsRsRsRsmmmbRgbRgRsmb
RsRsmbRgbRsRsRsmmbRsRsmbRsRsmbRsbRsRsRsmmbRsLsRsRsmbRsRsRsmmbRsRsmbRsR
sRsmmbRsbRsbsbRsRsmbLsRsRsmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRiRsmbRgbRsR
sRsmmbRgRsmbRgRsmbRsbRsRsmbRsRsRsRsRsLsRsRsRsRsmmmmmmmbRsRsRsRsmmmbRsR
sRsRsRsRsmmmmmbRsRsmbRsRsRsRgRsmmmbReRsmbRibRibRgbLhbLcRsbLsbLgLibLibL
gbLibLgRsbRgbRibRsRsmbRibRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsRsmbRsRsRsRsR
sRsRsRsRsmmmmmmmmbRsRsRsRsRsRsRsRsLsRsRsmmmmmmmmbRgbRsbRsRsRsRsRsRsmmm
mmbRgRsRsmmbRgRsRsmmbRsbRsRgRsRsRsRsmmmmbRsRsRsmmbLsRsbRsRsRsRsRsmmmmb
RgRibRiRsmbRgRsRsRsmmmbRgbRebRsbRsRsRsRemmbLsRsbRgRsmbRsRsRsRsRsmmmmbR
sbRgRsRsLsmmbRsRsRsRsmmmbRsRsRsRsmmmbRgbRsRsRsRsRsRsmmmmmbRsbRsRsRsRsR
sRsmmmmmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bLsbLsbRsLsLsRsLsLgLsLsmmbsbRgRsRsmmbRibRgbLjbLibRgbRgRsRgmbRsRsRsRsmm
mbRsRsRsRsRsRsmmmmmbLgbRgbRgbRsbLhbLgbLgLsbLsRsbLgLsbLsLsLsLsLsLsLsLsL
smmmmmmmmbLibRgRsmbRsbReRsmbRgRsmbRsbRiRsmbRiRsRsRsRsRsLsLsmmmmmmbLhLs
bLibLibLhLgbLsLgLsbRsbRjRsmbRhbLsbRgRsRsmmbLsbLsRsRsRsRsRsmmmmbRgbLsbL
sLsLsLsmmmbLsLsLsRsmmbRjbsbLiLsLsLsLsLsLsmmmmmbLibLsLsLsLsRsmmmbLsLsmb
RsbRsLsRsLsbLgRgLsbLsbLebRjbLgLsbRsRsmbLsLsmbRsLsRsLsLsRsLsLsmmbRsRsmb
LsLsmbRsRsmbRsbLsLsmbRsRiRsRgmbLiLsbRsLsLsmbRgRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bLgbLebRgRsRsRsmmmbRebRcbRebRibLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bRsLsbRsbRgRgbLsbRiLsbLjLiLsbRebLgbRgbRiLsbRibRgLsbRcbLgbLsLgLgbsbLgbR
sbLgLsbLgbRcbRibRgbLjLsLsmmbRjbRibLjb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bLgLsLsLsLgLsLsLgmmmbLgbLgLsLsLsLsLsLgLsLsmmmmmbRsbLgLsLebLgbLsLsLsmmb
LeLgLsLsLgLsLsLsLgLsmmmbLhbRcbRhRsRsRsRgmmmbRgbRsRibLsRsRsRsRsRsRsRgmm
mmmbRgbLsRsRsmbRsRsRsRgRsRsRgRgReRsRgRsRsmmmmmmmbRiRgRsRgRgRsRsRsRgRsR
sRsRsRsRsmmmmmmmmmmbRgRgRsRsRiRsRsmmmmbRgbRiRgRgRsRgRgmbRgRsRsRsRgRhmm
mbRibRiRsRgRsmmbRibRgRsRsmmbRibRgbRsbRsbRibRgbRsbLjbLibLobLgbRsbLibRib
RgbRiRsmbLgbRgRsRgReRsRsRsRsRgRsmmmmmmbRgRgRgRsRsRsRhRsRgRimmmmbLgbRsb
LibRebRibRsRsRsRsmmmbRsbRsRsReRiRsRgRsRgRimmmbRgbRgLsbRgbRsbRgbRsRsReR
gRsRgRsmmmbRgbRiRsRiRsRgRsmmmbRgRsRsmmbRgRsRsRsRsRgRiRgRsRgmmmmmbRgRiR
smbRgRsRsLsRsRsRsRgmmmmbRgRsRsRsRgRsRsRsRsmmmmmmmbRgRsRgRsRimmbLsbRgbR
gbRgbRsRsmbRsRsRsRsRgRsRsRsRsRgmmmmmmmbLgRsRsRembRsbRgbRgRsmbRiRsRsRsR
smmmmbRgRsRsRsRgRsRsRgRsRsRsRsRsRsRsRsRsRgmmmmmmmmmmmmmmbRiRsmbRgRsmbs
bRsRsRsRgRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRgRsRsRiRiRgRsRgmmmbRgRsRgRsmmb
RgbRiRsRgRsRsRsRgRsmmmmmbRgRgRsReRsmmbsbsbRgRsRsRiRsRgmmmbRgRsmbLebLib
LibLsRsbLgLsbLsLsLsLgLsLsLgLsmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 140840; End: 141340;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
bRgbRgRibRgRsmbRgbLsbRgbRsbRgbRgbRgbRgRgbRsbRgbRibRgbRgbRgbRgbRsbRgbRg
bLsbRsbRgbRibLsbRebRsbRgbRsbRgbRibRsLsbLsbRsbRsbRgbRgbRgbRsbRsbRsbRsbR
sbRgbRsbRgbLsbRsbRsbRsbsbsbRgRsRgmbRgbRsbRsbRebRgbRibRgbRibRsbRgbRgbLs
bRgbRgbRgbRgbRsbRgbRsbRsbLsbRsbRgbRsbRgbRsbRgbRgbRsbRgbRgbRgbRsbRsbRsb
RsbLsbRsbLsbRsbRsbRsbLibLebRebRebRobLebRib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bRsRsmbRsRsRsmmbRsRsmbRsRsRsmmbRsRsmbRsRsmbRsRsRsRsRsRsRsmmmmmmbLsLsmb
RsbRsRsmbLsbLsbRsRsRsRsRsRsRsmmmmmmbRsLsRsRsmbRsRsmbLsRsRsmbRsRsRsRsmm
mbRsbRsRsRsmmbLsRsRsRsRsmmmbRsRsLsRsmbRsbLsbsbRsRsRsmmbRsRsmbRsRsRsmmb
RsRsRsRsmmmbRsRsRsmmbRgRsRsRsRsmmmmbRsRsmbRsRsRsmmbRsRsRsRsmmmbRibRsRs
RsRsRsRsRsmmmmmmbRsbRsRsRsmmbRsbRsRsmbLsRsRgbRsRsmbLsRsRsmbRsRsRsRsRsR
smmmmmbRsRsRsRsmmmbRsRsmbRsRsRsRsRsRsRsRsRsmmmmmmmmbLsbLsRsRsmbRsbRsRs
RsRsRsmmmmbRgRsRsmmbRsLsbRsRgRsRsmmbRsRsRsRsRsmmmmbRgbRsRsRsRsRsRsRsmm
mmmmbRsRsRsRsRsmmmmbRsLsRsRsmbRsRgRsRsLsRsmmbRgRsRsRsmmmbRsbLsLsmbLsRs
RsRsRsRsRsmmmmmbLsRsbRsRsRsRsmmmbLsbRsbRsRsmbRgRsRsmmbRsRsmbLgLsbRsbRs
RsRsRsLsmmmbRsRsmbsbRsRsLsRsRsRsRsmmmmbRsRsmbRsRsRsmmbRsRsRsRgReRsmmmb
RcbRjbRgbRsbRsRsmbRgRiRsmbsbRsbLsRsRsRsmmbRsRsmbRsRsRsLsRsRsRsRsRsmmmm
mmbRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsmmbRgRsRsRsRsRgRsmmmmmbRgRsmbRsRsRsRs
RsRsRsmmmmmmbRgRgRgRsmbRsLsRsbRsRsRsmmbLsLsRsRsmmbRgbLsRsbRsRsmbRsbRsb
LsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRsRgRsRsmmbRsRsRsRsRsRsRsRsRsRsR
smmmmmmmmmmbLsRsRsRgmbRsRsLsmbRsRsmbRsRsRsRsmmmbRsRsRgLsmbRiRsRsmmbReR
gRsmbRibReRgRsmbRgRsRgmbRibRibRgbRgbRibRebRebRsbRgbRsbRgbRgbsbRsRsmbRs
LsbRsbLsRsbRsbRsbRiRsRsRsRsmmmmbReRsRsRimmbRibRebRebRgbRebRgbReRsmbRgb
RoRsmbRibRibRsbsbLsbRsbRsbRsRsRsmmbRsbRsRgRsRsRsRsRhmmmmbRhbRgRgRsmbRe
bRhRgbRgRsRsmmbRibRsbRgRsmbRibRebRibRibRibRsbRsRibRibLsRgbRgbRebRibLgb
LgbRebRsRsmbLgbRebRgbRsbRebLsbRebRgbRsRsRsRsRsmmmmbRgRsRgmbRebRgbRgbRe
RgbRsRsmbLsRibRibRebRebRibReb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bLhRsbLebLeLsbLeLsbsbLeRsbLeLsbLebRsLeLsbLsLsLgLsLsmmbRsLeLsLsmbLeLebR
sLgLebLebLgLiLgLsLsLsmmbLeLsLsmbLebLsLsLsLsLsmmmmbLsRsLiLebLgbLsLsmbLs
LsLembLsLiLibLeLsbLsLgLiLsLsmbLhLsLebLsbLsLgLgLebLebLebLebsbLsLeLsbRsL
eLsLsmbsbsbLiLsbLsLibLsLeLsbLebLebLeLsbLeLsbLeLsbLeLsbLsLebLhLsbLebRgL
sLeLsLsmbLeLsbLhLsLsmbLeLsbLgLsLsmbLsLibLeLsbLebLsbLeLsbLebLeLsbLeLebL
gLgbLeLsbLsLeLsbLsLeLsbLeLsLsmbLebLeLgLsbLhLsLsLsLemmbLebLeLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLiLsLsLgLsLsLsLgLsLgLsmmmbLgLgLsLsmbLgLsLsLsLsLsmmmmbLiLgLsLsLgLgLsLg
LsLsmmbLgLsLsmbLsLsLgLsLiLsLgmbLiLsLsLsmmbLsLsLsLsLgLsLgLsmmmbLgLsLsLg
LsLsLsLsLsLsLsLsLsmmmmmmmmmbRsLgbLsbLiLsLgLgLgLsLgLsLsLiLsLsmmbLiLsLsL
sLsLgLiLsLsLgLsLsmmmmmbLgLsLgLsLiLsLgLgLgbLgLsLiLsbLgLsLsLsLsLsLsLsmmm
mmmbLsLsLsLsLsLsLsmmmmmmbLiLsbLsLsLgLsLsLsLsmmmmbLsLsLgLsLsLsLgLsLsLsL
sLsmmmmmmmbsbLsLsLsLgLsLgLsLsmmmbLiLgLgLsLsLsLiLgmmbLsbRsLsLgLgLgLgLsL
smbLgLsLgLgLsLsLsLsLsLsLgLsmmmmmbLgbLsLgLsLsLsmmbLgLgLsLgLsLgLsLsLsmmb
LiLsLgLsLsLsLgLgLgLsLsLiLsLsRsLgLsLsLsLsLgLsmmmmmmmbRsLsbLsbReRgRgRsRg
mbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRgRsRsmmbRsbRsRsmbRsbLsbsbsbsbLsRsbRsbRsbLsRsbsbRgbRgbRgRsRsmmb
RsRgbRgbRsRsmbsbRsRsRsmmbsbRsRsmbRsbRsRsRsmmbLsRsbRgRsRsmmbRsbRgRsRsmm
bRgbRsRsRsmmbRsbRsRsRsmmbRgbRsRsRsRsRsmmmmbRgRsmbRgbRsbRgbRsbRsbRsRsmb
LsRsRsmbRgRsmbRsRsmbRsbLsRsbRgRsmbRsRsmbRsRsRsRsmmmbRsbRsbRsRsmbRsRsRs
mmbRsbRsbRsbRsRsmbRsbRsRsmbRsbRgbRgbRsRsmbRsRsmbsbRsbRsbRsRsmbRsRsmbRs
LsbLsRsbsbRgbRsRsRsmmbLsbRsbsbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsbRsRsmbR
sbRgbRsRsmbLsbRsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bLsLsLsLsmmmbRsbLsLsmbsbsbRsLsbLgLsbsbLsbLsbLgLsLsmbRsLsLsLsmmbLgbLsLs
LsmmbLgLsbLgbRsLgLsbLsbRsbLiLsbRsbLsbLsbsbLgLsbLgLsbLsLsLsmmbLsbLgbLsb
LgbRsbsbLgbRsbLsbLgLsbLgLsbsbsbLsbLgbLsLsLsmmbLsbLgLsbLsbLgLsLsLsLsRsm
mmbLsbLsbLgbLgbLgbLgbLsLsmbLsbLgbLsLsmbLsbLsLsmbLsbLgLsbLsbLgLsbLsLgLs
RsbLibLgbLgLsLsmbLgLsbRsbLgLsbLsLsmbLsLsmbLsbLgbLsLsmbLibLgLsLgbRgbLsb
LgLsbLgbLgLsbRsbLsLsLsmmbLsbLsLsmbLgbLgbLsbRsRsmbLgbLsbLsbLsbLsbLsbLgL
sbLgbLiLsbLsLsLsmmbLsLgLsbLsbsbLgbLgbLsbLsbLgbLsbLgbLsbLgLsLsLsLgmmbRs
bLeLgbsbLsbLgLgbLhbsbLibLibLgbLsbLsbLgbLsbLsbLgbLsLsLsmmbLsbLebLsbLgbR
gbLsbRsbLgbLgbLgLsbLgLgbLgbLgbLsbLgbLsbLgbLibRsbRgbRgbRsbRsbRsbRsbsbRs
bLsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bReLsbsbsbsbReRsmbRebRebRebRgbReRiRsmbLebLsbLsbRebRiReRsmbRebRibRibReb
RebRebRhRebReRsmbRebReReLsbRebRebReLsbReRsmbReRsmbRebRgbRibRebRebRebRs
RsReLsRsmbRsbRebRebRibRebReRsmbRiRsmbRebRebRebsbReRebRiRibRhbRebRibReb
ReRsmbReRsRsmmbReRsmbReRsmbRebReRebRebRgRebRebRiRsmbRebRibReRsmbReRgRs
mbRebRibRgbRgbRsbRgRsRsRsRgRemmmbRiRsmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bRgbLibLsRsbLsbLsbRsRsRsRsRsRgmmmmbRsRibRsbRsRsmbRgbRcbRsbRgRsmbRsbRgb
RgbRgbRsRsmbRgbRsbRsRsmbRibRsRsRsLsmmbRsbRsbRsRsLsRsRsmmbRibLibRsbRgbR
sbRgRsmbRibRgRsmbRsbRgbRsbRsbRsRsmbRsbRgbRibRsbRibRsbLsbRgbRsbRsbRsbRg
bRgbLsbRgbRgbRsbRgbLsbRgbRgbRgbRgbRsbLjbLcbLibLsbLsbLgbLsbLsbLgbLgbLsb
LsbLsRsbLgbLgbLsbLsbLsbLgbLibsbsbLgbLgbLgbLsbLsbLgbLsbLgbLgbLsbLibLgLs
bLsbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bLsbLgbLsLsmbLsLsLsLsmmmbsbLsbsbRsRsmbLsLsLsmmbLsLsRsmbLsbLgLsbLsbLsLs
RsLsLsmmbLsLsLsLsLsmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRgbRgbRibRgRsRgRsRsRsmmmmbRsRsRsRgLsmmbRgbRibsbRgRsmbRgRsmbRsRsRsmmbL
jbRcRsRsRsmmmbLsbLjbLiLsbRsbRibRsbsbReRsRsmmbRiRsRsRgmmbRgRsmbLsRsRsRs
RsRsRsRsRsRsRsRsRsmmmmmmmmmmmbLsRsbRsRiRsmbRibRibRgRsRsRsmmmbRgbRhRgbR
gRgbRsRsRsmmbRgRsRgmbRgRsmbRsbRgRsmbLiLgLsbLgbRibRsRsmbsbRsRsmbRsRgRsR
imbRsbRgRsRsRsRsmmmmbRsbsbRgRsRsRsmmmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLsLsmbLsbLsbLgbLiRsbLgbRibLiRsbLgbLgbLgLsbLcRsbLsbsbsbLsbsbLsbsbLsRsb
RsbLsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bLsLsLsmmbLsLsLsLsLsLsLsmmmmmmbsbLsLsLsLsmmmbRsLsbLgLsbLgLsbLgbLgbLcbL
gbLsLsmbLsLsmbLsLsLsLsLsLsmmmmmbLsbLsLsmbRsbLsLsLsLsmmmbRsLsbRiRsRsmmb
RsRsRgLsmbRsRsmbRsRsRsRsRsRsmmmmmbsbRgRsmbRgbRsbRgRsmbRgRsRsmmbLsRsRsR
sRsRsmmmmbRgbRgRsmbRgRsRsmmbRgbRsRsmbRgRsmbRsRsmbRsRsmbRgRsmbRsRsRsRsR
smmmmbLsRsRsRsmmbRhbLebRsbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbRsbLsLsLsmmbRs
LsLsLsLsLsLsLsLsmmmmmmmbLsbRsLsLsmbLgbLsLgbRsLsLsLsmmbLsLsLsLsmmmbLsLs
LsLsLsLsmmmmmbLsbLgLsbLsRsRsmbsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bsbRgbLcbRcbRebLjbLsbLjbRcbLcbLsLsLgLsmbLgLsLsLsmmbRcRgbRsRsRsRsRsRsRs
RsRsRsmmmmmmmmmbRsLsLsmbRsRsRimbRcbsbRsRsmbRsRsRgmbRgbLsRibRsRsmbLsbRs
RsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmbRsRgRsRsRsmmmbRcbReRgbLjbRh
RgbRgbLgLsLsmbLibRcbLjbLcbsbLsLsLsLsLsLsmmmmmbLgbLgLsbLsLsLsLsLsLsLsLs
mmmmmmmbLgLsbLsRsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmbLiLsbLcL
smbLibLib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bRsRgbRgbLhbRsRcRsmbLgbRgRsRsRsmmmbRgRsRgmbRebRebLjbLibLgbLibLibLibLeL
sbRcbRgbRibLcbLebLgRsbLgLsbLibLebLibLgLsLsmbLgbLobLibLsRsbLgbRsbLsbLsL
smbLsRsbLsbLgbLibLgbLsbLgbLgLsbLsbLgbLsbLgLsbLsbLibRgbsbLgbLgLsbLibRgb
RebsbsbsbLibRgLsbRibLcbRgbRgbRebRcbLgbLsbLeLsbRhbLgbsbLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsLsmmmbRhbRsRsRsmmbLsLsRsRsmmbLiLsLsLsLsLsLsLsLsRsLsLsLsLsLsmmmm
mmmmmmmbRgbRebRiRsmbLsbRsRsmbRsbLsRsRsmbRsRsRsRsRsRgmmmmbRsRsmbRsbRgRs
RsRsRsRsRgmmmmmbRsbLsRsRsRsRsRgRsRsRsRsRsRsRsRsRsRgmmmmmmmmmmmmbRsRsRs
RsRsRsRsmmmmmmbRsRsmbRiRgRsmbLsbLgLgLsLsLsLsLsLgLsLsLsLgLsLsLgmmmmmmmb
LgLsRsbLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsLsmmmbLgLsLsLsLsLsLgLsLsLsmmmmmmb
LsLgbLiLsbRsLsbLgbLsLsLsLsLsmmmmbLgLsLsLsLsLsLsmmmmmbLsbRsLsLsLsLgLsLs
mmmbsbsbLsRsLsbLsbRsbLsRsbsbRsRsmbsbLsbsbLsLsmbLsbLsbRsbsbsbRsbRsbRsbs
b

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bLsRsbRsRsmbRibRiRsmbRgRsmbRibRsRsRsmmbRibRiLsbRhbRgRiRsmbRgRsmbRgRgLs
RsbReLsbRebRiRsRsmmbRgbRiRsRembRsLsbRsRhRsRhmbRiRsRgmbRgbRibRgRsmbRgbR
gRsRsmmbRiRibLsbRhbRgbRsbRiRsmbRsRibRhb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bsbLgLsLsmbLsLsLsLsLsLsLsLsLsLsLgLgLgLsLsmmmmmmmmmmbRsRsmbLhLsLsLsmmbL
cbLcbLcLsmbLgbLebLgLebLebLgLsbLsLsLiLgLgLgLembLhbLiLgbLebLobsbLsbLgbRc
bReRiRsmbLjbLcbLibLibLgLsbLsbLgLsLgLsLsRsmbRiRsmbLhbLhLsbRsRsRsmmbLsbL
sLsmbLsbLsbLsbRsLsbRsRsRsRsRsRsRsRsRsRsRsRsRsRgRsRsmmmmmmmmmmmmmmbRiRs
mbsbLibRsbLobsbsbLgLiLsLsmbLibLgbLgLsLgbLgbLibLgbRsRsmbsbLsLiLgLsLsLsm
mbLgLsLsmbsbRsbLsbLgbLiLsLgLsLsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bLsLsmbLgbLebLeLsbLibLiLsbLgbLebsbLibLcbLgLsbLebLgbLebLibRsbLibLgbRsLs
bRsRsmbsbLsLsLsLsmmmbsbLsbsbRsbLsbLgbLgbsbLgbLsbLeRsbLebRjbLebLibLibLi
bLsbLsbLibLsLgbLhbLibLgbLibLebLibLibRsbLgLsbsbLsbLsRsbsbLsbLsbLsbLsbsb
LsbLsbLgLsbLsLsmbLsbLsbLsRsbLsLsLsmmbLsLsmbLsbLsLsmbLsLsLsmmbLsbLgLsRs
bLsbRsLsRsbRsRsLgmbLgbLsbLsbsbLsRsbRsbLsbRsbRsbLsbsbsbLsbsbLsbsbsbRsbL
sbLsbRsbsbLsbsbLsbsbLsbsbLsbsbLsLsmbsbsbsbsbLsbLsbLsbRsbRsLsRsLsRsbRjR
smbLsLsmbsbRsbsbsbRsLsbLsLsmbRsRsLsmbLsbLsLsmbLsbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bLsbRsRsRgmbsbsbsbRgRsmbRsbRsLsRsbRsRsLsmbsbLsLsRsmbLgLsbLsLsLsmmbRsRs
RsRgRgRsmmmbLcbLhbsbLibLcbLcbRibRobRgbLibRsRsmbRjbRcbRhbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bLcLsmbLiLsbLiLsbRhbLgbLiLsbLhbLibLjbLiLsLsmbLibLebLeLsbLhbLcbRcRsmbRi
RsmbLcbLebLgbRhbLibLsbRjbLibLebLeLsbLibLgbRsbReRsmbRsLsbRiRsmbLhbRibRc
bLgbRgRsmbRjbRebLcbLhbLiLebLebRebRgbRsRjLsbLgLsLsmbLgLsbRgbLgLsbsbLgbR
gbLgbsbRgbRgRebRibRcRsmbRibLibLiLsbLgRsbLebLeLsLsmbLibLgbsbRcbRgbRgRhb
RgbRcRsmbRcRsmbRgbLgLsLsLgLsmbsbRjbsbsbRsbRsRsmbLsRsbRsLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bLibRsbsbRsbLcbsbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsmmmmmbRsRsRsRsRsRsRs
RsRsmmmmmmmmbRsRsRsmmbRsRgRsmbRibRibRibRibRgbRgbRiRsmbRgbRsRsRsmmbRibL
cbLebLibLibRjbLgLsbLsLgLsbLsLsLsLsmmmbLsbLsbLsRsbLibLcbLeRsbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bRibsbsbsbRobLsbRgRgRsmbRcbLsLcbLebRcbLgbRiRibRebRcbLsbLsbRebLcbLsLsmb
LebLsbLgbLebRiRgRsmbLjRgbRiRsmbRiRsmbRibLjbLobLebLsbRibRsbRgbRibRsbRsb
RsbRgbRsbRsbRgbLsRsbRebLebLgbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
bLgLsLgLsbLsbLsbLgbRsbLcbLgbLsbRhbLgbLgLsbsbLgbLebLsLibLgbRsbLsLgbsbsb
LsbLsLsLsLsmmmbsbLsLsLsLsRsLsmmmbLsLebLebLgbLgbRgbRgbLsRsRsmbLsLsLsmmb
LebLsbLsbLsbLgbRgbLcbRhbLsLsLsmmbLgbLsRsRsRsmmbLsbLgLsLgbLsbLsbLsbRsbL
sLsRsmbRsbLsbRsbLebLgLgbRsLsbRsbRsbRsRsmbRsbLjbLgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
bLsbsbsbLgbLsbLgLhbLsbLgbLsbLibLsLsLsmmbLsLgLsbLsLsLiLsmbLgbLsbLgLsbLs
bRsLhbLsLsmbLsbLiLsRsbLgbLebRibLhbLhbLibLibRgbRebLjbRobReLsbLgbReRobLi
bLcbRhbRsbRsbRsbRsbRsbRgbRsbRgRgbRgbRsbLsbLsbRibRgRsmbRsbRsbLebRsbRjbL
sbsbRsbRsbLsbLsbLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bLsRgRsmbRsRsRsRsmmmbRhRsRsRsmmmbRgbRsbRgRsRsmmbRsbRgRsmbRiRsmbRgRsRsm
mbRsRgbRsRsmbRgRsmbRsRgbRsRsRsRsmmmbRsRsmbRibRiRsmbRiRsRsRsmmmbRsRsmbR
gbRsRsRsmmbRsRgbRsRsmbRgbLsRsRsRsRsRsRsRsRsmmmmmmmbRgbRsbRgRiRsmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLgLgLsbLsbLgRsbLibLgLsbLgLsbLsLsmbRsbLgbLsbLsbLsLsmbLsbLsbLsbLsRsRsmb
RsbLsbLsLsmbLsLsmbRsLsLsmbLgbLgbLebRsbLgbLsbLsbLgLsbLgLsbLsLgbLgLsLgLs
bLgLeLgLsbRsbLsbLsbLsbLsLsLsLsmmmbLsRsLsLsmbLiLibLgbLiLsbLsbLebLebLebR
sLsbsbLsLsRsLsmbRsRsLsLsLsmmmbLsbLgbLsLgRsbLsLsmbsbLsLsmbLsLsmbLgbLibL
gLeLsLibLgbLgbLgLiLsbRcLsbRibRiRsmbRhbRibRibLsLibLibLhbLgLsbLgbLhbRibR
sbLibLiLsbRibLgbLibLgbRsbRsLsbsbsbLiLibLgLsbLgbLgbLsRsLsbRjbRibRgLsbRs
RgLsbLjLgbRcLsbLibLgbLgbsbsbLsbLsbLgbLgLgbLsLgbLiLibLgbLgbLsLsmbLgLsLs
LsLsRsmmmbLsbLgbLsLsLgmbLsLsmbLiLgLgLsbLsLsLsLgLgLsmmbLgbLsbLsLsmbLgbL
gLgbLgLsLsmbLgLsbLgLsLsLgmbLsbRsLsbLgbRsbLsbLsbLsbLsbLsLsLsmmbLgLsLgbL
gbLgbLgbLgLsbLgbLsLsmbLsLsmbLibLgRsLsbLsbLiLsLibLsLsmbLsbLsbLsLgbLgLsb
LsLsLsLsmmmbLgLibLibLsbLgLhLgbLgbLgbLgbLiLgbLsbLgbLsbLsLgbLsLsLsLsRsmm
mbLsLiRsbLsbLsbLibLsbLgLsLsLiLimbRsLsbLgbLibLsbRsLsLsLsmmbLgLsRsbLgLeL
sbLgLsbRsbLebLgbLgbLgLgLsbLgbLsbLgLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
bsbRsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bsbLsbsbsbsbsbsbsbsbRibRsbLhbRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bRsbRiReLgbRjbRibRgbRgbRgbRibRsbRiRsmbsbRsRsmbsbRibRgRgRgbRsLsbRgbRibR
sRsmbRsbLsLsmbRibRgRsRsmmbRgLsbRgbRiRsRhRsmmbReRgbRsbRiRsmbRgRsmbRebLi
bLcbLibLgLsbLgbLhLsbLsLgLsbLibRcbLebLeLibLebLsbLibLsbLobRebRgbRgbLebLg
LsbLgRsbRjbRibRgbRibRsRsmbRsRsRsmmbRebRsbLeLgbLibLgLsLsmbRibLeLgLsLsLs
LsLsmmmmbLsLsLsLgmmbLgbLiLiLsLeLsbLibLiLgLsLgLsbLeLsLebLgbRcbLsLjbRibL
cbLeLsLsmbLgbLgLhbLsbLeLsbsbLsbLsLgLsLsLsLgmmbLgLsbRebLeLsLsmbRcbRgRsR
sRsRsmmmmbRsbLjbLsbLgLgbLgbLebLgLsLsmbLsLsmbLsLsLsmmbLsLsLsLsLsmmmmbRs
bLgLsbRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbRsbRsRsmbRgbRsbRsRsLsmbRsbRsRsmbRsbRgbRsbRsRsmbRsbRsbRsbRsbRsbR
sRsmbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbLsbRsbsbRsbRsRsmbRsbRsbRsb
RgbRsbLsRsbRsbRsbRsbRsbRsbRsbRsbLsbRsbRsbRsbRsRsmbLsbRsbRsbLsbRsbRsbRs
bRsbRsbRsbRsbRsRsmbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bLibLsRsRsmbRsRsmbsbLgbLsbLsLsLsLsLsmmmmbLsLsLsRsmmbLgRsbLgbLsLsmbLsbL
sLsLsLsLsLsLsLsLsmmmmmmmmbLsLsmbLgbLibRsRsRsmmbRsbLiLsbLgbLsLsmbLsRsLs
LsmbLsbLsbLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsLsLsmmmbLsLsmbLgLsLsLsRsLsLsL
gLsmmmbLsLgbRsLsLsmbLsLsLsLsLgRsmmmbLibLgLsbRgbRsbRsbRsRgbRsRsRsmmbRsR
smbRsbRsRsmbRsRgRsRsmmbRsbRgbRsbRsbLsbsbRgLsRsbRsRsRsmmbLsLsRsRsRsmmmb
LobLgbRsRsRsmmbRsRsRsRsmmmbRsRsRsRgmmbRgbRsbRsLsbRsRsRsRsmmmbRibRgbRsR
smbsbRsbRsRsmbRgRsmbLsRgRsRsRgmmbRsRsLsmbRsbRgbLsLsRsmbRsRgRsLsRsmbRsb
RsbRgbRsRsmbRsRsRsRsmmmbRgbRgRiRsmbRgRgRsRsmmbReLsbRgRgbRgbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bLsbLsbLgbLsbLsbLsbLgbLgbsbLsbLgbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bLsbLsLgLsbLgbLgLsLsmbLgbRsbLibLgbLgLsbLgbLgbLsbLgbRgbLcbLcbLgRsLsbLsb
LcLgbLibRsbRibRebRgbRhbRgbRibRsbRgbLsbRsbsbRgbLsLsLgLsmbLgbLibLgLsbLgb
sbLsbLsLsmbsbLgbLgbLgLsbLsbLgLsbLebLeLgLsbLcbRibRgbRsbRsbRsbRgbRgbRsbL
sbRgbLgbLebLsbLsbLiLsbRgbLgbRsbLgbLgbLsbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bLsRsbLsbLgLsbLibRgRibLiRsLsLsmbReRsmbLjbLjbLjbLgRsLsbLgbRsLsLsLsLsmmm
bRsbLgLsLsLsLsLsmmmmbLgbRsbLibLgLsLsLsLsmmmbLsbLgLsLsmbRgbRsLsRsbRibLi
bLgbLsbRsbLsLsLsLsLgLsLsLsLsmmmmmmbLgbLibsbsbRiRsLsmbRgbLjbLgLsbLsbLsL
sLsmmbLsLsLsmmbLsLsLsLsLsLsLsLgLsmmmmmmbLgLsLsmbRsRsLsLsmmbLsLsLsLsLsL
smmmmmbLsbRjbLsbRjRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLgbLsbsbLsbLsLsmbLsbLsLsmbLsbLgbLsLsmbLsLsmbLsbsbLsLsmbLgbLgbLsbRsbRi
bLibLgbLsbLsRsLsLsmbLsbLsbsbsbsbsbLsbLsRsbLsLsLsmmbLsbLsLsmbLsbLgLsLsL
smmbLsLsmbLsbRsbLsRsRsmbLsbLsbLsbLsLsmbLsbsbLsLsLsLsmmmbLsLsmbLsRsbRsb
sbsbLsLsmbLsLsLsmmbLsLsLsmmbLsLsLsLsLsmmmmbLsbLsbLsLsmbsbLsbLsLsmbLsbL
sLsmbsbLsbLsbsbLsbLgLsbRsbLsLsmbLsbLsbLgLsbLgLsLsmbLsLsLsLsmmmbLsLsmbL
sLsLsLsLsmmmmbLsLsLsmmbLsLsLgmbLsLsmbsbLgbLsbLsbsbLsbRgbRcbRoRsmbLjLsL
smmbLiLsbLgbRgbRibRgbLiLsLsmbLgRsbLsbRsLsbLsbLsLsmbLsLsmbsbLsLsLsmmbLs
bsbLsbLgLsbLsbLgLgLsbRibLsbLsLsmbLsbLsbLsbLgbLsbLgbLgRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bRgbRsRsRsRsmmmbRgbLibRsbLsbLsbRgbRiRgRsRsRsRsRsRsRsmmmmmmmbLsbRsbRgRs
mbLiLgLsLsLgLsmbRsbLsLsLsLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmmmbLsLsmbLsbL
sLsLsLsRsLsLsmmmmbsbLiLsLsLsmmbLgbsbLibLsLsmbRgbLsbRgbLgLgLsLsmbRsRsmb
LsLsmbLiLsLsmbRsbLsLsLsmmbLibLsRsbLgLgLsbRsLsLsmbRsbLibRgLsbLibLsLgbLs
bLgbLsbLsLsmbLsLsLsLsmmmbLsbRsbLsbsbLgLgLsLsLgLsLsmmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bRgRgRsmbRsbRsbLsRsbRsRibRebLsbLsRsbsbLgbsbLsbLsbLsbsbRsLsLsmbLebRsbLc
bLibLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bLsLsLsLsLsLsLsmmmmmmbLsLsmbLsbLsLsmbLsLsLsLsmmmbLsbsbLgbLsbLsbLsLsLsL
sLsmmmmbLsLsLsmmbLsbLgLsLsLsmmbLsLsLsLsLsLsLsLsmmmmmmmbsbsbRiRsmbRsRsm
bRsbRsRsmbRsRgRsRsRsRsRsRgmmmmmbRsbRsbRsbRsRgRsRsmmbRsRsRsRsmmmbRsRsRs
mmbRsRsmbRsbRsRsmbRsRsRgmbRsRgRsRsRsmmmbRsbLsRsbLsbRsRsRsRsRgRsmmmmbRs
RsRsRsmmmbRsRsRgmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bRobRsbRsRsmbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRsLsLsmbLgLsLgbLsLsLsLsLsLsLgmmmmmbLsLsLsmmbRsbLgLsbRsbLgRsbRsLsbLsLs
LimbLgbLibLsLsLsmmbLsLsmbLsbLsbLgLsLsLgmbLsLsLsLsmmmbLsbLsLsmbLsRsLsbR
sbLsLgbLgLsbLgLsLsmbLgLsbLibLibLgbLsLgbLibLgbLiLsbLgbLgbsbLgbLgbLebLgL
sbLgbLgbLibLgbLgbLgbLiLsbLgbLsLsmbLgLsbLgbLgLsLsLsLgmmbLsLsRsmbLsLsLsL
smmmbLsRsbLsLsmbLgbLsbLibLsLsmbLsbLgLsbRsLsLsLsLgmmbLsLsmbLsbLsLsmbLsL
ibLibRsbLiLsLsLgmbLsLsLsLsLsmmmmbLsLgbLsLsLsmmbLsLsmbLsbRsLsLsmbRsLsLg
bLgLsLsLsLsLsLsLsmmmmmmbLsbLibLgLsbLgLgbLgRsbLibLgLsLsmbLgbsbLgbRsbLsL
sLsLsLsLsmmmmmbLsLsmbLsLsmbLsLgLgLsbLgbRsLsLsLgLgmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bLsbLgbLgbsbLsbLsLsmbLgbLgbLgbLibLgbLgbLgbRsLsbLibLsbLgLsLgbLsbLgbLsbL
sLsmbLgbLsbLsbLsLsmbLsLsmbLsbLsbLsLgbLgbLsbLgbLsbLgLsLsmbLgbLibLgbLgLs
bLgbLibLibLgbLiLsbLgbLgLgbLiLgRsbLgbLibLgbLibLibLebLgbLebLebLgbLgbLgLs
bLgbLsLsmbLgbLsbLibLsbLibLsbLeLsbLgbLgbLgbLgbLibLibLibLibLhbLgbLgbLibL
sbLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbLsbLsbLgbLsLsmbLgbLgbLibLgbLgbLi
bLsLsmbLibLibRsbLsLsmbLsbLgbLgbLcbRsbRjbRgbLsbRsbLgbLibLgbLebLgbLgbLsb
LibLebLgbLsbLsbLgbLibLgbLsbRsbLsbLsbLgbLibLibLsbLgbLgbLgbLsbLsbRsbLebL
sbLibLgbLebLgbLgbLsbLsbRsbLgbLgbLgbLgbLgbLgbRsbRsbLsbLgLsbLsbLgbLgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bRsRsmbLsLsmbLgLgLiLsLibLeLebRsLsLgLsLsLsLsLsmmmmbLsbLgbLsbsbsbLgbsbRs
bRsbRsbRsbLsLsmbRsLsbRsbRsLsLsLsRsmmbRsbLsbLsbRsbLgbLsbRsbsbsbRsLsbLsL
sLsLsLsLsmmmmmbLsLsmbRsRsmbRsbRsbRsRsmbRsRsLsmbLsbRsbLsbLsbRsbLsbsbRsb
RsRsmbLsbRsLsbLsRsbLsRsbLsbRsbLsbRsbRsbRsbRsLsLsLsLsLsLiLsLsmmmmmbsbRo
RibLibLebLgLsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bLsRgRsmbRsRsmbRsRsmbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bRgbRsRsRsRsRgRsmmmmbRsbLsLsLsRsmmbRgRsRsRsRsRsRsRsRsRsRgRsRgRsmmmmmmm
mmmmbRcbRgRgRsLsLsmmbsbLgbLsLsRsmbLsLsmbLsbRgbRhbRgbReRsmbRiRgRgbRgbRg
bRsbRcbRsRsmbRcbRgbRgRsmbRiRgRsRsmmbRsbRsRsRsmmbRsbLebRsRsmbLgbLsbLsbL
gbLgbLsbLsbsbRgbRgbLgbRsbsbLgbLsLsLsLsmmmbLibRiRsmbRjRsRsmmbRsRsRsmmbR
sbLsRsRsRsmmbRgbLsLsLsmmbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bRobLsbLebRcbLcRsbRgbLobLebLcRsbRgRsmbRibRibLcbRcRsmbLhbLebRsbRcbRebRs
LsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bsbLgbLibRjbRhRsmbLibRsRibRgbRsLsRsRsmbLgbLjbRsbLsbLsbRiRsmbLsbRiRsmbR
gbRsbLsLgbLsLiLsbRibRibLcbLibLcbLsbsbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bLsLsmbLsLibLsbsbRsRsmbsbLsbRsLsLsRsRsmmbRsbRsbRsRsRsmmbsbsbRsLgbsbLgL
sLsLgmbLgLsLgLsLsmbLgLsLsmbRsbLebLhbLibRsbLgLgbRsLsRsbLsLsLsLgLgLsmmbL
sLgLgLsbLsLsLsmmbRgbRsbLhbLgbsbLsbsbRsbLiLsbRsLsbLsbLsbLsbLsLsmbLsRsbL
gLsLsLgLsmbLsLsLsLsLsLsLsLsRgmmmmmmmbRhbLsbRiRsRsmmbRgRsRsRsRsRsRsmmmm
mmbRsbRibRgbRgbLsbLiLgLgLgLgLgbLibLgbLsbLgbsbRsbLgbLsbLibRgbLibLibRsbL
sLsRsmbRiRsRgRiRsRsRimmmbRsRgRiRsRgRsmmbRhbRibRiRsRsRimmbRsRsmbRsbRgRs
RsRsRgRsRsRgRsmmmmmmbRgbRsbRsRsRgRsRsRsRsmmmmmbRsbRgRsRsRsRsmmmmbRgRsR
sRsmmmbLsRgRsRsRgmmbRsRsRsRgRgRsRgmmmbRsRsmbRgRgRsmbRsRsmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141342; End: 141842;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bRsbRsbRgbRsbRgbRsbLsbRsbRsbRsbRgbRsbRsbRsbLsbLsbLob

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 1; Drug: PCAP1 10 然 Apo 50 然
bRsbLsRsRsmbRebRibReRgbRibRibRsRibRgbRhbRibRgbRibRibRgbRiRsmbRibRgbRiR
sRsmmbReRsmbRibRibRibRibRhRsmbRibRibLsbRsRsRsRimmbRibRsbRibRiRsRimbRib
RibRibRgbRibRgbReRgbRgbRibRibRibRibRgbRibRibRgbRibRibRgbRibRibRibRiRsm
bRsRsRimbRibRibRgbRebReRsmbRibRibRibRgbRebRibRsRgbRgbRgbRgbRsLsbRgbRsb
RgbRsbRhRhRsmbRibRgbRgbRgbRiRsmbRgbRiRsmbRhbRgbRgbRgbRgbRsbRsbRsbRiRsm
bRibReLsLsmbRsRibRgbRgbRibRibRibRibRgRgRsRsmmbRgbRibLsbRgbRgbRgbRiRgbR
eRsRsmmbRsbRgbRgbRgbRgbRsbRgRsmbRgbRibRiRsmbRsRiRsRsmmbRibLsLsRsmbRgRs
mbRgbRsbRsbRsbRibRibRgbRgbRgbRgRgbRgbRsbRsbRsbRgbRgbRsbRsbRgbRsbRgbRhR
smbRsRsRsmmbRsbRgbRgbLsbRsbRgbRgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 2; Drug: PCAP1 10 然 Apo 50 然
bLsLebLebLsbLsbLibLibLsbLebLobsbLebLebLebLgLsLibLeLsbLebRsbLsRsbRcbLgL
ebLhbLebLeLsbLgbLsLebLiLsLsmbLiLebsbLeLsbLeLsLsLeLsmbLebLibsbsbLsbLsbs
bsbsbsbsbsbsbLsbsbsbsbsbsbsbsbRsbsbsbsbRsbRsbRsbLsbLsbsbLsbRsLsbsbLsbs
bsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 3; Drug: PCAP1 10 然 Apo 50 然
bLcLsLsLsmmmbsbLgbLgbLiLsLsLsLgLsLsLgLsLsLsLsLsLsLsmmmmmmmmmbLibLgLsLs
LiLsLsLsmmmbLgLgbsbLsLsLgLsLsLsLsmmmmbLgbLsLsLsLsLgLsLsLgLsLsLsmmmmmmb
LgLgLsLsLsmmbRjbLhLgLibLeLgbLiLsLsLsLsLsLsmmmmmbLgLsLsLsmmbLiLsLiRsRsm
bLsLibLebLgLsbRsbLiLsLgLsbLhLsLgbLibLiLsLsLsLsLgmmmbLgbLiLsLgLsbLiLsLs
LsLgLgLgLgLsLsLsLsLgmmmmmbLsLsLsLsLsmmmmbLibLiLsLiLsLgbLgLgLsLgLgbLsbL
gLsLsLgLsLsmmbLgLhbLibLeLgLsbLsLsLsLsLsLsmmmmmbLiLsbLsLgLsLibLibLiLsLs
LgLimbLgLsLsLsLsLsLsLsLgmmmmmmbLgLsLsLsLsmmmbLiLsLgbLgLgLsLgLibLiLsRsL
sbLiLgLhbLiLgLgbLsLsLsmmbLibLsLsLiLsLsmmbLgLsLsLsLsLsLgLsmmmmbLiLgbsbR
sbLgLsbLgLgLsLgRsLsbLebLebLgLsLsLsLsLgLsLsLsLsLsLsLsLsLgmmmmmmmmmmbLgb
LsLgLsbLiLgLgLgbLsLsLsLsLsLsmmmmmbLgLgRsbLgLgLsLgLgRsbLgbLibLsLibLibLi
LsLsLsLsLsLgLsLsLsLimmmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 4; Drug: PCAP1 10 然 Apo 50 然
bLsbRgRsmbRsRsRsmmbRsRsRsRsmmmbRsbRgRsmbLsRsbsbRsRsRsRsmmmbRsbsbRsRsRs
mmbRsRsRsmmbLsbRsRsmbRgRsmbRgbRgbLsbLsRsbRsRsmbRsRsmbRgbRsRsLsmbRgbRsR
smbRsbLsbsbsbsbsbsbsbRsLsRsbRsbRsRsmbsbRsbRsLsLsRsmbLsbRsRsmbLsRsbRsbR
gRsmbRsRsmbsbRsbRsbRgbRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 5; Drug: PCAP1 10 然 Apo 50 然
bLsbRgbRgbRsbRsbsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRgbRsbRsbRsbR
gbRgbRsbRsbsbRsbRgRsmbLsRsbRsbRsLsbRgRsmbRsbRsbRgbRgbRsbRsbRsbRsbRsbRg
bRgbRgbRgbRsbRgRsRsmmbRibRsbRsbRsLsbRsbRgbRsbRsbLsbRsbRsbRsbRsbRsbRsbR
sbRsbLsbRsbRsbRsbRsbRsbRsbRsRsmbRgbRsbLsbRsbRsbRsbLsbRsbRsbLsbRsbRsbRs
bLsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsb
RsbRsRsmbRsbRsbRsbLsbsbRsLsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsRsmb
RsbRsbLsbLsbRsbRsbRsbRsLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 6; Drug: PCAP1 10 然 Apo 50 然
bRgbRebReRsmbRibRgbReRsmbReRsmbRhbRgRhRsmbRebRebReRgRsmbRibReReRsmbsbR
eRsmbReRsRsmmbRgRiRsLsmbRiRibReRsmbRsRiRsmbRsbRgbReRsmbRebRiRgbRiRsmbR
sbReRsRsmmbRgReRsmbRiRsmbRsbRgRsRsmmbRiRsmbRibReRgRgbRiRsmbRebRcRibReb
sbRgbRgLsbsbRhbRebRebRgbRhbReLsbRebRiRgbRgbReRsRsRgRgLsmmbRibRebReRsLs
mbReRhRsmbRiRgRgRgRsmbRgbRibRgRsRsmmbLsRsbRsbRsbsbRsbRgRsRsRsRsmmmmbRe
bRhRsmbRsbsbRsRgRsmbReRsmbRibRibRgbReRsmbReRsmbRsbRhbRebRhbRebRiRgbReR
sRsRsRsRsRgRsRsRsmmmmmmmmbRsRsmbRiRibRgRsmbRiRsmbRgbRiRsmbRgRsRgReRsmm
bRibRsRsLsRsRsmmbRiRgRsRsLsmmbRgRgRgRgRsRsmmbRibRgbRgRsmbRsbRibLsbRibR
ebRsbRsRgbRiRsRsRsRsRsRsRgRsmmmmmmmbLsRsbRgRsmbRibRibRsbRsbRsbRibRsbRs
bRibRgRsLsmbRsRgRsRsmmbRebRebRgRsRsRsRsRsmmmmmbLsRsbRibRgRsmbRebRgRsRi
RsmmbsbRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 7; Drug: PCAP1 3 然 Apo 50 然
bLebRsbsbLsbLsbRsbRsbRsbRsbRsbRgbRsbReRsmbRsbRsbRsbRsbRsbLsbRsbRgbRsbs
bRsRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 8; Drug: PCAP1 3 然 Apo 50 然
bLsLsLgmbLsLsLsmmbLsLsLsLsRsmmmbsbLsLsLsLgLsLsLsLsLsmmmmmmbLsbLsLsLsmm
bLsbRsbLsLsRsRsmmbLsbRsLsRsRsLsmbRsbRsbLsRsbsbLsbLsbRsbsbsbLsbRsbLsbsb
LsbLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 9; Drug: PCAP1 3 然 Apo 50 然
bRiRsRsRsRgmmmbRsRsRsmmbRsbRsRsRsRgRsRsRsmmmmmbRsbReRsmbLcbLsRsLsRsbLg
LsLsLsLsmmmbLgLsLsmbLsbLgRsLsbLcbsbLsbLsbLsbLsbsbLgLsLsLsLsLsLsmmmmmbR
sLsLsLsLsLsmmmmbLcbRiRgbRgRsRsmmbRgRsmbLsbRsRsRsRsRsRsRsRsRsRsRgmmmmmm
mmmbRsRsRsmmbRsRsRsmmbLsRsRgRsRsRsRsmmmmbRgbLcRsbReb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 10; Drug: PCAP1 3 然 Apo 50 然
bLsbLsLsLsmmbLsbsbsbsbsbRsRsRsRsmmmbRgRsmbRsRsRsmmbLibLsRsLsbLsbRsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 11; Drug: PCAP1 3 然 Apo 50 然
bLgLsLsmbLsLsmbLgLgbLsLgbLsLsmbLsLsLsmmbLsLgLsbLsLsmbLsLsLsLsmmmbLsLsL
smmbLsLsLsmmbLsbLsbLsLsmbRsLsLsLsLsmmmbLsLsmbLgLgLsLsLsmmbsbsbLsbRsRsL
sLsLsLsLsmmmmmbLsLsLsLsmmmbLgLsLsLsmmbLsRsLsbLsbRsLsbLgLsLsmbRsRsLsLsm
mbRsLsLsmbLsbLsLsLsLsLsmmmmbRsLgbLsRsLsbLsbLgLsbLsLsLhLsmbLsbLiLsbLibL
sbLsLsmbLsLsLsmmbRsLsLsLsmmbLsbsbsbLsLsmbLibRsbLgbLsbLsbLsLgLsbLgLsbLs
LsmbLsLsmbRsLsbLsLsmbLsLsLsmmbLgLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 12; Drug: PCAP1 3 然 Apo 50 然
bLibRcRsmbLsRsbLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbsbLiRsbRgbLgbRcbRib
RsbRsbRsRsRgRsRsRsRsRsRsRsmmmmmmmmbRsRsmbRsRsRsRsRsRsRgRsRgRsRsRsRsRsR
smmmmmmmmmmmmbRgRsmbRiRsRgRsmmbLsbsbRiRsRgmbLsRsRgRsRsRsRsRsRgRsmmmmmm
bRsRsmbRsRsRgRsRgRsRsRsmmmmmbRgRebLjbLjbLsRsbRsLsLsmbLsLsmbsbLgbLgLsLs
LsLsLsLsmmmmmbLsbReRsmbLiLsLsLsLsLsLsLsmmmmmmbsbsbsbLgLsLsLsLsLsLsmmmm
mbLgbRcbRsRgRgRsRsmmbLiLsLsLsLsLsmmmmbLiLsLsmbReRgRsmbRgRsRsmmbLcbLibL
sbLgbLgbRebRsRsRsmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 13; Drug: PCAP1 1 然 Apo 50 然
bLgbLgbLhbLsbLsLsmbLgLsbRsbLibLsbLibLcRsbRgbLiLsbLsbLgbLgLibLsLibLebRs
RsmbRiRsmbRgbRgbLiLsbLgbLsbRibRgbLgLsbLgbLobLibLgbRib

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 14; Drug: PCAP1 1 然 Apo 50 然
bsbsbLsbRsbRcbLcbsbsbLsbRsLsbRsbLsLsmbLsbRjbsbLjbsbLsbRsbsbsbLsbLsRsLs
bsbLsbRjbsbRjbLsbRsRsmbRsbRgbRsRsmbRsbRibRgbRgRsmbRcRsmbRcRsmbRcbLsLjb
RcbLsbLeLsLsmbLsLsmbRjbRgRsRsRsmmmbRsRsRsmmbRsLsbLsLsLsLsLsLsLsLsLsmmm
mmmmmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 15; Drug: PCAP1 1 然 Apo 50 然
bLibLsbLcbRjbRiRgRsmbsbRcbLcbLeRsbLgLsLsLsmmbLcRsbLibRsbRsRsmbRsRsRsmm
bsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 16; Drug: PCAP1 1 然 Apo 50 然
bRjRsmbRoRsmbRgbsbRsRsmbRibRgbRgbRibRsbRgRsmbRgbRibRibRsbRsbLibLgbLjbL
gbLgbLsLsmbLsbLgbLsLsmbLsbLgbLsLsmbsbLsbLgbLgbLsLsmbLsbRsRsmbLsbsbsbLg
bLsLsRsLsmbLsLsLsmmbLgLsbLgbLgbLsLsmbLgbLgLsbsbLgbLgbLgLsLsmbLsLsmbLsb
LgbLgbLgbLsLsmbLsLsmbLsLsmbLsbLsbLsbLgbsbRsRsLsLsLsmmmbLsbLibLgLsbRebR
ibRjbRiRsmbRibRgbRsRhLsbRsRibRsbRiRsmbRiRsmbRgRsmbRgbRgbRsbRsbRgRsmbRg
RsmbRgbLjbLsbRcbRibRgbLgbLsRsbLsRsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 17; Drug: PCAP1 1 然 Apo 50 然
bLgbsbRcRsRsmmbsbRibLibLcbRsRsRsLsmmbLcLsLsLsLsLsmmmmmbLgRsRsLsLsLgLsm
mbLsRsLsbRsbLsbLsbLsbLgLgLhbLsLsLsLsLsLsLsLsmmmmmmmbRgLsLsLsLsLsLsLsmm
mmmmbLhLsLgLsbLsLsmbsbsbsbsbsbLgLsbLgLsLsLsmmbLiRsbLgLsLsmbLsLsLsmmbLs
RsLsbLsLgLiLgbLsLsLsLgmmbLhbLebLgLsLsmbsbLhbLgbRsLsLsLsLsmmmbRsRsmbRsR
smbsbRsRsmbRsRsRsRsRsRsRsRsRsRsRsRgRsRsRsmmmmmmmmmmmmmbLjbLebLgbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 18; Drug: PCAP1 1 然 Apo 50 然
bLsbRsLsLsLsmmbLsLsLsmmbLsLsRsLsmbRsbLsRsbsbLsbLsbLsLsmbLsLsmbLsLsmbLs
bLsLsmbLgbLeLsbLebLebLsbLsbLsbLsbLsbLsbLsbsbsbLsbRsRsmbLsbLsbsbRsbLsbL
sRsbRsRsmbsbRsLsbsbLsbsbLsbLsbLsLsLsmmbRsLsLsmbLsbLsLsLsLsmmmbLebLebLs
LsLsmmbLsLsmbsbLsLsLsRsmmbRgbLsbsbRsbsbRsRsmbsbLsLsLsmmbLsLsmbLiLsbRsb
sbsbLsbRsRsmbsbRsLgbLebLcbLcbLcRsbLsbRsRsLsmbRgRsmbRsRsmbRsbRgbLsbRgbL
gbLeLsbLhbLebLsRsbLsbRsbsbsbsbLsLsLsLsmmmbLsLsLgLsmbLiLsLgbLsLsLsmmbLs
LgbLsbRsbLsbLsRsbLgbLhbRsbRsbLgLsbLibLeRsbLsLsmbLebLibLsLsmbLgbLgbLgLs
RsbLgbLsbLsbRsbsbLsLsmbLsbLgbRsbLgbLsLsmbRsLsbRsLsbLgbsbLcbLibLebLhbLi
bLgLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
bRsRsRgRsmmbRgbRsbLsRsbRsbRsLsLsLsmmbLsbRsbRsbRjbRiRsRsRsmmmbRgbRgbRgb
RcbsbsbRgRgbRsRsmbLsbsbRsLsbRsRsRsmmbLgRsLsLsmbRebRgbLcbLcbLcbLsbLgbRo
RsmbRcbRsRsmbsbRobRibRiRsmbRsRsRsmmbLsLsmbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bRgRsmbsbRgbRsRsmbLebLeLsbLsLhbLsLsmbLgbLebLeLsLsmbRgRsmbLebRcbLibLjbL
sLcLgbLhbLgbLibLebRcRsmbLeLsbLebLcLibLgbLcbLobLcbLgbRsbRjRsmbLsbLsRsbR
sbRsLsbRsLsbLsLsmbLsbRcbLgbLgbLgbsbsbsbLgbLsbRsbLgbsbLsbRebRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRgRsmbLsbLgbLsbLsbsbsbLsbLsLsmbLibLiLsb
LsbRjbRsRsRsRsmmmbRsbLjbLhbLsRsbLsLsmbLiLsbLgLibLgLsbLebRiRsmbRibRgRsm
bLjbLibLgRsbRsbLgRsbLebLibLibLgRsbLsbLhbLebLibLcbRsRsLsmbRcRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bLgbLgbRsbLsbLsbLebRibRgbRibRgbRibLjbRebLiRsbLsLgbLsbLgbRjRgRsLsmbRsbL
sbsbsbLsbsbsbRsRsmbRsLsbLsRsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
bRgRsRsmmbLcbLsLsLsLsmmmbLsbLjbLgbLebLgbLsbRsbLgLsbsbLsLsmbLsLsmbRsbRs
bLsLsLsmmbLsbLebLebLsbsbLiRsLsRsRsLsmbLebLibsbLibLeLsLsmbLsbLsRsbRgbRs
bLgbLjbRsRsRsRsRsRsmmmmmbRsbLcbLeLsRsbLebLsbLsbLgbLiLsLsRsLsRsLsmbLgbL
ibLsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmm
mmmbLebLebLibLcbLeRsbLgbRsbLsbRsbRsRsmbRsRsmbLsRsbsbsbLsbLsbLsLsmbRsbL
sbRsRsRsRsRsLsmmmmbLsbRsbLsbsbLsbsbRsLsbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
bLsbLsLsmbLsbLsLsmbLsbLgbLsLibLgbRsbLsLsmbLsbLsbLgbLsLgbLsbLgbLsbLsLsL
sLsmmmbLibLsbLgbLsbLsbLsbLsbLgbLgbRsbLsbLgbLsbRsbRobLjbRebLobRsLsRsbRj
bLsbsbRsbRsLsLsRsmbRjbRsbRsRsmbLsLsmbLsbLsbLsbLsbLsRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 25; Drug: PCAP1 10 然 Apo 50 然
bRibRsbRgbRsbRibRsbRsbRiRsmbRgbRsbRgbRgLsbLsRgbLsbRsRsmbRsbRsRgbRsbRsb
RsbRgbRgbRsbRgbRibRsbRsbRgbRsbRsbRgbRsbRsbRsRsmbRsbRgRsmbRsbRsbLsbRgbR
sbRsbRsbRsbRsbLsbRsbRsbRgbLsRsbRsbRsbLsbRsbRgRgRgbRsbRsbLsbRsbLsbRsbRs
bRsbRsbRsbRsbRsbRsbRsbRsbLsbRsbRsbRsbRsbLsbRsbLsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 26; Drug: PCAP1 10 然 Apo 50 然
bLgbLsbLsbLsLsLsLsmmmbLgbLiLsbLsbLsbLgbLsLsmbLsbLgLsbLhLsbLgbLsLsmbLgb
LgbLibLsbLsbLsbLsbLsbLsLsLsmmbLgbLgbLsLsmbLiLgbLsLgbLsbLibLgbsbLsbLgbL
sbLgbLsbLsLsLsLsmmmbLsLibRsLsRsLgLsbLgbLgLsbLgLsbLibLebLsbLsLsmbLgbLsb
LgLsbRsbLsLsmbLiLsbLgLsbLgbLsLsmbLsLsmbRsbLsbLsbLsLeLgbLhbLgbLgbLsbLsb
LsLsmbLgbLgbLgbLibLsbRsLgbLsLiLgbLgbLsbRsbLsbLsLsmbLsbLgbRsLsbLsLebLib
LgbLsbRsbLsbLsbLebLibLsLsmbRsbLibLsLsmbLgLebLgbLsbLsbLgbLsbLebLsbLsbLs
bLsbLgbLgbLgbRsbLsbLgbLsbLsbLgbLsbLsLsmbLsbLibLsbLibLsLsmbLsbLeLsLgbLg
bLibsbLibLsbLgbLsbLgbLsbLibLgLsbLgbsbLgbLibLgbLsbLibLgbLgbLgbLgbLgLsbL
gLsbLgbLsbLgbLgLgbLgLsbLsbLgbLgbLgbLgbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 27; Drug: PCAP1 10 然 Apo 50 然
b

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 28; Drug: PCAP1 10 然 Apo 50 然
bLsRsbLgbLibLsLsLsmmbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLgLsbLsbLsLsmbLs
LsmbRebLsbLibLsLcbLgbLgLsLsLsLsmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgm
mmmmmmmmmmmmmmbRibRsbRsRsRsmmbRsbRsRsRgRsRsRsRsRsRsRsRsmmmmmmmmmbRsRsm
bLsbRsRsRsRsRsRsRsRsmmmmmmmbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 29; Drug: PCAP1 10 然 Apo 50 然
bLibLsbLeLsbLsbLsRsLsbRsbsbsbsbLsRsRsRsmmbLgLsLsLsLsmmmbRhRgbRsRsRsRsR
sRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbRibRibsbLcbLgLsLsLsLsLsLsLsLsLsLsLsLs
LsLsLsLgmmmmmmmmmmmmmmbLibLiLgbLebLgbLhLebLhbRsbLibLiLsbLsLgLgLsLsLsLg
LiLemmbLgbLsbLsbLibLhbLhbLgbLsbLsbLgLsLsLsmmbLgLsLsLsLsLsLsmmmmmbLsLsL
sLsLsLsmmmmmbLsRsbLgLsLsLsmmbLgLsLgLsLsmbLsRsLsLsLsLsLsLsLsLsLsLsLsLsL
sLsLsLsmmmmmmmmmmmmmmmbLsbLsLsRsmbLsLsLsLsLsLsLsmmmmmmbLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 30; Drug: PCAP1 10 然 Apo 50 然
bRsbRsbLsRsbLsLsmbsbsbsbsbRsbLsbLsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 31; Drug: PCAP1 3 然 Apo 50 然
bsbLsbsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 32; Drug: PCAP1 3 然 Apo 50 然
bRsbLsbsbsbsbLsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 33; Drug: PCAP1 3 然 Apo 50 然
bRebLgbLcbLsbLibLibLsbLgbLsLsLsmmbLsLsmbLibLhbRsbLgbLsbRebRgbsbLgbRgbR
gbReLsbLgbRgbLsbLebLgbRsRsmbLjbLgbLgbsbLsbLsbLsbRsbLgbRsbLibRebRgbRsbR
gbRsbRsbRsbsbLsbLsbLgbLiLsLsmbRsLsbLsLsmbLsLsLsmmbLsLsLsLsmmmbLsbLsLsm
bLgbLgbLsbRsbLgLsbLgbLsLsmbLgbLgLsbLgbLsbLgLsbLgLsbLsLsLsmmbLgbLsbLgbR
sbLsbLsbLsLsLsmmbLgbLsbLsbLgbLsLsmbLibRsbLsbLsbLebRgbLsbLibLibLgbLib

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 34; Drug: PCAP1 3 然 Apo 50 然
bRsbLjbLsLsLsmmbLgbRsRsLsmbLsLsLsLsLsLsLsmmmmmmbLgLsbRgbRjbLjbLsLsmbLi
bRsLsbRsbLsLsLsLsLsmmmmbRsbRgbLibRjbRsRhbLsbLibRsbLgLsbLgbLsLgLsLsLsmm
bLgbLgbRsLsbRsbLgbLcRsLsbLgbRgbsbsbRsbsbRibRsRsmbRsRsRsRsLsmmmbLjbRibL
sbLsLcb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 35; Drug: PCAP1 3 然 Apo 50 然
bLsbsbLsLsmbLsLsLsLsmmmbLsLsmbLsLsmbLsbLsbLsbLsbLsbLsbRsLgbLgbRibLiLsb
RcbLibLsbRsbRsLsbLsLsLsmmbLgRsbLsLsmbsbRsbsbLsLsmbRsRsmbsbRsbLsbLsbLgb
RsbLgbRgbLgbRsbLiLsbLsbLsbRsbLsbLsbLgbRsbLsLsmbRsbsbLsbLsbLsbRsbLsbLsb
LgbLsbRsbRsbLsbRsRsmbRsRsmbLsbRsbLsbRsbLgbLsbRsbLsbLsLsmbLsbLgbLsbRsbL
sbLsLgbLsbLsbLsbRsbLsbRsbLsbsbLsbLsbRsLsbLgbsbLsbLgbLsbLsbLsbLgbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 36; Drug: PCAP1 3 然 Apo 50 然
bLibLsbRsLsbLsLsLsmmbLibLhLsbRgRsLsmbLgLgLsLsLsmmbLsLsmbLsLsmbRsbLsLsL
smmbLiLsLsLsmmbRsLsLgLsLsLsmmbLgLsLsRsmbsbLebRibRibRsRsRsRsRsRsRsRsRsR
smmmmmmmmmbRsbLjbLiLsLgLsbRsbLsbLsbLgLsLsLgLsLsLsLsLsLsmmmmmmbLsLsmbLs
bLsbRsbLgbsbLgLsLsmbRsbLgRsbRsbRsbLgbLsbLsbLiLsLsLsLsLsmmmmbLsLsLgmbLs
LgLsbLsLsLsLsLsmmmmbLgLsbLiLgbLebLebLgbLsbLsLsmbRsbLibLgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 37; Drug: PCAP1 1 然 Apo 50 然
bLgbLgbLsbLgbRsbRsbLobLsbLsbLsbRsRsmbLeLsLsmbLsLsmbLsLsmbsbsbsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 38; Drug: PCAP1 1 然 Apo 50 然
bRsbRgbRsRsRsRsRsmmmmbRsRsRsRsmmmbLsbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmm
mmbRsRsRsmmbsbRsbRsRsRsRsRsRsRsRsmmmmmmmbLsRgRsRsRgmmbLhbRgRsmbRsRsmbR
sRsRsRsRgmmmbRsRsmbRsRsmbRgRgRsmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsmmmbR
gRsRsRsRsmmmmbRgbRsRsRsRsRsmmmmbRsRsRsmmbRsRgRsRsRsRgRsRsRsRsRsRsRsRsR
gRsRsRsmmmmmmmmmmmmmmbRsRsRsRsmmmbLsLsmbRsRsRsRsRsRsmmmmmbLcLsmbLcbLgb
LibLobRgRsmbRibReRsmbRsbReRibRhbRhbRhbRhbRsbRibRibRiRsmbRgbRibLsbRcbRs
bLsRsbRcbReRsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 39; Drug: PCAP1 1 然 Apo 50 然
bLsLsmbRgbRsbRsbRebLsbLoLsmbLcbLgbRgbRgbRibRibRgbRibLeLebRsRsmbRsbRibR
sbLgRsbLgbRibLsbsbRsbRgbRsRsmbRsbRsRsRsmmbsbLsbLebLcbRobRgbRiRsmbLgbLs
bRsRsRsmmbRsbRcbRsbRsbLgbLibRgbLgbRcbLgbLobLgbRcbRcb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 40; Drug: PCAP1 1 然 Apo 50 然
bRsLsLsLsmmbLsLsLsLsmmmbLgbLsbLsLsLsmmbLsLsmbLsLibLgbLsLsLsLsmmmbLsLsm
bLgbLsLsLsLsLsmmmmbLsLsmbLgLgLsbLjLgbLgLsbRsbLsLsmbLgbLsbLgbLsLgbRsLsb
LgbLsLsLsmmbLgbLsLsLgLsmbLsLsLsLsLsLsmmmmmbLsLibLgbLgLsbLebLgLsbLebLeb
LgbLhLsbLgbLsLsmbLgLgbLhbRsbLibLsLsmbLsLsmbLsLsmbLsbLsbRsbLibLgLsbLgLs
bLgbLsLsLgmbLsLsmbLsLsLsmmbRsRsmbLsbLsLsLsLgLsmmbLsLsmbRsbsbLgbLibRsbL
gbLsbLibLsLsLsmmbLsLsLsmmbLsbLgbLgbLgbLsLsmbLsbLsLgbLgbLgbLgbLsLgbRsLs
LsLsLgmmbLgbLgLgbLsbLsbLsLsmbLgLsbLsbLsLsLsmmbLsLsmbLgbLgLsLsmbLgbLgLs
bRsbLsbLsbLsbLebLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 41; Drug: PCAP1 1 然 Apo 50 然
bRsbLsbLsbLsbLsbLsbRsbLsbLsbLsbRsbLsbRsbLsbLsbLsbLsbRsbLsbRsbLsbLsbLgb
LgbsbLsbLsbRsbsbsbLsbLsbLsbRsbLsbsbLgbRsbRsbsbLsbRsbRsbRsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 42; Drug: PCAP1 1 然 Apo 50 然
bRsLsbLsLsmbLsbRsLsLsLsLgLsLsLsLsLsLsmmmmmmmbsbLsLsLsmmbRsbLsbLsbLsRsL
sLsLsLsmmmbLsbRsLsbsbRsLsbLsLsRsmbLsbRsRsmbRsLsbsbRsbLsbLgbLsbsbLsbsbR
sbLsbsbLsbLsLsmbsbLsbLsbRsbRsbRsRsRsmmbRsbRsbLsbRsbRsbsbRsbsbRsRsmbsbR
sbRsLsbRsbRsbRsRsmbsbRsLsbsbLsbLsbLsbLsLsmbRsbRsbRsLsbRsbRsLsbRsRsRsLs
mmbRsRsRsmmbLsLsLgmbLebRsLsLgLgbRjbLhbReRsmbRiLsbLiLsbsbRsLsRcbRgbLsbs
bLsLsLsmmbLsLsLimbsbsbLsbLsLsLsLsLsLsRsLsmmmmmbLsLsmb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
bLsbRgbRsbRsRsmbLsbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
bRsRsRsmmbLsRsRsRsRsRsRsRgRsRsmmmmmmmbRgRsRgRsmmbRsRsRsRgmmbLsbRibRgRs
RsmmbLgbRibRhbRibRgRsRsRsLsmmmbLsbRsbLsLsmbRiRsmbsbRsLsbsbsbLgbRsRsLsL
sLsLsLsLsLsLsLsmmmmmmmmmbRibRgRsRsRsRsRgmmmmbRibLsLgbRiRsmbRiRgbRgRsRs
RsRimmmbRibRgbLsLsmbRsbRsRsRsmmbRsRsRsRsRsmmmmbRsbLsbRsbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bRsRsmbsbsbsbsbsbsbRgb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
bLhLsLsmbRibLebRcbRsRsmbRibLibLhbLsbLiLsbRsRsmbRsbLibLgLsbLgbLsbLgLsbs
bLsbLgbsbLgLsbLiRsRsmbRjbRiRsmbRgbRebLebRsbRsbLsRsbLsLsmbLsb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bRibLgbRsbRsbRsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRgbRsbRgbRsRsRsRsRsRsmmmmmb
RsbRcRsRsmmbRgbRsRgRgRsRsRgRimmbRsRsmbRsbRsbLsbRgbRsbRsbRsbRsbRsRsmbRs
bRsbRsbRsRsLsmbRsbLsbRsbRsRsRsRsmmmbRsbRiRsRgmbLsbRgbRsRsmbRsbLsbRsbRs
bLsRgbRsbRsRsmbRebRsRsmbLobLsbLebRsbLgbRsbRsbRgRsmbRsbRgRsmbRsRsmbRgbR
gbRgRgbLsbRsRgbLsbRgbLsRsbLcLibLibLibRgbLgbRsbLebLebLebLobLibLhbsbLiRs
bLcbLgLcbLiLsbLibLobRebRgRsmbLiLeLsbLibLgbLiLsbRibLgbRhRsmbRibRgRsRsmm
bRgbRsbRgbRsbRgbRgbRgbLibLsLobLibRsbLibRiRsmbRsRsmbLibLsbLibRgbLibRsbR
sb

>ZF Recording 2016-05-17; tW: 300s; Start: 141844; End: 142344;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bRgbRsbLgbLsb

